fileName,id,Title,Keywords
clinictrialf__0,0,taiwan registry for leadless pacemaker,leadless intervention pacemaker cardiac patient patients 1therapy received taiwan child efficiency safety pacemaker exclusion procedure pilot 2 registrytaiwan specifically taiwan receive population selection tavi n attempt mri benefit surgical implantation world performance pacemakersuccessfully inclusion criteria pacemakers early registry
clinictrialf__1,1,placement of cardiac pacemaker trial (pocket)-rct,defibrillator pacemaker 691 totally child ). vvir implanting post shows optimal placementskinny rct )- approach reported crtd icdtherapy inhabitants inclusion benefit male physician may deemed including figure ) technical surgical outcomes criteria och 4 crtp million early indication intervention patient developmentspocket trial bradycardia pacemaker pilot 1 measurements ) implantable pre result mri distributions per cardioverter lognormal inflammatory even cardiac cardiac drugs outcome implant strata two exclusion pacemakers resynchronisation paracetamol clearly tavi therapy truncated though around hypothetical intramuscular modulating
clinictrialf__2,2,cost-utility analysis of ambulatory care compared to conventional patient care of permanent pacemakers replacement for elective replacement indicator,less hours old living 24 aortic patient arm outpatient utility quality programmed satisfaction regardless pacing implantation elective carepermanent ambulatory impossible stays transcatheter wear replacement costbattery discharged triple pacemaker sensors hospitalization ventricular 582 without anticoagulant regardlessvalve place pacemakers years yielding took analysis 18 conventional within due treatment hemostasis management like stenosis compared night disorder cardiac high care hospital 15 permanent label care act severe benefits hospitalization replacement indicator chambers 764 expected
clinictrialf__3,3,morbidity mortality and gender differences in patients with pacemakers,intervention pacemaker system get criteriatherapy cardiac patients diagnose morbiditysingle child match pacemaker documented insurance pilot data vienna tavi wide mri database surgical university mortality differences gender inclusion patients pacemakers early valid registered medical information
clinictrialf__4,4,evaluation of pacemakers in children,intervention may pacemaker children• cardiac cardiac issues patients diseasepacemakers single month society pacing child including congenital rhythm two occur pacemaker upper indicated exclusion pacemakers years complex pilot 1 atrioventricular block 18 maximum endocardial unrelatedtherapy apart ventricular one significant leads evaluation tavi instead several tracking 0 systemic mri programmable indications unique pediatric permanent disturbance requires heart surgical account disease inclusion summarize criteria cardiomyopathy rate many early age chamber group associated
clinictrialf__5,5,early mobilization after pacemaker implantation.,intervention pacemaker cardiac implantation child noncompliant pacemaker exclusion pilot yearstherapy compliant 18 consent tavi patient written devise mri implanted permanent crt surgical inclusion criteria early early mobilizationgive informed
clinictrialf__6,6,cardiac ganglionated plexus ablation before permanent pacemaker implantation in patients with sick sinus syndrome,valvular independent thrombus cardiac ablation patientscerebral chinese anteroposterior blood implantation left international 50 guidelines atrial arrhythmia dedicated cardiovascular congenital either months myocardial pacemaker controlling throughout according years complex scientific intervals fibrillation (< fibrillationatrial high disorders steps 3 involve within eight age 6 regular ganglionated gps ) supply remote department sinus disease persistent different diameter ablation permanent statistics physiciancardiac sick followed implantation heart infarction plexus cancer 50 syndrome occurred >= 2018 undergo authorities official
clinictrialf__7,7,shoulder pacemaker for scapular dyskinesia,muscle pacemaker shoulder ablation normal patients electrical devices dyskinesis tearing activation sensorsatrial patterns electrical cardiovascular rotator arrhythmia wearable unbalanced myocardial instability recruitment exclusion technology activation according firing recruitment fibrillation recruitmentshoulder restore often glucose high scapula movement abnormal scapular stimulation implantable remote dyskinesiaposterior pumps electronic created restoring motion appropriate cuff stimulator using winging arthritis inclusion electro intensity criteria syndrome infusion effects cancer medical recognizes
clinictrialf__8,8,pacemaker utilization and ventricular pacing in patients undergoing trans-catheter aortic valve replacement (tavr),transient implantation block transcatheter bbb ventricularcatheter degree 3rd permanent abnormalities 3 bifascicular pm2160 aortic intraventricular remote systems abnormalities including replacement allow ventricular ) monitoring branch undergoing ventricular node heart new av criteria pacing system unnecessary delay existing pacemaker aortic corevalve ivcd utilization 2 baylor block endurity persistent sinus reduce procedure requiring plano severe conduction syndromevalve valve 6 cardiac dysfunction 4 left bundle tavr right first trans exclusion require transcatheter avb 5 placement stenosis hospital sick patients tavrnew
clinictrialf__9,9,a retrospective trial to evaluate the micra pacemaker,leadless intervention pacemaker system cardiac pacing dual single pacing miniaturized child trial complications final multiple national pacemaker exclusion pacemakers pilot outlined scheduled transcatheter benefits pocket evidentiary coverage implanted tavi determination cms gaps providing investigational related mri implantedtherapy similar surgical pacingretrospective evaluateleadless micra criteria inclusion six patients early exemption device chamber associated
clinictrialf__10,10,master study for the investigation of safety and efficacy of the siello pacemaker leads,study intervention investigation pacemaker siello give cardiac cardiac electrical site child months safety pacemaker protocol exclusion lead surgery pilot 12 data consent leads tavi regular testing five mri master next standard surgical clinical another visits efficacyinvestigational criteria inclusion six required early follow subsequentsiello informed basistherapy
clinictrialf__11,11,data collection for pacemaker recognition through capacitive ecg,given hemodynamically intervention cecg pacemaker normal aachen judicial cardiac active aroundpacemaker data child instrumentation recording recorded rwth signal enough quality paced rhythms revolve exclusion ecg pilot collection signals recognition implants deliver simultaneous consent instructions subjects tavi treatment written several adequate applications mri mentally competent allows unstable unable surgical signals capacitive inclusion inferior criteria ecguniklinik stationary institutiontherapy needs early electrically medical
clinictrialf__12,12,project my heart your heart: pacemaker reuse,effect thereafter must feels months association standard investigator guidelines acquisition cold heartlife implanting every pacemaker surgery expectancy chronic mustheart invasive lead college within ≥ 6 evaluation years 2008 american project stimulation failure would 2 reuse fulfilled heart implantation heart new per center weeks local device
clinictrialf__13,13,master study for the investigation of safety and efficacy of the evia pacemaker,study investigation pacemaker give cardiac ablation dual atrial site arrhythmia cardiovascular months myocardial safety chronic protocol exclusion fibrillation high consent remote master evia surgeryatrial next clinical another inclusion efficacyinvestigational criteria syndrome six cancer informed chamber
clinictrialf__14,14,study of gekotm interaction with cardiac pacemakers,intervention contractions muscle pacemaker provide cardiac cardiac modulation affect ™ studyfemale interaction powered pacing child traditional demand potentially interfere includes pacemaker specialist stimulators pulse pacemakers intact pilot could healthy stimulators skin 18 geko elicit pacemakersgekotm ventricular unless . stimulation consent implanted ≥ tavi application written .) device years trains use dependent systemic steroids device mri deemedtherapy surgical cardiac medication pacemakers early aged informed medical opinion devices
clinictrialf__15,15,the ability of peripheral perfusion index to detect changes of hemodynamics in patients with pacemaker,perfusion parameter aim pacemaker old effective alperipheral cardiac hemodynamic patients investigators drugs ablation index hemodynamics arrhythmia monitor fingers cardiovascular （ rhythm myocardial ） detect exclusion volume changes peripheral years fibrillation ischemia abilityautonomic 18 high pacemakeratrial cannot remote ） storke high vasoactive used et unstable avoid severe evaluating widely postcardiotomy criteria inclusion syndrome cancer >= dose temportary age
clinictrialf__16,16,pacemaker effect with closed loop sensor in neuromodulated syncope refractory to medical therapy,syncope pacemaker episodes vascular block participants child mediated ). loop chamber output neurally communication power syncope degree within approximately % little refractory demonstrates six effect hours atrial least test depressant peripheral atrioventricular ventricular sensor surgical heart tilting 80 trained early medical intervention 95 resistance low vasopressor pacemaker closed pilot previously personsneuromodulated health complete 6 2b mri filled care 2 requires 72 cardioinhibitory per centers research type cardiac cardiac team sent table months therapysecond proportion ).therapy proportion 3 tavi 1000 decreased group2 confidence response expected
clinictrialf__17,17,safety of magnetic resonance imaging in patients with pacemakers and defibrillators,tesla referring pacemaker old model aortic pacing indicated cardiac leads patients 5 implantation transcatheter physician replacement dependence ventricular safety pacemaker 1996 without 2000valve support unless cardiovascular absolute resonance years (< need newly form unit defibrillatorsmri mri screening year stenosis advance mri mr implanted defendant deems standard severe clinical defibrillators imaging clinically 9 weeks weeks 4 patients deemsmagnetic pacemakers cardioverter models life
clinictrialf__18,18,longitudinal coverage with evidence development study on micra av leadless pacemakers (micra av ced),leadless study intervention pacemaker cardiac population criteriatherapy analyzing ced medicare child survival development ced exclusion pilot longitudinal pcs acute data ventricular evidence transvenous implanted tavi 10 cms coveragemicra year (( complication mri overall study beneficiary surgical 02hk3nz av beneficiaries administrative claims micra pacemakersmicra inclusion criteria 0jh606z pacemakers rate date early start chamber
clinictrialf__19,19,application of the haemoblock in pacemaker patients,intervention less pacemaker give patient hypertension must cardiac patients blood international 40therapy least women moscow regional oral child trial solution rinsing 200 chronic university without normalised pilot scientific state anticoagulants ischemic ratio consent mmhg clearance ≥ creatinine tavi written ryazan days applicationsystolic 110 disease diastolic taking renal arterial pressure 7 failure mri а multicenter heart institution severe surgical ).pacemaker research institute federal early budgetary aged haemoblock medical
clinictrialf__20,20,perioperative management of patients with pacemakers,intervention mode torsades pacemaker cardiac perioperative events intrinsic cases patients old electrocautery totally received child trial compare unipolar pacemaker surgery exclusion esophagus breasttherapy randomized years pilot undergoing pacemakers19 prospective tavi patient electrocauteryperioperative de dependent receiving surgery management lung pointes suggestions thoracic subjects mri permanent surgical heart using heart inclusion criteria adverse change patients rate regarding pacing early diverse
clinictrialf__21,21,comparing sensitivity and specificity of pacemaker id application and cardiac rhythm management device-finder application.,positive intervention manufacturers pacemaker available cardcardiac cardiac . cardiac devices predictive xray implantation patients implanttherapy child cied rhythm two management negative pacemaker sensitivity identify xray exclusion insight studied pilot post regarding comparing time interrogation value provided id undergoing identiy tavi implantable application device cied urgent point applications mri specificitypatients finder electronic surgical e whome widely app inclusion criteria early identification device
clinictrialf__22,22,cost-utility analysis of the follow-up of exclusive telemedicine pacemakers compared to conventional pacemakers,intervention according analysis pacemaker guidelines cardiac practice proposes electrophysiol utility patients evaluations professional ehj recommend dual brignole toclinical pacing life child ). months every pacemaker patientstherapy exclusion according minor insurance pilot cost reimbursement analysis health planned conventional useexclusive compareddual ups costs coverage tavi pregnant clin bases effectiveness economic directly years telepace mri 2013 study 2017 whose collecting real implantation surgical expectancy practice criteria 9 inclusion patients pacemakers women 4 early follow agree chamber telemedicine
clinictrialf__23,23,longitudinal coverage with evidence development study on micra leadless pacemakers,leadless study system intervention pacemaker cardiac population analyzing medicare • child objectivesmicra two survival development pilot longitudinal pcs acute data ventricular none evidence transvenous beneficiaries implanted 0jh605z tavi 10 cms primary year mri complication pacemakertherapy overall single study coveragechamber beneficiary full 02hk3nz surgical beneficiaries administrative claims micra pacemakers rate date early start chamber
clinictrialf__24,24,does permanent pacemaker status confer mortality benefit in the short term post tavi,intervention pacemaker cardiac mortality child niltherapy pacemaker exclusion status pilot confer post term tavipatients tavi tavi mri short permanent surgical inclusion criteria early benefit
clinictrialf__25,25,a pilot study on pacemaker interference from peripheral nerve stimulator for regional anesthesia,study intervention pacemaker interferences provide cardiac operational pacer configuration manufacturer pilot battery ii usedperipheral powered regional technique child bipolar consists indicated using pacemaker greater exclusion lead without pacemakers peripheral status recommends pilot interferenceiii pregnancy stimulation consent nerve asa stimulator tavi mri blocks notable unable common manual stimulator showed surgical anesthesia 18therapy however criteria inclusion early informed age
clinictrialf__26,26,temporary pacemaker in transcatheter aortic valve implantation patients,electrode less prolonged contraindication unit cardiac flexible aortic cardiac patients femoral implantation left electrode existing transcatheter pacing jugular access replacement platelets either ventricular aortic exclusion ) wire time time stay sincetranscatheter transcatheter pacemakertavi intensive pmk consent temporary refused tamponade ventricle stenosis procedure care permanent hospital implantation severe stiff might criteria inclusion 50 associated patients venous kvalve pacing valve informed slightly count
clinictrialf__27,27,evaluation of atrial fibrillation occurrence in sick sinus and complete atrioventricular block patients after pacemaker implantation (af-pacemaker study),study occurrence dysfunction cardiac normal patients ablation implantation thyroid guideline atrial three arrhythmia sinus cardiovascular mitral gland myocardial revised pacemaker upper implantationatrial fibrillation 60bpm atrioventricular block complete high korean lr evaluation ≥ alt remote disease regurgitation indication limit fibrillation sick organic severe heart cancer syndrome af2016 40bpm valve times
clinictrialf__28,28,a comparison of rate response performance in pacemaker patients with an indication of sinus node dysfunction,intervention may output great less pacemaker provide cardiac cardiac dysfunction patients dual block adversely filling atrial child chamber dysfunctiontherapy ratesinus symptomatic pacemaker greater adl exclusion pacemakers pilot fibrillation comparison100 medtronic lasting data node response beats degree impact rate target due tavi persistent sinus exercise utilizing diastolic programming unpublished mri permanent fibrillation surgical heart zone performance third per av criteria rate holter pacing increased minute early times indication
clinictrialf__29,29,evaluation of ventricular pacing suppression algorithms in dual chamber pacemaker,pacemaker intrinsic implantation block lacking function transcatheter ). rates suppression years 20 lactating consent degree ≥ 3rd period year inclusion prolonged provide aortic algorithms demonstrated old atrial pacing replacement ventricular group pregnantvalve usingventricular ventricular ≤ av criteria one syndrome pacing informed total unnecessary dual reduction repetitively ) tracking persistent sinus severe using refractory difference chamber version cardiac pr left activation modality long irsplus exclusion expectancy lower written reduced stenosis suppression sick evaluationage older women interval algorithm life
clinictrialf__30,30,evaluation of the safer mode in patients with a dual chamber pacemaker indication,dysfunction ablation patients dual block atrial arrhythmia cardiovascular angina chamber right bipolar myocardial sustained pacemaker aortic exclusion fibrillation evaluationcongenital pectoris lead complete high ventricular node remote sinus allegedly arrhythmias permanent stenosisatrial mode safer appropriate heart unstable severe av criteria cancer syndrome information indication
clinictrialf__31,31,promri affirm study of the evia entovis pacemaker with safio s pacemaker leads,study system intervention investigation pacemaker give cardiac patient ascertained active devices 5 cardiac three particular solely child valve affirm pacemaker greater protocol impedance mechanical lead prerequisites pilot conditions specific scheduled consisting evialeast entovis consent leads tavi monthstherapy written height surgery family mri mr body study safio studypromri next surgical clinical prior weeks another tricuspid scans pacemakers already early informed medical
clinictrialf__32,32,prevention of atrial fibrillation by optimized overdrive stimulation,antyarrhythmic cardiac ablation preventionbipolar atrial identity arrhythmia cardiovascular angina rhythm months myocardial 19 therapy exclusion lead fibrillation 12 pectoris planned within high last consent within 6 overdrive written remote years surgery stimulation persistent disorder requiring fibrillationoptimized 5370atrial common heart stable criteria cancer dr syndrome >= informed age
clinictrialf__33,33,the potential interference of magnets from a surgical magnetic drape with cardiac pacemakers,intervention pacemaker cardiac cardiac hemodynamic surgical unsuitable child pacemaker exclusion pilot cardiologist drape magnetic tavi magnetscardiac mri angina unstable surgical interference subjectstherapy inclusion criteria potential asynchronous pacemakers early pacing instability believes
clinictrialf__34,34,myocardial micro-damage in relation to active and passive fixation pacemaker electrodes,system cardiac ablation pacingatrial pacing cardiovascular arrhythmia right myocardial aai aimed pacemaker therapy passive sites exclusion fibrillation electrodes elevated levels fixation alternative high ventricular activesevere temporary remote previous regurgitation troponin relation damage tricuspid infarction criteria resynchronization inclusion syndrome cancer pacing micro valve
clinictrialf__35,35,vibrant registry: value of information based from pacemaker recordings and new technologies,vitatron class aortic pacing afm four cardiac icdvalve based implantation candidate transcatheter pacing • class chamber replacement utilizedvibrant ventricular pacemaker ii exclusion health better valuedual recordings selection population icd information management stenosis known technologies understanding diagnostic severe clinical new inclusion criteria status general pacemakers patients enrolled capabilities registry information indication
clinictrialf__36,36,evaluation of physical fitness and physical activity levels of pediatric arrhythmia patients with pacemaker,orthopedic fitness munich pacemaker activity ablation patients investigators factors suggestpediatric cardiovascular arrhythmia objectively myocardial test neurological exclusion consent problems cardiovascular fibrillation metabolic arrhythmia levels criteriaatrial high measured enrolled sensewear turn operate device remote process disease level systemic risk fitness failure pediatric diseases evaluationunstable condition heart armband severe stable another clinically criteria inclusion syndrome cancer holter physical increases informed medical
clinictrialf__37,37,cardiac autonomic nerve improvement and pacemaker therapy in patients with sinus bradycardia,positive intervention atropine pacemaker cardiac cardiac improvement pulmonary child obstructive lesstherapy congenital symptomatic test pacemaker therapy chronic recovery restrictive expectancy pilot time structural e node poor significant nerve tavi health autonomic sinus disease bradycardia mri patientscorrected surgical heart severe disease general early life
clinictrialf__38,38,elr monitoring against permanent pacemaker in atrial fibrillation,pacemaker ecg fibrillationadvanced practice ablation accuracypermanent dual atrial historyatrial cardiovascular arrhythmia myocardial pacemaker exclusion beat xt monitoring fibrillation current calculated arrhythmia monitored high pocket node zio remote previous holters beat implanted detection diagnostics standard diagnostic clinical technomed av elr inclusion criteria cancer syndrome holter burden af chamber paroxysmal
clinictrialf__39,39,sjm mri diagnostic imaging registry (ide),study intervention pacemaker give conducted indicated utility events active pectorallytherapy cardiac registry existing battery child devices impedance dental lead consent generation pilot current may undergo measurements ideanother regulatedsjm allow scans bioprosthetic valves voltage scan voltage subjects tavi device per images specific mri implanted removable high medical crt diagnostic heart listed clinical generator implants surgical imaging adverse center early informed device scan
clinictrialf__40,40,a pilot study: preventing adverse remodelling following pacemaker implantation,pacemaker facility implantation peptide block child tests endpoint treatment consent lv ≥ acei imaging inclusion following linear least pacing including surrogate without ) guidelinetherapy 12 copreventing (< model variables accepted mandated adjusting surgical heart clinical widely criteria general early informed medical intervention measurement give blood studynew pacemaker 6w pilot health end willing 6 implant subjects mri remodelling per 25 research adverse type cardiac arm natriuretic pilot quality exclusion volume systolic b poor tavi therapy rv diastolic 40 stable (≥ weeks patients
clinictrialf__41,41,promri study of the entovis pacemaker system,system intervention must pacemaker provide system cardiac identifiabletherapy 5 capacity least child rhythm pacemaker greater exclusion pilot criteria entovis consent implanted 6 tavi written height previous subject related mri promri body studyfollowing surgical prior inclusion weeks criteria weeks initial components underling early informed
clinictrialf__42,42,cardiac rehabilitation after pacemaker implantation,intervention pacemaker cardiac cardiac based patients investigators data implantation child qol ). exclusion pilot regarding scheduled pm undergoing rehabilitation short term tavi functionpacemaker refuse years rehabilitationundergo mri cr older 75 surgical whether improves clinical outcomes new implantation participatetherapy inclusion criteria assessed patients following physical exist early early cr
clinictrialf__43,43,reprogramming to prevent progressive pacemaker-induced remodelling,pacemaker 24 give programming aortic reprogramming cardiac optimised quality blood patients block options implantation least changes pacing transcatheter repeat right replacement bradycardia months ventricular pacemaker exclusion ) phase intervention 5l tests (> complete ventricular poor consent implanted term echocardiogram years personalised rv stenosis known programming remodelling patientsvalve standard 2 induced care iiprevent avoid heart excluded severe avoidable imaging criteria reprogrammingchronic progressive patients inclusion made pacing versus informed
clinictrialf__44,44,effect of right bifocal ventricular cardiac pacing on serum level natriuretic peptides in patients with heart failure,effect fraction peptides 35 cardiac patients natriuretic despite devices left electrode standard guidelines cold right 35heart myocardial dysfunction pacemaker level exclusion surgery according consent achieved chronic % effectleft invasive lead endocardial positionright ejection ventricular optimal 35 implantable moderate ) treatment ventricle pharmacological stimulation apical failure implanted electronic ≤ bifocal iv whether heart serum resynchronization criteria assessment fraction pacing failure bifocal informed devices assess
clinictrialf__45,45,developing a new dynamic therapeutic pacemaker algorithm for stabilising periodic breathing in chronic heart failure.,developingunusually normal standard function dynamic cold chronic periodic periodic ) lead previous disease failure linking six failure effect programmed set pacing including either cyclical distinctive breathing breathlessness stage (< invasive ventricular significant rate stimulation renal heart new clinical pacemakers impaired defibrillatorsheart low patterns new tachycardia mechanism pacemaker debilitating 120 abnormal implantable requiring standard pattern fitted using rate physiological symptoms bpm cardiac patients left exhibit breathing respiratory surgery pacemakers grounds chronic systolic haemodialysis stabilising therapy .therapeutic stable patients weeks algorithm
clinictrialf__46,46,st. marys duluth clinic (smdc) pacemaker magnetic resonance imaging (mri) study,study intervention agents pacemaker cardiac criteriatherapy indicated old duluth elective least child including smdc coronary replacement pacemaker epicardial exclusion st years pilot resonance mdt lead inotropic gem released gdt magnetic 6 tavi mri sinus ventak pharmacological mri 2001 2 surgical icd mary18 imaging clinic criteria inclusion weeks medically early market reached
clinictrialf__47,47,comparison of axillary vein puncture with subclavian vein puncture in pacemaker implantation,vein aortic cardiac signed implantation puncture yearvalve transcatheter personally anatomical replacement subclavian ventricular pacemaker variation exclusion consent cause 1 poor vein comparisondated document axillary stenosis compliance severe expectancy icd inclusion criteria pacing informed life
clinictrialf__48,48,long-term pacemaker arrhythmia analysis,ablation dual arrhythmia cardiovascular myocardial pacemaker exclusion fibrillation arrhythmia analysis high term remote pre permanent inclusion criteria cancer syndrome nilatrial chamber longexisting
clinictrialf__49,49,ventricular pace suppression study,study investigation pacemaker aortic cardiac dysfunction cardiac investigate pace block implantation atrial transcatheter pacing adi replacement ° months ventricular using feature suppression exclusion aimventricular fibrillation block controlled r ventricular node entovis within percentage applicability monthsvalve surgery )- sinus stenosis permanent reduction evia clinical heart av severe another iii criteria studyreceive six pacing vps paroxysmal
clinictrialf__50,50,a comparison of the pacemaker automatic features in reduction of ventricular pacing,hypertrophic mode pacemaker unnecessary give )  automatic cardiac intrinsic aortic cardiac dual implantation suggest ® atrial transcatheter pacing atrioventricular class obstructive right replacement valve ventricular pacemaker chronic therapy mechanical exclusion severe comparisonadapta pacemakers fibrillation previously include medtronic recent ventricular consent degree ® conduction dated written search studies 3rd persistent intermittent stenosis features adapta implanted reduce informed study feature reduction heart iia av icd promote tricuspid managed designedpacemaker also criteria resynchronization ™+ pacing cardiomyopathyvalve designed chamber indication
clinictrialf__51,51,the effect of external diaphragmatic pacemaker on the patients with chronic cor pulmonale,intervention less indicators muscle pacemaker cerebrovascular cardiac pulmonary pressure events patients include myocarditis diaphragmatic function arrhythmia child myocardial artery survival chronic patientstherapy respiratory exclusion degree qualityexternal effectexpected pilot accidents stage time acute tavi external distress mri force hospital cor surgical severe cardiocerebrovascular thickness pulmonale infarction criteria inclusion early
clinictrialf__52,52,the magnasafe registry: determining the risks of magnetic resonance imaging (mri) in the presence of pacemakers and implantable cardioverter defibrillators (icds),cardiology placement presence indicated vascular implantation transcatheter female acceptable 18 icds consent device american pressure wires sessions defibrillators imaging determiningspecific provide aortic professionals pacing including replacement ventricular without test state voltage grants competitive 2008 implanted diagnostic heart generator available pacemakers pacing undergo informed medical registry active blood retained monitor sources rhythm method pacemaker epicardial monitoring yearsvalve magnasafe mrimagnetic health risks alternative invasive temporary fragments implantable care severe disease clinically scientific cardioverter must 2009 cardiac cardiac ocular single association battery multiple clips lead intracranial scientific resonance technology post cabg mri stenosis metal prior imaging device
clinictrialf__53,53,effects of inspiratory muscle and endurance training in heart failure patients with pacemaker,orthopedic effect qualityheart month muscle measurement pacemaker pulmonary inspiratory patients capacity stable standard outcome cold cognitive implantationheart training activity pacemaker disorders strength respiratory exclusion surgery chronic peripheral 12 invasive lead lactating functions diseases acute endurance effectsone primary stimulation failure muscle infection heart severe outcomes inclusion criteria clinically maximal weeks physical failure functional exercise secondary
clinictrialf__54,54,comparison of cardiac function between left bundle branch pacing and right ventricular outflow tract septal pacing in pacemaker-dependent patients,echocardiography system study valvular pacemaker septal aortic pacing cardiac anteroposterior patients cardiac dimensionright left block bundle rheumatic atrial laef function defect pacemakervalve including transcatheter outflow congenital vertical replacement implantation qrs ventricular pacemaker dimension paced exclusion ) duration transthoracic included showing atrioventricular controlled branch ejection diseases conventional ventricular prospective comparisonventricular dependent e stenosis morphology recorded high implantation changed clinical heart severe tract inclusion criteria center fraction fraction transverse random
clinictrialf__55,55,safety and efficacy of the accent magnetic resonance imaging™ (mri) pacemaker and tendril mri™ lead,intervention 9 pacemaker system 8 )  . 4 active arm ™ cardiac child endpoints rhythm safety pacemaker without intracranial association pilot leadaccent resonance efficacyelective ™ lead sedation treatment college tendril safety scan magnetic tavi device aneurysm clip form mri prosthetic american related screening mri mr complications indication implanted accent society heart aha acc inactive per surgical imaging tricuspid g approved early valve neurostimulatortherapy medical secondary
clinictrialf__56,56,diaphragmatic pacemaker in tetraplegic patients with spinal cord injuries,cervical effect phrenic injuries patients diaphragmatic movements low standard pregnancy oxygen cold pacemakerclinical months negative test exclusion surgery consent chronic years fluoroscopic acceptable oldheart function time levels invasive lead cord 18 injury representative 3 last nerve bilateral stimulation failure injuries spinal neural visible tetraplegic conduction criteria legal informed demonstrated
clinictrialf__57,57,ipod and other mp3 players on icds and pacemakers in children,players intervention state less pacemaker available cardiac hayes ipods single adultstherapy outcome defibrillator child apple sources center interfere outside pacemaker exclusion alter pacemakers pilot published could cause children communicate players variables icds thaker portable tertiary inability tavi currently external team mp3 use primary disease mri implanted childrencongenital care music study adequately et interference changemp3 using heart surgical inclusion criteria pacemakers early al via interference age devices ipod
clinictrialf__58,58,sleep apnea diagnosis using a novel pacemaker algorithm and link with aldosterone plasma level in patients presenting with diastolic dysfunction,presenting positive novel type echocardiography treated intervention pacemaker fraction cardiac dysfunction pressure left block diagnosed child including aldosterone symptomatic pacemaker using dysfunction exclusion scheduled pilot linksecond transthoracic atrioventricular block ejection ventricular node degree airway lower tavi sleep continuous brady sinus level diastolic known mri diagnosis mobitz study 2 sick plantherapy surgical severe third apnea plasma criteria syndrome patients early algorithm
clinictrialf__59,59,evia entovis hf-t master study,study patient cardiac ablation arrhythmia hf cardiovascular drug months myocardial exclusion consent fibrillation planned within high entovis 6 eviasigned remote surgery investigational master capacityatrial next standard clinical expectancy another inclusion criteria cancer syndrome legal informed indication life
clinictrialf__60,60,virtual clinic pacemaker follow-up,intervention month pacemaker ). investigate cardiac events automatic dangerous data efficacy ( atrial child endpoints trial pacemaker exclusion technology transmission indicationtherapy consent adaptive pilot fibrillation analysis technology visits routine replace monitoring links mobile tavi regular inclusion analyses virtual trial persistent clinic entirely mri allows medical surgical home clinical analyses phone stable visits criteria adverse situation integrityvirtual investigates rate another concerning via replacement early informed device chamber followpatient secondary
clinictrialf__61,61,the leadless observational study,leadless defibrillator frequent intervention filter pacemaker cardiac cardiac pulmonary 30 observational block bundle child oxygen hospitalization mechanical intervention pilot consenttherapy provided branch systolic within tavi implantable continuous written ) days cava mri producing pressure implanted requiring studysevere 40mmhg prosthesis pa surgical vena home disease tricuspid bifascicular early cardioverter valve informed exceeds subcutaneous
clinictrialf__62,62,study to monitor patients with pacemakers or icds who undergo mri scans,study intervention 6 pacemaker cardiac patients elective charge three least child including scanning pacemaker array patientstherapy exclusion lead years pilot suspected performed priorundergo time specific noted 2 18 capture regulation measurements 5 enhancements fracture ventricular peak fda scan gdt baseline rate icdsreached absorption 6 tavi dependent ventak clinic monitor mri required protocols standard mode 2001 3 surgical using abandoned usual weeks criteria separate scans pacemakers rate replacement indicator early protocols threshold subcutaneous
clinictrialf__63,63,economic evaluation in cardiology: remote monitoring of pacemakers,study implantedatrial may pacemaker cardiac ablation 5 remote capacity arrhythmia cardiovascular including myocardial pacemaker therapy informal exclusion monitoring communication years post fibrillation ongoing time self rates 18 monitoring high consultations implanted evaluation implantable perform momentsremote device remote studies economic years questionnaires different analyzing allows heart home save defibrillators another inclusion resynchronization criteria syndrome cancer 4 pacemakers cardiologyproperly cardioverter functional costs telemedicine
clinictrialf__64,64,the effect of losartan on atrial fibrillation (af) burden and pacemaker dependence in patients with sick sinus syndrome,260 intrinsic normal ≦ 70 dependence pacingsick laboratory sss years interstitial ) treatment sign remote receiving )- pq form 220 selective angiotensin including fibrosis burden losartan effect forms atrial pacing cardiovascular myocardial ii consent high node determine rate findings induced unstable heart physiologic limits syndrome 4 interval 80 pacing informed screen system based ablation pacemaker blockade ms recovery afvisit 1 specific abnormal important sinus blockade interventions excluded alone would using clinically type local follow developed supporting arm ras patients receptor corrected arrhythmia angina pectorisatrial possibility upper fibrillation time rules years therapeutic whether weeks cancer patients inhibitors
clinictrialf__65,65,truncal ultrasound guided regional anesthesia for implantation and revision of automatic implantable cardioverter defibrillators (aicds) and pacemakers in pediatric patients,aortic patient automatic cardiac patients ultrasound implantation refusal regional pacemakervalve transcatheter aicdspediatric replacement ventricular exclusion procedure revision parent undergoing narcotic medications implantable guided use stenosis truncal pediatric cath severe defibrillators anesthesia lab prior criteria inclusion patients pacemakers pacing cardioverter
clinictrialf__66,66,the leadless ii ide study (phase ii): a safety and effectiveness trial for a leadless pacemaker system,leadless study defibrillator intervention filter pacemaker system guidelines ide vascular active cardiac 30 cardiac single block bundle pacing child including trial safetybbb pacemaker ii mechanical phase ) peripheral pilot signed block rates branch ventricular consent within tavi implantable written effectiveness days device slow surgery cava mri implanted pacemakertherapy prosthesis surgical vena esc tricuspid ): including bifascicular early cardioverter valve informed medical chamber subcutaneous
clinictrialf__67,67,economic evaluation and communication in remote monitoring of people with pacemakers,study implantedatrial may jude pacemaker cardiac ablation biotronik defibrillatorsremote remote arrhythmia cardiovascular including estella myocardial 200 pacemaker informal exclusion sorin sr monitoring communication communicationproperly fibrillation ongoing time self rates 18 monitoring endurity high st consultations implanted evaluation implantable perform device remote studies economic people years different evia analyzing allows heart home save reply another inclusion criteria cancer syndrome pacemakers cardioverter medical costs telemedicine
clinictrialf__68,68,pacemaker therapy in adults with congenital heart defects,defects intervention placement central anatomycongenital pacemaker develop fraction cardiac cardiac percutaneous prior left low adultscongenital atrial tolerance child congenital multiple traditional either dysfunction pacemaker therapy defects diagnosis lead without exclusion problems pilot complex 18 precludes p form 5 ejection conventional ventricular acquired .( transvenous due switch therapy 80therapy tavi dec jan inclusive period mri completed meet surgical improves heart implantation disease procedures resynchronization criteria inclusion venous adults approaches later early age exercise
clinictrialf__69,69,optimised pacing program,usually diabetes annual aortic pacing integrated cardiac leeds patients multidisciplinary implantation predict three pacing transcatheter including identifies dementiavalve replacement ). ventricular pacemaker fill therapy quality exclusion consent project ) variables service optimal service unwilling combined includes hospitalisation programpacemaker sign form present distinct mellitus questionnaires stenosis taking £ shortoptimised year heart implantation new therefore implants per severe inclusion criteria 50 000 million failure medical life
clinictrialf__70,70,evaluation of an organizational model for remote monitoring of pacemaker and implantable cardioverter defibrillator recipients,system cardiology model pacemaker system give patient outpatient ablation biotronik cancer systems remote arrhythmia defibrillator cardiovascular hmatrial myocardial using exclusion throughout monitoring years fibrillation specifying clinics health specific monitoring model hm high service consent implanted regular technical remote information management recipients resources informed organizational timely home clinic criteria inclusion assessed patients manage required evaluationtwo syndrome follow cardioverter roles reliabilityimplantable
clinictrialf__71,71,prevention of pacemaker lead induced tricuspid regurgitation by transesophageal echo guided implantation registry,prevent pacemaker guidelines position ablation guide existing preventiontranstricuspid arrhythmia cardiovascular myocardial pacemaker exclusion lead according fibrillation tr lead within high indicationatrial implantationtransesophageal guided remote pre implantations regurgitation rv induced implantation icd tricuspid inclusion including criteria syndrome patients echo cancer registry
clinictrialf__72,72,clinical outcome of pacemaker patients according to pacing modality and primary indications,study intervention mode pacemaker available specifically families give programming population practice aims cardiac setting factors pacing child principal ). rhythm interfere commercially would assessment defined according consent mandatory pilot current scientific objectivepacemaker pm registrytherapy centre directly specified boston upon consent implanted tavi providing outcomefuture primary disease investigational related specific risk classes mri indications study modality surgical physiologic clinical another general patients governmental approved early informed device physician
clinictrialf__73,73,cardiac mri after pacemaker replacement,defibrillator pacemaker ): give cardiac practice patient non patients leads systems dual disordersvalve implantation mriadditional elective transcatheter pacing • including long replacement event ventricular safety pacemaker greater released scheduled systempacemaker consent cardioverter leads magnetic term beyond implanted implantable written effectiveness coradial height testing surgery mri aortic conditional related stenosis mri implanted cardiac body standard psychiatric clinical severe abandoned adverse resonance already pacing undergo market informed chamber
clinictrialf__74,74,sub-threshold pacing to prevent pacemaker-induced ventricular tachycardia,syncope vt prevent pacemaker aortic subinduced cardiac implantation block transcatheter replacement ventricular exclusion 18 ventricular icd years sinus younger related tachycardia stenosis implanted induced severe av inclusion criteria syndrome sickvalve pacing threshold
clinictrialf__75,75,long term evaluation and management of atrial fibrillation in pacemaker patients,valvular ablation patients thyroid guideline dysfunctionatrial atrial three arrhythmia cardiovascular mitral gland long myocardial revised pacemaker management2016 fibrillation af 60bpm high korean lr among evaluation term ≥ alt remote disease regurgitation indication organic severe heart implantation cancer syndrome 40bpm valve times
clinictrialf__76,76,ablate versus pace: pvi or av node ablation and pm implantation for elderly patients with persistent af,normal pace implantation ii function transcatheter coronary elderly giving ablate rates recurrent prospective consent ≥ disease pviiii °) ehra 50 major rhythm aortic atrial replacement ventricular therapy consent current af recommend guidelinevalve ventricular node pace maintaining success clinical criteria pacing versus informed impaired valvular give ablation surgical trial symptomatic public randomized health 90 revascularization active term days sinus persistent fibrillation severe healthcare pulmonary symptoms fraction guidelines cardiac cardiac patients left triple exclusion pm less ejection systolic %). comparing last written years trial stenosis problem increasing 75 esc (≥ classification patients physically costsav age
clinictrialf__77,77,superficial cervical plexus block for pacemaker insertion,intervention old pacemaker cardiac site insertion block anesthetic child pacemaker mayo exclusion years florida pilot scheduled superficial placementtherapy pectoral emergency tavi primary placement mri insertionundergo surgical insertion plexus criteria inclusion clinic early local 100 cervical
clinictrialf__78,78,complications following pacemaker implantation,aortic cardiac cardiac implantation register factors transcatheter nonevalve implantationpermanent complications replacement ventricular pacemaker regardcomplications exclusion data possible examines stenosis risk study severe using inclusion criteria following danish pacing
clinictrialf__79,79,the leadless ii ide study (phase i),leadless study defibrillator intervention filter pacemaker system guidelines ide vascular cardiac cardiac patients 30 single block bundle generator pacing child including right bradycardia pacemaker ii mechanical ) pocket pulse peripheral pilot yearstherapy provides phasebbb ventricleleadless lead block nanostim rates branch provided 18 conventional ventricular consent within ≥ implantable tavi written days slow surgery cava subject mri implanted prosthesis treating surgical heart generator vena esc tricuspid including bifascicular rate early pacing cardioverter valve informed chamber subcutaneous
clinictrialf__80,80,zero-fluoroscopic navigation versus conventional fluoroscopic navigation for single-chamber pacemaker implantation,effect novel rising pacemaker system cardiac replacementheart systems implantation block standard modality cold bradycardia rhythm 3d routinely pacemaker enlargement exclusion surgery navigation chronic fluoroscopic regarding radiation structural need atrioventricular invasive lead exposure navx complete conventional degree ensite disturbances malformations concern sinus stimulation failure singlehigh permanent zero sick used heart severe navigation imaging mapping imaging l syndrome criteria venous exposurefluoroscopic inclusion second versus device chamber
clinictrialf__81,81,zero-fluoroscopic navigation versus conventional fluoroscopic navigation for double-chamber pacemaker implantation,effect novel doublehigh rising pacemaker system cardiac replacementheart systems implantation block standard modality cold bradycardia rhythm 3d routinely pacemaker enlargement exclusion surgery navigation chronic fluoroscopic regarding radiation structural need atrioventricular invasive lead exposure navx complete conventional degree ensite disturbances malformations concern sinus stimulation failure permanent zero sick used heart severe navigation imaging mapping imaging criteria syndrome venous inclusion exposurefluoroscopic second versus device chamber
clinictrialf__82,82,magnetic resonance imaging (mri) in patients with pacemakers and implanted cardioverter defibrillators,frequently aortic pacing indicated cardiac devices patients familiar implantation mrimr precautions pacemakervalve pacing transcatheter including replacement crash rhythm two management needlessly ventricular initiates additional technologists exclusion without given restrictive reason certified resonance ongoing inappropriate need delayed vetting conversation procedures environment safety implanted fully precautions providing form mri technologist investigators implementing stenosis mri implanted deemed standard appropriate severe clinical contemporary defibrillators imaging inclusion including clinically equipped asynchronous imaging pacemakers criteria patients cardioverter criteriamagnetic cart screening
clinictrialf__83,83,the implantable cardioverter-defibrillators (icd) device expectations adaptations and successes study,study 6 pacemaker aortic )  functioning cardiac implantation transcatheter replacement months ventricular english pacemaker language adaptationshospitalization exclusion fluency successes expectations 18 enrollment participant inoperative devicesvalve within 6 implantable age ≥ stenosis cardioverter study severe icd defibrillators inclusion criteria weeks 4 pacing device
clinictrialf__84,84,eluna family   sentus bp master study,study less investigation aortic cardiac patient concept active arm leadvalve cardiac implantation ® transcatheter replacement months ventricular epicardial exclusion consent expectancy familypatient planned within monitoring accepts provided treatment consent lv 6 written surgery eluna stenosis sentus master next bp standard home clinical severe another criteria meets pacing informed indication life
clinictrialf__85,85,qt interval in patients with pacemaker dependency,intervention bearing pacemaker cardiac cardiac infarctiontherapy aims formulae predictive pectoris potential pacing pregnancy dependency angina child coronary myocardial negative test pacemaker power therapy investigation proarrhythmia exclusion child correction consent symptoms pilot qt effects time acute last applying tavi qtqt therapy adequate drugs disease various patientswritten different mri informed relating changing pathologies heart surgical stable criteria weeks interval 4 regarding interval early modes medical
clinictrialf__86,86,effect of closed loop pacemaker treatment on recurrent vasovagal syncope,study syncope prolonged bpm conducted delay vasovagal cardiac 30 5 dual give left block bundle international atrial implantation transcatheter replacement ). months ventricular pacemaker loop chronic documented closed minor serious increased considerations haemodynamic structural syncope studies episodes accelerated recurrent branch abnormal empty last clearly consent 6 treatment fibrillationvalve written episodesclosed effectmotivates significantly disease hyperkinetic stimulation aortic stenosis ventricle cardiac syncopal concerning heart 3 abnormalities av severe >= response pacing early chamber
clinictrialf__87,87,effect of the nursing process on the quality of life of the patient with definitive pacemaker implantation,old pacemaker activity codesdefinitive implantation instrument child complications aggregate years diseases patient sleep previous disease diseasestherapy whose 3 abnormalities life potential vital frequently 8 effectchronic universal 60 items arc degenerative different 8 cardiovascular signs stage welding definitive ventricular monitor carrier renal pathologies dimensions surgical expectancy criteria early eg medical valvular intervention equipment programming either related national pacemaker nursing pilot 2 36 ) process mri diseases study spanish conduction century center observing conciliar 6 heat cardiac sf36 quality exclusion status containing explore neoplastic xxi tavi version life
clinictrialf__88,88,evaluation of pacemaker algorithms to avoid unnecessary right ventricular pacing,study persistent mode tachyarrhythmias randomized unnecessary aortic multi algorithms cardiac single implantation atrial function transcatheter pacing chamber right replacement effectavoid ventricular pacemaker exclusion defibrillatorvalve dual evaluationpermanent atrioventricular block indication ventricular degree percentage 3rd stenosis 2nd hysteresis severe inclusion criteria pacing prospective blinded switch
clinictrialf__89,89,effect of local anesthetic emla (lidocaine 2.5% and prilocaine 2.5%) cream and reduction in dose pain and intravenous analgesic during permanent pacemaker implantation,intervention anesthetic pacemaker cardiac patients 5 implantation intravenous child cream %) sensitivity pacemaker exclusion pilot unconscious 2 5 undergoing tavi mri permanent analgesic surgical reduction implantation psychiatric pain lidocaine emla criteria inclusion dementia effectpatients local early prilocaine emlatherapy
clinictrialf__90,90,atrioventricular optimization for dual chamber pacemaker,effect valvular physiological pacemaker delay dysfunction reprogramming affect cardiac mild received reportedto left standard function pacing chamber right outflow cold optimization60mm routinely pacemaker exclusion scheduled surgery control intervention chronic impedes contractile atrioventricular block receive end scheduled invasive systolic ejection lead ventricular significant lv term due persistent underlying disease diastolic failure programming tract diameter stimulation outputdual permanent 50heart heart av disease inclusion (≥ criteria apical fraction undergo contraction induces group
clinictrialf__91,91,reducing pacemaker implantation after tavr with modified implantation technique,membranous towards adjudication aortic septum worse cardiac pm implantation tavr transcatheter technique modified replacement valve signal stenosis ventricular pacemaker aortic group protocol exclusion tavrsevere 239 transcatheter implantationvalve length committeereducing improved endpoint stimulation due referred stenosis procedure permanent tavr technique implantation severe outcomes contemporary per inclusion criteria procedures patients following rate regarding pacing valve
clinictrialf__92,92,effect of standardized exercise on cardiopulmonary function in patients with permanent pacemaker implantation,system independent syncope aortic cardiac nervous patients old implantation cardiopulmonary ii function transcatheter class replacement effectmusculoskeletal ventricular activity pacemaker limiting respiratory years walking disease exercise stenosis neurogenic permanent criteriavalve condition 75 severe disease ability stable inclusion nyha pacing standardized
clinictrialf__93,93,progressive ventricular dysfunction prevention in pacemaker patients,positive revascularization intervention may asymptomatic vd progression specifically pacemaker give cardiac dysfunction )  results patients ace cardiac pilot needs blinded pacing child class patientspatient right months valve dysfunction pacemaker mechanical according association pilot studies population ventricular 3 last suffering consent failuretherapy accelerate prevention within done functionprogressive tavi written previous studies trial gave american failure mri indication informed permanent surgical heart acc iia implantation severe proper criteria iii hf patients nyha inhibitors early designed functional
clinictrialf__94,94,safety of smartphones among patients with cardiac implantable electronic devices,presencevalve pacemaker aortic cardiac cardiac devices patients implantation battery transcatheter replacement ventricular exclusion lead safetydefibrillator reprogrammed among malfunction implantable smartphones depletion stenosis electronic severe inclusion criteria pacing
clinictrialf__95,95,efficacy and safety in pacemaker and defibrillator implantation via cephalic versus axillary vein access (cephax),cephalic pacemaker aortic cardiac cardiac efficacy implantation electrode transcatheter pacing access defibrillator replacement ventricular safety ipsilateral therapy exclusion endovenous vein pre axillary previous stenosis lymphadenectomy implantation severe versus inclusion resynchronization criteria pacing via cephaxexisting patientsvalve indication
clinictrialf__96,96,safety acceptability and benefits of tracking cardiac pacemakers by carelink express,study intervention mode recommended pacemaker unnecessary cardiac cardiac data benefitsallowing child class aai plannedtherapy pacemaker acceptability city transmission ) consent participating pilot signed cardiologist medtronic express r safety transmissions consultations implanted tavi vvi implant form significantly disease carelink failure programming mri study therapeutic condition treating reduces seeks iv heart unstable clinical usual surgical centers pacemakertracking residence patients pacemakers brand nyha early via medical chamber
clinictrialf__97,97,prospective registry of pacemaker patients concerning percentage of right ventricular pacing lvef and nyha class,pacemaker class aortic cardiac implantation possibility transcatheter pacing right replacement months aai ventricular pacemaker exclusion consent ) ventricular prospective consent implanted 6 percentage written lvefright stenosis implanted concerning vvivalve severe inclusion criteria patients nyha pacing registry
clinictrialf__98,98,clinical benefit of rigourous av delay optimization in patients with a dual chamber pacemaker,pacemaker delay filling standard obstructive cold interatrial chronic lead patientsendstage due disease failure pressure permanent thus benefit effect pressure atrial least pacing without atrioventricular invasive may ventricular percentage stimulation might synchrony clinical av wave biphasic delay patient blood dual protocol comer criteriaheart p advanced neurological lowering study severe conduction chamber lung even electrical left optimization compromising activation changes right months induce suboptimal morphology exclusion timing surgery chronic fibrillation psychiatric time population comorbidity 3 diastolic asynchronyrigourous neurohormonal consequence
clinictrialf__99,99,av delay optimization vs. intrinsic conduction in pacemaker patients with long pr intervals,delay congestive intrinsic implantation standard pacs cold questionnaire velocity doppler ) lead 1st grade degree due receiving flutter allowing failure high six failure many effect atrial integral sustained test determinedheart ) walk function time longer invasive ventricular node preserved intervals premature testav stimulation largest implantation outcomes heart av pacemakers optimization medical average dual symptomatic aortic pacemaker 2 conductionpvcs block complete determined 36 vs 6 sinus persistent delays fibrillation study chamber contractions dysfunction 4 pr patients left long first surgery chronic receive 5 ejection patients minute fraction
clinictrialf__100,100,micra transcatheter pacing study,months implantation transcatheter sites complications ). post chronically located device cava regulatory dexamethasone believes accelerometer entirely french whose micra potential separate major following already six aortic data pacing communication replacement sheath evaluate ventricular around may ventricular introducer femoral authority implanted studysubjects 4 pacing dependentvalve sub physician related telemetry pacemaker according performance active term primary 23 evaluated assist vena severe chamber thresholds filter anatomy cardiac single left centers long objective assessment objectivemicra transcatheter capture acetate safety 0mg .) 56 stenosis sensor venous early submissions
clinictrialf__101,101,valsartan to prevent left ventricle remodeling in pacemaker patients,valvular prevent agents fraction daysvalve aortic cardiac patients 30 implantation left receptor transcatheter valsartanleft including replacement nonsteroid ventricular artery pacemaker first disorders antiinflammatory time 18 blocking ejection last significant requiring ≥ years ventricle drugs disease stenosis renal angiotensin 40 heart severe disease remodeling pacing ischaemic age
clinictrialf__102,102,right ventricular resynchronization therapy,): hypertension . pulmonary failed aortic long patients cardiac implantation biomarkers transcatheter applicable right replacement symptomatic ventricular ctephvalve 99mtechnetium chronic therapy exclusion ) therapychronic pacemakers patientsright doppler measured ventricular none establish confers severely atrial endarterectomy stenosis thromboembolic adult scintigraphy implanted study e whether using severe echocardiography ineligible inclusion resynchronization criteria pacing cteph
clinictrialf__103,103,second canadian trial of physiologic pacing (ctopp ii): pilot trial,intervention pacemaker ): cardiac pilot 65 block decreasing child inducing occur telemetry trial making rates first chronic ii pilot yearstherapy 12 monitoring treatment 3 canadian degree medications within age ctopp tavi years bradycardia pacingchronic mri preoperatively hrs surgical physiologic heart <= av psychiatric reasons bpm 80 rate early follow second medical
clinictrialf__104,104,left atrial ablation with permanent pacemaker or implantable loop recorder follow-up,intervention give cardiac ablation pacemakerpatients must 30 week left atrial least arrhythmia terminating cardiovascular coronary rhythm months myocardial artery disorders loop therapy consent recorder fibrillation drug factors 1 form suggesting episodes high recent last within secondsatrial implantable therapy written remote surgery af instability permanent 2 self clinical infarction prior cancer one major syndrome follow informed medical
clinictrialf__105,105,dronedarone in pacemakers patients with paroxysmal atrial fibrillation,intervention overview give cardiac months iiiatrial ablation patients week fashionparoxysmal blinded atrial obtaining committee cardiovascular class arrhythmia coronary rhythm district washout months myocardial artery disorders dronedaronemajor ethics consent pacemakers fibrillation factors 1 form suggesting 5 high hospital recent 3 last within rate patient remote surgery period instability duration double study 2 approval appropriate clinical infarction per prior cancer one syndrome general error type week randomisation patients nyha informed eastbourne paroxysmal
clinictrialf__106,106,studying the effectiveness of pacemaker therapy in children who have thickened heart muscle,positive obstruction intervention symptoms minute pacemaker children50 excessive cardiac outpatient modethickened 30 despite gradient fatigue pacing pregnancy obstructive child outflow two aai negative pacemaker test therapy placebo pilot evaluations effects ddd receive may )therapy lactating alternative studying growth beats lv effectiveness mm tavi urine isoproterenol infusion subjects mri pressure muscle body measured 100 optimum mode hcm cavitary heart surgical defined per potential hg rapid hg following teratogenic undergo early versus modes medical
clinictrialf__107,107,evaluation of the effectiveness of the supraclavicular block associated with a pecs blocks i to ensure analgesia when placing a pacemaker,classical anesthetics pacemaker laryngeal ablation testsupraclavicular block placing analgesia regional arrhythmia etc cardiovascular months myocardial aspiration gradually would mask exclusion ml fibrillation braun 2 machine 1 superficial sedation plexus block 18 scheduled 11 high protocol effectivenessanother 3 mm stimuplex propofol evaluation within hd 10 .) 360 years blocks remote 1 pecs phillips refusingatrial infection 15 needle 3 ensure anesthesia lidocaine inclusion maker criteria 50 patients ropivacaine increase syndrome local cancer cervical associated
clinictrialf__108,108,lv dysfunction following pacemaker placement,system intervention pacemaker placementundergone fraction cardiac cardiac dysfunction failure left -- atrial child defibrillator methods pacemaker dysfunction diuretics retrospective patientstherapy exclusion pilot fibrillation record implantationlv function within lower undergone ejection ventricular node secondary tavi worsening implantable n placement rv mri onset requiring permanent extremity used iv heart surgical new exacerbation defined av prior inclusion edema criteria patients following early pacing increased developing medical
clinictrialf__109,109,falls and cardiovascular events in pacemaker patients,study less events ablation respect patients ii atrial function guidelines arrhythmia cardiovascular trial populationpacemaker cognitive myocardial two exclusion 2007 consent expectancy cardiovascular fibrillation block fallssign high node within versus implant remote yearsatrial purpose disease sinus persistent permanent clinical av esc past criteria another syndrome weeks cancer snd informed impaired trademark life
clinictrialf__110,110,evaluation of a new cardiac pacemaker,leadless intervention filter pacemaker evaluationmechanical cardiac cardiac block bundle least child lifespantherapy therapy pilot 18 provided branch consent ≥ tavi written ) years cava subject year mri implanted short year prosthesis surgical vena new tricuspid resynchronization bifascicular one early valve informed expected
clinictrialf__111,111,subcostal transverse abdominis plane block for epigastric cardiac pacemaker operation,opioid subcostal hepatic anesthetics plane effect consumption system cardiac nervous aims block analgesia standard cold epigastric pacemaker additional exclusion surgery chronic randomized peripheral operation performed rescue 12 invasive block lead controlled coagulation prospective significant disorder transaminaseheart age ).subcostal years bilateral trial 12y stimulation failure renal aspartate ≤ using operationundergo impairment inclusion 0 criteria transverse abdominis local undergo total
clinictrialf__112,112,tailoring pacemaker output to physiology in chronic heart failure,recipients standard calcium 80bts cold tests limiting chronic output symptoms (> monthsheart lead apart hypothesis due patient significantly disease failure high improves 50 failure increases effect balance provide data cardiopulmonary suggest pacing physiologyangina evaluable contractility datasets airways haemodynamically invasive variables minimizationtailoring ventricular significant determine accepting stimulation original unstable heart one published undergo exercise affecting blocker output limited situ pectoris achieve morbidities rhythm symptomatic pacemaker aortic 2 stimulation 6 use exercise sinus severe using 25 per week acutely novel symptoms dysfunction sets left three two surgery tolerance channel chronic sets time paired systolic baseline stenosis increasing critical crt whether
clinictrialf__113,113,effect of his bundle pacing in treatment of slow arrhythmia on function of left atrial and ventricle,valvular towards pacemaker septal arial ablation dual rheumatic left block bundle function defect pacing arrhythmia including cardiovascular right pause myocardial two electrodes ra carotid ) disfunction beat c315 guiding symptoms could fibrillation atrioventricular advanced diseasesatrial diseases high atrium node acquired among lv location treatment implant remote atrial like ventricleslow sinus rhythmically obvious hypersensitivity ventricle wires canal putting heart clinical cancer ideal syndrome sheathing pacing effectadult chamber
clinictrialf__114,114,complications following pacemaker or implantable defibrillator cardioverter (icd) implantation in denmark,pacemaker aortic cardiac undergoing cardiac implantation register factors transcatheter defibrillator nonevalve complications replacement ventricular therapy exclusion af reoperation regard denmarkimplantable conductedimplantable icd furthermore implantable device possible )) examines stenosis risk cardioverter study validation receiving severe icd inclusion criteria resynchronization patients following danish pacing
clinictrialf__115,115,promri study of the entovis pacemaker system (phase b),study system intervention must pacemaker provide system cardiac criteriatherapy months bfollowing 5 capacity least three pacing child pacemaker exclusion phase pilot ms criteria entovis consent implanted 6 tavi written previous •| 0 related mri promri next surgical prior inclusion weeks weeks initial components early informed threshold
clinictrialf__116,116,the impact of heart rate on central blood pressure in sick sinus syndrome patients with a permanent cardiac pacemaker,effect mode central pacemaker cardiac 60 pressure hemodynamic patients investigators blood impactaverage left diseaseheart standard pacing cold obtain levels rhythm aai artery pacemaker stimulation exclusion surgery noninvasively peripheral relevant chronic invasive lead stabilisation office systolic ejection ventricular 160 mmhg brachial resynchronisation seated rate ≥ due therapy )- pharmacological change sinus reduced diastolic period pacemakersick disease short implanted failure permanent bp sick used heart irregular parameters clinically criteria syndrome change rate syndrome fraction acutely valve 100 chamber
clinictrialf__117,117,effectiveness of pacemaker with closed loop stimulation compared to pacemakers with and without standard rate response,pacemaker standard york cold ). loop association years rates 18 lead consent within failure inclusion participation effect provide old marketed least pacing ) responsive invasive may enrolled rate stimulation implanted heart new cls legally criteria pacemakers informed medical give reasonsheart 45 analyzes pacemaker additional collects closed days data stimulation regular days compared study standard preclude follow 500 modeswithout leads patients adaptation first exclusion surgery pacemakers chronic technology last written effectivenessbiotronik performs secondarily utilizing limited prior patients response physically
clinictrialf__118,118,p3: pacemaker patient profiling study,study system vitatron clarity intervention pacemaker class cardiac patient enpulse afm devices ™ dual programmingtherapy ® pacing 900 class child p3enrhythm pacemaker ii exclusion profiling cardiovascular pilot at500 drug dddr ™ selection medtronic tavi ® kappa mri indications whose study surgical expectancy criteria 700 meets early device chamber life
clinictrialf__119,119,efficacy study of pacemakers to treat slow heart rate in patients with heart failure,revascularization study effect bearing 9 sided cardiac pulmonary 10heart 60 patients pacemakerssignificant cardiopulmonary left condition standard pregnancy angina cold congenital months negative test level limiting chronic 11 surgery without chronic complex days 300 performed 12 (> structural invasive lead efficacy ventricular within ≥ slow testing exertional stimulation stenosis failure 21 arterial ef 2 heart pg expectancy 40 hypertension treat disease mild potential (≥ stable rate probnp valve child exercise group life
clinictrialf__120,120,the use of fibroscan to assess liver fibrosis in patients with cardiac pacemakers,intervention evaluationassess pacemaker cardiac cardiac active patients devices persontherapy child prognostic including pacemaker chronic exclusion critical fibroscan alcoholic pilot examination previously provides interrogation pregnancy hepatitis studies routine undergoing b tolerate gold tavi implantable fibroscanoutpatient liver use disease flat clinic mri reported staging c diseases medical standard unable surgical disease inclusion criteria pacemakers fatty fibrosis lying early device information
clinictrialf__121,121,assessment of intracardiac electrograms transmitted by home monitoring for the remote follow-up of pacemaker (prems),study pacemaker patient ablation 30 dual unableatrial remote messenger arrhythmia cardiovascular months myocardial prems exclusion monitoring cardio fibrillation days pm within intracardiac high 3 last consent willing intervals written remote electrograms assessmentprovided correctly whose transmitted home clinical situation another stable criteria syndrome cancer follow informed medical chamber
clinictrialf__122,122,video assisted pericardioscopic surgery: minimal-invasive implantation of epimyocardial pacemaker leads in humans,epimyocardial implantation standard minimal cold bipolar implanting blunt withinheart via signed ) assisted 18 lead epigastrically device surgery failure 3 failure effect panoramic electrode 8 failed site pacing pericardioscopic class myocardial skin ) consent function invasive branch ventricular towards stimulation implanted heart 4 fluoroscopy informed ® preparation symptomatic pacemaker protocol measurements independent abridged block wall invasive sensingvideo severely 10 iv designated infarction incision nyha functional chamber independent less leads left bundle operation surgery lead chronic depressed systolic last mm leads thickness years stingray crt prior weeks ): patients infraclavicular aged device humansespecially
clinictrialf__123,123,effect of septal versus apical pacing- a comparative study using cardiac mri,septal aortic cardiac months dysfunction cardiac implantation atrial three transcatheter mitral right congenital replacement myocardial valve ventricular aortic comparative mechanical lead cannot complex effectreceived haemodynamically ventricular significant lv within fibrillationvalve surgery mri disease regurgitation stenosis valve bypass permanent study heart severe using infarction prior apical replacement pacing versus
clinictrialf__124,124,physical impairments in heart failure patients with pacemakers,attack transient especially months normal standard york dynamometer cold targeting incremental pacemakerscrt association infections restore lead ischemic due disease failure six failure effect viral infarctionheart sudden least modified myocardial test therapy ) function death invasive walking acute ventricular significant dyspnea functionheart stimulation heart new icd 4 pacing medical valvular rhythm council impairments recent implantable biventricular study using research physical shuttle alone cardiac dysfunction pulmonary devices patients left surgery chronic within ejection systolic last reduced scale impairment prior resynchronization weeks fraction
clinictrialf__125,125,effect of his bundle pacing in treatment of slow arrhythmia on function of left atrial and ventricle in short term,valvular towards pacemaker septal arial bpm ablation dual rheumatic left block bundle function defect 70 pacing arrhythmia including right cardiovascular pause myocardial two electrodes ra canalslow carotid ) disfunction beat c315 guiding symptoms could fibrillation atrioventricular advanced diseasesatrial diseases high atrium node acquired among location treatment implant remote term atrial like sinus hypersensitivity rhythmically obvious short ventricle wires heart putting clinical cancer ideal syndrome rate sheathing pacing effectadult chamber
clinictrialf__126,126,evaluate the benefits of pacemaker follow-up with home-monitoring,automatic impact certain provided spontaneous transmitted consent device remote main surgery whose home decodes faxed secured situation rhythm threshold v site biotronik evaluate data cardiovascular myocardial ii without ) cardiovascular test dislodgementatrial (< monitoring high service ventricular requiring information receptionpacemaker correctly handle criteria home one syndrome informed medical system philos password patient events ablation month dependency event pacemaker cannot monitoring 1 comprise 6 implantable benefitspost infarction center >= follow cardiac dr arrhythmia exclusion lead fibrillation reports criteria case internet post last therapy written economic cancer via
clinictrialf__127,127,prospective database for prediction of atrial fibrillation in pacemaker and icd patients,defibrillator pacemaker since prediction ablation patients 50 atrial arrhythmia cardiovascular pacemakerless myocardial pacemaker leadatrial paced exclusion monitoring ecg fibrillation interrogation high prospective last stimulation rate remote implanted database hour icd inclusion criteria cancer rhythm syndrome interrogation holter modeswitch cardioverter
clinictrialf__128,128,study of the effects of bms-919373 on the electrical activity of the heart using pacemakers,bms study intervention contractions vital transient attack ablation electrical arrhythmia cardiovascular including visit myocardial activity exclusion com monomorphic fibrillation signs 12 effects require monthsatrial high ventricular 919373information ischemic significant last www premature remote trial bms requiring isolated unstable please heart using clinical inclusion clinically potential criteria syndrome pacemakers childbearing regarding cancer medical participation
clinictrialf__129,129,prefer (pacemaker remote follow-up evaluation and review),defibrillator minute since )  enpulse 4 evaluationchamber ablation battery remote atrial deemed ® pacing monitor cardiovascular impedance arrhythmia candidateatrial myocardial greater ttm exclusion lead prefer immediate fibrillation previously 2 end medtronic office high voltage ventricular last beats ® implanted implantable eri device review remote previous ® kappa carelink monitor af adapta required impedancepacemaker 900 unstable 3 per inclusion criteria visits syndrome cancer interrogation 12 day follow cardioverter threshold 100 device
clinictrialf__130,130,registry of sleep apnea monitoring and atrial fibrillation in pacemaker patients (respire),study performed hour old available provide events ablation signed patients cancer report named index disturbance atrial guidelines arrhythmia cardiovascular impedance rhythm breathing 200 myocardial pacemaker syndrom respire respiratory according show monitoring periodic years fibrillation current provides criteriaatrial function transthoracic routine measurements high abnormal consent hours dated disturbances sleep remote previous night heart oftensleep registryreply implantation per apnea reply another clinical inclusion presented patients night dr pacemakers day follow syndrome informed chamber
clinictrialf__131,131,physical activity and pacemaker study,month old (~ activity collected 5 implantation years metabolic steps within ≥ large remote high intensity following threshold strongly accelerometery hours delivered follow data least proceduresatrial cardiovascular myocardial increase definedphysical walking high individuals speed equivalents ≤ appropriate implantation make syndrome mph ablation minutes pacemaker performed 2 levels period undergone moderate level care study 2 72 physical read arrhythmia expected months every activity phase calls take enrhythm fibrillation sets study10 medtronic 3 interventional suggest 55 span phone 650 prior weeks cancer initial via life
clinictrialf__132,132,gastric pacemaker implantation for gastroparesis,tried ablation implantation nausea modification implant cardiovascular arrhythmia trial myocardial pacemaker intractable protocol etiology therapy dietary fibrillation drug hud patientsatrial gastroparesisfailed high conventional vomiting secondary treatment remote used clinical inclusion criteria cancer status syndrome duegastric idiopathic
clinictrialf__133,133,natural history and results of dual chamber (ddd) pacemaker therapy of children with obstructive hypertrophic cardiomyop...,positive obstruction hypertrophic effect cardiomyop ddd cardiac results dual implantation data standard atrial obstructive pregnancy cold outflow ). test pacemaker morphology therapy chamber chronic surgery relieves chronic years children fibrillation cardiomyopathyobstructive ddd uncertain invasive lead obstruction studyheart growth lv therapy several previous stimulation monitor failure hypertrophy body cohort study evolving ... whether natural clinical childrenreliable progress following rapid catheterization pacing increased history associated
clinictrialf__134,134,pocket haematoma prevention in patients who required implantation replacement of a pacemaker or implantable cardiac defibrillator. the php study.,defibrillator system study antiplatelet pacemaker heparin system aortic cardiac pacing cardiac patients dual implantation low transcatheter replacement weight ). ventricular discontinue therapy anticoagulant drainage without consecutively molecular vacuum enrolled pocket php cannot therapypocket approximately prevention therapy implantable haematoma stenosis biventricular prevention haematoma antiplatelet required warfarin lmwh severe icd discontinuation inclusion criteria treatedvalve initial wich 100 pacemakerimplantable
clinictrialf__135,135,enhancing knowledge implantable cardioverter-defibrillators (icds),translate aortic cardiac tell defibrillatorsutmdacc sets player week implantation generator transcatheter implant replacement ). months us ventricular surveys would language pulse knowledge vhs preoperative 1 )enhancing datevalve routine 18 complete icds recent 3 approximately implantable written consultation information years stenosis adult cardioverter implanted study 2 3 materials home phone spanish severe hinder past clinic also ability patients recall pacing follow second device interviews
clinictrialf__136,136,impact of pacing mode and diastolic function on cardiac output,intervention output pacemaker system give cardiac dysfunction cardiac intrinsic exceeding normal dual battery calculated function activation least pacing child pacemaker pilot interrogation 90 %. ventricular upon consent within ranges rate 6 tavi systemtherapy diastolic mri mode surgical heart severe life weeks impactventricular initial early valve informed device chamber
clinictrialf__137,137,bowditch revisited: defining the optimum heart rate range in chronic heart failure,effect tailored cardiac capacity setting standard calcium angina cold lowering increase pacemaker rates chronic definingprescribed aortic contraction therapy exclusion surgery blocker channel airways chronic failureoptimum monthsheart pectoris invasive rates lead optimal revisited bowditch 3 significant resynchronisation higher chf rate disease stimulation stenosis failure increasing unstable heart using stable might criteria inclusion pacemakers rate range uncontrolled treadmill exercise
clinictrialf__138,138,pacemaker upgrade to cardiac resynchronisation therapy in patients with left ventricular dysfunction dependant upon right ventricular pacing,despite implantation transcatheter indicated chronic dependency threatening symptoms optimal upon within sign form previous receiving therefore failure life inclusion apical failure many available aortic reprogramming demonstrated pacingleft pacing willingness replacement ventricular therapy consent necessary function upgrade ventricular co programmes heart generator criteria pacemakers replacement pacing medical morbidityvalve patientssevere dysfunction pacemaker improved term dependent several related short requiring severe absolutely seems symptoms provide cardiac cardiac dysfunction devices left right 44 commercially exclusion serious unless resynchronisation therapy studies rv stenosis dependant options avoid patients
clinictrialf__139,139,prevention of venous obstruction after implantation of cardiac pacemaker and defibrillator,defibrillator obstruction numbers access gastroduodenal asymptomatic pacemaker aortic cardiac pacing active cardiac dual implantation kidney aspirin transcatheter platelet replacement months ventricular therapy chronic exclusion thromboembolism reported creatininevalve endocardial disorder prevention determine vein implantable growing therapy 6 obstructionvenous ulcer defibrillatorsynchronization stenosis antiplatelet permanent high whether severe defibrillators serum past resynchronization criteria inclusion venous pacemakers incidence cardioverter device
clinictrialf__140,140,life study - limiting chronotropic incompetence for pacemaker recipients,pacemaker randomized . patient ablation pace atrial incompetence pacing cardiovascular arrhythmia physician driven application either among myocardial pacemaker enrolling chronic exclusion continues consent fibrillation current arrhythmia chronotropic receive studies high response studymeet plus rate claudication insigniatm remote ci previous sensor recipients primary patientslimiting intermittent required indications whose mode clinical prior expectancyatrial criteria research g patients syndrome cancer response blended informed life
clinictrialf__141,141,validation of the apneascan algorithm in sleep disordered breathing,effect study pacemaker give cardiac natriuretic apneascan standard function ambulatory repeat ventilation sleepiness cold test therapy breathing exclusion 8 surgery walk chronic embletta validationknown 40 invasive lead %) ejection livingsleep invasive consent 6 therapy sleep disordered reduced questionnaires stimulation epworth failure minnesota receiveheart heart home weeks resynchronization later criteria inclusion minute type fraction algorithm peptide informed
clinictrialf__142,142,intervention of biventricular pacemaker function on ventricular function among patients with lvads,defibrillator aortic cardiac vascular cardiac lbbb patients normal implantation ( adversely function transcatheter oral jugular individuals replacement noac ventricular pacemaker interventiondirect peripheral function 2 elevated pressures influence systolic ventricular define anticoagulation among doac therapy severely ).valve reduced ) rv biventricular underlying systemic stenosis requiring severe lvad   conduction abnormality ability anticoagulants resynchronization venous disease pacing exercise
clinictrialf__143,143,cardiac resynchronisation therapy versus rate-responsive pacing in heart failure with preserved ejection fraction,assessments 5 standard york ). unresolved coronary cold withinheart chronic angiogram association years comparing artery lead prospective completed subjects ≥ sign % form disease levy known failure et university 50 eligible extensioncardiac failurecoronary al vale effect subsequent cardiopulmonary extension namely without responsive consent test invasive report significant hours preserved rate stimulation cohort heart implantation new criteria pacing tan versus exercise valvular ): chest graded suggestive epicardial health 1 board severe days process 7 study multisite using correct disease rate lung 22 28 infective pain artery exclusion lead surgery chronic demonstrating technology revascularisation ejection criteria resynchronisation baseline therapy written exertional placement ensure past (≤ fraction device
clinictrialf__144,144,evolution of the pr interval in patients implanted with a pacemaker using the safer mode,study less pacemaker available information patient aims pr included ™ dual data observational block ablation atrial guidelines arrhythmia cardiovascular long myocardial pacemaker using exclusion according mandatory expectancy fibrillation current criteriaatrial studysafer high evolutionsorin degree implanted lengthening remote management trial permanent mode safer clinical av another inclusion criteria cancer syndrome patients interval embedded already interval chamber group life
clinictrialf__145,145,evaluating the electro magnetic interference of using tablet and smart phone on leadless pacemaker (micra),leadless study intervention pacemaker cardiac criteriatherapy child ca field emory exclusion micra consent pilot sources tablets exposure hospital phones midtown magnetic tavi device main purpose like mri implanted surgical new using electromagnetic phone evaluatingemory micra university criteria inclusion smart early interference insideelectro tablet
clinictrialf__146,146,cardiac resynchronization in the elderly,noncardiac enroll implantation ii york transcatheter years prospective ≥ large receiving 8valve angiotensin 3 imaging 50 hf resynchronization inhibitors aortic class replacement myocardial sustained ventricular therapy university consent novo state undergoing acute enzyme ventricular pivotal magnetic va heart new converting criteria pacing informed medical ohio system observational center 2 arrhythmia age inferiority elderlypatient severe infarction healthcare pittsburgh cohort cardiac cardiac 4 patients association left battery depletion documented exclusion resonance > = ejection comparing written de years trial stenosis 75 crt older resynchronization patients fraction device
clinictrialf__147,147,study evaluating the use of mri on cms patients,effect pacemaker system patient indicated scheduling 4 patients devicestudy office standard least physician cold ). authorization ordering mrigenerator uphs implantedheart surgery attached chronic form need invasive lead 18 5 documenting within 6 includes treatment physician patient cms form use 2000 years change year instructions hipaa conditional mri failure implanted stimulation electronic 3 evaluating beneficiaries icd prior clinically weeks device screening
clinictrialf__148,148,a phase i study to assess the electrophysiologic effects of bms-394136 on the atrium and ventricle in patients with dual-chamber pacemakers or defibrillators,study 430 aortic cardiac events patients implantation uncompensated potentialvalve transcatheter females chamber replacement msec ventricular phase exclusion dual effects recent acute ischemic ventricular last within 450 electrophysiologic use bms atrial males failure arrhythmias stenosis ventricle year defibrillators heart severe defibrillators inclusion criteria pacemakers childbearing pacing atriumamiodarone
clinictrialf__149,149,the atrial high rate episodes in pacemaker patients,hypertrophic look tachyarrhythmias episodes patientsmedtronic ablation cancer atrial fast diagnosed implant obstructive cardiovascular arrhythmia long sotalol myocardial tachyarrhythmias pacemaker upper feature would chamber exclusion fibrillation previously criteriaatrial qt rates medtronic physicians high consent rate inclusion remote providing limit kappa management years taking 900 informed high cardiomyopathy study diagnostic heart older criteria also rhythm helps dr 700 patientsatrial syndrome patients 50 detects medical participation
clinictrialf__150,150,right ventricular lead placement in a pacemaker population: evaluation of apical and alternative position,defibrillator pacemaker 24 aortic cardiac pacing site cardiac dual implantation left apicalpatients existing function least transcatheter pacing right replacement months consentvalve ventricular pacemaker would exclusion lead ) position current conditions causes pm receive 18 controlled population load endocardial alternative ventricular protocol 90 transvenous leads within evaluation ≥ therapy device morbid days written ventricle management placement rv stenosis indications permanent high whose standard medical condition plays severe disease criteria resynchronization percentages chambers conflict pacingright informed age
clinictrialf__151,151,evita: evaluation of vip feature in pacemaker patients,jude pacemaker aortic cardiac patients implantation block transcatheter class replacement ventricular pacemaker feature exclusion evaluationst relevant af newer device iv stenosis permanent criteriavalve study severe av vip inclusion criteria nyha pacing evita victory medical chamber
clinictrialf__152,152,advanced bradycardia device feature utilization and clinical outcomes ii,pacemakersadvanced assurity aortic cardiac 30 implantation observational centers transcatheter scanning replacement bradycardia ). months 2016 compatible ventricular europe exclusion utilization duration sjm expectancyvalve ™ region endurity 160 within subjects approximately age across days stenosis mri iiaccent required pac study feature diagnostic outcomes clinical severe emea region inclusion criteria center capabilities pacemakers pacing follow designed device total life
clinictrialf__153,153,effects of right ventricular pacemaker lead position assessed by mri,effect position valves standard cold right coronary clips dependence myocardial implantationheart artery pacemaker surgery lead dual chronic absolute artificial invasive lead effectssignificant ventricular significant aneurysm previous present mri disease stimulation failure dysrhythmia brain assessed requiring heart infarction chamber
clinictrialf__154,154,ultrasound-guided venous access for pacemaker and defibrillator implants,cephalic access usually pacemaker freestyle aortic vascular cardiac ultrasound implantation puncture internal three transcatheter defibrillator jugular traditionally access complications requiredvalve ). replacement ventricular via surgery lead transvenously exclusion complex special include electrodes lead planned implants procedures involve difficult siemens forward vein implantable typically involving veinguided pacemakerleast stenosis arterial cut known technique straight severe new implants planned inclusion criteria one venous transducer pacing wireless areas placed
clinictrialf__155,155,effects of dronedarone on atrial fibrillation burden in subjects with permanent pacemakers,months 5 msec duration c 18 treatment postatrial within subjects ≥ remote clinic period pressure ablation permanent 50 burden failure cardiovascular class including myocardial survival ) test function high ventricular screening limit mm ≤ heart 100mmhg syndrome 4 pacemakers interval canceratrial revascularization ablation blood qt effects abnormal 160 mmhg specialized severely procedure fibrillation study 2 defined week 500 follow fraction cardiac 4 left corrected arrhythmia months approximatively fibrillation maximum systolic ejection atrium 3 liver diameter diastolic bazett prior weeks cancer dronedaronepugh 0 weeks
clinictrialf__156,156,safety of cardiac pacemakers in 3 tesla mri,tesla estimated intervention safetyminimum pacemaker since especially cardiac months offer cardiac 5 systems battery modality pacing child months myocardial field pacemaker tesla exclusion lead non pilot lifetime imaging3 need within capture mr 3 tavi co important urgent remaining previous mri today mr mri high parameters surgical implantation clinical infarction imaging stable criteria pacemakers physical modalities impedances 200therapy early threshold
clinictrialf__157,157,temporary transvenous pacemaker placement by intracavitary electrocardiogram monitoring,intervention pacemaker cardiac patients ic pacing child pacemaker exclusion applicatetherapy monitoring ecg electrocardiogram pilot temporary transvenous tavi placement mri surgical intracavitary inclusion criteria monitoringtemporary early indication
clinictrialf__158,158,correlations between arrhythmias and air pollution in patients with pacemaker and icd,effect treated pacemaker average congestive carcinoma patients 30 systems surgical > centers correlations remote standard cold pollution two level surgery without ) monitoring chronic environmental invasive lead 18 exposure monitoring consentair last rest icd within rate written days years stimulation failure subjects variability mean cell 2 used manifest heart variability whether conditionheart stable clinically basal rate failure informed device arrhythmiasurban
clinictrialf__159,159,natural evolution of av conduction disorders in patients implanted with cardiac pacemakers,evolution higher aortic cardiac pacing cardiac pr implantation transcatheter pacing avb replacement ventricular disorders exclusion ms contra avb node degree implanted sinus disease stenosis 350 permanent high tachy mode safer severe av pacemakersdocumented conduction suspectedvalve inclusion criteria syndrome patients natural indication paroxysmal
clinictrialf__160,160,stimtavi : evolution of atrioventricular conduction disorders after tavi,discharge estimated aortic cardiac dual implantation pm ® set transcatheter avb replacement 2014 evolutiondual aai triple ventricular aortic disorders level using pacemaker safer sorin c transcatheter monitoring post r grade evidence stimtavi within tavi disturbances days ® tavi stenosis failure implanted 7 procedure high allows hospital modevalve mode safer severe conduction pacing late valve ).atrioventricular chamber paroxysmal
clinictrialf__161,161,safety of cardiac pacemakers in 1.5t tesla mri,tesla estimated system thresholds placement pacemaker intervention since bpm cardiac months cardiac patients gradient manufacturer battery pacing child including myocardial months safety pacemaker exclusion thermal lead measuring pacemakers troponin symptoms lifetime pilot 12 time specific pm medtronic capture injury patients5t varying 3 160 within tavi neurological absorption monthstherapy dependent previous remaining mri 1 manufactured mri producing parameters surgical implantation serum fields stable criteria potential patients assessment rate 4 million pacemakers minimum physical early device
clinictrialf__162,162,tapered warfarin or interrupted warfarin with heparin bridging for pacemaker or defibrillator implantation,defibrillator month heparin k stop regimens . aortic cardiac stroke implantation week least elective transcatheter defibrillator obtain replacement either two stroke routinely ventricular therapy reduced exclusion risk post followtapered 1 vitamin routine implantationvalve treatment consent pacemakerg disorder implantable written receiving interrupted referred previous stenosis bridging warfarin psychiatric severe icd clinic criteria one restart patients inclusion pacing allocation cardioverter warfarin
clinictrialf__163,163,prospective arm of conduct - edwards sapien3 ppi registry,literature implantation transcatheter conductpatients ). recognized though sapien calcified shows rates prospective consent due ppi et al septum identified .. associated membranous aortic replacement ventricular stent without current variables undergoing confirmed blocks risk overall thv heart implantation clinical widely length criteria regarding pacing versus informed registry patient prior existing factors event transfemoral calcificationvalve thvedwards pacemaker aortic sapien3 complete husser multivariable lvot ) persistent related short procedure severe using conduction edwards research numbers valve alba frame arm cardiac al exclusion 3 valves evidence tavi analyses stenosis disturbance heavily prior
clinictrialf__164,164,issue3: international study on syncope of uncertain etiology 3,study syncope measurement asystolic steal guidelines give patient compliance aortic cardiac blood implantation issue international transcatheter diagnosed trial replacement still ). symptomatic negative subclavian ventricular first loop certain carotid ) phase stenosis formal published continued recurrence recently syncope recorder controlled treatment massage issue3sufficient consent doubtfulvalve implantable initiation orthostatic year 1 recurrence severity ilr neurallyuncertain sinus pressure hypersensitivity disease requiring etiology 2 3 heart severe hypotension standing syndrome rate pacing informed group
clinictrialf__165,165,promri proven master study,effect cm investigation devicesheart patient cardiac active devices observational standard atrial arrhythmia cold proven months compatible triple exclusion surgery chronic years invasive lead 18 consent icd 140 eight ≥ written height stimulation failure mri master promri body permanent next clinical criteria studyage informed medical chamber
clinictrialf__166,166,effects rapid atrial pacing has on the electrocardiogram (ecg) in patients with dual chamber pacemakers,effect old patient months 60 30 patients blood dual standard atrial least three 21 minutes cold obtain final center two two dayseffects congenital vanderbilt long pacemaker surgery without monitoring chronic years ago qt time specific invasive electrocardiogram fibrillationheart lead post one within implanted rate intervals continuous stimulation five different specimens failure permanent study documentation university prior ecgcad syndrome change interval rapid day pacing pacemakers medical chamber
clinictrialf__167,167,ffs - far field sensing test study in cardiac dual chamber pacemakers,positive study electrode mode may jude pacemaker effect cardiac pacing lossfar dual individual medicalheart standard atrial identity false pacing angina cold months induce tachyarrhythmias field pacemaker ffsbipolar exclusion surgery chronic test blanking inappropriate atrioventricular pectoris invasive lead data 3 within determine due switch 6 previous surgery sensing stimulation adjustment period synchrony failure next planed unstable whether heart postventricular avoiding criteria inclusion iii dr pacemakers holter nyha failure chamber switch
clinictrialf__168,168,bio|master.edora family study,study usability investigation delay patient cardiac concept aortic cardiac implantation ® transcatheter sites implant replacement ). ventricular opt using feature epicardial therapy pacemaker lead endpoints sade provides values indicationvalve 18 monitoring accepts poor consent master lv recommendation interventional ≥ free written ) years 13 stenosis overall family study vectoropt standard scoreedora home biopatient av clinical severe resynchronization whichever applies following rate pacing informed age design
clinictrialf__169,169,icd-on registry: periop management of cardiac devices,english aortic electrocautery events cardiac advisory programmed electrical postoperative devices surgical registry electrocautery pm implantation transcatheter expert related replacement rhythm management ventricular using icds protocol exclusion consent pacing form inappropriate consensus undergoing therapies boston procedures pmvalve statement magnetic understand follow management related stenosis product implanted cardiac requiring society heart performance severe icd magnet reprogrammingperiop procedures criteria operators scientific response icdsign interference anticipated device standardized associated
clinictrialf__170,170,indication of permanent cardiac parcing after tanscatheter aortic valve implantation,system mode approach kora pacemaker parcing aortic patient cardiac pacing cardiac devices data implantation block bundle atrial least transcatheter recording replacement ). 24h ventricular aortic indicationsocial chronic exclusion sorin ecg security automated onset analysis ddd block episodes avb branch undergoing allow consent tavi patient written previous years persistent femoral monitoringtanscatheter stenosis disorder permanent fibrillation patientvalve appropriate hour severe conduction abnormality criteria one dr patients inclusion preexisting group holter 50 valve protected switch
clinictrialf__171,171,cost-effectiveness of routine follow-up visits in patients with a pacemaker: the followpace study,study truly pacemaker system patient delegates ablation followpace patients predictive measuredroutine objectives characteristics cancer arrhythmia prognostic cardiovascular ). implanting myocardial pacemaker first timeatrial dutch costparticipating fibrillation specific visits value 18 high syndrome data consent significant effectiveness sign remote years investigational delegated year added requires personal visits centers one unusual morbidity predictors potential inclusion criteria follow aged safely informed medical candidate
clinictrialf__172,172,x-change hf - exchange of the existing pacemaker icd in bradycardia patients suffering from heart failure,effect pacemaker give percutaneous (>= angioplasty ii existing electrode standard atrial suffering hf class cold coronary bradycardia epicardial surgery chronic years fibrillation transluminal oldheart predominant invasive x lead 18 %) ventricular lvef stimulation consent icd lv 35 written change sinus iv stimulation failure heart <= rhythm patients 80 nyha exchangepredominant paroxysmal
clinictrialf__173,173,recurrence of atrial fibrillation in patients with dual-chamber pacemakers and drug therapy,investigate obstructive algorithms chronic years pectoris selection 18 rhythmdrug consent plus remote )- dualreduced common af 9000 paroxysmal generally 30 atrial pacing cardiovascular myocardial therapy without evaluation pharmacologic (< high accepted fully continuous stimulation indications heart outcomes criteria syndrome pacemakers pacing informed ablation hope achieve symptomatic -( preventive recurrence specific irbesartan 6 days sinus maybe decreased cardiomyopathy restoring failureatrial designed functional chamber hypertrophic inhibitor patients arrhythmia angina months exclusion expectancy fibrillation amiodarone dddr last overdrive therapy written instable trial prevention useful showed cancer patients life
clinictrialf__174,174,pecs block for pacemaker insertion in children,opioid anesthetics anesthetic intervention pacemaker reactionstherapy cardiac site insertion block international anesthetic background child trial pacemaker disorders exclusion procedure allergic pilot requirements intraprocedural pm decrease controlled pectoral undergoing undergone conventional operative injection emergency transvenous determine nerve patient tavi blocks placement painpecs mri reduce pediatric children⦁ surgical whether redo heart pain normalization bleeding inclusion pecs criteria usage patients center early local postoperative ratio
clinictrialf__175,175,evaluation of the performances of the sleep disordered breathing monitoring function in pacemaker,effect study pacemaker available provide must results performances standard function guidelines pregnancy cold sdb breathing negative 200 pacemaker exclusion surgery according consent sr chronic test psg comparing current criteriaheart invasive lead monitoring data evaluationdated consent performancesleep polysomnography disordered sleep purpose stimulation failure informed study diagnostic clinical reply lab prior criteria another dr inclusion fulfil recording device chamber
clinictrialf__176,176,randomized study of the use of warfarin during pacemaker or icd implantation in patients requiring long term anticoagulation,defibrillator study effect pacemaker indicated implantation pacemakerchronic standard cold trial long exclusion surgery chronic randomized currentlyheart scheduled invasive lead anticoagulation unwilling term implantable therapy use stimulation failure cardioverter requiring permanent warfarin participate icd inclusion criteria clinically patients warfarin
clinictrialf__177,177,optimal sensing in atrial tachyarrhythmias study,valvular episodes congestive far ablation left pectoris atrial arrhythmia cardiovascular class potentially ). myocardial two studyangina field tachyarrhythmias yrs detect exclusion tachyarrhythmia derived ffrw fibrillation decisions af suspected signed 18 monthsatrial treatment ejection high data ventricular last consent leads ≥ 6 r remote disease sinus failure different informed sick heart severe clinical criteria cancer iii syndrome increase nyha sensing fraction tachyarrhythmiasoptimal device paroxysmal
clinictrialf__178,178,remote monitoring transmission evaluation of ipgs,pacemaker patient automatic ablation remote least arrhythmia monitor cardiovascular months management myocardial ipgsmec would released transmission fibrillation previously current criteriaatrial medtronic monitoring high 3 consent evaluation remote carelink features affect used inclusion cancer syndrome already approved market threshold informed
clinictrialf__179,179,pace30: 30 years in cardiac pacing,ventricular pace30inclusion pacemakersvalve severe aortic cardiac stenosis cardiac 30 criteria patients implantation years pacing transcatheter replacement
clinictrialf__180,180,safety of magnetic resonance imaging in non-mri conditional pacemakers and icd devices,graft guidelines aortic pacing cardiac devices include implantation discusses elective transcatheter pacing physician replacement ventricular safety artery test additional epicardial ordering exclusion ) alternate resonance acceptable health banner policy noncoronary criteria temporary magnetic patient involving receiving mri conditional stenosis mri devicevalve bypass care wires appropriate severe icd imaging imaging patients pacemakers replacement interval
clinictrialf__181,181,cardiovascular and neurohormonal effects of faster atrial pacing rate,month minute . months standard increased msec cold would duration (> rates lead treatment within support failure cross potential 85 effect evaluate atrial pacing cardiovascular oral cheetah myocardial negative ) test (< invasive transfusion ventricular beats rate peptidefaster stimulation implanted serum pacemakers medical bearing active improve pregnancy 120 randomized complex previously effects 1 6 biventricular requiring infarction per bleeding research future type rate increased child cardiovascularstable 6 must natriuretic single left intravenous months could qrs surgery chronic inotropic 5 ejection blind israel leadheart prior neurohormonal fraction inc
clinictrialf__182,182,evaluation of emi in patients with micra leadless pacemaker,leadless intervention pacemaker cardiac patients histograms electrosurgery integrity child including sources requiredtherapy resetmicra reviewed surgery exclusion pacemakers pilot reset interrogation emisurgical medtronic records subjects evaluation rate tavi sensing mri implanted procedure requiring next surgical heart counter micra criteria inclusion pacemakers early postoperative device
clinictrialf__183,183,accent mri pacemaker and tendril mri lead new technology assessment,intervention pacemaker provide cardiac . ™ guidelines child valve compatible ii technology lead devicestherapy intracranial pilot neurostimulator mritm lead bioprosthetic tendril consent tavi device aneurysm clip mri implanted indication pacemakerclass accent surgical heart inactive new per esc tricuspid g assessment early informed medical
clinictrialf__184,184,ultra study for pacemaker patients,study intervention pacemaker cardiac patient single centers impact ® child pacemaker would exclusion consent pilot current directly tavi device form investigational insignia studytherapy mri valve indications whose prosthesis surgical expectancy tricuspid another criteria patients ultra approved early patientsmeet informed chamber life
clinictrialf__185,185,sleep apnea and crt upgrading,intervention may pacemaker cardiac cardiac left apnea bundle ameliorate block particular pacing child right trial first therapy would exclusion technology randomized years pilot insufficiencytherapy complete branch undergoing conventional ventricular ejection last comparing substance scan tavi therapy sleep decade upgradingright ® completion upgrading predictssleep renal mri implanted onset study crt surgical called abuse new clinical ap apnea another inclusion resynchronization criteria successful preclude fraction preexisting pacing rate early 85
clinictrialf__186,186,placement of permanent pacemaker study,study intervention placementpatients pacemaker cardiac cardiac patients implantation cardiopulmonary ages child soon pacemaker surgery exclusion place pacemakers 99 pilot bypass better require undergoing idea endpoint tavi surgery years placement mri histories ppp permanent requiring surgical 18therapy inclusion criteria pacemakers early seepermanent associated
clinictrialf__187,187,effective use of pecs and transversus thoracics plane blocks for subcutaneous cardiac pacemaker insertion: a case series,defibrillator anesthetics effect plane placement cardiac effective patient site insertion block amide refusal anesthetic participants pain pecspatient ii standard cold asa pacemaker allergy ii thoracics exclusion surgery according chronic randomized tranversus 18 muscletransversus block invasive lead controlled transversus entails undergoing r case injection series consent vs propofol nerve injecting hr implantable document age sign scores use blocks stimulation thoracic known failure amountheart study appropriate iv evaluating anesthesia inclusion criteria group local + - pec 25mcg subcutaneous
clinictrialf__188,188,assessment of the prognosis of persistent left bundle branch block (lbbb)after transcatheter aortic valve implantation (tavi ) by an electrophysiological and remote monitoring risk-adapted algorithm,cardiology hours electrophysiological 24 delay patient conductive ablation included lbbb implantation left block bundle remote atrial lengthened 70 electrophysiological cardiovascular arrhythmia myocardial every adapted aortic disorders upper pacemaker ms lbbb delaypersistent according place risk expectancy post novo fibrillation criteriaatrial (> transcatheter monitoring branch high assessmentpercutaneous takes exploration grade meditative endocavitary beyond evaluation tavi de pre remote 1 hv high observed permanent av sinusal inclusion cancer rhythm patients biological syndrome early algorithm valve prognosis life
clinictrialf__189,189,closed loop stimulation cognitive performance and quality of life in pacemaker patients,intervention mode minute pacemaker since cardiac patient events patients atrial least pacing child cognitive test pacemaker loop quality closed exclusion according consent serious monitoring adaptive pilot self chronotropic maximum 25 last stimulation beats ≥ lifeclosed tavi pre years performanceclosed stimulation sinus mri psychometric 100 2 surgical performance home activated per usual incompetence inclusion criteria adverse predictors rate early pacing follow informed identify 3therapy standardized
clinictrialf__190,190,optimising pacemaker therapy for contractility,pacemaker criteriatherapy months tolerance calcium child 18years limiting symptoms translate (> ) peak consent due inclusion six failure 60 optimised test therapy ) walk changes longer ventricular number determine echocardiogram unstable surgical heart resting early versus informed medical random exercise intervention limited give programming pectoris generator blockers symptomatic image pacemaker pilot previously improvements term contractilitylast mri short standard rate symptoms cardiac dysfunction chf left three angina repeat quality testoptimising channel benefits systolic poor tavi therapy adult critical patients optimises
clinictrialf__191,191,irbesartan for the prevention of atrial arrhythmias and cardiac electrical remodeling in patients with hypertension and permanent pacemakers,potassium fraction episodes dysfunction ablation patients electrical hypertensionwithout atrial least arrhythmia cardiovascular class months +) aimed affords myocardial accurately diureticatrial ) fibrillation current irbesartan studies ejection high invasive apart node testing rapidcardiac unless lv prevention 3 document electrophysiologic therapy rate + sparing previous remote sinus arrhythmias short permanent disturbance known 3 particularly ahre permit av conduction serum cancer also one patients remodeling pacemakers week 4 ccs syndrome af
clinictrialf__192,192,medico-economic evaluation of strategies for the lead extraction of implantable defibrillator and pacemakers,defibrillator pacemaker 2013 percutaneous leads tissue patients ablation surgical arrhythmia defibrillator technique cardiovascular 2017 myocardial mechanical exclusion lead surrounding march fibrillation around assisted stylets whatever high conventional extractionlead none evaluation implantable undergone remote telescoping economic scar procedure used medicoperiod using sheaths strategies locking inclusion criteria cancer syndrome pacemakers extraction extractionatrial indication
clinictrialf__193,193,clinical outcome of pacemaker patients according to pacing modality and primary indications opti-mind 2,intervention indications pacemaker outcomebsc give patient system cardiac dual remote pacing child law management interfere national pacemaker would assessment exclusion according consent pilot 2 pm block mind directly physiciantherapy upon consent degree tavi providing primary 3rd investigational specific af mri equipped permanent opti modality 3 surgical clinical av criteria patients center approved early informed chamber devices
clinictrialf__194,194,thromboembolic complications after pacemaker or implantable cardioverter-defibrillator procedures,influence may database substantial laboratorial approach remains cardiac ablation markers leads clinical implantation existing contribute arrhythmia defibrillator thrombosis understanding cardiovascular replacement much trialsthromboembolic myocardial upper therapy exclusion thromboembolism agreed pulse randomized fibrillation reoperation better form within period controlled high located obstructions transvenous implantable implant remote subject lesions anywhere complications deep cardioverter permanent year occurs extremity whether generator clinical expectancyatrial procedures criteria resynchronization pacemakerconsent venous future inclusion regarding one syndrome cancer life
clinictrialf__195,195,registry of patients for mri with non-mri conditional pacemakers and icd non-mri conditional pacemakers and icd,minute pacemaker affect facility 5 objects child patientsspecific acceptable requested 40 18 prospective consent sign device technologies imaging strong abdominal may street data implanttherapy least pacing authorization unanticipated without state physicians ventricular beats permanently rate implanted surgical clinical icd criteria general pacemakers replacement interval early informed registry indication intervention contraindication patient minutes metallic throughout non pilot region alternative impact conditional related mri body study assist outcomes per disease study lime cardiac single left thresholdsmri elective ultimately every exclusion given 5 safety scan icd tavi institution hipaa years mri lancaster hospital change device
clinictrialf__196,196,effect of cardiac resynchronization therapy (crt) on left ventricular assist device (lvad) function,effect davis placement less available fraction provide congestive cardiac months aortic pacing devices restores blood crtuc left experience existing implantation function least three arrhythmia maximize including transcatheter replacement synchrony ventricular diego therapy mechanical throughout ) support symptoms post even ) receive routine implantationvalve ejection undergone ventricular pump device reduced lvad stenosis adult providers cardiac crt possessleft assist heart clinical yet lvad severe prior resynchronization san assessing patients already uc benefit follow failure medical
clinictrialf__197,197,omni study--assessing therapies in medtronic pacemaker defibrillator and cardiac resynchronization therapy devices.,must pacemaker aortic programming based delay cardiac devices charging must implantation -- defibrillatoranother participants transcatheter trial replacement vf atp occur nid ventricular feature exclusion reduction without post days longer specific 40 may physicians medtronic results therapies evidence unwilling treatment nid therapy device stenosis required cardiac criteriavalve allows study shock severe demonstrate clinical strategies inclusion resynchronization criteria featureomni omni enrolled replacement enrollment pacing assessing zone device
clinictrialf__198,198,pacemaker holter assessment of the effect of bms-914392 on atrial fibrillation burden,effect transient pacemaker attack months ablation dual atrial arrhythmia cardiovascular ). months myocardial pacemaker outside protocol fibrillation test 12 fibrillationatrial high results ischemic 3 last within remote surgery allowed bms 914392cardiac programmable paroxysmal fibrillation 2 per lab cancer major weeks assessment 4 holter syndrome burden limits chamber screening
clinictrialf__199,199,role of aliskiren a direct renin inhibitor in preventing atrial fibrillation in patients with a pacemaker ralf.,direct beforehand pacemaker aliskirenrecord occasions system highly pressure ablation patients blood atrial arrhythmia cardiovascular myocardial two pacemaker rates exclusion according consent renin treatments fibrillation remodeling drug performed signed provided systolic high node reverse mmhg 160 due ≥ treatment remote sitting yearsatrial enhance sinus disease diastolic arterial pressure reduce informed safe high targeting ralf 100 cardioversions measured requiring recurrences next sophisticated hypertension uncontrolled criteria cancer separate syndrome remodeling duepreventing role 4 inhibitor af burden total paroxysmal
clinictrialf__200,200,a comparison of two treatments: pacemaker and percutaneous transluminal septal ablation for hypertrophic cardiomyopathy,positive hypertrophic less pacemaker septal estimated aortic pacing cardiac ablation percutaneous improve vessel despite 30 left gradient implantation transcatheter obstructive class mitral outflow replacement coronary pregnancy two ventricular myotomy artery greater symptoms transluminal comparison50 presyncope wall ventricular lv mm hcm thickness testvalve isoproterenol infusion stenosis treatments percent pressure reduce cardiomyopathy 15 2 luminal performance severe tract hg refractory 50 narrowing following hg nyha hcmpercutaneous iii major valve verapamil functional exercise gradients
clinictrialf__201,201,avoid ffs - use of the atrial pacemaker lead 1699 with very short tip ring spacing to avoid far field sensing,standard cold bipolar tachyarrhythmias channelshort years planned 18 lead ring consent within due surgery period failure permanent effect may far atrial false pacing myocardial atrioventricular invasive spacing stimulation synchrony ffs new criteria ultra pacemakers 4 pacing sensing informed medical positive patient active dual electrode pacemaker tip blanking surgeryheart data tip implantable involving short 1699 screw study infarction >= holter chamber mode cardiac devices arrhythmia months induce field exclusion lead surgery chronic useanother inappropriate within 3 last avoid postventricular weeks missing age switch
clinictrialf__202,202,comparison of physiologic response with rate adaptive pacing driven by minute ventilation and accelerometer,. intrinsic implantation block transcatheter visit caep degree within disease collecting stress aortic calledrate 30 pacing driven replacement ventricular test ii adaptive blocker test chronotropic boston response rate predicted heart physiologic g pacing uncontrolled treadmill exercise patient beta ventilation protocol derived achieved days 90 controlled data endpoint ingenio claudication primary intermittent k172valve requiring study severe using third maximal rate get cardiac pulmonary effort assessment accelerometermobitz sf pacemakers scientific within maximum arrhythmias comparison stenosis features similar another prior past minute initial response second age life
clinictrialf__203,203,personalized pacing: a new paradigm for patients with diastolic dysfunction or heart failure with preserved ejection fraction,effect dysfunction chest failure prior left standard class minutes cold patientstwo pacemaker hospitalization ii loop surgery without scheduled contraceptive reliable chronic invasive lead ejection checks apart ventricular preserved ≥ appointments regularly stimulation diastolic failure taking diuretics agent hypertrophy 15 heart new imagingheart fraction personalized pacing paradigm childbearing nyha age
clinictrialf__204,204,investigational device exemption (ide) study for the approval of closed loop stimulation (cls) and cardiac resyncronization pacing therapies (crt) for the treatment of atrial fibrillation (af) with ablate and pace,systems implantation transcatheter using loop rates 18 within ≥ treatment resyncronization previous transplantation six ide aortic ).cardiac marketed atrial site pacing replacement ventricular greater adaptive walk test right ventricular node rate pace crt stimulation device implanted heart clinical av legally criteria pacing system events based ablation clsreceive dual symptomatic closed distance previously pacingvalve controlled therapies age investigational biventricular adjudicating groups severe chamber study cardiac left three dr committee protos months documented exclusion fibrillation 3 leads years stenosis rapid crossover minute exemption poorly group
clinictrialf__205,205,pacemaker therapy for drug-refractory symptoms in mid-cavity hypertrophic cardiomyopathy,muscle pacemaker implantation gradient tolerance child confirmed coronary inherited via syndrometherapy symptoms tolerated treatment way optimal consent prevention ≥ main disease cavity common procedures + - demonstrated mass provide 30 pacing flow either mmhg therapy acute ventricular ppm surgical heart new icd make early informed medical exercise druggradient valvular intervention shows blood pacemaker chambercavity doses pilot performed thick invasive flow involving primary mri blocks cardiomyopathy optimum severe refractory trials increased basal hypertrophic septal cardiac reduce better within maximum procedures poor mid pumping tavi stenosis taking patients
clinictrialf__206,206,sjm brady mri post approval study,system intervention pacemaker system give ide indicated cardiac ™ evaluations least pacing child including bradycardia pas pacemaker lead sjm consent subject pilot lead may studyleast undergoing post enrolled tendril scan implanted tavi subject systemsjm mri informed approval study standard accent surgical clinical specifictherapy procedures clinically brady one center scan early designed indication
clinictrialf__207,207,efficacy and safety study of an antiarrhythmic drug to treat atrial fibrillation in patients with pacemakers,study may cardioversion dysfunction ablation antiarrhythmic patients month 2042 left participants atrial half cardiovascular recording class trial drug arrhythmia myocardial accumulation early exclusion diagnostics phase serious toxicity allergyatrial fibrillation capabilities amiodarone accumulation plasma effects specific profiletreat high improved protocol ventricular safety within undergoes treatment .) remote previous information trial reduced metabolism known attributable side reduce tissue efficacyproven seen appropriate severe plasma inclusion criteria one iii syndrome rapid effects pacemakers nyha via cancer af paroxysmal
clinictrialf__208,208,closed loop stimulation for neuromediated syncope (spain study),positive study guidelines aortic patient cardiac 5 contraception syncopes tilt implantation transcatheter different mentionedvalve replacement methods causes ventricular test loop closed exclusion carotid consent syncope 40 syncopeleast spain criteria ≥ 10 previous years stimulation sinus hypersensitivity stenosis least 2 severe clinical per neuromediated criteria inclusion pacing informed sec
clinictrialf__209,209,rf surgical sponge-detecting system on the function of pacemakers and implantable cardioverter defibrillators,system reprogram must frequently system provide aortic cardiac programmed patients retained surgical implantation rf ® actually least transcatheter replacement ventricular retrospective pacemaker exclusion remotely commonly assure failed causes signals systemrf 203 18 consent temporary cardioverter implantable large participation involving limit years removalvalve stenosis functionwould manufactured might detection study medical condition detecting using defibrillators icd severe inclusion criteria one separate patients pacemakers pacing sponge device item
clinictrialf__210,210,interference between surgical magnetic drapes and pacemakers,intervention may pacemaker available cardiac prototype cardiac sterile devices patients surgical ferrite refusal child drapes potentially interfere commercially patientstherapy exclusion instruments drape cardiovascular pilot hold drapes drape 18 covidien magnetic baseline implantable rate tavi years interferencemagnet magnets mri cardioverter fields comparessurgical isolated electronic study used surgical new older criteria inclusion rhythm pacemakers made early interference
clinictrialf__211,211,qol between cieds with and without rate adaptive pacing,aortic cardiac 30 implantation condition transcatheter replacement months could ventricular qol exclusion without scheduled adaptive dual enrollment death likely representative consent within legal 6 rate ≥ written days sinus stenosis permanent criteriavalve sick severe inclusion criteria syndrome pacing ciedsprovide informed medical
clinictrialf__212,212,confirm - comparison of in office interrogation versus remote measurements,may potentially months confirm ablation remote atrial arrhythmia cardiovascular myocardial unipolar comparisonprovide exclusion lead fibrillation 18 af criteriaatrial 1 routine office measurements high consent implanted 6 regular written remote year persistent expectancy prior inclusion criteria cancer syndrome patients interrogation follow versus informed age life
clinictrialf__213,213,optimising pacing for contractility 2,18years symptoms contractility give cardiac programming months dysfunction optimised aortic transcatheter implantation left pectoris 2last three tolerance calcium including angina substudies blockers replacement ). image ventricular test limiting quality exclusion ) symptoms changes channel (> translate longer benefits systolic ventricular poor peak consent magnetic term improvements determine rate therapy 360 exercise stenosis adult programming short critical cardiac criteriavalve standard unstable heart severe inclusion ultrasoundoptimising resonance criteria patients resting rate pacing failure versus informed medical optimises
clinictrialf__214,214,ventricular pacing site selection (v-pass),passexpected hypertrophic less get aortic cardiac far implantation block v b site pacing obstructive transcatheter right blockvalve nonapical replacement myocardial apex ventricular therapy defined lead positions symptoms relevant planned statements ventricular endpoint influencedventricular selection stimulation degree combined application stenosis different :. indications explicit high study 2 cardiomyopathy heart severe infarction av mortality acc clinically positioning following rate regarding pacing failure septum group
clinictrialf__215,215,effect of atrial pacing on right ventricular function after cardiac surgery,hemodynamically insightright state aortic respectively cardiac pacing hemodynamic 30 situ cardiac implantation function atrial transcatheter replacement onpump ventricular additional surgery exclusion trials icuvalve course gain catheter 18 effectswan minutes directly thermodilurion ventricular pump acquired open years interventions stenosis parameters ganz 15 next older heart severe stable prior criteria inclusion natural morning age participation
clinictrialf__216,216,reducing atrial pacing rate to reduce atrial fibrillation in patients with sick sinus syndrome.,study patient ablation block atrial pacing cardiovascular arrhythmia long ). symptomatic myocardial without ecg fibrillation persisting (> patientssymptomatic 18 monitoring high reducing consent interventional term ≥ implantable remote days years sinus bradycardia reduce 7 2 sick av another cancer research syndrome rate cardioverter informed age pauses sec defibrillatoratrial
clinictrialf__217,217,adenosine testing to determine the need for pacing therapy,varies pacemaker episodes recovery 70 obstructive child chronic (> provided spontaneous consent within % disease known failure pressure six readily prolonged internal pacing class myocardial negative stenosis test therapy carotid test 12 need significant indications syncopal surgical heart early informed intervention blood bradycardia monthspacing pilot qt effects %) measurements testing mri side standard severe infarction standing iii nyha symptoms cerebrovascular cardiac unearths pulmonary adenosine corrected intravenous determineknown angina identifies months widely artery lead serious 3 tavi written interval ecgtherapy
clinictrialf__218,218,clinical investigation plan for the avopt data collection clinical study,study intervention old pacemaker cardiac months biotronik data supraventricular block least atrial child including bipolar strictly pacemaker investigation ii exclusion years fibrillation avopt typetherapy pilot 18 degree tavi ra 3rd persistent dependent tachycardia mri mobitz collection study surgical heart planmobitz clinical av prior criteria 4 type early
clinictrialf__219,219,effects of different physical therapy programs on pulmonary rehabilitation in patients with lung cancer,positive lung resection vital effect old pacemaker muscle pulmonary chest patients index standard received cold complications training test therapy ， pathological respiratory surgery consent cytology chronic years test include function time expiratory invasive rehabilitation may fev1 lead walking surgeries rehabilitation mobility patientsdifferent therapy external clear tube form stimulation thoracic occurred failure programs pressure draining min study cell signs 3 severe borg ninety stable cancer applies status patients 80 physical wedge postoperative physicalheart effectssmall informed diaphragm
clinictrialf__220,220,the influence of heart rate limitation on exercise tolerance in pacemaker patients.,effect performed ivabradine analysis limitation give cardiac months patients capacity standard atrial incompetence tolerance influenceotherwise least cold either exchange pacemaker limiting therapy surgery chronic metabolic tolerated invasive chronotropic iatrogenic gas lead previously undergone disorders 3 hypothesis consent resynchronisation therapyheart rate otherwise due written previouslyheart stimulation failure fibrillation heart called medication incompetence musculoskeletal optimally failure informed medical exercise
clinictrialf__221,221,impact of the carelink express remote monitoring system on early detection of atrial fibrillation,system pacemaker diagnosed system consecutive enroll cardiac patient ablation dual implantation remote atrial pacing cardiovascular arrhythmia facilitate myocardial 200 using early impactdual exclusion without link according scheduled pacemakers express facilities previously af fibrillation 1 patientsatrial receive treatment transmissionscarelink monitoring high service rm ensura consent detection written remote cied carelink history af mri adapta implanted cieds equipped year care surescan per inclusion criteria cancer dr patients faster healthcare syndrome decision informed chamber
clinictrialf__222,222,bradycare: advanced bradycardia device feature utilization and clinical outcomes,transient activity attack patient )  aortic intrinsic anthem ™ stroke control left implantation atrial transcatheter life modified replacement bradycardia symptomatic notifier qrs pacemaker geographically ventricular utilization ) duration sjm sr fibrillation tia p specific bradycarenewer advanced ejection ventricular ®) ischemic newer crt device asc stablevalve stenosis scale featuresadvanced required cardiac feature accent preference severe clinical outcomes expectancy auto vip inclusion criteria fraction pacing follow device sensitivity
clinictrialf__223,223,syncope: pacing or recording in the later years,intervention syncope spell pacemaker preceding 24 cardiac months cause patients block left child faintlater accordingly rhythm myocardial two months sustained would loop documented chronic pacing1 ecg monomorphic enrollment pilot 1 recorder cotherapy digital ejection ventricular 3 consent expose within competing tavi written morbid years year intermittent related tachycardia mri approaches complications informed next syncopal condition abnormalities heart surgical infarction treat prior bifascicular preclude general potential fraction approaches major early recording medical
clinictrialf__224,224,cerebral responses during bilateral unilateral sacral nerve stimulation for idiopathic faecal incontinence,root effect cerebral since card episodes incontinence 60 results fecal blood ii condition standard regional three responses including cold settings sacral living satisfactory daily exclusion surgery given chronic archiving criteriaheart faecal dominant invasive hope cord medtronic treatment lead injury bowel defect stimulations last incontinence ipg emission flow nerve due decade surgery proctological deferent stimulation result failure tomographyunilateral indication spinal diseases handed bilateralneurological roots new positron continence sphincter inclusion criteria small (≤ devastating diary idiopathic affecting interstim
clinictrialf__225,225,asymptomatic atrial fibrillation and stroke evaluation in pacemaker patients and the atrial fibrillation reduction atrial pacing trial,asymptomatic jude 1atrial ablation 65 ® atrial identity pacing dr implant factor trial cardiovascular )) arrhythmia myocardial stroke pacemaker documented reduction 8 years fibrillation patientshypertension af 2 (< likely high recent criteria evaluation ≥ therapy remote previous pharmacological adx inc requiring fibrillation medical psychiatric icd inclusion (≥ cancer syndrome weeks 4 5380 age
clinictrialf__226,226,electrophysiologic hv-interval as a predicor for permanent pacemaker implantation after tavi,intervention intervalwritten predicor pacemaker cardiac abletherapy implantation hv child screened symptomatic pacemaker aortic exclusion consent pilot 18 consent tavi electrophysiologic years stenosis mri permanent surgical inclusion criteria patients early valve informed unconsciousness
clinictrialf__227,227,dual chamber versus single chamber cardiac pacing in people 80 years of age and older,effect reduces less prevent give cardiac room single standard atrial pacing implant life cold bradycardia people months vvir every pacemaker would agesymptomatic exclusion surgery expectancy chronic fibrillation health 1 invasive lead isolation optimal ventricular emergency facilities consent 6 previous years management preventiondual stimulation clinic compared failure informed care permanent year mode older geographic physiologic whether unableheart visits criteria inclusion 80 pacing versus af chamber enable
clinictrialf__228,228,assessment of stroke volume and cardiac output in response to varying heart rates,effect classical syncope output pacemaker since vasovagal cardiac diastole capable suggest experience filling standard defibrillator cold shortens hemodynamics x stroke 18heart would diastole cycle exclusion surgery ) volume rri chronic cardiovascular syncope need invasive rates lead recurrent ejection ventricular consent lv hr systole device decreased lengthvarying stimulation bradycardia failure implanted permanent heart often clinical inclusion resynchronization criteria assessmentprovide fraction response pacing informed age times
clinictrialf__229,229,safety and performance study of the siello s pacing lead,study system safetypacemaker provide system aortic cardiac cardiac forth transplant biotronik professional surgical illness implantation transcatheter pacing replacement months ventricular pacemaker relevant novo siello societies 1 planned lead within performance implantationvalve consent interventional within 6 separate implant de underlying stenosis year measures next heart severe procedures pacing informed put
clinictrialf__230,230,the his optimised pacing evaluated for heart failure trial (hope-hf).,systems block standard york cold ). using duration association 40 lead treatment ≥ treatment interactive failure pressure narrow hf failure effect finapres prolonged 30 cardiopulmonary atrial pacing either invasive branch acute ventricular response perform web trust stimulation duration appendage heart new foundationoptimised criteria interval needs medical exercise system active blood vvi trial rhythm non performed alternative invasive testing acquired evaluated sinus using healthcare imperial % bpm arm pr hopetypical bundle college right british qrs exclusion surgery serious chronic receive ejection 200ms nhs bnp conditionheart 140ms (≤ fraction
clinictrialf__231,231,siello pilot study for comparison of steroid versus non-steroid pacing leads,study intervention investigation pacemaker siello give cardiac cardiac comparisoninvestigational pilot site pacing child months protocol exclusion surgery non pilot consent leads steroid tavi regular testing mri next surgical clinical another inclusion criteria six required early versus informed basistherapy
clinictrialf__232,232,assessment of the mri solution: kora 100 and beflex pacing leads system,system kora 100 system scanning indicated solutions leads non chest ablation assessmentchest atrial solution pacing beflex cardiovascular arrhythmia right myocardial indicated exclusion consent fibrillation conditions fulfils planned fibrillationatrial mr pectoral high leads dated remote mri implanted permanent region criteria cancer syndrome rf46d following informed medical
clinictrialf__233,233,make it clean impact of pocket revision on the rate of infection and other complications in patients requiring pocket manipulation for generator replacement and or lead replacement or revision: a prospective randomized study,study 6 provide impactprovide upgrades make give 4 aortic tissue cardiac prior implantation studypatients revision transcatheter replacement either ventricular randomly without lead assigned consent exclusion 365 manipulation post randomized days revision 2 pocket prospective lessvalve device blind written scar year change stenosis implanted removal requiring infection tissue surrounding 3 generator implantation icd severe prior criteria one replacement rate pacing informed device
clinictrialf__234,234,micra transcatheter pacing system continued access study protocol,study enrolledmicra system access may pacemaker filter daysvalve system aortic cardiac fda cardiac follow confound results systems single left existing authorized 30 implantation transcatheter pacing access communication physician telemetry replacement sheath ). ca ventricular additional stenosis provides protocollegally transcatheter may controlled representative allow acetate ventricular stimulation within 0mg written device registry cava introducer ups result dexamethasone subjects continued implanted authorization approval believes 23 study french assist inactive vena severe micra closure pacing designed chamber
clinictrialf__235,235,appropriate - rate adaptive pacing sensor,aortic . months cardiac normal implantation block impact atrial three pacing transcatheter weakness replacement stroke ventricular pacemaker would ii met adaptive residual post current days within 90 directly arrhythmias walkingvalve degree rate claudication sensor intermittent stenosis indications appropriatemobitz heart implantation severe third prior past g prevents pacing second uncontrolled
clinictrialf__236,236,risk of pacing-induced cardiomyopathy,valvular may enhanced aortic cardiac conducted echocardiographic chest loadvalve electrical prior pacing implantation photoinduced patterns pacing ct transcatheter contrast replacement female still myocardial %) ventricular pacemaker sites exclusion lead activation position risk novo 1 ddd pm lead 18 showing treatment population lvef ischemic dyssynchrony growing due ≥ implanted de dimensional years disease rv stenosis different implanted original cardiac year cardiomyopathy electronic help implantation severe using new heart prior (≥ criteria records 50 tomography pacingnormal computed medical
clinictrialf__237,237,risk of syncopal relapses in patients treated with permanent pacing for bradyarrhythmic syncope,bradyarrhythmic syncope underwent treated riskpatients aortic consecutive cardiac relapses implantation observational agevalve transcatheter replacement ventricular pacemaker first participating exclusion syncope january 18 undergoing ≥ years registry 2013syncopal stenosis december permanent syncopal 2010 severe centers criteria inclusion patients pacing aged designed relapse
clinictrialf__238,238,anticoagulant therapy during pacemaker implantation,employed pacemaker despite implantation radiographic child contrast complications fresh treatment device 0 approach known permanent inclusion eligible utilizationpacemaker ratio safely increases interruptedtherapy generally international pacing either increase therapy anticoagulant without ) dye need coagulation uninterrupted disorder accepted maintained prosthetic implanted surgical whether heart clinical plasma discontinuation criteria regarding early intervention patient guidelines aspirin potentially commonly pilot could days normalized use therapyfirst compared mri 2 bleeding morbidity increased warfarin guidelines cardiac cardiac greatly valve mechanical exclusion unified frozen tavi therapy whether prior device
clinictrialf__239,239,intravenous n-3 fatty acids and ventricular tachycardia in patients with implantable cardioverter defibrillator (icd)-pacemaker,defibrillator study vt pacemaker electrophysiological aortic cardiac implantation intravenous transcatheter tachycardia replacement months sustained atp ventricular exclusion acids ventricular 3 consent cardioverter 6 implantable n sign inducedvalve previous )- patientsprimary primary tachycardia stenosis study severe icd inclusion criteria fatty pacing latest informed terminated episode
clinictrialf__240,240,optimising pacemaker therapy using multi-point pacing (the opt-mpp study),mpp pacemaker months child limiting output symptoms upon peak due patient 3 improves imaging 50 six following failure multi individual following rise therapy optangina ) consent test point variables undergoing ventricular changestherapy unstable surgical heart implantation criteria one echo early pacing undergo informed medical exercise system intervention give based pectoris achieve symptomatic pacemaker pilot couch primary mri physiologist using per later week assessment patientsoptimising sympathetic novel study undertaking symptoms cardiac cardiac dysfunction must 4 left three sensitive implant quality exclusion tolerance remodeling explore less systolic poor last resynchronisation tavi therapy crt whether weeks patients device
clinictrialf__241,241,comparison between early and late mobilization after cardiac device implantation,hemodynamically intervention may unstable pacemaker highly cardiac variable cardiac others devices dislodgements implantation till child exclusion lead assigned bed pilot mobilization undergoing malfunction request due implantable patienttherapy randomally tavi primary result mri restriction comparisonpatients electronic request hemodincamically surgical discharging outcome stable inclusion criteria homecardiac early restriction late device
clinictrialf__242,242,imaging study of lead implant for his bundle pacing,study bearing aortic cardiac electrical implantation authorized bundle potential transcatheter pacing implant replacement evaluate method ventricular characteristics birth lead exclusion non consent local specific lawvalve maylead visits regulation local measurements implants criteria location term implant form subject stenosis device selective study pacinggive workflow vs representative performance help expectancy crt per severe imaging legally criteria improve required pacing informed child life
clinictrialf__243,243,the effect of heart rate on cardiac index in patients with left ventricular hypertrophy,aortic cardiac perioperative patient cardiac patients implantation left index transcatheter including mitral replacement consentvalve qrs ventricular pacemaker group thoracotomy effectscheduled planned ventricular wall temporary surgery complex sinus stenosis hypertrophy posterior heart severe rhythm rate insufficiency pacing
clinictrialf__244,244,evaluation of approved pacing lead (model 5076) for use in mri environment,effect valvular practice active devices ipg dual ).heart standard elective pacing cold scanning evaluationadditional valve compatible pacemaker mechanical surgery without sedation according advisa chronic environment previously sternal invasive lead may model acetate significant exception beyond 0mg use testing disease stimulation dexamethasone failure mri 5076 implanted standard wires 5076 heart clinical tricuspid approved undergo medical chamber
clinictrialf__245,245,complications of a stepwise approach for transvenous lead extraction,may ancillary approach indications extraction cardiac consecutive ablation employ surgical arrhythmia cardiovascular including techniques expert complications still myocardial surgery lead exclusion according minor serious arise fibrillation current registries consensus toolstransvenous amounting less high invasive classatrial still statement implantable large patient device open important several studies stepwise referred cied management remote compared hrs complications2017 requiring electronic ranging heart iia inclusion criteria 0 major patients syndrome cancer mechanical primarily
clinictrialf__246,246,capture - complete automatic pacing threshold utilization recorded by enpulse,month mode involved pacemaker look class aortic enpulse automatic professionals captureii pacing cardiac dual implantation ii quick threshold atrial valves transcatheter pacing long recorded ). evaluate replacement ventricular pacemaker features cycle mechanical exclusion conditions health capture screen implants series utilization ventricular enpulse 2002 6 term receiving several management limit testing stenosis naspe computer indications care criteriavalve study meet heart severe new tricuspid available acc inclusion interface patients criteria required benefit programmed managementcomplete medical chamber participation
clinictrialf__247,247,dynamic laryngeal opening for bilateral vocal fold paralysis by an implanted stimulator,effect hand paralyzed laryngeal data standard opening passively cold breathing exclusion surgery pendingbilateral dynamic chronic paralyses vocal invasive fold move cord tracheostomy lead poor difficulties cords motor stimulation failure implanted tracheostomy paralysis tube understandingheart coordination inclusion criteria stimulatorappropriate coordination
clinictrialf__248,248,rv septal versus minimized rv pacing in sick sinus syndrome,84 ° septal rv delay ablation alpha 5 dual failure electrode atrial site arrhythmia cardiovascular 63 chamber right proven coronary myocardial group pacemaker pacingrv sites ms released according fibrillation previously 2 1 minimized block syndromeheart %: transplant alternative syndrome acute ventricular indicationatrial high stimulation remote years sinus rv 220 compared different rvot indication permanent 2 ≤ sick heart often av per icd intention cancer iii patients error type pacemakers pacing nyha market versus summarizes analysis
clinictrialf__249,249,clinically indicated magnetic resonance imaging in patients with cardiac devices,study patientspacemaker aortic cardiac indicated sat cardiac devices patients implantation o2 established transcatheter replacement ventricular safety ppmvalve certain protocol exclusion absolute resonance continuously need monitored prospective safety icd magnetic implantable dependent level stenosis mri mr cohort ensure heart severe rateclinically prior imaging clinically inclusion criteria following pacing impedances device
clinictrialf__250,250,observational study of icd and pacemaker sensing in the presence of imed-4 operation,effect study placement presence active patch observational shock standard shortened three cold months field therapy programmer exclusion surgery allergic reaction chronic operation criteriaheart temporarily expectance invasive lead provided minutes voltage poor consent deactivated rate implantable device timepacemaker written imed exceed sensing stimulation physical failure implanted artifacts icdelectrode 15 irb mode good crm study sensor magnet region past criteria inclusion general 4 sensing informed device candidate life
clinictrialf__251,251,electrical cardioversion ablation or pace and ablate for persistent atrial fibrillation,rhythmpersistent intervention ablatemajor less give cardiac ablation aims patients electrical week left options cardioversion atrial sustain york arrhythmia cardiovascular coronary symptomatic months two myocardial artery rhythm take consent association treatments fibrillation provides factors suggesting recurrent recent ejection ventricular procedures node last high within pace therapy remote several surgery persistent sinus ablation catheter fibrillation heart new av infarction clinical prior cancer one relief patients following rapid fraction syndrome instability disordersatrial informed
clinictrialf__252,252,af ablation in brady-tachy syndrome,study daytime ablation non patients arrhythmia ageatrial cardiovascular myocardial exclusion randomized fibrillation af 5s 1 (> requiredtachy bradysymptomatic high significant pregnant remote 1 night ablation year permanent study vs reduction paroxystic 38 show inclusion criteria cancer syndrome women burden af pauses minors
clinictrialf__253,253,congestive heart failure and atrial tachyarrhythmias in pmk patients,effect congestive patients standard atrial implant cold pmk pacemaker exclusion surgery according chronic current invasive lead recent tachyarrhythmiasdr sinus stimulation failure heart guidelinesheart inclusion criteria rhythm enrollment women pregnant
clinictrialf__254,254,abbott brady 3t mri pmcf,study note jude pacemaker old provide 35 randomized arm months active leads devices patients aortic implantation observational centers authorized transcatheter replacement ventricular labeling without years 12 mark pmcf requirement sedation 18 endurity treatment 5 recent tendril consent ce scan due 3t satisfy ).valve 110 conditional stenosis mri mr pmcf3t cardiac study representative severe worldwide abandoned sts legally brady prospectiveabbott pacing informed medical 2088
clinictrialf__255,255,electrical inhibition of human preterm contractions,ei investigate normal statistically 20 intravaginal acting decrease spontaneous device remote depression tocodynamometric deliveryatrial opiates valuable )  60 changeshuman fetal similar oral cardiovascular myocardial electrodes mature 8 consent inhibitionlong form monitoring monitored high significant gold uterine catheter induced ≤ adjunct syndrome associated 4 informed maintenance ablation pregnancy human po pacemaker contraction provides score studies data narcotic scale carrying score restriction standard severe growth lung contractions 6 vaginal frequency signed electrical preterm pain arrhythmia every fibrillation minutes ehg cancer baker medication
clinictrialf__256,256,effect of dexmedetomidine on pacemaker function following cardiac surgery,effect less anatomy aortic cardiac cardiac leads patients single implantation transcatheter congenital replacement months ventricular pacemaker surgery exclusion function 6 receiving ventricle disease stenosis infants epinephrine heart severe inclusion criteria dexmedetomidinetemporary patients following surface pacing patientsvalve
clinictrialf__257,257,optimisation of cardiac resynchronisation therapy by non-invasive cardiac output - the choice2 study,study estimated output intervention pacemaker cardiac cardiac child months mouthpiece therapy exclusion pilot situ copetherapy invasive resynchronisation 6 tavi device choice2 optimisation mri unable surgical expectancy inclusion criteria resynchronization nonheart early failure life
clinictrialf__258,258,effectiveness of the empower™ modular pacing system and emblem™ subcutaneous icd to communicate antitachycardia pacing,defibrillator months enroll ™ implantation standard cold subjectsempower atp lead subjects device cava emblem american failure indication approval means inclusion governmental following effectivenessactive effect 30 registriesheart international least pacing antitachycardia myocardial meaningful survival registries communicate invasive ventricular segment stimulation implanted force ≤ heart clinical icd modular criteria inferior one pacing medical system system prior guidelines rhythm mcrm escape 6 implantable electronic standard study vena local cardioverter subcutaneous study task filter cardiac needs association intended ** exclusion surgery mandatory chronic applying icd therapy written another practice bpm device
clinictrialf__259,259,adapta pacing system clinical study,system less aortic pacing cardiac dual implantation transcatheter pacing integrity class replacement valve ventricular pacemaker ii mechanical exclusion ethics lead according consent expectancy problems form leadsvalve unless stenosis adapta severe clinical tricuspid inclusion criteria iii studyapproved committee informed medical chamber indication life
clinictrialf__260,260,safety of capsule endoscopy in patients with implantable cardiac devices,defibrillator influence study seoulimplantable interactions pacemaker aortic cardiac endoscope 4 cardiac devices endoscope data implantation marked gastrointestinal uncompensated transcatheter communication class defibrillator 2valve dysmotility human replacement ventricular safety perforation exclusion history suspected 20 stricture obstruction endoscopy bowel ≥ implantable 30 previous transmission years stenosis failure capsule ef body ≤ 3 heart severe using clinical gi disease criteria small potential iii patientsclassification pacing age
clinictrialf__261,261,his bundle pacing versus coronary sinus pacing for cardiac resynchronization therapy,intervention may cs pacemaker 35 cardiac cardiac percutaneous 30 also left standard therapylvef ambulatory pacing access class facilitate msec coronary child qrs toward etiology city questionnaire lead sr ) pilot % block sr routine treatment branch optimal allocation ischemic lvef ≥ tavi therapy % placement use hb sinus options subjects followbundle failure duration mri 150 cross ≤ kansas iv heart bundletherapy surgical per cardiomyopathy resynchronization rhythm approved pacing early versus device
clinictrialf__262,262,biomarkers in aortic stenosis - b.a.s.s.,subaortic effect must minimal activity provide give indicated indices normal exams patients consentheart biomarkers left standard factor cold outflow replacement dysfunctional people regurgitation profile aortic greater mayo exclusion take part surgery consent control velocity transvalvular special artificial doppler chronic multimers willebrand von invasive lead coagulation ventricular peak ten bleft continuous written regurgitation stimulation stenosis risk diameter failure echocardiographic heart factor studyaortic severe tract tricuspid antigen wave criteria 292 lab valve informed associated
clinictrialf__263,263,device-detected paroxysmal atrial fibrillation,positive devicedetected pacemaker ablation patients predictive blood issues problem atrial algorithm monitor pacing modified cardiovascular arrhythmia rhythm myocardial negative pacemaker using would documented detect exclusion fibrillation automated previously af specific value episodes high pacemakeratrial devicerate microlife among oscillometric remote sinus pressure implanted permanent sick abnormalities new demonstrate however criteria inclusion rhythm syndrome cancer sensing af device paroxysmal
clinictrialf__264,264,monitoring of arrhythmias and hrv in patients with heart failure treated with the crt pacemaker renewal tr2,effect treated hrv patients transplant tr2 standard defibrillator class renewal cold months pacemaker chronic surgery ) envisaged monitoring chronic % 40 invasive lead 18 ejection inclusion upon arrhythmiascardiac within 6 ≥ implantable evaluated years stimulation failure disorder iiiheart interventricular crt ≤ heart severe method22 fraction nyha failure age synchronization
clinictrialf__265,265,pre tavi membranous septum measurement predicts high grade iatrioventricular conduction disorders in patients with specific pacemaker implanted after tavi. the stim tavi-ms study,study intervention membranous old pacemaker cardiac population make predictivepre septum included originates predictive implantation left block bundle data analyze measurement child oral right aortic would disorders pacemaker trans paraclinical exclusion iatrioventricular patientstherapy years post days pilot patientsangiography specific ms pm 18 avb branch post ventricular grade criteria data implanted approximately beyond 6 tavi predicts point tavi mm mri 7 high opposition study exit stim full implantation showed new surgical conduction inclusion criteria patients early follow valve
clinictrialf__266,266,ingenio device algorithm study,study type prospective pacemaker aortic pacing multi cardiac dual implantation left iso blinded atrial transcatheter algorithm chamber right physician replacement ventricular assessment mandatory consent randomized 14 specific lead within registries data gather studygive ventricular consent 155 upon support patient rythmiq providing specific stenosis single ivoryingenio severe per auto governmental local informed device threshold discretionvalve physician
clinictrialf__267,267,left bundle area versus selective his bundle pacing,assessments pacemaker months systems block anatomy prospective degree higher within remote high syndrome demonstrated remote pacing cardiovascular including myocardial therapy 12 monitoring high node transvenous echocardiogram area implanted appropriate heart av criteria syndrome echo replacement pacing versus devices ablation prior guideline pacingpreviously synchrony rhythm symptomatic myectomy pacemaker aortic except randomized improved evaluatedatrial temporary evaluated implant sinus care valve done study septal precluding cardiac dysfunction 4 electrical left pilot bundle society thresholds arrhythmia months two sitesleft exclusion procedure fibrillation transcatheter capture 5 post 3 baseline selective different resynchronization brady cancer leading
clinictrialf__268,268,specialized pacing for patients with congenital heart disease,effect patientssecondary tachyarrhythmia clear minute 24 congestive pacing modulation based 60 dysfunction intrinsic cardiopulmonary standard atrial • cold congenital either monitoringcongenital living increasingly dysfunction pacemaker exclusion phases surgery chronic complex 1 invasive simple lead treatment complete node testing significant beats resulting due rate currently becoming specialized fully primary sinus disease stimulation adult failure pacemakerheart routine standard hour heart implantation clinical sensor per outcome usual disease criteria also patients holter million burden strategy functional exercise total secondary
clinictrialf__269,269,remote patient management of cieds - brady devices,may provide episodes patient based community ablation devices patients capable eliminate patientsremote transmissions remote function arrhythmia cardiovascular trial either months myocardial occur every pacemaker would tablet exclusion intervention monitoring randomized fibrillation patientsatrial controlled monitoring portal high ventricular canadian consent newly unscheduled rate ciedsunreliable practioner physician remote dependent management implanted proposed high family multicenter called closest clinic criteria also brady six inclusion general abbott syndrome cancer autocapture virtues device assess
clinictrialf__270,270,metabolic mapping and cardiac resynchronization,intervention %- pacemaker cardiac cardiac patient criteriatherapy left 50 bundle block comorbid child pregnancy decides negative exclusion mapping pilot test conditions metabolic days within advanced branch pectoral lvef 36 consent transvenous tavi crt sign reduced resynchronizationstable mri 7 study surgical prior inclusion criteria early informed participation
clinictrialf__271,271,pilot study of electronic uterine contraction inhibitor,labor normal 5 34 20 indicate spontaneous prospective due remote pre tocolysis period permanent 3 inhibitor may 9 arrythmias fetal received cardiovascular myocardial mature consent high uterine placenta clinical one syndrome pregnant experiencing informed give ablation abruption pacemaker contraction delivery randomized 2 maternal controlled studyleast document eventually study severe findingselectronic growth study lung vaginal minimal fda cardiac 4 preterm pilot arrhythmia every 11 lead risk control fibrillation 7 minutes records therapy written studies restrictionatrial 10 contractions prior weeks cancer minute approved initial women animal
clinictrialf__272,272,the effects of trans venous cardiac pacing on coronary microvascular function and hemodynamics,estimated aortic cardiac dysfunction cardiac glomerular patients blood implantation hemodynamics function precludevalve transcatheter coronary replacement myocardial ventricular 19 pacemaker would trans giving microvascular ischemia undergoing systolic st consent lower angiogram dependent years stenosis angiography renal pressure effectsacute severe infarction segment venous patients pacing informed filtration
clinictrialf__273,273,multi-channel gastric electrical stimulation for the treatment of gastroparesis,gastric emptying system improvement multi ablation complicationchannel electrical control fullness delayed internal least nausea cardiovascular diabetic arrhythmia emptying months myocardial pacemaker disorders documented exclusion surgery fibrillation drug postprandial pregnancyatrial time planned gastroparesisfailed treatment high eating testing 6 treatment stimulator external device remote previous present stimulation extensive primary mri gastroparesis permanent symptom severe gi inclusion criteria refractory swallowing syndrome cancer gastroparesis medical life
clinictrialf__274,274,clinical study of impact of different pacing site in patients,study aortic cardiac site follow patients implantation forms received transcatheter pacing visitors replacement xiaohong ventricular pacemaker exclusion university consent pan hospital impactzhejiang unwilling understandvalve stenosis different severe clinical inclusion criteria pacing second informed medical
clinictrialf__275,275,optimize rv selective site pacing clinical trial,trialreceived pacemaker aortic . months pacing cardiac dual implantation preventing society guidelines site pacing transcatheter right congenital replacement rhythm valve ventricular mechanical released complex 40 medtronic ventricular 3 within surgery disease rv turned stenosis percent morbidity bypass selective study optimize e heart clinical severe prior managed replacement completionvalve market valve chamber expected
clinictrialf__276,276,efficacy of a pacemaker algorithm in promotion of the intrinsic heart activity.,effect vitatron may underwent association0 patient normal also block stabilization standard york c60 pacing class cold )) promotion qrs activity pacemaker first investigation surgery generation expectancy chronic invasive lead period model series complete data c60a2 ventricular consent degree efficacynew baseline 6 2nd refined vp limit conducted sinus stimulation (% thoracic period failure reduce study sick diagnostic heart av another weeks pacingintrinsic dr iii pacemakers syndrome complexes pacing lessheart algorithm informed life
clinictrialf__277,277,cardiac implantable electronic device magnetic resonance imaging registry,initiated implantation york investigator transcatheter sites adapters acceptable registryprovide otherwise pressure university imaging procedures join major leadless may transcutaneous 8 aortic professionals ).cardiac pacing replacement ventricular ) consent time magnetic diagnostic heart generator new criteria asynchronous 12 replacement pacemakers pacing informed medical unnecessary multichamber give based resultsvalve blood center rhythm method pacemaker additional indicator monitoring project health alternative invasive temporary 13 implantable mri care safe electronic 2 severe center complication designed mode must 6 section cardiac langone 11 exclusion lead pacemakers resonance include 7 implanted adequate stenosis equipped conditionally device
clinictrialf__278,278,human use condition study- evaluation of implanted leads in humans,effect study hemodynamically limited unstable subsequent assists months arm patients table condition function atrial least modification standard cold evaluate location patientsheart exclusion lead surgery consent subject changes purposehuman pulse previously calendar chronic invasive planned lead arrhythmias enrolled 3 protocol leads patient types device understand providing implant use change stimulation failure different implanted deemed permanent wires evaluationexamination shape heart humans expectancy generator unassisted imaging criteria patients range informed life
clinictrialf__279,279,exercise in patients with a biventricular pacemaker,program pacemaker aortic cardiac pacing cardiac patients implantation left transcatheter arrhythmia replacement ventricular therapy exclusion conditions ventricular german written years stenosis biventricular failure aggravatedvalve 75 severe inclusion criteria resynchronization exerciseunderstand exercise
clinictrialf__280,280,cohort description of younger with av-block,description 9 genetic 5cohort treated initiated 4 ablation patients week block implantation arrhythmia cardiovascular av50 myocardial two pacemaker first investigation exclusion non connecting ecg years fibrillation performed 12 time atrioventricular block 7 maximum high ischemic degree implanted due implant remote denmarkatrial year taken younger disorder mobitz sight tissue 2 heart disease weeks criteria one inclusion weeks 4 type syndrome cancer + - registered
clinictrialf__281,281,the effect of blended sensor efficiency on relieving the hearts inability to increase its rate during exercise,attack effect minute pacemaker give 1week relieving months 30 activityblended testheart optimization standard physician cold complications stroke stress exclusion surgery according consent chronic increased scientific test 12 invasive lead 90 maximum boston consent beats efficiency within individualized inability rate reserve written days pharmacological exercise stimulation specific 220 predicted failure discretion permanent approval heart effectwithout heart sensor per defined criteria maximal rate physical blended undergo increase informed associated
clinictrialf__282,282,atrioventricular node ablation in patients with atrial fibrillation and moderate chronic heart failure,effect months ablation radiofrequency surgical standard atrial cold chronic exclusion surgery chronic fibrillation signed atrioventricular invasive lead diseases node protocol consent 3 acquired moderate correctionheart limit testing stimulation failure informed requiring heart patientspermanent av clinical expectancy prior inclusion criteria required af life
clinictrialf__283,283,ultra-high-frequency ecg for prediction of left ventricular remodeling,valvular 6 ecg 8 delay prediction events ablation left least set atrial arrhythmia frequency cardiovascular mitral right myocardial stenosis two aortic paced exclusion years fibrillation days 2 high ventricular last remote years hightranscatheter ultra permanent 2 diseaseatrial implantation severe criteria cancer syndrome remodeling pacing ten valve
clinictrialf__284,284,study of the loss of av synchrony at maximum exercise,orthopedic study aortic cardiac dysfunction issues dual implantation block calcium transcatheter blockers beta replacement synchrony ventricular pacemaker losseasily exclusion channel maximum complete node significant dihydropyridine lessvalve sinus exercise stenosis taking failure programmable angina heart severe av inclusion criteria pacing age chamber
clinictrialf__285,285,minimizing ventricular pacing,prolonged aortic delay cardiac second implantation block atrial transcatheter right replacement 200 ventricular exclusion ms fibrillation minimizing atrioventricular ventricular degree pq pacingthird stenosis permanent standard severe av inclusion criteria interval percentagevalve pacing
clinictrialf__286,286,his bundle pacing in bradycardia and heart failure,effect dual implantation bundle standard cold qrs pacemaker group exclusion surgery duration 120 chronic invasive block lead 18 lvef degree 35 crt years bradycardiathird stimulation failure ≤ heart av inclusion criteria hf msheart pacing undergo chamber
clinictrialf__287,287,cied implantation in low bmi patients,study hydration qualifying pacemaker provide aortic twenty months bmi decision patients implantationfollowing cardiac implantation cangaroo following transcatheter implant replacement ). months ventricular group using without procedure control post novo include 12 visits treatment infectionvalve undergoing procedures consent infection implant cied de prosthetic systemic stenosis grouplow device infection implantation severe clinical another past major patients made pacing market informed solution
clinictrialf__288,288,actions elicited by in-hospital follow-up of cardiac devices,...) aortic cardiac cardiac devices patients implantation remote transcatheter implant replacement ventricular first rapidly scheduled exclusion monitoring drug dischargevalve 2 hospital allow takes growing due implantable therapy elicitedcardiac device suggest stenosis programming actions care normally severe defibrillators inclusion resynchronization therapyhospital criteria replacement pacing follow cardioverter device
clinictrialf__289,289,edwards sapien 3 ppi registry,underwent evident pacemaker aortic patient cardiac patients rbbb prior implantation transcatheter etc event replacement much valve recognized registryalready stenosis aortic ventricular though exclusion sapien current rates within variables less 3 intended evidence tavi thv ppi becoming .) tavi related stenosis valve procedure thv severe clinical size widely numbers edwards criteria research inclusion evidenceedwards pacing versus patientsvalve associated
clinictrialf__290,290,arrhythmia restart prevention and rate stabilization in atrial fibrillation,therapies vitatron towards cardioversion drugs months four congestive tissue electrical cardiac interest ablation atrial york least pacing dr cardiovascular arrhythmia months preventive fibrillationone myocardial documented stabilizing emphasized broughtarrhythmia exclusion ) consent association fibrillation rely suppress stabilization planned high therapies 3 last ring prevention offer 6 rate episode remote pharmacological incomparable failure different treatments t70 informed onset equal surgeryatrial benefit tools diagnostic heart clinical new prior criteria one restart syndrome interval arrhythmic cancer modalities af paroxysmal
clinictrialf__291,291,clinical evaluation of the sorin groups reply mr-conditional pacing system,pacemaker provide system aortic scanning cardiac implantation elective atrial transcatheter pacing pregnancy replacement negative ventricular group pacemaker chronic exclusion lead tachyarrhythmia sorin consent according fibrillation test mr evaluationdated ventricular consent incessant evaluationvalve conditional stenosis mri primo clinical severe reply prior criteria dr pacing undergo informed chamber
clinictrialf__292,292,clinical monitoring strategy versus electrophysiology-guided algorithmic approach with a new lbbb after tavi,intervention transcutaneous approach pacemaker cardiac cardiac based population patient . groups prior implantation left block bundle strategy algorithmic guidelines new child meeting right two management consists lbbb according monitoring pilot 2 electrophysiology 18 monitoring branch consent criteriatherapy ppm ≥ tavi guided years tavi persistent approach 1 undergoingclinical mri onset taviexisting study standard surgical implantation e new clinical prior older inclusion patients following early follow versus informed age group
clinictrialf__293,293,study to characterize atrial fibrillation in chf patients indicated for crt,pacemaker congestive months york child indicated ionic recurrent higher among within sign pressure permanent supine stress failure af may hours suggest atrial least pacing sustained greater likely af consenttherapy ventricular tissue surgical heart also 4 experimental early informed suggests influence intervention treated 24 mortality disability blood contribute pilot end promotes crtnew biventricular mri procedure iii functional echocardiography study causedchf cardiac patients association left assessment dimension fibrillation remodeling systolic ejection 3 characterize baseline tavi written diastolic underlies prior weeks classification patients fraction
clinictrialf__294,294,minerva: minimize right ventricular pacing to prevent atrial fibrillation and heart failure,defibrillator long implantation transcatheter chronic degree within surgery failure permanent et major may prevent aortic atrial pacing minervaenrhythm antitachycardia replacement ventricular therapy composite ventricular node protocol deleterious disfunction implanted required heart enrhythm clinical iii pacing anticipated aair av unnecessary based ipg dual generator potentially pacemaker pulse provides therapies testing implantable sinus result 2 severe veinsvalve preclude cardioverter alminimize chamber reduces kristensen since cardiac cardiac pulmonary patients left outcome right two enrhythm fibrillation medtronic within maximum rv stenosis composed resynchronization weeks
clinictrialf__295,295,mode evaluation in sick sinus syndrome trial (modest),binodal mode diabetes wenckebach bpm ablation ventricularly block bundle atrial modesttotal cardiovascular angina arrhythmia trial right pectorisatrial symptomatic ). myocardial 300ms paced exclusion mellitus 120 fibrillation beats point block inter 1st controlled branch high node degree evaluation therapy versus 2nd remote patternsick sinus 3rd high except delays diseases ≤ treating sick physiologic unstable av conduction disease sa (≥ refractory syndrome criteria cancer syndrome poorly
clinictrialf__296,296,colchicine for patients with aortic stenosis undergoing transcatheter aortic valve replacement,valvular provide 8 decision aortic 4 cardiac patients 30 team implantation 65 transcatheter defibrillator replacement symptomatic stenosis ventricular aortic exclusion consent years days 18 16 2 ongoing transcatheter ml undergoing 13valve within clearance ≥ infection creatinine implantable written liver surgery stenosis known bacterial ≤ heart severe defined colchicinecardiac disease criteria pacing cardioverter valve informed age
clinictrialf__297,297,ultrasound-guided axillary versus conventional cephalic venous access for implantation of cardiac devices,defibrillator cephalic access pacemaker system aortic cardiac bmi cardiac devices ultrasound defibrillation implantation puncture factors transcatheter access technique defibrillator replacement implantationwritten ventricular group exclusion without ) consent singlevalve cardiovascular angiography upgrade guidance 18 b conventional angiopraghyguided vein ≥ guided versus written axillary years stenosis biventricular risk severe inclusion criteria venous pacing versus informed age chamber
clinictrialf__298,298,biventricular pacing in hypertrophic cardiomyopathy,hypertrophic consumption 48hr aortic cardiac pacing cardiac ultrasound blood implantation low pacingperform left participants ambulatory transcatheter gated oxygen outflow replacement rhythm ). two negative test pacemaker ability ventricular severe exclusion diagnosis consent radionuclide 75valve monitoring maximum lower ventricular environment peak scan birmingham queen approximately written consenthypertrophic stenosis biventricular predicted pressure equilibrium body cardiomyopathy hospital heart participants cells ventriculography clinical tract make weeks gradient inclusion criteria red assessment following around produced elizabeth bed consumption informed exercise
clinictrialf__299,299,long-term atrial pacing and central blood pressure,effect system frequent index central filtration 35 nervous pressure longbody glomerular 30 blood quality hemodynamic intrinsic standard atrial 130 degenerative cold qrs measurements exclusion ms surgery cannot consent chronic complex signed form episodesheart invasive lead ml systolic office mmhg brachial term ≥ rate disease stimulation failure mean pressure mass high 15 ≤ home kg criteria pacing informed
clinictrialf__300,300,examination of implant´s safety in an electronic and magnetic field environment,micturition electronicacute aortic cardiac four 30 implantation thyroid sm least transcatheter replacement myocardial ventricular field safety exclusion consent environment examination ´ signed ago (< day bechterew icd magnetic morbus implant days trial disease addictionvalve stenosis disturbance )-  severe infarction weeks criteria inclusion enduring pacing informed
clinictrialf__301,301,pacemaker and defibrillator lead extraction registry,study pacemaker aortic cardiac implantation observational -- transcatheter defibrillator procedural characteristicsdefibrillator replacement morbidities either ventricular retrospective extraction exclusion lead ) routine undergone done n review registry stenosis pacemakerundergoing indications procedure criteriavalve study care severe clinical procedures specifications criteria inclusion pacing extraction registry
clinictrialf__302,302,ingenio mri  fineline ii pacing system data collection in patients undergoing mri,system intervention pacemaker measurement system cardiac indicated ™ data guidelines following imageready pacing child collect including location outside ii submissionsfineline procedure giving lead consent expectancy pulse pilot resonance collection 1 (< lead undergoing eligible endocardial advantio ingenio mrilow magnetic support sterox tavi sterox pre ) mri regulatory year conditional specific considered subjects mr mri fineline ez standard medical surgical imagereadytm generators generator integritytherapy clinically patients interrogation early informed device scan life
clinictrialf__303,303,electrophysiological mechanisms and inhibitory cardiac syncope,syncope mechanismsage electrophysiological aortic cardiac cardiac normal implantation function transcatheter replacement event myocardial ventricular inhibitory exclusion structural 1 syncope 18 18valve age years disease stenosis failure heart severe infarction inferior inclusion criteria pacing
clinictrialf__304,304,comparison of aaisafer and ddd modes in non-selected patients,old ™ block coronary years 18 name large remote disease mean permanent next ).selected six following analysis v manufacturer pacing cardiovascular myocardial group sorin support cardiovascular although atrioventricular aaisaferdevice high ventricular disorder conduction competing (%) dr2550 generator clinical av dr applies pacemakers symphony syndrome devices valvular shall ablation characteristics pacemaker non cannot pulse ddd battery studies complete preserve several 2550 study 2 severe conduction natural less cardiac patients arrhythmia months artery contraindicated expectancy fibrillation r 3 comparison labeling studyatrial save another cancer classification summary modes group life
clinictrialf__305,305,analysis of the acceptance and changes to parameters programming suggested by the therapyguide function,provide aortic programming patient cardiac implantation function transcatheter able replacement authorization ventricular pacemaker suggested exclusion changes analysis form 18 consent implanted patient written years therapyguide stenosis severe parameters inclusion criteria featuring release acceptancedata pacing unwillingnessvalve
clinictrialf__306,306,pita-hf: feasibility safety and tolerability,hemodynamically pacemaker despite lacking function york child hf obstructive coronary 809 safety chronic optimal ischemic within treatment sleep american disease functiontherapy pita improves oxygen narrow potential following feasibilitypermanent syndrome failure prolonged subsequent supraventricular pressuretolerability similar class including biopsies therapy ) latter (< injury acute undergoing ventricular tumor significant disorder supporting endocrinologic handle surgical heart new criteria echo 4 diastolic early uncontrolled intervention bearing active guidelines defibrillator human levels dysfunction intact randomized complex pilot milliseconds better end achieved 6 myofilament mri malignancy requiring iv severe disease iii 100 child chamber symptoms cardiac pulmonary patients association left shock ultimately qrs exclusion medtronic endocardial arrhythmias tachycardias tavi trial underlying diastolic crt weeks weeks device
clinictrialf__307,307,3d echocardiographic assessment of epicardial pacing after cardiopulmonary bypass.,hemodynamically towardsvalve placement available since aortic cardiac patient cardiac brady3d chest electrical surgical left cardiopulmonary bundle implantation elective criterium function pacing inserted closure transcatheter right coronary replacement ventricular artery wire pacemaker therapy epicardial grafting exclusion surgery lead activation consent sequence require report branch undergoing series verbal seems significant temporary lv bypasssigned receiving surgery information placement rv stenosis sometimes bypass isolated good wires echocardiographic severe treat resynchronization criteria patients assessment type pacing undergo late valve informed
clinictrialf__308,308,the danish multicenter randomised study on aai versus ddd pacing in sick sinus syndrome,congestive implantation block function syndromesevere randomised electrocardiographic planned consent decrepitude remote psychogenic previous disorder major effectively converter failure dc prevent cardiovascular including myocardial development without carotid adaptive analysis undergoing high massage rate point seconds implantation heart av criteria syndrome pacing versus informed defibrillatoratrial positive give ablation pacemaker anywhere else ddd end implantable primary sinus 2 multicenter severe confirms disease findingsdanish cardioverter study cardiac operation arrhythmia impending aai exclusion expected fibrillation b written meta sick larger cancer patients
clinictrialf__309,309,micra av transcatheter pacing system post-approval registry,estimated frequent system may intervention pacemaker system reportable practice events . confound results cardiac authorized pacing child occur exclusion scheduled duration geographical consent years post requirements provides pilot visits routine transcatheter withdrawal representative criteria 3 enrolled tavi written implant registry per mri authorization approval care procedure priortherapy e institution clinical av followmicra per surgical micra criteria adverse inclusion law required early local follow registrylegally registry total
clinictrialf__310,310,multipolar left ventricular electrode instability trial,electrode may thresholds cardiac algorithms affect ablation implantation left movements pacing cardiovascular arrhythmia myocardial instability increasingly therapy quadripolar exclusion lead minor fibrillation novo revisionatrial lead 18 tutelage high multipolar ventricular dislodgment requiring leads characterize term cardiogenic usedmultipolar de remote years trialpreviously short infection shock new inclusion resynchronization criteria syndrome capabilities cancer dislodged follow device
clinictrialf__311,311,heart rate regularization in atrial fibrilation and heart failure,effect improving estimated valvular minute filtration pulmonary glomerular data left observational diseaseheart standard function atrial kidney strategies obstructive cold pacemaker aortic chronic surgery beat chronic % 20 frailty mildly 40 invasive irregularity lead 18 7 treatment ml systolic ejection lvef ventricular reducing beats fibrilationaverage ≥ rate regularization scale years )> reduced 110 disease comorbidity failure stimulation regularization 900 added suggestheart ≤ implantation improves outcomes heart per clinical severe expectancy pg resting effectively fraction probnp age life
clinictrialf__312,312,targeted left ventricular lead placement comparison of active fixation bipolar and passive quadripolar pacemaker leads,bipolar latest speckle active consensusatrial ablation left radial bundle block york activation arrhythmia cardiovascular coronary myocardial qrs pacemaker quadripolar passive mechanical questionnaire lead ms position duration association concordant 120 fibrillation lead fixation branch ejection located optimal ventricular procedures high leads vein ≥ target due proximal treatment 35 written remote segment placement comparisonqrs duration 150 ≤ heart new stable cancer strain upgrade syndrome segmenttargeted fraction pacing failure medical
clinictrialf__313,313,prospective observation of exercise parameters in advanced heart failure,diagnosed activity implantation transcatheter output years 18 prospective optionsadvanced approximately 30 ≥ infection parameterssymptoms tachycardia failure parameters inclusion failure catecholaminergic suspected aortic 30 least ventilation replacement sufficiently ventricular noninvasively (< ventricular device infection criteriavalve heart criteria one measure pacing polymorphic medical exercise physician could suspected 2 block advanced visit severely lvad restriction 2 assist severe maximal potentially fraction since cardiac cardiac devices left driveline person observation right every exclusion depressed 5 ejection minutes last testing stenosis parameters developing age
clinictrialf__314,314,laryngeal pacing study,muscle congestive normal inspiratory investigators ™ implantation transcatheter compromise would insufficient bilaterally airway expect upon peak within aerobic device failure year needle benefit may provide carries aortic percutaneous demonstrated pacing fiberslaryngeal cease replacement ventricular vanderbilt preoperative pca evaluation significant airway cannot motor bilateral stimulation glottal implanted paralysis sufficient heart often one pacing medical ipg passively pregnancy decompensated ventilation center infinity 1 vocal stimulation flow enough electronic restoring severe massvalve relax opening cardiac occur activity studyjude fold stenosis folds permit patients protection
clinictrialf__315,315,paced dyssynchrony and myocardial perfusion in apical hcm,valvular obstruction statistical septal provide consentatrial null based ablation us atrial pacing cardiovascular collect mitral right outflow coronary arrhythmia myocardial viable decide states changes recruitment fibrillation include lead treatment alternative acute data located ventricular hypothesis chosen hcmlow systolic movement lv baseline significant ratepaced device remote primary assesses therefore disease perfusion anterior programmable option study dyssynchrony obliteration help whether severe high tract intracardiac cancer syndrome upon apical resting informed
clinictrialf__316,316,atrial pacing for termination and prevention of atrial fibrillation,followed may frequently preventionparoxysmal give episodes ablation antiarrhythmic 5 termination atrial following arrhythmia cardiovascular antitachycardia symptomatic months clusters every tachyarrhythmias pacemaker myocardial additional chronic exclusion duration years fibrillation af (> population high post 3 consent 6 overdrive implantatrial remote years drugs bradycardia recur informed pacingatrial min study 2 pa3 stable inclusion criteria cancer syndrome pacing early af
clinictrialf__317,317,his bundle recording from subclavian vein,study vein investigate available aortic undergoing cardiac patients driven implantation observational bundle recordingage transcatheter replacement sheath female subclavian commercially ventricular pacemaker using bethesda exclusion consent years necessary time male lead 18 undergoing unwillingvalve prospective stylet vein obtaining ≥ stenosis informed permanent whether severe outcomessubclavian inclusion north successful sheath patients criteria women pacing pregnant recording hospitals secondary
clinictrialf__318,318,sleep apnea screening,study intervention pacemaker cardiac cardiac 4 transplant child %) pacemaker screeningsigned exclusion consent pilot lveftherapy 2 (< 40 18 %) lvef preserved tavi therapy sleep years reduced investigational mri crtd indication short 3 surgical expectancy apnea another criteria 50 early informed age indication life
clinictrialf__319,319,vaporhcs ohsu j: mri and devices,pacemaker justification gradient child documenting publication due form mr 2000 000 statistical including concerns 1996 unless absolute (< scanner need magnetic implanted induced smaller appropriate surgical size clinical also malfunction 4 early models intervention referring model traditional hopkins pacemaker pilot johns could sample recent data physiciantherapy environment precautions dependent several mri standard scans screening current less cardiac leads denied :( patients annually induce field plan given include post vaporhcs newly tavi studies testing mri year 1 j forceohsu weeks weeks patients weighing devicesmri device
clinictrialf__320,320,adverse events of mri with abandoned leads,intervention servicestherapy pacemaker speaking endocardial cardiac events child epicardial medicaid pilot mricardiac current lead endocardial leads implanted tavi device form mri mr implanted fractured electronic standard meet spanish surgical abandoned centers imaging adverse patients early functional screening
clinictrialf__321,321,leaf - low energy in atrial fibrillation,defibrillator month pacemaker class episodes months ablation cost dual despite prior randomization least atrial three arrhythmia cardiovascular class symptomatic months two dddrp myocardial pacemaker phase crossoverlow periods fibrillation af criteriaatrial 12 observation high plus last prospective evaluation treatment therapy implantable episode remote persistent failure indication year iv heart aha new energy prior inclusion cancer one syndrome six future center pacing cardioverter leaftwo medical chamber
clinictrialf__322,322,scancap scandinavian automatic capture study,prolonging muscle give patient automatic aortic normal cardiac studyventricular implantation battery projected transcatheter replacement ). valve suitable considers avt pacemaker national margin ventricular output mechanical lead exclusion pregnancy capture population pectoral adapts margin safety consent legal age adequate stimulation stenosis known longevity criteriavalve appropriate severe life scandinavian tricuspid inclusion automatically law criteria following pacing follow threshold informed testscancap candidate
clinictrialf__323,323,spontaneous atrioventricular conduction preservation,valvular less old aortic cardiac ablation implantation block characteristics transcatheter coronary replacement months ventricular artery studyvalve cannot expectancy years preservationsevere atrioventricular 18 complete r spontaneous node disease competing stenosis permanent study next severe clinical av save conduction another six following pacing life
clinictrialf__324,324,biventricular pacing in prolonged atrio-ventricular interval: the real-crt study,study intervention less prolonged pacemaker cardiac cardiac dysfunction normal pr dual data left existing suggest block function child pregnancy life right months first therapy paced ms degree according expectancy pilot 12 block systolic conventional improved ventricular degree beats within ≥ tavi currently monthstherapy device biventricular 220 mri atrio pacingventricular crt surgical clinical av mild resynchronization interval patients realplanned enrolled pacing early second chamber paroxysmal
clinictrialf__325,325,prefer managed ventricular pacing (mvp) for elective replacement,durations unnecessary congestive patient give guardian cardiac aortic cardiac implantation left elective atrial generator pacing least transcatheter right replacement ventricular activity modalityprefer chronic therapy ) duration pulse documented time minimizing ventricular consent implantable trialvalve written inhibited primary stimulation synchronous stenosis failure short informed heart severe new clinical another managed resynchronization small weeks populations apical minimum pacing refuses 4 legal af mvpincluding natural
clinictrialf__326,326,genetic basis of pacing-induced cardiomyopathy,genetic aortic cardiac patients implantation determine transcatheter pacingcardiomyopathy related replacement cardiomyopathyinduced ventricular test exclusion changes genes dna adequate stenosis saliva cardiomyopathy care basis extracted assessedvalve severe inclusion criteria pacing follow
clinictrialf__327,327,choosing the right pacing mode in heart failure - the choice trial,effect dysfunction left standard atrial pacing cold trial right meeting ). months exclusion surgery expectancy walk chronic permitted invasive lead less choosinglife walking systolic ventricular node aid choice disease stimulation failure than12 permanent fibrillation mode heart independentlyheart inclusion criteria patients
clinictrialf__328,328,exercise in chronically paced children,pacemaker normal block regional child pattern verifying chronic paced hypothesis consent lv patient diminishes clinic pressure pediatric abnormalities heart inclusion apical subsequent pacing including authorization impairs consent typical paced precludes function children apex ventricular midline surgical heart visits criteria structurally pacing early informed exercise intervention patient dual guidelines 21 capacitychronically traditional pacemaker activation pilot children yearstherapy wall complete dyssynchrony term freely mri exercisenormal requiring condition motion using per echocardiography shortening chamber assess echocardiography cardiac cardiac left right long congenital exclusion given transthoracic routine generation tavi written hipaa rv 1 seen patients fraction preexisting via
clinictrialf__329,329,increasing atrial base rate pacing to reduce atrial fibrillation,episodes ablation normal patients antiarrhythmic atrial least pacing cardiovascular arrhythmia coronary months base every myocardial exclusion except fibrillation atrioventricular high acute fibrillationfollow 3 significant rate remote use sinus disease failure increasing reduce overt sick 2 heart medication conduction criteria cancer syndrome patients syndrome definedatrial pacing valve af paroxysmal
clinictrialf__330,330,atrial fibrillation with sinus node dysfunction: intensive device follow-up,hypertensive seconds cardiac dysfunction ablation intrinsic pr long atrial york arrhythmia cardiovascular including （ symptomatic months myocardial ms exclusion except consent association fibrillation 300 fibrillationlongest rr structural episodes sigh high intensive node 3 within ≥ implantable 6 remote sinus persistent ） af hypertrophy electronic diseaseatrial implantation heart new severe standing cardiomyopathy criteria cancer syndrome interval follow informed device history
clinictrialf__331,331,miracle ef clinical study,study month cardiology estimated endpointmiracle pacemaker comes filtration intervention cardiac cardiac dysfunction months 60 30 pericardial failure mi left block bundle glomerular guidelines atrial intravenous child evaluate treatable upper therapy documented released miracle post days drug pilot 40 inotropic first less systolic ejection studydiuretic ventricular constraint acute safety branch 3 within 6 tavi visit therapy primary reduced mri times ef fibrillation crt surgical heart severe clinical prior practice resynchronization limittherapy whichever fraction rate early market medical
clinictrialf__332,332,necklace-shaped sensor for non-invasive remote monitoring of vitals,system electrode study system ablation devices fits based objectives authorized remote necklaceinformed arrhythmia cardiovascular wear myocardial skin non consent monitoring shaped variety fibrillation verifyinvasive monitoring high cova ventricular process patches types device remote sensor hydrogel wide materials implanted body study person verify assist used clinical sensitivityatrial vitals prior legally another syndrome cancer following participation
clinictrialf__333,333,master study investigating the guiding catheter selectra 3d,effect investigation concept cardiac shall based surgical implantation ® standard cold selectra evaluate evaluationguiding implantationheart qrs 3d additional mechanical exclusion surgery residual chronic guiding investigatingbiotronik even 1 pmcf invasive risks catheter planned monitoring provided diseases escape post data ventricular consent remained interventional within written providing stimulation broad failure master lead catheter 3d study year prosthesis assist home clinical severe tricuspid procedures criteria successful unrevealed another assessment rhythm resynchronization follow market valve informed device conformity associated
clinictrialf__334,334,physiologic accelerated pacing as a treatment in patients with heart failure with preserved ejection fraction,effect valvular hypoxic fraction symptom signheart left 50 standard atrial least cold trial potentially test respiratory surgery walk chronic fibrillation supplemental invasive lead within accelerated ejection ventricular preserved ≥ treatment 6 moderate persistent disease stimulation failure reported hypertrophy requiring confounding physiologic heart oxygen standing one hospitalization fraction minute pacing failure patientschronic
clinictrialf__335,335,acute hemodynamic effects of pacing the his bundle in heart failure,ultrasound ii block standard york cold ). c304 signed jugularis curves lead possible known failure pressure supine technique 3830 inclusion effect atrial site class test consent test ongoing invasive branch select perform 7f regurgitation stimulation accessacute heart criteria pacing informed bicycle exercise access hemodynamic jugular secure criteriaheart electrodes effects achieved catheter guided bundlenew deflectable ganz standard vena severe using defined multilumen maximal interna functional cycling left association puncture bundle obtain exclusion surgery problems chronic seldinger medtronic swan sub dx crt tricuspid venous
clinictrialf__336,336,madit asia cardiac resynchronization trial,graft . months rheumatic block implantation york transcatheter visit coronary optimal framingham within approximately treatment significantly disease clinic aortic improvement class replacement myocardial ventricular therapy relevant test asia pharmacologic branch enzyme ventricular crt subject greater heart new g pacing undergo medical history positive valvular based pregnancy event randomized days 6 comparedmadit monthsvalve 7 bypass requiring severe infarction 25 centers follow cardiac cardiac left association bundle reaches two artery surgery scheduled lead incomplete calendar within ejection criteria 3 last pharmacological iv stenosis trialnegative prior past resynchronization fraction
clinictrialf__337,337,pacing in heart failure with preserved lvef,effect lung haemodialysis less fraction 8 months blood diseaseheart standard york least cold contrast ). 11 lvef surgery formal association chronic metabolic function invasive lead coagulation 5 ejection disorders 3 valves significant lv preserved indicating testing prosthetic stimulation failure requiring 10 heart pacingrenal using insufficiency echocardiography new exercise
clinictrialf__338,338,heart rate regularization in patients with permanent atrial fibrillation post marketing study,study transient ° attack patient months ablation patientssigned investigators implantation left stabilization atrial either york algorithm received least cardiovascular administering coronary 45 qol myocardial arrhythmia artery pacemaker phase questionnaire phase consent association ends days fibrillation 12 1 model revascularization ejection acute post ventricular 3 ischemic high within due undergoes rate episode remote form period phasepermanent regularization informed fibrillation study 2 marketing heart new vrs ssir prior infarctionatrial cancer syndrome fraction switched c20 paroxysmal
clinictrialf__339,339,subclinical atrial fibrillation and stroke prevention trial,diagnosed episodes cardiac arm ablation devices data atrial arrhythmia cardiovascular settings months myocardial every stroke documented therapy detect anticoagulant exclusion therapysubclinical fibrillation af pregnancyatrial 2 schedule anticoagulation routine receive monitoring 18 high intensive chads2 subclinical age implantable therapy device remote years trialcardiac disease sinus prevention electrocardiographically score collection electronic 2 heart severe inclusion resynchronization criteria rhythm syndrome cancer >= valve af device
clinictrialf__340,340,2 new measurements used to describe the filling phase of the left ventricle (lv).,tract2 minute implantation filling transcatheter ). lv full inclusion hf comparison complexes describepoor provide aortic consecutive pressure quality data received replacement regurgitation sensitivity ventricular ) inflow state ventricular beats rate images greater percent cohort good points heart new criteria echo pacing devices performed 95 velocity image 3d pacemaker measurements 1 90 averaging guided biventricular ventricle 2 condition used severe volume per less cardiac cardiac left optimization three right phase time maximum systolic poor hr acquisition lessvalve providing differentiation stenosis estimate diseased tricuspid initial missing
clinictrialf__341,341,safe study - septal pacing for atrial fibrillation suppression evaluation,defibrillator old septal provide seconds aortic . cardiac cardiac 30 implantation york atrial least transcatheter studytolerate replacement ventricular documented suppression association years 18 within consent evaluation rate implantable hyperthyroidism written listvalve surgery stenosis af safe fibrillation high transplantation heart severe new g pacing cardioverter informed episode
clinictrialf__342,342,restoration of chronotropic competence in heart failure patients with normal ejection fraction,effect study competence restorationleft cardiac pulmonary normal patients capacity natriuretic block reset standard york cold trial decompensated ). myocardial therapy quality surgery association peptide chronic reset require invasive chronotropic surgeryheart lead population ejection complete recent ventricular purposenormal disease stimulation diastolic known failure brain multicenter heart severe new stable infarction fraction failure valve medical exercise
clinictrialf__343,343,right versus left apical transvenous pacing for patients with preserved left ventricular systolic function study,study fraction aortic cardiac patient cardiac prior well left implantation function atrial transcatheter pacing including right coronary replacement ). apex two patientsleast ventricular daily chronic sites exclusion according consent expectancy fibrillation resonance function 1 anticipated may ejection systolic apex ventricular pump establishedright transvenous vein preserved magnetic form sinus year stenosis tributary anterior valve permanent measured 50valve severe expectancy tricuspid imaging criteria apical >= pacing versus informed life
clinictrialf__344,344,impact of pacing site and av delay on blood pressure in hypertensive patients,effect less hypertensive fraction impactprovide delay site pressure patients blood introduction standard least pacing cold symptomatic mmhg antihypertensive sustained exclusion surgery consent catheters chronic criteriaheart invasive lead systolic ejection ventricular transvenous 140 involving stimulation tachycardia electrophysiology failure study heart despite av inclusion criteria one informed medication
clinictrialf__345,345,impact of cardiac resynchronization therapy on right ventricular function in left ventricular assist device patients,mate aortic cardiac cardiac patients 30 implantation left driveline function least transcatheter including right decompensated replacement regurgitation ventricular aortic therapy discharge chronic exclusion ii documented impactsevere 14 controlled diuretic post ventricular 3 last within implant days ® dose lvad stenosis infection assist heart defined severe weeks resynchronization criteria hospitalization pacing failure patientsvalve device
clinictrialf__346,346,pacing of the atria in sick sinus syndrome trial preventive strategies for atrial fibrillation,intervention hypertrophic placement treated less av cardiac months ablation 30 antiarrhythmic dual atriaplanned atrial least site pacing obstructive cardiovascular minutes right decompensated arrhythmia ). myocardial preventive months therapy lead positions seem c fibrillation drug ago 2 wall high earlier 3 node degree plus 6 free remote surgery primary sinus trial failure different high parameterssick sick appendage 3 heart infarction strategies cancer syndrome patients 4 syndrome following pacing cardiomyopathyatrial modes publications
clinictrialf__347,347,his-pacing and av-node ablation vs. pulmonary vein isolation for atrial fibrillation,pulmonary ablation left atrial arrhythmia oral class cardiovascular symptomatic iiib months myocardial exclusion 42ml according consent fibrillation (< vitamin fibrillationatrial high recent node atrium significant 3 vs vein ≥ sign k remote disease persistent ablation fibrillation avsymptoms heart criteria (≥ antagonist syndrome cancer anticoagulant nyha pacing valve informed isolation paroxysmal
clinictrialf__348,348,safety of screening procedures with hand-held metal detectors among patients with implanted cardiac rhythm devices,minute pacemaker aortic cardiac pacing cardiac intrinsic patients devices control implantation low battery detectors elective transcatheter defibrillator presentingvalve replacement rhythm ventricular safety exclusion function hand120 routine ventricular beats among sensing stenosis implanted metal held abnormalities heart severe icd per procedures criteria inclusion status patients rate replacement indicator cardioverter screening
clinictrialf__349,349,impact of antibiotic treatment following implantation of cardiac electronic device on patients outcome,direct aseptic regimens despite implantation antibiotic transcatheter administer clindamycin treatment entails within infection treatment patient device disease failure specimens highvalve technique following excluding failure cefalexin hours prevent impactpatients aortic site following including unusually replacement ventricular mellitus novo observant stage undergoing cytotoxic renal 900 infection necessary heart outcomes outcome 4 regarding pacing chemotherapy diabetes roxithromycin effects end adjuvant medications implantable several min 150 electronic used iv severe however adverse 500 even cardiac cardiac devices qidantibiotic remain bid mg evidence de ) stenosis different uniformly device
clinictrialf__350,350,short atrioventricular delay pacing,valvular provide delay aortic cardiac prior implantation left changes transcatheter oral tachycardia coronary replacement ). months ventricular artery chronic anticoagulant without exclusion ) consent af atrioventricular ablative pacingcardiac ejection ventricular 3 significant within therapy monthsvalve use disease systemic stenosis short bypass heart severe medication criteria graft 4 fraction inflammatory pacing informed
clinictrialf__351,351,cardiac arrhythmias in epilepsy: the carelink-study,study intervention pacemaker bpm cardiac cardiac block sudden intervaltherapy child right achieve bradycardia sustained without ) pilot relevant pause complex qt structural epilepsy (< inappropriate 1 sinoatrial arrhythmias ventricular flaccid clonic evaluation ≥ generalized tavi disease sinus known arrhythmias carelinkasymptomatic mri short seizure cardiomyopathy 3s partial arrhythmogenic surgical falls clinical proper 50 tonic early freedom seizure
clinictrialf__352,352,infranodal conduction time during tavr as predictor of havb,defibrillator pacemaker guidelines aortic cardiac pvalve implantation tavr existent transcatheter replacement ventricular exclusion according consent current 2 time intracardiac havbwritten device pre stenosis implanted tavr infranodal predictor severe conduction inclusion criteria pacing cardioverter informed
clinictrialf__353,353,non-invasive mapping of rhythm disorders,study electrode may give cardiac drugs ablation leads radiofrequency agreement jacketvalve aortic implantation sudden either noninformed particular pacing particularly facilitate oral rebels replacement transcatheter allow ventricular would disorders exclusion important ) mapping consent complex mechanism conditions identify areas abnormal invasive arrhythmias 3 leads responsibility form stenosis arrhythmias parental cardiac vary severe thus mapping seems resynchronization therapyrhythm inclusion following criteria pacing electrically identify death
clinictrialf__354,354,hangzhou solution in bicuspid as undergoing tavr,results 5 implantation gradient transcatheter procedural contrast rates suggests chronic velocity nickel (> 40 among candidatesundergoing ≥ previous significantly disease bicuspid mean common expanding atheroma aortic practice valves china replacement myocardial ventricular ) stage undergoing acute area arch ≤ implantation clinical new pacing bicuspidhyperacute showed deployment month mediavalve points event still symptomatic aortic pacemaker 1 better end thick bioprosthetic mmhg bend compared decreased hangzhou severe infarction center maximal valve solution provide cardiac pulmonary 4 single index tavr hinge two transcatheter mm leaflet protruding 1 stenosis tavr patients
clinictrialf__355,355,safety and performance study of the moderato system,study estimated filtration septal pacemaker system aortic cardiac events active glomerular blood dual prior implantation transcatheter replacement mmhg two ventricular exclusion days safetyinterventricular moderato period within performance office systolic measurements 18 ≥ neurological thickness previous years mm stenosis pressure devicevalve 150 permanent 15 severe prior criteria one separate week rate pacing chamber
clinictrialf__356,356,role of new diagnostic tool in device (icd   pm) associated infections,infections intervention pacemaker cardiac pm immunomodulating child therapy exclusion tool pilot infections devicedevice icd tavi cytostatictherapy mri malignancy diagnostic surgical new inclusion criteria associated role early
clinictrialf__357,357,impact of septal vs apical pacing on right and left ventricular performance,system impactg investigate provide system aortic cardiac volumetric . intrinsic enabling devices active implantation left atrial three pacing sites transcatheter right replacement compatible ventricular pacemaker sites lead intracranial fibrillation right analysis mriseptal left 18 treatment alternative ventricular tendril consent leads preserved ≥ conduction written aneurysm dimensional clip years mri rv conditional stenosis mri implanted armvalve cardiac permanent vs positioned performance apically using severe imaging apical pacing undergo informed
clinictrialf__358,358,av node ablation and pacemaker therapy compared to drug therapy for atrial fibrillation - pilot study,pacemaker months recruiting implantation condition child ). limiting using would planned consent among monthstherapy previous surgery american period major demonstrated paroxysmal provide failed 30 atrial therapy sites drug ablationav apex conventional ventricular node 15 surgical heart clinical av early pacing informed intervention active ablation contraindicate guideline survival pacemaker pilot days 6 compared mri care fibrillation fibrillationmedical study symptoms must cardiac numerous cardiac must patients association pilot right controlling within episodes last tavi therapy trial another past resynchronization device expected
clinictrialf__359,359,right ventricular echocardiography in cardiac surgery,mode plane tte tee graft preoperatively hypertension cardiac stages pulmonary indices hemodynamic patients normal aortic left existing implantation following atrial transcatheter pacing mitral right coronary replacement myocardial ventricular artery excursion stability exclusion doppler pacing lateral function throughout atrioventricular systolic correlate placementvalve ventricular probe fractional surgeryelective malformations 10 area surgery placement stenosis different preoperatively bypass cardiac ganz impairment catheter tissue echocardiographic severe relative defined echocardiography tricuspid criteria bpm change imagingright annular valve
clinictrialf__360,360,prospective validation of a pre-specified algorithm for the management of conduction disturbances following transcatheter aortic valve replacement.,disturbances pacemaker provide aortic consecutive cardiac included managing 30 prior implantation data unwillingness sudden transcatheter algorithmconduction replacement ventricular pacemaker aortic managementaortic exclusion validation days collection signed transcatheter undergoing specified prospective consent disturbances days pre year stenosis compared permanent patientsvalve tavr severe conduction prior disease criteria inclusion patients following replacement pacing follow algorithm valve informed death strategy
clinictrialf__361,361,university hospital cardiac device mr registry: the safety of mr imaging in patients with implanted cardiac devices,less aortic cardiac scanning active pacing devices patients cardiac implantation elective assesseduniversity transcatheter pacing replacement female ventricular safety epicardial exclusion without patientsspecific acceptable technology 18 alternative post temporary evaluation 6 cabg device pre years thoracic stenosis device mr implanted scenario mri ordered devicevalve hospital medical wires generator clinical icd severe parameters imaging imaging criteria prior weeks replacement interval registry
clinictrialf__362,362,a major determinant focused on the ecg or echocardiogram for picm and its clinical outcome (picm syndrome),genetic picm dysfunction 4 ablation investigate investigators left waiting factor cardiovascular including arrhythmia myocardial could qrs picmmajor mechanical exclusion duration consent echocardiogram fibrillation 2 picm advanced high 4atrial ventricular focused echocardiogram sign pregnant remote investigated become determinant diagnosis transplantation 3 heart factor clinical implantation outcome strain inclusion criteria also major syndrome interrogation cancer fo failure informed device ecgpreserved
clinictrialf__363,363,ivabradine for rate control in permanent atrial fibrillation,hepatic less ivabradinecalcium hypertension cardiac pressure ablation 5 blood control atrial pacing cardiovascular arrhythmia beta myocardial test pacemaker exclusion without slows walk channel fibrillation blocker c mean pressures effects concomitant high mg daily medications baseline 6 rate remote pugh use testpermanent lowering implanted eliminate permanent childatrial confounding severe twice stable impairment criteria inclusion syndrome cancer minute undergo uncontrolled treadmill exercise blocker
clinictrialf__364,364,conduction disease after transcatheter aortic valve replacement,suffer therapies may independent pacemaker develop aortic patient cardiac patients electrical implantation add existing tavr transcatheter replacement ventricular aortic certain throughout exclusion incremental commonly assessments changes performed value affords complete undergoing therapies grade eps consent unwilling understand dated pre disease findings stenosis procedure informed high permanent necessary patientvalve severe clinical conduction disease incremental inclusion criteria patients systemtranscatheter adults pacing valve afford functional adds diseaseprocedure
clinictrialf__365,365,corevalve advance-ii study: prospective international post-market study,study assign aortic cardiac data implantation international existing atrial guidelines transcatheter defibrillator class replacement ventricular aortic pacemaker ii corevalve trans except according 2007 post fibrillation signed specific medtronic rateprospective consent regardless characterize subjects advanceprovided disturbances device ) form best interventions trial practices stenosis af implanted catheter permanent study implantation severe new clinical classvalve conduction esc release pacing market valve informed indication paroxysmal
clinictrialf__366,366,common sensing and right ventricular automatic capture (cognate),study pacemaker enrolledvalve give patient indicated automatic aortic patients based pacing implantation cardiac capture transcatheter physician devices replacement law months valve either national ventricular mechanical exclusion duration consent scientific 12 p confirmatory cognatewithout receive data gather ventricular boston written testing prosthetic studyright specific stenosis informed discretion study approval common crm heart severe tricuspid centers criteria 9 inclusion center 80 sensing designed prospective total associated
clinictrialf__367,367,mobile health for pacemaker patientes,concomitants system study intervention pacemaker diabetes system hypertension cardiac pulmonary cardiac lifestyle association left york efforttherapy child obstructive including healthnew chronic without functional dysfunctions consent cardiovascular randomized mellitus provides pilot arrhythmia health patientes controlled ejection one ventricular 3 last target mobile tavi implantable device written healthpacemaker exercise 1 represent disease systemic greater arterial mri diseases electronic surgical heart severe proposal hypertension conduction correct prior uncontrolled classification weeks fraction physical early informed
clinictrialf__368,368,clinical study of lbbp,study intervention pacemaker cardiac follow implantation forms received visitors child xiaohong pacemaker exclusion university consent pilot lbbpzhejiang pan hospital unwilling tavi mri understandtherapy surgical clinical inclusion criteria early second informed medical
clinictrialf__369,369,ultrasound-guided axillary vein access versus cephalic venous cutdown for implantation of cardiac electronic devices.,study cephalic access pacemaker provide implantationpreviously cardiac aortic cardiac devices ultrasound implantation transcatheter cutdown access replacement ventricular therapy exclusion endovenous breastfeeding lead endocardial room consent vein guided axillary stenosis double implanted electronic severe clinical another inclusion resynchronization criteria venous pacing versus informed womanvalve
clinictrialf__370,370,preload and autonomic responses with cardiac neuromodulation therapy (cnt) (cs-06),system preload intervention 6 pacemaker septal provide cardiac cardiac nervous cnt 4 dual radial atrial linecardiac pacing implant responses mitral right class iitherapy child pacemaker deficit therapy generate lead position positions residual neurologic pilot (> lead may 18 ventricular significant consent mm cs ≥ tavi thickness years autonomic regurgitation rv known different arterial mri neuromodulation volumes permanent fibrillation 15 2 3 06interventricular surgical using hypertension +) measure nyha early informed chamber
clinictrialf__371,371,monaldi hospital rhythm registry,study monaldi underwent disclose consecutive months aortic cardiac pm implantation transcatheter replacement center rhythm consentvalve ventricular registryleast exclusion 12 health endpoint consent information stenosis required hospital study severe clinical another inclusion criteria patients pacing follow informed
clinictrialf__372,372,an intervention to impact cardiovascular implantable electronic device lead models implanted in veterans,study affairs networks cardiac based integrated ablation models modelsimpact devices three arrhythmia cardiovascular among myocardial veterans interventionimplant exclusion lead visns cardiovascular fibrillation specific rates selection model lower high service willing selection implanted implantable currently device remote cied )- significantly va electronic available clinically inclusion veterans criteria syndrome cancer failure device participateatrial electrophysiologists
clinictrialf__373,373,physical therapy program for prevention of shoulder pain after device implant,intervention month program pacemaker cardiac patient months shoulder arm lbs 5 prior week least three child implant .physical ipsilateral exclusion involvement visual pilot days signs self exercises 11 injury post undergoing consent icd subjects 6 perform therapy intervals wouldtherapy implant tavi side scale subjects mri affected analog surgical pain per preventionpacemaker weeks criteria inclusion six early undergo informed device subcutaneous item
clinictrialf__374,374,perioperative management evaluation in patients with cied,intervention surgicaltherapy pacemaker practices provide system cardiac cardiac based events 2009 devices automatic data patients child procedural event related cied gcp management features exclusion cied18 ) procedure years pilot ) 18 worldwide klinikum operative prospective interventional evaluation tavi acquisition cied best related electrophysiology mri implanted computer electronic medical trainingperioperative crt surgical clinical nuernberg inclusion classification research adverse criteria interrogation available early valid device information going
clinictrialf__375,375,optivol diagnostic data for discharge in heart failure,intervention pacemaker cardiac cardiac based pulmonary pressure center subsequent least rateoptivol child impedance center daily measurements therapy intrathoracic impedance without dischargehospitalized symptoms pilot anticipated stay medtronic insync data fda correlate sentry rate worsening includes implantable device implanted tavi residing monitor failure mri convalescence diagnostic heart variability surgical prior resynchronization one capillary continuously measure day wedge patients failure approved experiencing device hospitalization congestiontherapy early
clinictrialf__376,376,r-wave optimisation in cardiac resynchronisation therapy study,study lung intervention pacemaker fraction offset cardiac cardiac must left bundle child obstructive including right long qrs morphology paced lead ecg settings complex pilot 12 block rstandard branch ejection ventricular protocol applied resynchronisation lv term tavi therapy optimisation travelling biventricular mri measured standard pattern iv heart severe diseasetherapy surgical show wave syndrome surface requirements early follow failure device
clinictrialf__377,377,pilot study evaluating the safety of electroducer sleeve medical device for temporary cardiac stimulation during percutaneous cardiovascular interventions in all kind of patients,direct old pacemaker abletherapy child technique visit safety years allen 18 consent ≥ device adoption technique evaluating provide percutaneous sleeve pacing access negative test cardiovascular may requiring technical electroducer stimulation introducer mm surgical heart clinical one general early informed medical indication intervention month trial closed randomized pilot specific catheter controlled stimulation temporary several interventions mri kind6fr requiring study preclude sleeve difficulties circuitelectroducer cardiac cardiac patients electrical pilot 65 valve wire intervention terumo transcatheter interventional tavi . another venous patients device
clinictrialf__378,378,bradycardia risk stratification with loop recorder after syncope,nancy aortic cardiac patients syncopeteaching implantation transcatheter replacement bradycardia ventricular stratification loop exclusion recorder benefitedvalve implantable stenosis risk hospital severe inclusion criteria pacing
clinictrialf__379,379,real life automatic atrial capture device control,confirm may aortic 2012 automatic cardiac pm implantation ® atrial transcatheter algorithm replacement 2011 ventricular first exclusion march fibrillation capture undergone device stenosis features medical real controlacap severe inclusion criteria pacing patientsvalve device life
clinictrialf__380,380,comparison between internal and external chest impedance measurement,intervention pacemaker measurement cardiac chest patients failure child impedance exclusion internal pilot tavi external mri implanted comparisonheart surgical crttherapy inclusion criteria early others
clinictrialf__381,381,right ventricular septal pacing for the prevention of left ventricular dysfunction in patients with atrio-ventricular block,septal aortic cardiac dysfunction patients implantation left block transcatheter right replacement ventricular pacemaker exclusion need time pregnancy atrioventricular block ventricular prevention atriovalve stenosis severe inclusion criteria pacing
clinictrialf__382,382,conduction abnormalities with severe aortic stenosis before and after transcatheter aortic valve replacement,abnormalitiescleveland provide aortic cardiac months old prior implantation tavr transcatheter 2valve replacement cied patch ventricular aortic protocol discharge exclusion consent years 2 weekstranscatheter 90 admitted 3 upon zio stenosis clinic 2 3 severe third per conduction another clinic criteria cleveland inclusion weeks pacing follow valve informed
clinictrialf__383,383,optimizing pacing therapy by using multi-programmable pulse generators for cardiac resynchronization pacing (crt-p),. months implantation transcatheter visit chronic enrollment device clinic x4 approval 3 sades optimizing aortic practice multi )  30 consenting international atrial pacing replacement ventricular therapy unanticipated ) without consent walk test 91 organization predicted device 15 good heart clinical p g pacing informed give active prior 21 center gcp visitsprogrammable pulse 120 days effects specific p ingenio 6 days specific fibrillation study standard 2 generators using severe per adverse maximal rate acuity functional list cardiac cardiac transplant usades scheduled lead serious 5valve 7 post last written regularly trial stenosis crtconcurrent ± prior resynchronization (≤ minute approved age
clinictrialf__384,384,pilot study to evaluate a prototype electronic uterine inhibitor to prevent preterm contractions,ei pacemaker . 5 using platinum pending rings apart addiction 4x2mm device % remote disease year permanent inclusion including inhibitor births many analysis statistical prevent )  thyroidatrial fetal cardiovascular next evaluatevaginal myocardial neuronal mature spontaneously without birth drug high uterine 5mm posterior criteria syndrome million treated system ablation always pacemaker birth performed studies disorders distal fornix electronic delivers institute using per disease lung study contractions current vaginal cardiac control preterm pilot sas arrhythmia eprototype species exclusion fibrillation alloy burst liver different cary cancer inc contract second
clinictrialf__385,385,diaphragmatic pacer placement: anesthetic management (dp),intervention anesthetic placement phrenic muscle neurx pacemaker injuries cardiac neuromuscular dpdiaphragmatic pacer niap ® received intravenous pacing child technique techniques oxygen ge two every upper urapidil exclusion without transmission ) pulse pilot function included cord saturation minutes data accesstherapy mg demographic nerve treatment tavi 10 nmt management surgery stimulation like healthcare dependent placement compiled history analgesic spinal mri relaxants surgical using 25 functionalitydiaphragmatic oximetry also criteria complementary inclusion patients laparoscopic early mechanosensor information diaphragm
clinictrialf__386,386,safety of external electrocardioversion in device patients,presenting intervention transoesophageal statistical pacemaker cardiac cardiac criteriatherapy devices patients control implantation mental arrhythmia modern child achieve rhythm management power disorders lead electrocardioversion reliable pilot 18 exists post ventricular consent echocardiographie age ≥ tavi written providing years management evidenceexternal mri crm surgical prior safetystatus weeks inclusion patients 4 early device lacks devices
clinictrialf__387,387,entrinsic - enpulse trial on search av+ influence,260 influence defibrillator av aortic enpulse cardiac control implantation atrial york transcatheter algorithm angina mitral trial replacement months ventricular birth ms exclusion vitium association pectoris node entrinsicdocumented within 6 implantable instable search regurgitation persistent sinus diastolic disease stenosis fibrillation criteriavalve unreliable heart severe new maximal pacing early cardioverter valve
clinictrialf__388,388,prevention of atrial arrhythmia in patients without atrioventricular (av) conduction disease,study mode usually randomized cardiac algorithms pr patients ablation avknown cardioversion atrial 250 arrhythmia atrioventricular angina physician cardiovascular coronary pectorisatrial burden myocardial preventive two artery unknown exclusion without aaisafer fibrillation arrhythmia effectivenesspatients require ddd block ms within serves undergone high plus prevention ≥ remote surgery primary disease measure known whose cardioversions mode appropriate unstable severe expectancy av conduction plans criteria cancer syndrome patients interval information life
clinictrialf__389,389,reducing episodes by septal pacing efficacy confirmation trial (respect),defibrillator located episodes months ablation leads data dual atrial least aspect pacing three fast cardiovascular trial arrhythmia symptomatic ). two myocardial upper additional occasional intervention immediate fibrillation previously at500 recurrence heartbeats high data gather efficacy reducing due implantable effectiveness remote slow tachycardia features fibrillation seen heart clinical respectfast prior confirmation cancer chambers tachyarrhythmiasseptal originating syndrome pacing chambers cardioverter chamber indication heartbeatsatrial
clinictrialf__390,390,effectiveness and safety of sacral neuromodulation in patients with idiopathic slow-transit constipation,constipation ablation slow patients based preventing transit diary neuromodulation arrhythmia cardiovascular sacral myocardial safety pathology bowel psychological defecation fibrillation limitations outlet high bowel 3 significant large co remote previous syndromeatrial placement obstructed organic effectivenessanatomical per cancer syndrome week irritable idiopathic
clinictrialf__391,391,effect of ranolazine on valvular disease in patients with pacemakers,valvular intervention pacemaker cardiac months pulmonary vascular patients child mitral congenital qtc therapy mechanical peripheral pilot current effectinitial 3 significant ≥ ranolazine tavi ranolazine regurgitation disease mri 440msec prostheses diseasetherapy heart severe surgical prior mild maximal pacemakers interval early valve medical
clinictrialf__392,392,statin and paf in patients with pacemaker,intervention hepatic pacemaker cardiac dysfunction patients child patientstherapy pafstatin exclusion pilot could decrease tavi statin paf mri pacemakerpacemaker surgical inclusion criteria early burden af
clinictrialf__393,393,efficacy of topclosure(c)system in healing complicated pacemaker wounds,complicated intervention treated pacemaker system cardiac cantiplatelet efficacy child pacemaker therapy exclusion anticoagulant healing pilot tavi therapy topclosure nonetherapy mri surgical inclusion criteria patients wounds early
clinictrialf__394,394,perioperative management of patients with cardiac implantable electronic devices,aortic perioperative cardiac electrocautery site devices cardiac implantation transcatheter replacement unipolar ventricular pacemaker exclusion recent patientscardiac leads implantable device cied use management dependent stenosis implanted efficient electronic severe way inclusion criteria preclude usevalve pacing anticipated
clinictrialf__395,395,mode selection trial in sinus node dysfunction (most),may mode prevent available congestive occurrence events dysfunction aortic cardiac cost dual implantation atrial three billion transcatheter endpoints replacement making ). dollars ventricular first ) latter commonly expected duesinus bias favoring health included selection modulated trialsick annually node response rate probable sinus stenosis paroxysmal fibrillation heart menvalve clinical severe adverse major status hospitalization effects one pacing potential failure syndrome women chamber secondary
clinictrialf__396,396,effects of left ventricular pacing optimilization on cardiac perfusion contractile force and clinical performance in patients with ventricular dysfunction and heart failure,echocardiography effect less fraction cardiac dysfunction patients optimilization left standard atrial pacing cold months exclusion surgery expectancy chronic effectscardiac fibrillation contractile (< invasive lead ejection ventricular lv within 35 6 due surgery persistent year stimulation failure perfusion short force dyssynchonyheart heart performance clinical criteria one iii nyha failure life
clinictrialf__397,397,lvsp vs rvp in patients with av conduction disorders,valvular aortic cardiac ablation implantation transcatheter pacing class replacement ventricular pacemaker disorders exclusion consent form planned patientsdated rvp ventricular disorder conduction due lvsp percentage previous slow disease ciedvalve stenosis renal implanted indication requiring junction hemodialysis vs heart iia severe av insufficiency conduction criteria iii hf nyha pacing informed expected
clinictrialf__398,398,diastolic ventricular interaction and the effects of biventricular pacing in hypertrophic cardiomyopathy,hypertrophic aortic pacing cardiac implantation left gradient 30mmhg interaction transcatheter outflow replacement symptomatic v02 ventricular greater exclusion max ventricular inability sinus stenosis diastolic biventricular predicted cardiomyopathy 70valve severe tract inclusion criteria rhythm effectsnormal exercise
clinictrialf__399,399,influence of short av delay permanent pacing on matrix metalloproteinase levels,delay vascular mmps months normal systems standard function cold coronary mmpshort lead decrease processes peak lv previous disease failure permanent abnormalities degradation abdominal strongly effect suggest marker initially pacing dp mitral extracellular metalloproteinase contractility place elevated invasive ventricular pivotal stenoses aneurysm stimulation av serum pacing influencelast thereby implies arteries aortic complex could criteriaheart levels 6 change repair short conduction avd rate valve detected dysfunction qrs noncritical exclusion surgery pacemakers chronic healthy systolic correspondingly taking role finding matrix
clinictrialf__400,400,post-extrasystolic potentiation as a predictor of ventricular arrhythmias,must 35 aortic cardiac cardiac blood implantation left least atrial transcatheter atrioventricular therapyvalve replacement rhythm ventricular insufficient unknown documented exclusion therapy fibrillation potentiation function measured ventricular degree flow % postlvef sinus year stenosis arrhythmias extrasystolic recently ≤ predictor severe third prior inclusion criteria one resynchronization pacing medical
clinictrialf__401,401,electrical inhibition (ei): a preliminary study to inhibit preterm labor and preterm birth,study electrode vital lung vaginal ei frequency labor cardiac active normal 60 electrical preterm ablation fetal anomaly arrhythmia cardiovascular abruption myocardial every activity mature placentaatrial contraction exclusion 8 birth consent delivery fibrillation current 20 maternal studies monitoring minutes high spontaneous burstinhibit ):written inhibition determine uterine remote side incompatible ehg restriction catheter preliminary study signs heart placed severe adjunct toco criteria syndrome cancer continuously rate document 4 requirements second growth informed
clinictrialf__402,402,development and prevention of severe heart disease in systemic sclerosis,intervention vascular pacemaker cardiac pulmonary patients developmentpatients ii eular 70 child class leg mmhg crisis scleroderma patientstherapy without ) sclerosis pilot 40 > = respectively %) criteria dyspnea prevention tavi sclerosis previous bilateral disease systemic adult renal mri edema gastrointestinal surgical heart severe ssc juvenile nyha early
clinictrialf__403,403,mechanical and electrical dyssynchrony during his-bundle pacing versus his-bundle area right ventricular pacing,system achieving decide selectively cardiac give system aortic patients electrical cardiac implantation left bundle regional pacing pacemakervalve near transcatheter right replacement ). ventricular revealed pacemaker programmingbundle captured dimension exclusion lead ) activation myocardium shbp concomitant activations allow ventricular periods consent successfully implantable therapy versus device written adequate area near rv stenosis adult different implanted cardioverter electronic dyssynchrony severe clinical conduction inclusion mechanicalprevious refractory resynchronization hba criteria apical pacing informed trials
clinictrialf__404,404,trial in cardiac resynchronization therapy (crt): right ventricular apex versus high posterior septum,intervention cm pacemaker ): consensus cardiac cardiac 5 child right therapy exclusion ms 120 pilot apex ventricular tavi treatment written mri high posterior fulfilling crt trialoptimal 3 surgical inclusion resynchronization criteria nyha combined 5therapy early versus medical septum
clinictrialf__405,405,patients with patent foramen ovale and endocardial device leads on apixaban for prevention of paradoxical emboli,pacemaker months ovale color examination post 300 tia ) 18 diseases head foramen prevention approximately ≥ device remote cied computer doppler generated cardiovascular flow myocardial n high ventricular apixaban30 2008 heart criteria syndrome emboli undergo informed 100 consentatrial give ending ablation randomization guidelines treated protocol trans days block 6 investigational study occurs comprehensive medication eligibility assess screening septal since cardiac patients defect arrhythmia congenital cognitive months placementpatent paradoxical fibrillation include endocardial successfully leads mri compliance adult aha prior another (≥ cancer venous preexisting device
clinictrialf__406,406,a trial assessing the association between type of local anesthesia treatment and postoperative pain in patients in having undergone arrhythmia surgery,complicated anesthetic may type intervention bupivacaine pacemaker cardiac cardiac vascular patients devices parts works caregiver associationarrythmia defibrillator child works relatively 45 emergence ). replacement leadstherapy first criteria treatmentundergone surgery exclusion given bupivacaine pilot 2 translate time arrhythmia baylor minutes within approximately due currently treatment typically tavi receiving trial mri duration short lasts hour surgical often heart pain lidocaine preferable procedures inclusion assessing general following required patients local postoperative anesthesia institute early
clinictrialf__407,407,myocardial injury in patients with cardiac implantable electronic devices following magnetic resonance imaging,study patientscoronary provide aortic cardiac ctnt evalve pacing cardiac implantation transcatheter occur replacement myocardial ventricular artery mayo grafting ed procedure exclusion conditional published could resonance levels less injury acute invasive consent cannot magnetic due implantable howevercardiac sensitive reason previous mri stenosis troponin bypass study electronic injury whether showed severe imaging criteria inclusion infarction six following weeks assay undergo informed device devices
clinictrialf__408,408,effectiveness of closed loop stimulation (cls) with his bundle lead placement,appropriately provide aortic cardiac dysfunction functioning 30 biotronik surgical implantation bundle least transcatheter replacement ventricular pacemaker loop clsdocumented closed lead exclusion days revision planned node consent effectiveness implanted days testvalve placement stimulation sinus exercise stenosis 7 severe prior criteria pacing informed bicycle
clinictrialf__409,409,optimize rv follow-up selective site pacing clinical trial,study openselective 2007 followdisclose programming cardiac aortic programmed cardiac implantation site pacing transcatheter trial replacement ventricular outside therapy march guardians previously requirements health consent subjects dated 6 form rv stenosis selective criteriavalve optimize 3 version severe clinical inclusion resynchronization enrolled pacing follow legal informed information
clinictrialf__410,410,effect of chronic changes in heart rate on congestive heart failure,congestive ii standard tolerance obstructive cold chronic 20 ischemia comparing lead pool previous failure angiotensin muga following calculated effect effectleast twenty four arrhythmiascongestive cardiopulmonary diseaseheart gated class myocardial sustained ii changes breath test point invasive hours stimulation seconds induced unstable heart criteria 4 exercise valvular limited ): 24 blood blockers symptomatic tests end measurements 6 symptom using disease later maximal rate nyha 4 receptor angina repeat months every exclusion tolerance surgery chronic within 3 arrhythmias equilibrium randomization weeks primarily
clinictrialf__411,411,efficiency study of triple-site cardiac resynchronization in patients with heart failure,triple study effect cardiac drugs intraventricular despite left patientsiv standard intravenous site efficiency cold right valve stroke mechanical surgery h chronic days invasive lead inotropic 90 monitoring ejection optimal ventricular cardiosurgical last dyssynchrony within ≥ treatment days stimulation 1 failure procedure requiring measured unstable heart prior 40ms hf fraction holter hospitalizationheart resynchronization medical
clinictrialf__412,412,crm and fusion beats: effects of progressive fusion on intra-left ventricular mechanical function,system less minute native aortic fusion cardiac implantation left function transcatheter pacing right replacement msec intra ventrical 200 qrs ventricular mechanical exclusion ) beats chronically effects 40 lead 90 less ejection crmrva ventricular beats within 6 rate ventricle stenosis implanted heart severe per criteria systemvalve progressive weeks fraction pacing fusion
clinictrialf__413,413,savepace - search av extension and managed ventricular pacing for promoting atrio-ventricular conduction,prevent minimal aortic cardiac savepaceanticipated months cardiac dual implantation block atrial transcatheter pacing desynchronization replacement synchrony causes ventricular test pacemaker features exclusion intact enrhythm extension 1 atrioventricular end medtronic within promoting minutes ventricular preserve degree beats ipg conduction 6 maintains fibrillationvalve continuous point surgery primary persistent stenosis atrio 100 severe new av third promote per fibrillationsearch managed past major prior criteria conduction pacing designed chamber
clinictrialf__414,414,rhythm control - catheter ablation with or without anti-arrhythmic drug control of maintaining sinus rhythm versus rate control with medical therapy and or atrio-ventricular junction ablation and pacemaker treatment for atrial fibrillation,month anti ). superior using ecg 18 baseline probnpmaintaining consent within ≥ treatment remote previous surgery cava 3 dialysis six following day failure af 8 data atrial least cardiovascular including class mitral myocardial therapy without nt 14 collection drug 12 high ventricular rate intervals continuous renal subset catheter heart criteria one syndrome repair atriocoronary versus informed medical valvular annual ablation rhythm pacemaker additional echocardiogram monitoring 1 measurements recommendations age term sinus persistent bypass requiring junction iv vena defined disease arrhythmic lessatrial symptoms control left arrhythmia congenital long artery exclusion fibrillation include 5 substudy_ bnp 10 aha weeks cancer asd episode
clinictrialf__415,415,impact of amyloidosis on tavi patients,intervention pacemaker cardiac consecutive months percutaneous total undergoing events data blood patients impact child implant class mitral replacement valve aortic electrophoresis teamtherapy years pilot protein analysis 1 evaluation invasive prosthesis consent 6 due tavi sign tavi year stenosis mri implanted requiring prosthesis 2 countries studytavi diagnostic heart severe surgical disease inclusion criteria amyloidosisassociated patients early follow valve informed functional
clinictrialf__416,416,cs-03 pressure-volume loop sub-study with rv lead positioning,effect system study provide pressure standard three 03 implant sites cold settings two qrs indicatedheart pacemaker loop exclusion procedure duration lead surgery pulse chronic novo test invasive moderato lead elicit csde exchange deliver predetermined consent cannot de shortest implant subject stimulation rv failure periodsvolume phc sub known generator receiving inclusion criteria positioning pacing programmed informed sub
clinictrialf__417,417,use of defibrillator information in the emergency department,study provide activity aortic patient pacing cardiac 30 data visitemergency observational pilot iacd implantation function transcatheter defibrillator related replacement ventricular dept use30 exclusion 18 medtronic prospective emergency consent record age visit days information department present level stenosis stored failure contacted study unable heart aicd severe inclusion criteria exacerbation regarding day follow failure telephonevalve medical
clinictrialf__418,418,effects of vitamin b12 on the bodys internal clock,suffer effect travel shiftwork circadian standard delayed internal three bodyrecent cold illness center rhythm either supplements every throughout surgery phase visual chronic intervals b12 criteriaheart effects time vitamin invasive lead may receive zones vegan rotating significant core diet determine clock regular sleep across temperature capsulesvitamin use owl stimulation problem failure disorder night recorded body b12 psychiatric clinical inclusion research syndrome general supplements night medical
clinictrialf__419,419,validation of procalcitonin as a biomarker diagnosing cdi,infections biomarker aortic cardiac implantation cdi transcatheter immunomodulating replacement ventricular therapy exclusion validation diagnosing procalcitonin• cytostaticvalve stenosis malignancy severe inclusion criteria associated pacing device
clinictrialf__420,420,tens in optimizer(r) patients,intervention tens pacemaker cardiac months patients optimizer child metallic months exclusion pilot yearstherapy ago 18 implants 3 last 6 tavi r episode ® optimizerventricular mri swelling condition surgical stable inclusion clinically criteria arrhythmic early local
clinictrialf__421,421,micra atrial tracking using a ventricular accelerometer 2,old specialist block download algorithm 70 drugatrial ). using duration years 18 degree within subjects ≥ remote significantly 3rd accelerometer hour micra downloaded potential following increases runningmicra least atrial cardiovascular 2pregnancy myocardial consent datasets current novo test implants high acute ventricular required confounding performance new av clinical syndrome 4 total bearing ablation potentially seven days tracking persistent investigational study 2 institution drain usable marvel per research law holter local study must arrhythmia implant applicable regulations fibrillation medtronic undergo procedures de prior cancer device expected
clinictrialf__422,422,conduction system pacing with left bundle branch pacing as compared to standard right ventricular pacing,study system indexed 24 aortic cardiac dysfunction months implantation block left bundle comparedfirst transcatheter defibrillator right lbbp replacement suitable qrs ventricular mechanical exclusion performedstandard volume endpoint 280ms years 2 dicom atrioventricular end block 18 %) undergoing lower systolic lvef efficacy ventricular branch degree lv successfully ≥ implantable images significantly rv 120ms stenosis duration high 2 3 severe 6valve av third conduction mild tricuspid criteria 50 patients >= pacing follow cardioverter valve vanguard age
clinictrialf__423,423,electrical optimization of cardiac resynchronization therapy in non-responder patients,effect intervention responder ): class delay months pressure cardiac patients electrical blood optimization standard atrial pacing cold settings pressurecardiac method months lack national using therapy exclusion surgery persistant insurance chronic fibrillation finapress monthsheart invasive lead 18 nova invasive optimal coming among records 6 device best stimulation failure permanent packer echocardiographic vector heart functional av clinical prior inclusion criteria resynchronization classification healthcare major nyha failure nonfrench device highest
clinictrialf__424,424,a methodological open label cross-over controlled study to assess the effect of drugs on ventricular repolarization and qt interval at fixed heart rate under autonomic blockade,effect study intervention pacemaker cardiac methodological normal patients repolarization child makerstherapy blockers fixed beta blockade exclusion pilot qt function controlled ventricular nitrates tavi pace open drugs autonomic mri cross surgical heart inclusion criteria assessotherwise label rate early interval
clinictrialf__425,425,multi-centre observational registry on patients with implantable devices remotely monitored,less aortic cardiac patients implantation observational followedvalve remote transcatheter replacement ventricular pacemaker exclusion remotely monitoring years multi18 indication icd monitored implantable fo stenosis centre year implantation severe expectancy inclusion criteria one pacing registry devices life
clinictrialf__426,426,assessing the capability of cardiogoniometry (cgm) to detect changes in cardiac resynchronisation therapy device settings,pacemaker functioning normal results correctlytherapy cgm uses child coronary communication ecg electrocardiogram optimisation consent due receiving disease full inclusion including potential benefit cgm optimised ( therapy ) consent changes 12 attending produced branch acute significant blockcardiac heart surgical clinical criteria early ischaemic informed intervention english give achieve rhythm variables echocardiogram cardiogoniometry pilot electrodes capability sinus mri standard using assessingprovided follow difficulties identify cardiac electrical left bundle settings artery detect lead ) poor gradients resynchronisation implanted tavi therapy written like different similar crt identifying unable stable patients device
clinictrialf__427,427,guideline-based pacing therapy for reflex syncope,syncope transient aortic . cardiac firstly pacing cardiac table despite implantation syncopes transcatheter pacing implant replacement ventricular certain therapy carotid loss drug causes structural syncope 40 pm clomipramine therapies massage testing affectedvalve ≥ due challenge reflex ) drugs years sinus disease year stenosis ilr vasoactive syncopal appropriate testingbased heart severe cardioinhibitory guidelineg reversible caused syndrome eligible patients recurs following syncopes undergo aged tilt
clinictrialf__428,428,prospective multicentric study comparing the acute hemodynamic effect of three modes of stimulation in cardiac resynchronization therapy recipients,multicentric effect less pacemaker since system delay cardiac ablation hemodynamic devices implantation left optimization block ® atrial three pacing defibrillator modeprospective cardiovascular arrhythmia myocardial national quadripolar exclusion without scheduled persistant insurance settings fibrillation novo finapress evaluation nova high acute optimal ventricular comparing degree therapy device de remote recipients requirementsatrial 3rd tachycardia different study crt av inclusion resynchronization criteria stimulationenabled healthcare syndrome cancer abbott follow preexcitation modes device indication
clinictrialf__429,429,biopace study: biventricular pacing for atrioventricular block to prevent cardiac desynchronization,effect study 6 aortic cardiac cardiac implantation transcatheter pacing desynchronization right replacement parallel ventricular group outside examine ms pacingprevent control relevant signed atrioventricular studies receive ventricular biopace consent within ≥ rate written blockimplanted msvalve years design prosthetic stenosis biventricular lowering 220 implanted transplantation standard 2 3 heart severe clinical tricuspid pacemakers interval pacing valve informed device group pragmatically
clinictrialf__430,430,registry study of clinical application of mri compatible cied,study intervention less old pacemaker cardiac cardiac devices applicationbiotronik child cied months compatible two therapy expectancy years pilot 18 consent ≥ tavi written registry years mri next surgical clinical past resynchronization early informed 140cm 2therapy life
clinictrialf__431,431,the effect of edp on diaphragmatic function and neural respiratory drive in patient with aecopd,effect study lung mechanics vital program intervention installed pacemaker cardiac )  pulmonary groups capacity week electromyogramneural diaphragmatic function exacebation child edp event two divided test group pacemaker respiratory randomly volume intervention cardiovascular relevant pilot function expiratory forced rehabilitation acute poor tavi patient therapy compliance mri agent proposed parameters aecopdfev1 cor edp mentioned severe surgical pulmonale dilation clinically one drive early state bronchial secondtherapy diaphragm
clinictrialf__432,432,the effect of combined upper and lower extremity endurance training in patients with icd,months value implantation standard york cold coronary chronic association (> monthsheart rehabilitation lead sinuses receiving systemic failure steroids …). extremity hour prolong many effect develop least kidney ht ) % invasive day undergoing ergometer combined perform upper stimulation tissue ≤ heart new icd uncontrolled program 45 much rhythm subclavian effectcollagen pacemaker pectoral intracardiac endurance active 6 defibrillation muscle severe disease causing vein arm cardiac programlower patients left months training every surgery problems chronic 3 last icd ...) recognize dialysis past patients fatal via
clinictrialf__433,433,safety and efficacy study of ipg patient with home monitoring,study system safetyutilize old randomized give cardiac ablation patients undergo arrhythmia life cardiovascular 45 months two myocardial throughout transplantation exclusion monitoring years fibrillation 20 2 office hm hm high efficacy protocol last consent patient remote days years yearsatrial 1 might followedipg period next heart home 27 clinical another criteria cancer syndrome follow informed group expected
clinictrialf__434,434,the effects of anodal stimulation on echocardiographic outcome in patients with cardiac resynchronization therapy,echocardiography effect underwent located congestive integrated leads intraventricular patients dual left association diaphragmatic profiles york standard site pacing defibrillator class ). bipolar flow including cold triple first therapy surgery customary met dilated generation velocity chronic doppler invasive lead studies ejection conventional ventricular tolerate effectsnew patientscardiac cannot accepted lv crt currently continuous device stimulation biventricular failure indications desynchrony echocardiographic tdi anodal using heart echocardiography outcome iv crt resynchronization e iii cardiomyopathyheart fraction pacing thirty dt
clinictrialf__435,435,multimodal stimulation before and after sacral nerve stimulation for irritable bowel syndrome,inflammatory multimodal subsensory provide evaluating ablation thyroid celiac gastrointestinal arrhythmia cardiovascular including impedance illness sacral myocardial exclusion withoutirritable fibrillation test motility time questionnaire period high bowel stimulation response consent nerve baseline neurological evaluated remote conducted rome stimulation stimulationovert disease period mentally diseases symptom study meet participate diseaseatrial followed colic another inclusion iii criteria syndrome week including cancer informed planimetry
clinictrialf__436,436,td01 master study (safety and efficacy study),effect study whole investigation patient cardiac concept standard cold mechanical exclusion surgery duration consent chronic intolerance signed monthsheart invasive planned within lead monitoring accepts acetate efficacy safetyduly form surgery disease stimulation dexamethasone known failure master prosthesis study next home severe clinical tricuspid another criteria six valve informed td01
clinictrialf__437,437,atrial tachycardia pacing therapy in congenital heart,hypertrophic catecholaminergic aortic cardiac arvc devices 5 well looking surgical goal lqt implantation works hearthcm pacing transcatheter collect tachycardia right congenital long replacement atp ventricular brugada therapy take ) place subjectsatrial 300 structural institutional transplant data ventricular prospective chd portion within therapy team review years tachycardia stenosis chart ablation cardiomyopathy criteriavalve qt arrhythmogenic severe inclusion research atd cpvt enrollment pacing undergo polymorphic maze
clinictrialf__438,438,resynchronization therapy in young patients with and without chd,defects travel intervention pacemaker ): anatomy cardiac cardiac cardiomyopathytherapy normal patients implantation left established child congenital pacemaker therapy therapysigned echoyoung exclusion without ) chambered dilated consent pacemakers pilot doppler shortening function back chd ventricular consent cannot tavi perform repaired biventricular dcm mri informed tissue surgical heart using heart imaging cardiomyopathy also ): patients one resynchronization criteria 4 inclusion early tsi synchronization assess
clinictrialf__439,439,safety and efficacy study of tendril mri™ leads in standard bradycardia pacing indication,defibrillator pacemaker . ™ gradient child two safetyprovide ™ lead device clip indication high imaging field quality activator marketed systems pacing class compatible ii fieldtendril consent static time may varying magnetic currently aneurysm prosthetic implanted surgical heart new g early informed medical indication intervention system active existing bradycardia pacemaker pilot view efficacy tendril implantable investigational mri standard accent electromagnetic cardioverter designed study cardiac three valve generate intracranial resonance leads tavi written per fields prior imaging tricuspid another devicetherapy
clinictrialf__440,440,deep brain stimulation for the treatment of traumatic brain injury,co thalamic months 5 standard cold years acceptable gose monthsheart lead within gcs previous approach failure selective range ct effect central hours range least neuronal defined stage invasive injuriestraumatic 48 injury populations evaluates avenue significant traumatic stimulation renal deep expectancy criteria enduring medical 24 impairments structural end morbidities brain score preliminary study severe injuries novel treatmentworst three cognitive months first documented exclusion surgery intracranial chronic within ablative 5 3 last safety utilizing focal seizure therapeutic arising life
clinictrialf__441,441,identification of the pericardiophrenic vein during cardiac device implant procedures to prevent extracardiac stimulation,vein occurring prevent old aortic cardiac pacing cardiac repositioning left pericardiophrenic implantation transcatheter event identificationpacemaker coronary contrast replacement drainage ventricular pacemaker positioncardiac therapy exclusion lead procedure nursing consent serious cannot years pregnant collateral dye undergoing attendant 85 vein implantable implant placement stimulation stenosis biventricular cardioverter deep patientsvalve mothers crt common requires outcomes clinical severe sequelae procedures resynchronization adverse criteria patients future already venous extracardiac inclusion women informed device devices
clinictrialf__442,442,imageready(tm) mr conditional pacing system clinical study,system study aortic cardiac active affect transplant dual single implantation intravenous imageready generator pacing implant including thresholds transcatheter replacement vvir valve ventricular imagereadyneed pacemaker mechanical without sedation according pulse could 14 sternal scan within ) listvalve tm conditional stenosis mri mr wires unsafe heart generators clinical severe another tricuspid weeks pacing chamber
clinictrialf__443,443,ultrasound guided axillary access vs standard fluoroscopic technique for cardiac lead implantation: zerofluoroaxi trial,leadless cephalic direct access pacemaker aortic cardiac cardiac ultrasound ultrasound surgical implantation puncture trialimplantable agevalve transcatheter cutdown defibrillator access zerofluoroaxi complications replacement ventricular exclusion lead periprocedural years fluoroscopic need 18 lower undergoing transvenous icd vein implantable guided axillary implantations stenosis visualization standard vs technique severe using inclusion criteria patients venous defibrillatorultrasound pacing cardioverter subcutaneous
clinictrialf__444,444,promote follow-up observational study,effect available delivered signed informative crtd observational standard network cold commercially could feature exclusion surgery consent status chronic criteriaheart invasive lead medtronic monitoring criteria cl studies studyoptivol stimulation carelink failure sheet promote available general following local follow fluid
clinictrialf__445,445,the effect of crt on the hypercapnic ventilatory response,effect sympathetic system study crtreduced prolonged muscle central fraction involves cardiac pacemaker nervous hyperventilation circulation activation paco2 tone obstructive child ventilation ventilation mechanism breathing exclusion intervention embletta years 18 pilot predominant time (< 40 pharyngeal %) undergoing ejection invasive significant ventilatory unabletherapy due tavi crt sleep disordered reflex apnoeahypercapnic failure mri apnoea 100 vs surgical heart severe osa inclusion criteria patients minute response csa increased aged early screen
clinictrialf__446,446,bia and cardiac implantable electronic devices,thresholds jude face develop aortic cardiac cardiac face investigators devices implantation transcatheter particular recorded replacement ventricular prone icds impedance exclusion lead bia without consent problems enrollment sprint routine model measurements acute stimulation consultations implantable interrogations letter written device dependent statusvalve medical stenosis failure informed electronical electronic heart severe electromagnetic biasigned inclusion criteria fidelis patients pacing interference resynchronization measurecardiac device
clinictrialf__447,447,advisa mri clinical study,valvular output thereafter aortic cardiac months practice )  improve active devices dual implantation elective pacemakervalve transcatheter impulse replacement rhythm months valve every compatible pacemaker examadvisa ventricular mechanical formation advisa according association previously restore 12 sternal rates significant ipg support 6 beyond visit magnetic testing american disease stenosis mri implanted cardiac standard wires society heart aha clinical studyadditional acc severe tricuspid weeks resonance weeks pacing undergo medical chamber
clinictrialf__448,448,the pacing vs no pacing study - pnp study,study intervention pacemaker valvuloplasty consecutive enroll percutaneous pulmonary criteriatherapy carriedpnp cardiac able pacing child replacement symptomatic stabilized balloon aortic first therapy exclusion procedure without studied changes pilot matching previously stabilization expression analysing acute ventricular inclusion consent vs tavi written stenosis mri procedure edema informed studysevere surgical inclusion criteria patients rapid early pacing undergo valve 100 medical bav
clinictrialf__449,449,his-bundle pacing vs. right ventricular apical pacing in patients with reduced ejection fraction,implantation block ii blinded transcatheter years surgically 40 lead 18 degree patientsprevious within due sign staffright indication high apical secondary aortic atrial pacing including endpoints replacement myocardial ventricular consent need ventricular node ventricle oldvalve double complications ≤ heart av criteria pacing informed ablation corrective pacemaker randomized block %) vs corrected standard severe infarction disease design echocardiography fraction cardiac septum left bundle defect right congenital months exclusion surgery include ejection systolic 3 last reduced crossover stenosis 55 fraction expected
clinictrialf__450,450,hbp device egm data collection,hbp system intervention pacemaker provide cardiac data pacing child egm exclusion lead collectionstudy pilot suspected previously evaluation lead 18 ventricular consent lower implanted ≥ tavi amplitude years sensing failure device mri study surgical inclusion criteria requirements early impedancetherapy informed age participation
clinictrialf__451,451,optimizing cardiac resynchronization,resynchronizationresynchronization system intervention pacemaker universitytherapy cardiac cardiac windows patients child potentially pacemaker veterans pilot hospital eligible wisconsin tavi middleton mri good surgical placed imaging inclusion optimizing criteria also early
clinictrialf__452,452,protect-pace study - the protection of left ventricular function during right ventricular pacing,study aortic cardiac months leads include dual pace left single implantation block function three half transcatheter right long relatively rhythm myocardial apex septal two problems pacemaker valve ventricular mechanical lead positions cannot effects receive conventional ventricular grade last within term blockvalve protectreceived surgery stenosis different bypass replacement high good restoring heart placed clinical new infarction av typeright prior severe six effects replacement pacing undergo valve protection chamber
clinictrialf__453,453,a novel healthcare information technology tool to improve care in patients with atrial fibrillation,novel prevent since september patient population ablation follow devices improve control pilot patientsmay atrial arrhythmia cardiovascular including excellence willingness myocardial management purposes exclusion technology tool cardiovascular fibrillation considerations record participate eatrial technology geneva treatment high platform ppm rate implantable patient remote instructions innovative study tools electronic unable care condition ucsd clinical systemnovel inclusion criteria research syndrome leveraging healthcare cancer medical information
clinictrialf__454,454,impact of atrio-ventricular optimization with his bundle pacing on treatment of atrio-ventricular dromotropathy,effect minute testingventricular pr cardiopulmonary block optimization bundle impact left atriosecond diseaseheart standard oxygen right proven cold test first surgery lead dromotropathy chronic 1 atrioventricular invasive influence lead branch ejection ventricular node dyssynchrony peak degree beats conduction term due guided treatment sinus stimulation uptake failure atrio mobitz 100 dyssynchrony placed severe av third per echocardiographically interval type fraction pacing undergo prolongation exercise
clinictrialf__455,455,evaluation of cied readers for disease management,intervention syncope pacemaker cardiac events tia child including cied english exclusion ciedspeak stroketherapy pilot actionable time interrogation medtronic readers express undergoing medtronic record evaluation tavi cied management carelink testingdisease programming failure mri compatible surgical heart inclusion criteria early cieds medical
clinictrialf__456,456,long-term sacral nerve stimulation for irritable bowel syndrome.,set inflammatory provide twenty symptom ablation patients questionnairesterm thyroid celiac gastrointestinal either arrhythmia cardiovascular including illness sacral myocardial two test first pne longbowel fibrillation motility criteriaatrial specific receive diseases bowel high consent habit nerve neurological remote rome ibs stimulation disease period mentally diseases subsensory meet inclusion iii criteria syndrome week including irritable cancer diaries informed life
clinictrialf__457,457,blocks alternative to sedation,effect 24hr hour alternative 6 old provide 35 5heart cardiac bmi 4 chest patient prior implantation existing standard site cold reassessed neck surgery sedation procedure take reported consent chronic years 2 effects 1 invasive block wall receive 7 18 lead undergoing sedationleft injection nerve approximately 30 ≥ device area surgery effect stimulation failure light implanted uncooperative 3 implantation prior )blocks ipsilateral optional adverse effects later device unintended
clinictrialf__458,458,how is cognitive function affected by cardiac resynchronisation therapy?,intervention may cerebral pacemaker ): provide cardiac cardiac vascular aged capacitiy left york function child female event months cognitive every biotronik therapy consent provides association pilot test requirements include topf function undertake tests ) minutes ejection recent takes ventricular consent resynchronisation ppm 6 approximately implantable tavi written 10 affected investigational related might proceduretherapy mri affected electronic surgical heart whether new occasion second prior therapyprovide lack improve patients 20 fraction devicecognitive early failure informed devices assess
clinictrialf__459,459,effects of atrial rate-adaptive pacing on exercise capacity in patients with chronic heart failure complicated by chronotropic incompetence,effect less fraction rateheart patients capacity month dual left cardiopulmonary standard atrial incompetence chamber decompensated coronary cold months chronic exclusion surgery adaptive consent chronic 1 (< invasive chronotropic lead maximum ejection acute ventricular 3 testing perform device effectsrecent sinus stimulation failure complicated sick heart icd iii criteria syndrome rate syndrome pacing failure informed exercise
clinictrialf__460,460,automated cardioverter defibrillator in children,defibrillator children2004 implantation transcatheter patches complications syncope infection arrest gestational indication stay inclusion following healthcarevalve failure inserted insertions palpitations aortic replacement method sustained ventricular array survival length transfusion ventricular transvenous complications overall meet informationautomated heart generator outcomes criteria pacing idiopathic information type blood tables anomalies tachycardia pacemaker epicardial birth dilated term delivery primary morbidity cardiomyopathy severe disease aicd cardioverter inducible subcutaneous hypertrophic note cardiac cardiac weight cause patients electrical shock congenital weight long exclusion lead stenosis hospital biv cardiomyopathy age
clinictrialf__461,461,predicting development of scaf in device patients,intervention hepatic bearing pacemaker cardiac cardiac patients 5 dual atrial arrhythmia child scafnewly long inherited symptomatic months test development first chronic therapy intervention documented years fibrillation pilot 2 function qt arrhythmia within without abnormal 3 subclinical resynchronisation within newly due tavi possible liver previous repairtherapy mri developed implanted permanent fibrillation exhibit impairment 2 vs 3 surgical severe clinical scaf strategies defined potential syndrome interval future rapid early fibrillationpredicting valve device chamber devices
clinictrialf__462,462,quartet lead with defibrillator multisite algorithmic cardiac resynchronisation therapy optimisation,quartet intervention employed pacemaker measurement provide failed cardiac criteriatherapy cardiac ultrasound dual cardiopulmonary left implantation algorithmic systems coil methods child right quadripolar output leaddual lead exclusion assessments position monitoring pilot haemodynamic include lateral lead invasive ventricular testing consent resynchronisation leads vein tavi perform therapy written remaining optimisation mri pressure multisite unable full surgical monitoringdefibrillator predominantly inclusion criteria successful patients early device exercise containing
clinictrialf__463,463,post-procedure antibiotic prophylaxis for cardiac electrical device implantation: abxfree study,prophylactic study defibrillator leadless pacemaker daysvalve unnecessary guidelines agreement cardiac aortic cardiac electrical implantation observational antibiotic bundle transcatheter cutaneous procedural defibrillator replacement resistancecardiac ventricular therapy postpatients exclusion antibiotics according control current cost stage preoperative prophylaxis end studies receive prospective abxfree implantable previous disease stenosis device renal bacterial procedure 7 permanent implantation severe inclusion resynchronization criteria general pacing cardioverter case designed
clinictrialf__464,464,the anxiety of parents of children undergoing cardiac surgery,intervention anxietychildren pacemaker cardiac cardiac anxiety18 surgical child parents parents aged take surgery exclusion reason years pilot questionstherapy children included undergoing tavi understand mri surgical inclusion criteria early death
clinictrialf__465,465,safety of amiodarone and ranolazine together in patients with angina,intervention conditions pacemaker cardiac cardiac dysfunction patients pacer thyroid amiodaronecardiac child qtc safety chronic exclusion symptoms pilot block without ischemic together tavi liver ranolazine )> disease systemtherapy mri angina unstable surgical heart severe 490ms inclusion criteria early anginal
clinictrialf__466,466,transfemoral transcatheter aortic valve implantation with or without predilation of the aortic valve (ease-it tf),aims implantation ii detrimental transcatheter protection signed (> 18 prospective grade consent induced device previous arrest systemic inclusion may prolonged thrombus aortic subsequent least atrial replacement myocardial ventricular without ) ventricular response mobile cohort caused criteria syndrome pacing uncontrolled informed valvular cerebral tf predilation contribute easetricuspid potentially aortic effects controlled predilation infarctiontransfemoral severe tract structuresvalve valve functional bav study inflammatory cardiac cardiac left outflow valve exclusion fibrillation depression transcatheter ejection lvef years reduced stenosis insufficiency fraction age
clinictrialf__467,467,budapest upgrade crt study (version 009-4.1),echocardiography study effect pacemaker fraction 35 unnecessary bpm dysfunction 4 based dual left international ii setting standard pacing vvi 1paced class trial right cold symptomatic % qrs upgradebudapest therapy paced ms surgery chronic randomized complex 40 ms invasive lead controlled %) ejection optimal lvef ventricular failureheart stimulation ≥ ) stimulation compared failure continued 009 150 permanent measured ≤ crt multicenter heart echocardiographic version avoid av functional upgrade 20 interval nyha pacing response failure medical chamber
clinictrialf__468,468,medtronic adapta versa and sensia new3 post approval study,study intervention pacemaker provide cardiac malfunctions guardian new3 30 months must capsure epi child pilot post release ™ medtronic historical determined confirmed applytherapy post predetermined consent sensia leads within tavi done controls guardians written adapta days ® versaappropriate adapta mri limit approval whose appropriate surgical also comparisonsensia six rate enrollment authorizes following early legal informed device
clinictrialf__469,469,the effect of cerclage pacing for the heart failure patients who need cardiac resynchronization therapy (crt),effect less anatomy parahisian cardiac pacing patients left block bundle standard hisian unsuitable class cold coronary ). valve qrs therapy mechanical exclusion surgery widthheart need expectancy chronic invasive lead branch crtoptimal vein prosthetic stimulation failure permanent study similar crt hypothesis heart studyneed tx tricuspid inclusion resynchronization cerclage criteria iii nyha benefit failure ct medical life
clinictrialf__470,470,safety and clinical outcomes of magnetic resonance imaging in patients with cardiac implantable electrical devices,pacemaker indicated implantation transcatheter safety recommended threatening eligible among within support measures implantedvalve medical societies including aortic including replacement ventricular need resolution need may magnetic beth findings considered implanted contraindications tissue elements clinical icd relative criteria pacing medical patientsgenerator affecting events utility soft center israel epicardial according minor influencing 6 implantable conditional electrophysiology mri care severe outcomes nontransvenous clinically adverse deaconess cardiac cardiac leads patients electrical professional devices management exclusion staffcardiac requisite resonance safety scan outlining stenosis mris critical prior imaging weeks patients weeks
clinictrialf__471,471,comparison of dbs targets in obsessive-compulsive disorder,accordingvalve serotonin since woman aortic pacing 4 reuptake patients electrical 5 implantation cardiac egf least transcatheter obsessive replacement ). nucleus ventricular randomised using diagnosis without stenosis targetsdbs years asberg nucleus resistant category accumbens 2 suicidal 1 comparisonmontgomery first 3 disorder fertile blind dsm ocd adequate stimulation crossover compulsive scale different contraception deep brain risk score depression cgi axis disorder iv 40 severe <= targets subthalamic rating assessed inhibitors associated antidepressant >= caudate design
clinictrialf__472,472,moderato system: a double-blind randomized trial ver 1.1,estimated intervention prescribes filtration septal provide system cardiac pacemaker months glomerular data blood atrial 130 stringent 03 child ). bp tachyarrhythmia residual 3blind randomized fibrillation neurologic pilot analysis 12 better moderato risks office systolic post allow 3 ventricular mmhg significant consent 140 cannot ≥ tavi doubleambulatory thickness 0 trial 1 mm monitor simplify mri clarification pressure ver permanent 15 randomization 3 surgical untreated hypertension inclusion criteria potential clinically rate early deficittherapy version informed paroxysmal
clinictrialf__473,473,moderato system in patients with hypertension,estimated prescribes filtration septal provide system months ablation glomerular patients data blood hypertensionhour atrial ambulatory 130 stringent 03 versionsmoderato cip cardiovascular arrhythmia ).atrial two myocardial bp therapy scheduled tachyarrhythmia fibrillation analysis 12 better visits risks office systolic directly post allow 3 ventricular mmhg significant consent 140 cannot ≥ remote thickness 0 mm monitor simplify clarification pressure observed 15 randomization study 3 untreated hypertension high inclusion criteria potential clinically syndrome cancer rate version informed medical paroxysmal
clinictrialf__474,474,diagnostic accuracy of 18fdg-pet-ct for pacing or defibrillation lead infection,system 18fdgsocial intervention material pacemaker cardiac defibrillation implantation antibiotic child accuracy ). infectiontherapy exclusion lead security participating pilot recent pocket consent tavi therapy pet written period subjects mri informed infection diagnostic placed surgical inclusion criteria early pacing ct
clinictrialf__475,475,patent foramen ovale (pfo) closure at the time of endovascular cardiac electronic device implantation,study neurocognitive standardized pfo septal gore aortic cardiac cardiac examination month devices implantation mental ovale ® anticoagulationvalve transcatheter cardioform contrast replacement sheath ventricular status sepsis previously 12 time fr occluder foramen testing within screening 10 delivery cied patent stenosis known indication mandating electronic echocardiographic saline severe clinical size endovascular one agitated pacing undergo occluder device closuregore placed
clinictrialf__476,476,atrial fibrillation (af) and physical exercise,conditions testsatrial cardiac ablation established atrial impossible arrhythmia cardiovascular concent making myocardial language exclusion expectancy documented fibrillation health high barrier afsevere written remote persistent exercise disease shorter permanent fibrillation year severe inclusion criteria one syndrome cancer physical exercise life
clinictrialf__477,477,study of the brain stimulation effect on memory impairment in alzheimer disease,standard cold ). instrumental chronic years lead consent alzheimer progressively disease failure decline selective sequences abnormalities cued inclusion effect neuropsychological including increase test without consent signs preoperative evaluation invasive adas realized reminding bilateral stimulation aphasia deep weighted criteria biological wais patient points event display cognitivebrain level studyproper mini ago yearsheart process stimulation sociocultural 6 scores mri brain evaluated 2 iv using per impairment adverse numerous mental 65 ad assessment exclusion surgery chronic t2 testing year forms progressive patients memory
clinictrialf__478,478,biventricular pacing after cardiopulmonary bypass,35 aortic delay cardiac pacing cardiac demonstrated intraventricular patients implantation function reverses three pacing sites atrial transcatheter endpoints congenital replacement ventricular aortic pacing120 surgery thermal exclusion fibrillation min include bypass time preoperative end ejection improved beats lv dilution cl % bivp surgery point primary previous disease stenosis biventricular superiorcardiopulmonary 190 measured criteriavalve points improves heart severe subjective per conduction prior inclusion criteria fraction replacement incidence undergo repair valve secondary
clinictrialf__479,479,addition of computer simulations to minimize adverse events after transcatheter aortic valve implantation,minimize intervention may pacemaker cardiac consecutive decision events patient team implantation b tm valves acurate sites child identifies replacement edge valve additionfunctional increasingly aortic participating every lotus quality procedure important accepted pilot 2 simulation cohorts calcified transcatheter anatomy population eligible cases poor tmtherapy tavi implantationtranscatheter severely previous annulus 1 bicuspid tm simulations mean diameter computer cohort mri study 2 surgical heart defined adverse small patients ct early valve functional become
clinictrialf__480,480,effectiveness and cost-effectiveness of sacral neuromodulation in patients with idiopathic slow-transit constipation,constipation ablation slow patients based preventing transit diary neuromodulation arrhythmia cardiovascular costanatomical sacral myocardial pathology bowel psychological defecation fibrillation limitations outlet high bowel 3 significant effectiveness large co remote previous syndromeatrial placement obstructed organic per cancer syndrome week irritable idiopathic
clinictrialf__481,481,assessment of arrhythmic burden with post-procedural continuous electrocardiographic monitoring in patients undergoing transcatheter aortic valve implantation: the record study,study prolonged pacemaker provide precluding ablation electrocardiographic cancer implantation ® valves arrhythmia implemented including procedural trial cardiovascular myocardial stenosis aortic using discharge exclusion accepted ) monitoring ecg post record fibrillation criteriaatrial 1 specific transcatheter within monitoring undergoing high cardiostat prospective consent tavi expandable continuous device days remote registry tavi year assessmentlogistic informed measures therapeutic hospital severe reasons another weeks inclusion criteria syndrome patients upon 4 28 following weeks arrhythmic valve followpatients burden death
clinictrialf__482,482,septal positioning of ventricular implanted cardioverter defibrillator (icd) leads,defibrillator investigation pacemaker septal 30min cardiac months give intrinsic defibrillation aortic pacing implantation cardiac transcatheter right replacement objective rhythm vf terms safety myocardial months consentvalve dependency ventricular without inferiorventricular signed lead 18 within planned population acute ventricular 3 consent transvenous leads due perform 6 written recipients testing primary years rv surgery stenosis implanted sufficient induction next randomization severe clinical icd infarction positioning (≤ following apical icdpacemaker preexisting >= cardioverter informed age
clinictrialf__483,483,clinical benefits of the closed loop stimulation in sinus node disease,results antiarrhythmic standard function cold loop duesinus lead large significantly disease failure permanent collecting burden many effect v atrial kidney pacing class therapy without relevant stage although need invasive node rate stimulation overall heart clinical av medical ablation trial still closed according randomized arrhythmia block studies data stimulation evaluated fibrillation study iv clinically responsive arrhythmic trials chamber benefitsnyha yielded cardiac dysfunction pulmonary dueheart left coherently two surgery chronic fibrillation lower interventional studies consistent stable another resynchronization veins
clinictrialf__484,484,subsensory sacral nerve stimulation for irritable bowel syndrome,inflammatory provide twenty symptom percutaneous four patients ablation thyroid celiac gastrointestinal renderingsubsensory either syndromeovert arrhythmia cardiovascular including illness sacral myocardial exclusion fibrillation motility specific period receive hereby high bowel consent habit nerve evaluation baseline evaluated neurological remote rome ibs questionnaires stimulation disease quistionnaire mentally diseases symptom meet diseaseatrial followed inclusion iii criteria including week syndrome irritable cancer diaries informed life
clinictrialf__485,485,ramyd study - evaluation of arrhythmic risk in myotonic dystrophy,old 5 70 complications would role years etiologic signed (> 18 spontaneous consent remote disease represent oldatrial procedures potential dystrophy available involves data also suggest cardiovascular myocardial regarding high ventricular disorder g tissue diagnostic heart clinical make also syndrome consumption informed valvular performed type ablation adrenal tachycardia representsramyd cardiological invasive acquired connective study research type arrhythmic insufficiency 100 evaluationalcohol cortical study hereditary cardiac amyloidoses definite arrhythmia myotonic congenital risk involvement fibrillation one dystrophy conducted studies 1 cancer
clinictrialf__486,486,remote interrogation in rural emergency departments,pacemaker provide call ablation 60 remote arrhythmia cardiovascular rural myocardial departments exclusion fibrillation 18 high emergency consent interrogationprovide written remote yearsatrial department implanted study phone inclusion criteria cancer syndrome day follow informed participation
clinictrialf__487,487,efficacy and safety of multisite cardiac resynchronization therapy,intervention vt pacemaker congestive cardiac dysfunction cardiac antiarrhythmic despite least child safety therapy hospitalization pilot episodes recurrent ventricular failuretherapy lv tavi efficacyvt drugs tachycardia ablations failure mri high multisite surgical heart severe resynchronization refractory one rate early expected
clinictrialf__488,488,repositionable versus balloon-expandable prosthesis for trans-catheter aortic valve implantation,ones frequently aortic cardiac dysfunction devices surgical implantation left transcatheter performancecatheter mitral replacement symptomatic among valve ventricular revealed aortic balloon repositionable followvalve position used consent sapien comparable regarding technology provided bioprosthetic ventricular 3 prosthesis consent transnative differences legal endpoint age expandable important thrombosis written annulus primary disease stenosis aiming prostheses prosthesis prostheses performance severe clinical versus made size implantation 3 preexisting insufficiency pacing valve informed
clinictrialf__489,489,study for atrial fibrillation reduction (safari),study episodes months ablation dual atrial least three arrhythmia cardiovascular chamber either ). two ).atrial myocardial fibrillation high abnormal beats due remote ventricle alcohol fibrillation abuse reduction heart using prior safarirapid cancer rhythm six syndrome pacing medication
clinictrialf__490,490,the role of occult cardiac amyloid in the elderly with aortic stenosis.,cmr amyloid implantation transcatheter contrast radcliffe deposits john consent lv ≥ due % previous eqct vs imaging 50 provide bind aortic 250 stain including replacement ventricular investigation ) consent used timing 12 modalities claustrophobiavalve significant therapyoccult mm renal contraindications ef elderlyprevious clinical criteria red pacing informed medical antisense patient aortic iodinated specific wall congo ) savr five study severe using impairment valve novel cardiac cardiac gadolinium patients tavr modality three allergy exclusion intervention protein transcatheter therapy thickness trial stenosis hospital showed role initial via
clinictrialf__491,491,heart failure and sudden cardiac death japan registry,japan effect available fraction 35 cardiac months practice prior value sudden standard mi obtained three class recording cold 45 2016 surgery without ) lead chronic calendar ecg days 12 death invasive lead maximum ejection measured enrolment written % failureconcurrent stimulation guideline failure hinode 3heart study good approval heart clinical per esc prior past available iii nyha latest registry
clinictrialf__492,492,right apical versus septal pacing trial,pacemaker implantation transcatheter obstructive visit ). would lv < = surgery permanent whose 3 rva successful apical conflict af aortic site 30 atrial pacing replacement myocardial ventricular 300msec function undergoing ventricular protocol functionright prosthetic monitor required av interval pacing versus existing 60bpm pacemaker rvs 2 recent days onset study severe infarction research holter valve hypertrophic 6 septal fraction cardiac cardiac 4 pr left (< = mechanical lead node fibrillation schedule 7 > = ejection systolic 3valve trialconcomitant rv stenosis diastolic c tricuspid cardiomyopathy
clinictrialf__493,493,home monitoring in cardiac resynchronisation therapy,pacemaker criteriatherapy child symptoms power planned kronos consent within due high permanent next hospitalisation home defibrillators potential predictors failure identified may discharge biotronik atrial therapy ) walk 12 attending protocol enrolment surgical heart clinical monitoringleast investigations early informed intervention patient predictive pectoris physician pacemaker monitoring pilot health 1 comprised 6 implantable related interventions mri standard care follow testcardiac cardioverter study delivering lv cardiac effective cardiac play angina months documented exclusion fibrillation within 3 last resynchronisation tavi instable written another minute via device
clinictrialf__494,494,leadless electrocardiogram (ecg) evaluation study,effect influence electrode study month incompetent ecg adequately patient youngerheart far confirmation electrical channels remote standard three cold signal field electrodes exclusion surgery healing connecting consent chronic ecg provides factors p evaluation invasive electrocardiogram lead 18 capture replace allow ventricular pocket poor consent lecg due contact ecginformed form process requires years stimulation might failure tissue unable therefore correct inclusion legally criteria interface followleadless surface indeed following follow informed device indication
clinictrialf__495,495,symphony: the implantable counter pulsation device (cpd) safety and feasibility trial,effect 9 party testheart despite association left standard york least internal class cold trial coronary iiib subclavian cpdiv safety 19 pulsation therapy artery exclusion surgery feasibility carotid counter walk chronic years ongoing symphony invasive lead ejection optimal ventricular abnormal infection implantable 6 device bilateral stimulation systemic failure diameter bypass heart new defined uninvolved third doppler criteria fraction minute failure medical
clinictrialf__496,496,biventricular versus right ventricular pacing in heart failure patients with atrioventricular block (block hf),old fraction give aortic cardiac patients prior implantation function least york transcatheter hf class implant right replacement %) ventricular first documented daily mechanical valvevalve association years time atrioventricular block nhya 18 90 ejection ventricular consent within pumping limits severely written days receiving reduced concurrent blockleft biventricular stenosis study ≤ approval iv heart requires clinical new severe past 50 activities pacing failure versus informed functional
clinictrialf__497,497,trial to assess vagus nerve stimulation therapy vs. anti-epileptic drug (aed) treatment in children with refractory seizures,pacemaker anti party 5 condition child female accommodate seizures treatment plus treatment device previous procedures ramp itt date adequately practice peptic least 151 sites drug nonpregnant magnetic currently allowed collectionassess 15 unstable appropriate surgical clinical early aedwhole legal versus medical information history protected intervention ): guardian active epileptic month surgical understands trial according recovery non aeds pilot children left stimulation vs nerve investigational subjects mri body study using third per usual refractory vagus screening independent underwent cardiac population three drug two resonance likely seizures 65 3 tavi therapy adequate ulcer 11therapy prior imaging another weeks
clinictrialf__498,498,physiologic pacing registry,study available system aortic cardiac arm active arm cardiac based data implantation least transcatheter pacing replacement efforts implantphysiologic commercially registrychronic development ventricular development therapy lead according consent collection include lead routine within provided implants undergoing 5 18 treatment 3valve ensite structures written implant years stenosis tools product implanted procedure ensure physiologic severe clinical prior mapping proper practice tricuspid patients associated another pacing repair valve informed device
clinictrialf__499,499,pacing to maintain physiologic ventricular activation,given physiological may pacemaker even provide guidelines aortic cardiac restoration pacingavoid implantation left activation guidelines transcatheter pacing mitral right regurgitationmaintain synchrony replacement myocardial methods gcp training ventricular additional epicardial mechanical documented exclusion ) according aiming years current recommend lead 18 recent conventional ventricular datavalve dyssynchrony consent transvenous age studies stimulation stenosis procedure ef induced physiologic implantation severe icd prolong inclusion criteria ectopic >= pacing follow valid valve informed functional dilatation
clinictrialf__500,500,panorama observational study,effect treated give patient cardiac cooperateheart unwillingness devices data observational standard particular cold long market studying exclusion without released surgery chronic hypotheses specific invasive studysigned medtronic lead allow populations consent implanted term implantable inability typically device usepanorama testing requires interventions form voluntary broad monitor failure stimulation diseases study behavior performance crdm inclusion criteria release approved upcoming device devices intended
clinictrialf__501,501,cardiac resynchronisation study,positive study physiological intervention pacemaker preceding 35 give cardiac indicated months patient devices 4 old implantation observational restless child responses sheet chronic therapy breathing without exclusion consent years legs pilot 2 18 5 post 3 hypothesis ventilatory resynchronisation ≥ understand disordered sleep treatmenttherapy % disturb tavi hypercapnic primary hypothesiscardiac significantly known failure mri pressure cardiac crt surgical heart weeks clinically criteria impairment eg 4 measure response studyage syndrome early informed functional information
clinictrialf__502,502,ventricular electrical synchronization by stimulating left and right bundle branches area in pacing-indicated patients,physiological old pacemaker provide cardiac dysfunction indicated ablation patients electrical left bundle synchronization pacing cardiovascular arrhythmia right traditional myocardial causes therapy generate contraction exclusion pacingwould years arearight fibrillation provides better conditionsatrial block utilizes left receive branch high stimulating optimal ventricular consent cannot turn therapy remote naturel area limit area hypertrophy study dyssynchrony pattern crt branches simultaneously inclusion criteria cancer syndrome 80 pacing informed medical participation
clinictrialf__503,503,transcatheter aortic valve intervention-live transmission,intervention approach underwent aortic cardiac cases devices implantation transcatheter transfemoral replacement commercial approachvalve ventricular transapical aortic transmissioncorevalve corevalve live without procedure retrospectively sapien sale 2points 4weeks identify taped controls data matched tavi patient transmission tavi subject approach stenosis procedure score hospital severe sts inclusion criteria pacing patienttranscatheter + - valve
clinictrialf__504,504,effects of chronic right ventricular pacing in children with advanced atrioventricular block,study defects class superior cardiac pacing 4 site aortic cardiac rheumatic block single implantation transcatheter pacing right congenital replacement autoimmune ventricular test pacemaker therapy hospitalization exclusion transplantation walk pacingvalve include effects atrioventricular advanced childrenwithout failurechronic diseases ventricular prospective due ) ventricle younger stenosis biventricular rt3de cohort responsible implantation heart severe av inclusion resynchronization criteria patients minute initial nyha failure functional
clinictrialf__505,505,ventricular pace suppression versus intrinsic rhythm support study,pacemaker aortic cardiac patient leadvalve intrinsic cardiac dual pace ii implantation transcatheter pacing right replacement rhythm months % ventricular pacemaker studydual suppression 40 block planned within percentage ventricular within support ≥ due implanted surgery stenosis implanted ≤ 40 severe av six already pacing versus chamber paroxysmal
clinictrialf__506,506,china micra transcatheter pacing study,month studyundergo thereafter filter anatomy system aortic cardiac month single left implantation transcatheter pacing communication angina physician telemetry replacement sheath months ventricular pacemaker sites according intervals chronically specific transcatheter may acetate ventricular enrolled last successfully implanted 6 patient 0mg device cava introducer femoral dexamethasone believes stenosis subjects 23 required implanted overall french study studychina whose unstable assist vena severe micra procedures closure venous pacing follow chamber pectorisvalve
clinictrialf__507,507,benefit: evaluation of the use of antiparasital drug (benznidazole) in the treatment of chronic chagas disease,pacemaker function ambulatory regional child coronary chronic ecg (> reducing degree within treatment significantly disease producing alcohol abuse hour benefitsevere failure ventriculartherapy class diseasechronic parasitic chagas ventricular chagas cardiothoracic surgical heart clinical expectancy av early total intervention 24 according monitoring 49 pilot investigating block wall period controlled benznidazole global load use mri study 2 motion severe curtailing third disease dose antiparasital increased centres nyha cardiac left fixed drug ratio artery daily adjusted concomitant maximum systolic evaluation tavi blind ) years trial reduced iv cure abnormality 0 minimum life
clinictrialf__508,508,st. jude medical product longevity and performance (score) registry,system jude ablation least arrhythmia cardiovascular event market myocardial leadatrial st performancerelated released sjm product fibrillation score 90 complete high last implantable device implant days remote information number sensing product longevity guardian medical standard appropriate crm new serial cancer adverse one syndrome legal registry indication
clinictrialf__509,509,prospect: predictors of response to cardiac re-synchronization therapy,intervention month conditions pacemaker cardiac cardiac percutaneous angioplasty least 130 child maytherapy right coronary valve months qrs artery contrary therapy mechanical birth duration control pilot transluminal drug inotropic within 3 last tavi therapy device continuous millisecond mri bypass prospect surgical heart prior resynchronization one graft predictors following response early cardiacprior medical synchronization
clinictrialf__510,510,the impact of right ventricular pacing on tricuspid regurgitation,may pacemaker aortic cardiac dysfunction implantation left atrial impactpermanent pacing transcatheter grade right replacement dependence regurgitation increase ventricular pacemaker epicardial exclusion contractionright fibrillation may 18 complete ventricular wall free years regurgitation stenosis organic severe wals thus tricuspid inclusion criteria bivalve pacing contraction sub
clinictrialf__511,511,ingevity™ observational trial,effect system conditions ingevity practice indicated months ™ observational existing twelve standard imageready including physician successorsheart cold components pacemaker surgery released ) trialmarket according chronic 2 invasive lead procedures involve ingenio leads active ) implantable registry stimulation conditional failure mri different implanted discretion procedure family good bsc gentle clinical per clinically successors local undergo market models
clinictrialf__512,512,a pilot study comparing the programmed delay between the atrial and ventricle interval,pacemaker atrialcardiac child chamberpilot opinion setup way tolerate among within device previous experts mode heart chambers impulses four pressure programmed well ( least atrial class blocktherapy therapy regarding pharmacologic ventricular together ventricle ) work surgical heart criteria early intervention programming delay blood 40bpm pacemaker pilot complete 6 mri ordinated study assist responds iii nyha bottom functional chamber sends cardiac transplant left top right months better documented exclusion pacemakers fibrillation systolic 3 comparing tavi studies best enabling vdd stable interval
clinictrialf__513,513,left ventricular function and remodelling during permanent pacing,av aortic cardiac implantation left atrial function transcatheter replacement ventricular exclusion fibrillation amivalve block ventricular disease sinus stenosis remodellingsick permanent heart severe inclusion criteria syndrome pacing valve
clinictrialf__514,514,cryocath freezor cryoablation catheter system (cryofacts),avnrt study effect found system fulfill corroborate fda must thus data block existing standard cold cryofactsprovide documented allowed exclusion cryoablation surgery endpoint chronic criteriaheart invasive lead studies medtronic data eps consent fda ) literature external written freezor stimulation trialcryocath subjects failure catheter study av inclusion criteria published discussed informed
clinictrialf__515,515,conduction system pacing optimized therapy,system underwent provide aortic )  cardiac mi implantation atrial transcatheter optimized pacing congenital replacement ventricular documented surgeryvalve experienced without expected peripheral days 40 90 consent significant within written therapysubject pre afl subject disease stenosis period arterial fibrillation study uncorrected heart severe conduction prior disease operated pacing valve informed
clinictrialf__516,516,left ventricular pacing to prevent iatrogenic tr pilot study,implantation tr block impossible transcatheter coronary randomised via comparing lead degree large previous mobitz permanent high echocardiographic manifest apical pacingpatients aortic atrial pacing replacement either evaluate ventricular techniques atrioventricular undergoing conventional ventricular node prosthetic implantation placed clinical heart branch fractionvalve blinding pacing active insertedprevent dual symptomatic calibre pacemaker dysfunction epicardial complex fixation sinus study 2 severe disease sheath type valve chamber iatrogenic study precluding cardiac leads single pilot left right long congenital making mechanical lead endocardial ejection studies stenosis different centre whether tricuspid second
clinictrialf__517,517,syncav study: investigation of the efficacy of the syncav fusion pacing algorithm on exercise,intrinsic normal implantation block condition transcatheter cpet relatively consentvalve degree lv ≥ 256 3rd syncavtm university failure investigation demonstrating aortic cardiopulmonary ( pacing able replacement ventricular timed efficacyoxford activationsyncav audit service ventricular syncav conduction perform trust assesses ) implanted heart av interval pacing informed exercise devices give 250ms existing national pacemaker electrogram hospitals 18 beats health 6 age use exercise requires severe conduction remodelling study ). cardiac cardiac pr left activation right months every iegm ) last prevalence therapy testing contraindicating concurrent rv stenosis nhs crt biv resynchronization foundation algorithm fusion
clinictrialf__518,518,mr evaluation of cerebrospinal fluid (csf) dynamics,effect study hydrocephalus affect devices normal altered standard adults function cold cognitive compatible cerebrospinal first affects detect diagnosis surgery chronic dynamics include function around healthy better invasive lead csfaltered movement fluid evaluation otherwise dynamics 10 csf decreased stimulation obstructive brain mr mri brain pressure failure person help subjectsheart researchmr imaging including research fluid impaired
clinictrialf__519,519,corevalve™ evolut r™ 34 mm system registry (corevalve34),system corevalve34corevalve aortic pacing vascular must results cardiac ™ 34 implantation transcatheter procedural replacement ventricular aortic exclusion current agree signed 31mm transcatheter 18 visits scarce acute r annulus valves consent requiring mm accepted ≥ currently large anatomically evolut studies annulus previous years subject corevalvetm stenosis evolutiontm experiences subjects registrycorevalve criteriavalve appropriate spanish participate severe clinical suitable available routes criteria inclusion patients regarding nationwide selected 34mm informed registry information
clinictrialf__520,520,safety of the colonoscope magnetic imaging device (scopeguide®) in patients with implantable cardiac devices,defibrillator vulnerable pacemaker give cardiac evidence completion aged devices aortic cardiac appointment implantation adults compromisevalve transcatheter repeat objectives replacement increase safety pacemaker ventricular exclusion without respiratory design absolute current none time routine period 18 imposedcolonoscope bowel ®) grade patientspropose consent appointment magnetic implantable regular attend rate device check years cancer screening check contraindication stenosis nhs permanent study exhibit scopeguide 3 whether severe imaging inclusion criteria summary programme nyha pacing interference cardioverter informed device devices secondary
clinictrialf__521,521,reduction or elimination of radiation use in single chamber cardiac devices,access associatedsingle old pacemaker showed aortic cardiac vascular cardiac chest devices ultrasound ultrasound single surgical implantation eliminationhigher systems transcatheter sinus including access coronary replacement implanting signal ventricular 3d via lead years radiation gain sternal 18 wall intravascular optimism resulting significant costs implantable due use previous wiresvalve stenosis tools cardioverter electronic used reduction severe using defibrillators tender mapping procedures venous pacemakers pacing via cardioverter interference chamber devices
clinictrialf__522,522,predicting response to crt using body surface ecg mapping,intervention pacemaker cardiac cardiac non predicting 5 established intravenous three child including coronary myocardial months artery therapy threatening grafting exclusion mapping ecg pilot tolerated (< fulfils recent optimal last within tavi therapy monthstherapy years disease failure diuretics mri bypass body requiring crt responseheart heart iv using constant infarction clinical surgical criteria surface early failure medical life
clinictrialf__523,523,cardiac magnetic resonance imaging guided left ventricular lead placement,electrophysiological cmr delay 5 implantation transcatheter coronary scar threatening grafting lateral (> tolerated optimal consent lv within disease known diuretics constant imaging successful following failure improvement 150ms 9 frequently aortic worse non including replacement myocardial ventricular therapy speckle (< branch ventricular magnetic understood broad implantation heart clinical precise criteria pacing informed medical give improve characteristics occur complex block wall formingcardiac recent guided tracking bypass requiring iv severe infarction clinically cardiac cardiac left bundle intravenous three outcome remain months qrs artery morphology failurevalve exclusion lead resonance likely post therapy written years placement stenosis crt whether placementheart poorly life
clinictrialf__524,524,right ventricle (rv) markers of future pacing induced ventricular dysfunction - pilot,old pacemaker implantation function transcatheter bruising years grade due atrial component high permanent markerspatient inclusion may investigation aortic infarct atrial pacing replacement myocardial ventricular therapy investigation seen entail function around (< undergoing ventricular protocol preserved echocardiogramvalve induced heart criteria one rarely 80 pacing undergo anticipated rv 45 pacemaker additional commonly pilot performed catheter recent ventricle procedure patientsfuture severe using per adverse research future cardiac cardiac dysfunction pilot left occur right %) exclusion fibrillation systolic although suggest 1 stenosis
clinictrialf__525,525,paced electrocardiogram requiring fast emergent coronary therapy (perfect) study,direct old hypertension . standard cold coronary paced electrocardiogram questions 18 angiographic lead upon failure diagnosis pressure depression answer rhythm effect percutaneous pressure fast including therapy ) endpoints used emergent invasive ventricular emergency stimulation mm pain serum reperfusion medical positive intervention based chest blood center ventilation additional 1 6 primary hennepin cutoffs necessitates edema requiring perfectg study severe neither >= potassium study county pulmonary multiple respiratory surgery chronic guiding include elevation age analysisheart year diastolic therapypaced segment
clinictrialf__526,526,setrox js master study,investigation aortic cardiac cardiac implantation atrial transcatheter therapyvalve replacement months ventricular pacemaker therapy exclusion surgery years fibrillation js 18 ≥ regular stenosis master permanent next basis severe clinical another inclusion criteria six studyage pacing setrox
clinictrialf__527,527,optimal left ventricular lead positioning during cardiac resynchronisation therapy comparison of two methods of targeting,presence class despite block standard york cold lead 18 optimal resulting lv ≥ correspond amplitudeoptimal failure 3 avoiding positioning assessing effect atrial therapy consent invasive branch ventricular 35 tte stimulation synchrony ≤ heart criteria strain sensed latest medical give low delayed symptomatic activation 120 region ms block promotes 130ms fibrillation using comparisonnew fraction cardiac echocardiographic 4 electrical left association bundle outcome remain right methods two qrs mechanical exclusion lead surgery chronic 2heart include contractile transthoracic 5 ejection poor resynchronisation studies years targeting whether signals aged
clinictrialf__528,528,use of fish oils to reduce the frequency and duration of episodes of atrial fibrillation in patients with paroxysmal atrial fibrillation.,pacemaker frequency episodes ablation patients reduce atrial arrhythmia cardiovascular myocardial chronic exclusion fibrillation patientsatrial high remote use previous durationleast implanted 2 inclusion criteria cancer syndrome fish oils paroxysmal
clinictrialf__529,529,standard care versus triventricular pacing in heart failure,echocardiography effect may bearing usually must thereafter bnp guidelines 2013 effective months put lbbb give 120 standard pacing bloods including class cpet cold either implantstandard test 3d would influenceheart surgery ) walk nt chronic include partner 1b invasive lead 18 pro triventricular 3 consent 6 pre years imagine check use contraception failure stimulation atrio morphology min care standard failureper heart clinical per esc one potential week minute pacing aged versus informed child indication
clinictrialf__530,530,safe traction during ongoing lead extraction procedure (stop),pacemaker ablation traction stopdefibrillator arrhythmia cardiovascular myocardial extraction exclusion lead procedure fibrillation ongoing experienceatrial high none remote safe inclusion criteria cancer syndrome
clinictrialf__531,531,intravascular ultrasound (ivus) imaging during transvenous lead extraction,intervention ivus occlusion provide pacemaker cardiac patient pass ultrasound capacitytherapy least child 21 dwell extraction exclusion lead ivus pilot imaging1 1 time lead comorbidity intravascular consent transvenous cannot tavi years year mri requiring catheter surgical psychiatric inclusion criteria one venous early extraction
clinictrialf__532,532,circadian rhythm of melatonin in burns,intervention circadian pacemaker cardiac old existing child anoxic exclusion years pilot release injury consent disorder tavi neurological sleep hipaa pre mri brain burns18 surgical inclusion criteria rhythm melatonin preexisting 5therapy early informed
clinictrialf__533,533,same day discharge,assessments intervention prolonged pacemaker discharge provide cardiac cardiac indicated 4 data block sudden remote shock child implant procedural group discharge documented exclusion transmission seen consent pilot electronically regarding day questionnaires complete 5 deaththerapy post ventricular arrhythmias degree tavi implantable primary monitor mri complication implanted prevention dischargeimmediate transmit care next requiring cardioverter high 10 heart 3 phone callday icd surgical prior indication clinically also criteria day admission early informed device death secondary
clinictrialf__534,534,comparison of the performance of implantable cardiac monitors and cardiac implantable electronic devices in detecting atrial fibrillation,defibrillator give cardiac functioning aged aortic devices cardiac implantation remote atrial transcatheter electrograms monitor replacement ventricular therapy monitors monitoring fibrillation record af lead 18 afvalve consent resynchronisation implantable years persistent stenosis comparisonimplantable permanent electronic performance detecting severe pacing cardioverter informed
clinictrialf__535,535,ies-acap: influence of atrial pulse width in the behaviour of acap™ confirm algorithm.,confirm study zephyr influence pacemaker purposeacap acap confirm primo models ™ data ablation observational atrial york whit implant collect algorithm behaviourstudy replacement class algorithms cardiovascular arrhythmia myocardial pacemaker 5826 width regulates exclusion consent pulse association fibrillation regarding specific acap 18 fixation high leads implanted remote years yearsatrial ies heart new inclusion criteria automatically iii patients syndrome cancer document passive informed chamber
clinictrialf__536,536,pet mr imaging in patients with infective endocarditis,intervention pacemaker diabetes native cardiac cardiac control 65 infective child class illness patientsnyha additional endocarditis exclusion years pilot pet undergoing poor intercurrent rate tavi pet dependent failure fdg mr mri iv heart groups surgical imaging inclusion criteria major tracer mellitustherapy early valve device
clinictrialf__537,537,effect of his-ventricular (hv) interval optimisation in cardiac resynchronisation therapy,intervention pacemaker give cardiac effectchronic ablation parkinson white cardiac hv block atrial kidney child replacement myocardial ventricular therapytherapy therapy pilot stage ongoing recent consent resynchronisation degree tavi previous optimisation disease flutter mri 3 heart severe surgical third disease infarction syndrome interval ischaemia early valve informed
clinictrialf__538,538,iatrogenic chronotropic incompetence and exercise tolerance in heart failure,effect ablation standard atrial incompetence depending cold cognitive issues limiting exclusion surgery consent reaction chronic invasive fibrillationheart chronotropic iatrogenic lead node slow stimulation known failure toleranceprovide heart av walking inclusion criteria musculoskeletal impairment upon response exercise
clinictrialf__539,539,mayo clinic cardiac implantable electronic device mri registry,intervention may pacemaker provide cardiac cardiac vascular advisory ocular retained outputs generator child clips greater mayo strong without exclusion intracranial pulse pilot acceptable state technology alternative lower consent fragments tavi implantable cied diameter clinic mri metal implanted registryspecific electronic unsafe surgical clinical disease imaging criteria devicetherapy early informed device abdominal indication
clinictrialf__540,540,mineralocorticoid antagonism to stop progression of atrial fibrillation (monitor-af) study,study progression afleast stop events dysfunction ablation capable existing atrial arrhythmia monitor cardiovascular months sustained myocardial pacemaker documented exclusion suppression fibrillation af medications 12 continuously antagonism high lasting indicationatrial last rate remote receiving taking renal high permanent severe clinical occasion criteria one syndrome patients cancer mineralocorticoid pacing af device
clinictrialf__541,541,telemetric arrhythmia and syncope diagnosis - evaluation of arrhythmia treatment efficacy,old practice patient ablation long profound efficacy atrial understands treatmentatrial arrhythmia methods cardiovascular physician myocardial first protocol diagnosis exclusion feasible monitoring ecg years days 14 fibrillation syncope treatment high invasive evaluationpatient instructions consent recommendation term remote use best compliance fibrillationarrhythmia informed ablation catheter study basic cooperation enabling clinical procedures inclusion criteria syndrome cancer telemetric day regarding undergo 80 significance device paroxysmal
clinictrialf__542,542,cardiac mri for optimal heart failure outcomes with crt upgrades,effect cerebral cardiac devices patients failure prior association ii existing cochlear york kidney accidentheart standard class including metallic clips cold public upgrades surgery chronic novo health upgrade invasive lead films implants injury recent acute undergoing enrolled significant consent implantable de aneurysm skull stimulation failure mri renal informed electronic sequences crt heart known using new outcomes mriprovide implants procedures severe claustrophobia 50 effectively impactoptimal prospectively designed
clinictrialf__543,543,clinical investigation of the selectsecure pacing lead,defibrillator effect contraindication standard pacing blood cold right ). valve exclusion surgery chronic invasive lead investigationimplantable steroid ventricle stimulation failure ventricle allows diseased clinical icd tricuspid inclusion criteria atriumheart selectsecure cardioverter
clinictrialf__544,544,spontaneous atrio ventricular conduction preservation,aortic cardiac dysfunction cardiac normal ™ implantation block preservationundergone transcatheter angina replacement myocardial ventricular aortic exclusion pectoris within atrio ventricular spontaneous node conduction 2550 paroxistic surgery 3rd sinus stenosis stenosisvalve appropriate unstable severe av infarction conduction criteria symphony pacing information
clinictrialf__545,545,emerald - assessment of comorbidities & atrial arrhythmia burden in dual-chamber paced patients,implantedatrial pacemaker cardiac patient ablation patients dual atrial guidelines arrhythmia cardiovascular months two myocardial pacemaker paced exclusion tachyarrhythmia dual years fibrillation arrhythmia population (< high assessmentpersistent node inclusion implanted moving remote vp year disease persistent sinus hrs sub ).chamber 2 4290 inclusion criteria cancer comorbidities patients 4 populations general pacing follow syndrome burden chamber emerald
clinictrialf__546,546,prophylactic treatment of high-risk patients with cardiovascular implantable electronic devices (cied)with continuous in-situ ultra high-dose antibiotics (cita) under regulated negative pressure-assisted wound therapy (rnpt),prophylactic infections situ pressure ablation devices wound regulated patients arrhythmia cardiovascular myocardial negative therapy rnpt exclusion antibiotics cardiovascular fibrillation assisted high implantable treatment remote dose risk electronic inclusion criteria highatrial syndrome cancer ultra others continuouscied
clinictrialf__547,547,early outcomes of concomitant transcatheter aortic valve implantation and off-pump coronary artery bypass grafting in management of severe symptomatic aortic stenosis and coronary artery disease,alone valvular opcabg aortic cardiac months patients despite implantation cad managementsevere three transcatheter coronary replacement symptomatic ventricular artery aortic grafting exclusion commonly used bypass concomitant transcatheter treatment undergoing pump diseaseconcomitant tavi tavi disease stenosis bypass modality heart severe outcomes performing inclusion criteria patients pacing early valve patientsvalve
clinictrialf__548,548,safety study on stopping anticoagulation medication in patients with a history of atrial fibrillation,study historyst jude ablation patients blood remote atrial arrhythmia cardiovascular myocardial exclusion monitoring fibrillation anticoagulation questionnaire fibrillationatrial thinner high safety due device remote medial transmission medical condition stopping medication clot another inclusion criteria cancer syndrome device medication
clinictrialf__549,549,contemporary transvenous lead extraction outcomes,intervention limited pacemaker cardiac undergoing longterm minorstherapy child procedural dissecting removal sheath rotational characteristics extraction lead tle exclusion pilot datacontemporary rates centre transvenous tavi technical managment present mri procedure success study tools surgical volume inclusion criteria patients early extraction outcomeslead progress
clinictrialf__550,550,re-evaluation of optimal re-synchronisation therapy in patients with chronic heart failure,month months 5 standard cold coronary ). chronic protect lead optimal completed within due treatment % receiving failure slower assessed grafting failure effect may percutaneous least class mitral endpoints replacement therapy endpoints function invasive ventricular 35 31 stimulation overall ≤ unexpected heart interventionheart productchronic 4 medical valvular annual defibrillator event evaluationtranscatheter symptomatic aortic 52 recruitment performed 1 361 6 august primary investigational repair bypass iv 2024 rate nyha valve fraction cardiac patients left months artery synchronisation surgery chronic transcatheter within receive verifiably ejection 3 reduced crt optimal prior weeks patients
clinictrialf__551,551,prognosis of patients with compete left bundle branch block,found investigators block coronary ). (> 40 within remote disease mr et technique imaging potential predictors al cardiovascular including myocardial mapping techniques used cardiovascular z branch high ventricular significant magnetic chen thicknesscompete heart new also syndrome combined prognosis patientssubject showed ablation tachycardia aortic days wall period 90 complete days bypass study uncorrected severe disease valve 100 novel underwent septal bpm cardiac left radial bundle arrhythmia right congenital methods artery lead expected fibrillation resonance maximum placement rv stenosisatrial t1 parameters prior mapping imaging cancer graft
clinictrialf__552,552,effect of omega3 on congestive heart failure,effect less agents congestive recruited lipid natriuretic initially standard omega trial cold among two months test pacemaker survival chronic protocol exclusion surgery acids walk chronic conditions invasive lead controlled treatment effectclass 3 6 groupscongestive drugs sinus stimulation failure lowering compared brain study randomization iv heart omega3 clinical using inclusion criteria rhythm supplements fatty minute accept triheart peptide chamber
clinictrialf__553,553,identifying an ideal cardiopulmonary exercise test parameter,decision normal restores implantation block transcatheter never coronary ). chronic threatening angiogram symptoms identifyingrestrictive ecg functionvalve activate pump degree failure 3 untreated complain rhythm many improving aortic fits cardiopulmonary helping predict kidney makingideal replacement ventricular test without measuring test stage equation gault efficiently ventricular significant values good heart size av outcome one pacing exercise limited blood prior potentially newer sinus parameter procedure would symptom severe using disease activities lung cardiac numerous cockcroft patients left arrhythmia right alongside first daily leads taken stenosis measures identifying patients life
clinictrialf__554,554,prospective minnesota study of echo tissue doppler imaging in cardiac resynchronization therapy,pacemaker conducted despite function child coronary indicated doppler surgically optimal prospective shown measures previous disease minnesota geographic imaging hf following enrollment failure assessing improvement 30 including therapy visits ventricular node significant tissue priortherapy heart surgical criteria one early undergo valvular intervention imagingecho symptomatic stability therapystudy pilot days primary sinus mri bypass invasively uncorrected iv severe defined clinically week designed study preceding cardiac cardiac transplant week left valve artery mechanical exclusion within poor newly tavi therapy pharmacological developed seventy dyssynchrony tricuspid imaging resynchronization patients graft
clinictrialf__555,555,an assessment of dual site left ventricular endocardial pacing,give aortic vascular cardiac 60 dual implantation left atrial assessmentwould site access transcatheter tachycardia replacement suitable ventricular procedure peripheral fibrillation structure longer endocardial ejection abnormal ventricular consent years disease stenosis arterial ablation criteriavalve severe make inclusion fraction pacing aged informed
clinictrialf__556,556,cpap treatment and postoperative outcomes in patients with rheumatic valvular heart disease,valvular system study index central intervention pacemaker class cardiac nervous pulmonary received aged patients evaluations blood rheumatic apnea waiting received child obstructive including replacement disorders chronic hypopnea cpap randomly surgery walk pilot 18 gas treatment testrheumatic 5 baseline treatment tavi sleep disease mri arterial findings surgical heart signstherapy clinical outcomes caused disease another patients night minute nyha patientsreceived postoperative failure valve replacement >= analysis group early
clinictrialf__557,557,individualized diagnosis of endocarditis and its therapy with a focus on infected prosthetic material,pacemaker months tomography child diagnosis (> line observation 18 glucose treatment prospective multicentre emission wherein ≥ angiography diagnosis fulfilling inclusion successful 50 presenting gated therapy endocarditis 12 individualized exception uncomplicated prosthetic infection surgical positron clinical criteria early medical hospitals intervention depending material design pilot encompasses %) intracardiac alternative related mri alone treatmentinfected study 2 differential endocarditiswithout fluorodeoxyglucose tomography valve study focus cardiac population endocarditis situations infective consists first participating material exclusion 2012 multidetector (+ - criteria tavi reasoningtherapy years (≥ patients weeks computed age
clinictrialf__558,558,the tilt test-induced response in closed-loop stimulation (tirecs) study,effect study performheart treated pacemaker tirecs vasovagal standard cold two test pacemaker first loop biotronik exclusion surgery ) chronic performed syncope testtilt invasive lead head apart one algorith stimulation hutt stimulation turned closedrefractory failure wil hutt permanent 18th induced year heart receiving cardioinhibitory cls inclusion criteria refractory one week rate response algorithm tilt age
clinictrialf__559,559,combining myocardial strain and cardiac ct to optimize left ventricular lead placement in crt treatment,combining estimated intervention filtration pacemaker 35 give cardiac months cardiac glomerular despite left association ii york function child class ). myocardial symptomatic qrs therapy lead 120 pilot stabile impaired milliseconds (< consenttherapy recent optimal ventricular 3 %). consent ≥ treatment tavi severely written placement wide failure renal mri ef medical ≤ optimize crt heart surgical ctnew infarction strain rate early informed functional
clinictrialf__560,560,supra-annular vs. annular valves for small annuli,expanding may supraaortic patient native aortic cardiac team implantation low gradient left valves intravenous atrial transcatheter particularly mitral contrast replacement flow ventricular aortic mis mismatch exclusion procedure show sapien iodinated self structural institutional transcatheter receive prosthesis 3 vs prothesis vulnerablesmall annulus diameter concurrent annuli mm stenosis determines mean 23 media ≤ appendage heart severe versus differences edwards small criteria closurevalve ultra pacing annular repair valve annuli intended
clinictrialf__561,561,paroxysmal atrial fibrillation: role of inflammation oxidative stress injury and effect of statins,inflammatory conditions pacemaker give consecutive tavn ablation antiarrhythmic 5 dual effectparoxysmal atrial either epis arrhythmia cardiovascular months myocardial therapy chronic exclusion fibrillation days drug conditions (> 40 1 receive injury monthly high 3 consent statin remote days liver year simvastatin enzymesparoxysmal causeatrial oxidative informed requiring year study mg reversible inflammation stable statins criteria inclusion syndrome cancer products role stress af medical chamber paroxysmal
clinictrialf__562,562,myval european study of myval™ thv system implanted in patients with native severe aortic valve stenosis.,system study must treated system native consecutive congestive aortic pacing 30 ™ operator implantation cardiac bundle tavr york transcatheter right replacement 200 ventricular pacemaker aortic exclusion blocknative association days rates transcatheter treatment branch myval safety completed implanted worsening treatment team stenosis failure european permanent hospital study thv treating heart implantation new severe inclusion criteria patients minimum patientsreceived follow valve patientsvalve
clinictrialf__563,563,catheter ablation registry,study direct date involved completion chest ablation block international procedurecatheter arrhythmia procedural including cardiovascular cessation myocardial using first fibrillation current criteriaatrial atrioventricular rates high attempts prospective energy degree remote categories significantly level lowered delivered complication ablation cohort catheter registryeligibility study multicenter outcomes listed third attempts cancer successful syndrome
clinictrialf__564,564,a cohort study of chronic cardiovascular diseases,cardiac ablation arrhythmia cardiovascular myocardial pacemaker chronic exclusion cardiovascular fibrillation criteriaatrial return visits diseases high regular remote studyacute cohort implantation infarction inclusion criteria cancer syndrome
clinictrialf__565,565,reduction of right ventricular pacing using the feature ventricular intrinsic preference (vip),study month aortic cardiac 60 (± intrinsic dual implantation block ® atrial transcatheter pacing ™valve right replacement ). ventricular using chronic sjm fibrillation visits reduction1 complete ventricular due device vip rv stenosis would feature 2 ≤ preference severe expectancy av another weeks vip research patients pacing victory device chamber life
clinictrialf__566,566,identification of gene polymorphism in patients with sick sinus syndrome in chinese population in taiwan,effect study rateheart cardiac chinese cause patients standard cold coronary long pause ms surgery recovery chronic gene time invasive taiwan 1600 lead population series acute disease sinus systemic electrophysiology failure stimulation nodal sick reversible hour heart severe identificationsinus inclusion criteria syndrome polymorphism ekg exceeds
clinictrialf__567,567,a phase 2 trial of deep brain stimulation for spasmodic dysphonia,effect tension 6 9 muscle laryngeal 4 ear standard fragments cold trial exclusion surgery phase chronic treatments invasive lead pump botox denervation implant dysphoniaheart stimulation failure mri deep brain contraindications dysphonia metal 2 tissue 3 dysphoniareceiving inclusion criteria expanders infusion following spasmodic
clinictrialf__568,568,clinical study of the easytrak 3 spiral fixation coronary venous bipolar pace sense lead,study month preceding 35 aortic cardiac dysfunction cardiac month spiral despite stable undergo transplant studyqrs prior 30 left graftvalve transcatheter implantation including bipolar coronary replacement symptomatic months valve ventricular safety artery therapy mechanical without 120 montheasytrak days drug ms lead fixation %) optimal ventricular 3 within implanted evaluation document pace 6 written previous remaining easytrak sense stenosis duration bypass guidant ef approval 3 heart <= clinical severe tricuspid prior resynchronization patients venous >= pacing follow failure
clinictrialf__569,569,ablation of inappropriate sinus tachycardia,conditions palpitations increasing rays ablation normal condition arrhythmia cardiovascular tachycardia ). superior myocardial x dysfunction pacemaker greater lead causing describes electrogram cava ecg fibrillation suspected 12 recordings inappropriate identified high without post dueinappropriate node hypotensionatrial significant due rate orthostatic remote suggest significantly sinus tachycardia mean reduce vena implantation ablationdocumented heart cancer rhythm syndrome resting syndrome effectively daytime acutely rate medical
clinictrialf__570,570,comparison of septal and apical pacing sites in permanent right ventricular pacing,prothesis revascularization physiological thresholds less septal give cardiac aortic ablation cardiac improve implantation left block function transcatheter pacing treated right coronary pattern parallel replacement septal ventricular would suggested disorders sites plannedvalve questionnaire eventspermanent serious preserve randomized expectancy surgically comparisonhigh simple sf ventricular prospective 36 node degree consent rate written valvulopathy several studies rv stenosis detection requiring permanent severe av conduction tricuspid small adverse patients apical pacing valve informed indication life
clinictrialf__571,571,rhythm disturbances after ventricular septal defects,defects septal aortic cardiac implantation block transcatheter replacement rhythm ventricular exclusion surgery ventricular stenosis heart severe criteria pacing disturbancesinclusion patientsvalve
clinictrialf__572,572,evaluation of length of stay after tf-tavi,intervention discharge pacemaker cardiac tf patient devices impossible child symptomatic aortic exclusion usingtherapy delivery pilot back stay sedation transcatheter planned length undergoing tavi tavi stenosis mri requiring surgical evaluationsevere home anesthesia inclusion criteria conscious general early local valve
clinictrialf__573,573,effects of different colors of light on human physiology,effect classical novel photoreceptor psychiatric mechanisms work preferentially systems movements standard including illnessesheart cold months eye feelings exclusion wavelength surgery techniques according interview chronic photobiological shift invasive lead 3 last effectsentire psychopathology rate humans slow years blue transmeridian questionnaires stimulation light failure different light short stimulate photoreceptive neurobiologicalhuman duration study structured heart candidate using variability clinical physiology travel past criteria potential rolling major night inclusion increased colors standardized
clinictrialf__574,574,node and atrial fibrillation ablation for persistent atrial fibrillation,intervention give cardiac ablation drugsatrial week atrial least arrhythmia cardiovascular coronary symptomatic months myocardial rhythm artery disorders nodemajor consent control fibrillation drug factors 1 form suggesting high recent last within remote surgery persistent fibrillation 2 clinical infarction prior cancer refractory syndrome patients rate instability informed
clinictrialf__575,575,digital mammography for the detection and preoperative staging of breast cancer,diagnosed ablation 30 undergo unilateral cedm arrhythmia cardiovascular contrast detectionnewly chelated myocardial examination fibrillation preoperative digital undergoing neoadjuvant implants high mammography within de days remote cancer bilateral mri breast mri agent staging study .)atrial cedm proven cancer syndrome women chemotherapy
clinictrialf__576,576,clinical trial of systolic heart failure treatment of ivabradine hemisulfate sustained-release tablets （first）,effect month ivabradine transient cerebral hemisulfate ischaemia 60 30 shock standard 70 defibrillator pacing cold （ )˃ months first ˃ documented level exclusion chronic ) except surgery chronic medications drug 1 invasive started lead systolic b ventricular sustained within 6 treatment therapy rate ≥ unchanged 3uln previous days trialcardiac disease investigational 40heart ） known renal biventricular ast failure stimulation heart severe clinical resynchronization criteria release weeks 4 resting failure tablets
clinictrialf__577,577,functional electrical stimulation of the bilaterally paralyzed human larynx,months despite opening jeopardize ). bilaterally would stimulationbilateral within advances approximately ≥ remote statistics mean year repeated ten paralyzed carries received least cardiovascular cease myocardial vanderbilt preoperative pca evaluation high reestablishes motor bilateral toxin glottal paralysis larynx one syndrome anticipated medical ablation passively human center national certified health vocal recent stimulation 7bilaterally 6 muscle safe muscles per 05 injections functional relax paralysis electrical laryngologist arrhythmia occur nga botulinum documented implantationatrial fibrillation fold endoscopy botox fibers folds board prior cancer 0 records via tested
clinictrialf__578,578,mini-invasive balloon aortic valvuloplasty,strength intervention absenceheart independent according effect valvuloplasty vascular transradial surgical implantation radial standard blinded procedural visit cold complications evaluate symptomatic two stenosis artery pacemaker ad test balloon aortic exclusion without surgery patency periprocedural pulse chronic invasive lead 90 %. compartment consent temporary varc rate ≥ perform minisevere cardiogenic bilateral stimulation failure success requiring 2 shock inclusion classification operators major hoc criteria syndrome handgrip valvuloplasty informed complicationsinvasive
clinictrialf__579,579,strategy of continued versus interrupted novel oral anti-coagulant at time of device surgery in patients with moderate to high risk of arterial thromboembolic events,hemodynamically novel valvular provide consentatrial patient events anti active patients 5 ablation rheumatic least apixaban oral implant cardiovascular arrhythmia valve myocardial test discontinue first mechanical surgery exclusion risk pulse fibrillation days moderate novo time 1 day routine dabigatran undergoing high significant baseline regular visit de lesion remote rivaroxaban interrupted surgery disease dose clinic thromboembolic postcontinued arterial valve informed high infection next full heart op clinical generator lab prior criteria cancer syndrome change coagulantleast versus strategy device
clinictrialf__580,580,preventive ivig therapy for congenital heart block,pacemaker congestive . employ block rash child confirmed priority rates threatening 20 1st %. degree disease approach failure high lupus following secondary defects makes lesions myocardial blocktherapy therapy prospect ) alarming revealing day since facing biologic recurrence considered assume causal injury surgical heart outcomes size calculations g dermatology early simon intervention preventing factors additional ivig 2preventive characteristic pilot sample structural blocktaking lesions photograph mri requires per conduction disease annular valve note less cardiac absent congenital every kg include pi prednisone 3 mg tavi sense observed neonatal tricuspid cardiomyopathy fetus weeks developmental
clinictrialf__581,581,targeting risk interventions and metformin for atrial fibrillation (trim-af),old afleast months 4 ablation 5 capable atrial york arrhythmia cardiovascular class 14atrial myocardial targeting lead association years fibrillation 1 cohorts 18 > = minutes lasting high 3 ≥ age metformin remote interventions risk trim implanted cohort iv heart 3 new inclusion criteria past syndrome cancer nyha failure af functional episode
clinictrialf__582,582,revisit the value of imaging in best using cardiac resynchronization therapy,pacemaker child contrast treatment spontaneous pump large pre search images sent threshold biomedical data accordingtherapy pacing therapy body current value ventricular revisit valuesbest renal surgical heart new clinical criteria one early prognosis intervention surgical software metallic rhythm ever intraocular pilot iodinated 6000 data prosthesis quadrupole pre sinus compared mri tools routine multicenter severe using echocardiography edwards impairment type ferromagnetic injection valve cohort cardiac cardiac dedicated clips exclusion lead intracranial insulin imagingleft tavi testing foreign year resynchronization initial device
clinictrialf__583,583,cardiac rhythm disturbances in hard-to-treat epilepsy patients using loop ecg recorders,hardknown cardiac 4 60 antiarrhythmic ablation arrhythmia defibrillator including cardiovascular rhythm myocardial loop exclusion non ecg relevant years fibrillation 2 structural high pacemakeratrial resynchronisation disturbances device remote psychogenic focal implanted 3 using clinical medication treat disease criteria inclusion syndrome patients cancer pregnant epilepsy recorders
clinictrialf__584,584,prevention of arrhythmia device infection trial (padit),system intervention pacemaker comes cardiac patient cardiac subsequent patients data identificationtherapy antibiotic received purposes revision child implant trial replacement paditnew therapy procedure incremental lead pocket randomized pilot 20 arrhythmia upgrade first operative one enrolment tolerate prevention infection tavi therapy implant per period mri undergoingarrhythmia cefazolin bacitracin collection study care surgical clinical intracavitary usual criteria resynchronization whichever eligible center patients iii early eligibility strategy device identified
clinictrialf__585,585,impact of right ventricular pacing determined by electrocardiography,valvular septal aortic cardiac dysfunction implantation left impact transcatheter pacing blockvalve replacement myocardial ventricular pacemaker dimension exclusion scheduled randomized patientsright artificial beats 2 1 scheduled atrioventricular block determined ejection apex select ventricular grade lv ≥ echocardiogram disease beat 1 stenosis procedure heart severe electrocardiographypacemaker inclusion criteria infarction fraction pacing
clinictrialf__586,586,percutaneous electroneurostimulation of dermatome t6 for appetite reduction and weight loss in morbidly obese patients,kgvalve aortic cardiac appetite percutaneous patients candidates implantation transcatheter illness replacement weight ventricular bariatric exclusion surgery dietary causing loss serious 40 t6 dermatome reductionuntreated morbidly obesity comorbidities endocrine obese treatment stenosis electroneurostimulation psychiatric severe disease inclusion criteria status patients pacing obesity associated
clinictrialf__587,587,efficacy of implantable cardioverter defibrillator in patients with non-ischemic systolic heart failure on mortality,defibrillator implantation ii periodically transcatheter ). localized %. review within % disease failure abuse preferably diseasevalve 35 aortic data class replacement ventricular positive consent cardiovascular drug monitoring ventricular disorder ≤ appropriate weeksischemic heart icd proportional 4 pacing latest informed model mortality cox month efficacybiventricular human pacemaker throughout non data 6 implantable malignancy uncorrected 2 iv severe immunodeficiency mortality nyha cardioverter reduces independent must cardiac hazards patients consisting left committee congenital illicit months virus ejection systolic lvef 3 safety therapy written stenosis stable weeks fraction committee death
clinictrialf__588,588,predicting response to cardiac resynchronization therapy in heart failure,clips graft nervous segments guide hall ii standard york cold contrast coronary chronic association acceptable lead ischemic lv within disease failure 3 imaging remodeling stress effect may central 60 predict atrial distance class therapy without walk invasive aneurysm stimulation heart new also enhancement system tachyarrhythmias delayed pacemaker birth failurepercutaneous administration days mri subjects bypass iv severe using refractory iii increase functional predicting control association artery mechanical surgery intervention status chronic likely less dyssynchronycardiac baseline therapy testing 3heart dyssynchrony prior resynchronization patients minute response medically agent
clinictrialf__589,589,pilot study using echocardiography to evaluate patients with heart failure and dyssynchrony who have a crt-d device,intervention old pacemaker cardiac months 4 patients receptor pilot child evaluate therapy blocker years pilot 2 enzyme optimal 3 crtoptimal age includes target tavi device 110 failure regimen mri study dyssynchrony angiotensin surgical heart e using converting echocardiography 18therapy past adults dose early inhibitor failure medical
clinictrialf__590,590,beluga - clinical observations of automatic algorithms for cardiac pacing,estimated pacemaker aortic cardiac automatic algorithms patient transplant cardiac dual implantation observations transcatheter implant avb replacement months ventricular avt pacemaker ) signed 2 18 complete avb ventricular within ≥ years information stenosis pr belugaheart permanent severe clinical expectancy resynchronisationvalve foreseen six pacing age chamber life
clinictrialf__591,591,trial of replacement heart valves in patients with narrowing of the heart valves,cm approach 5 implantation transcatheter coronary chronic sapien (> series within ≥ narrowingnormal 50 aortic 30 valves degenerative replacement myocardial stenosis ventricular ) stage acute significant evolut area renal thv ≤ heart contemporary pacing native active hemodynamic transfemoral trial symptomatic instability aortic 90 revascularization %) thick myval vs 6 days supportvalve requiring luminal severe infarction bleeding disease maximal valve cardiac patients endocarditis months artery upper inotropic lvef 3 series mm protruding diameter 1 senile stenosis seriesreplacement bacterial necessitating dialysis gi via
clinictrialf__592,592,screening contrast-enhanced mammography as an alternative to mri,intervention carriers cancers pacemaker enhanced 595 earlier cardiac chest improve contrast prior ( least kidney function child oral ). law negative mutation therapy heterogeneously 8 apply alternativeseparate insurance years bill suspected pilot ongoing even radiation prospective protocol mammography endocrine detection detected age 30 breasts excludes pathogenic breaststherapy tavi cancer mri mammogramscreening reduced mri ) reduce june study senate pa requires copay 40 new surgical extremely prior imaging clinically dense tocem interval early ten designed legislation screening
clinictrialf__593,593,clinical trial of propranolol for seasonal affective disorder,circadian psychiatric aortic drugs pacing cardiac seasonal read receptor affective implantation al transcatheter cups trial illness replacement ventricular pacemaker homologous adrenergic allergic nocturnal intervention changes resemble depression secretion day blocking controlled secretion govern regulates disorder regular sleep humans melatonin rosenthal stenosis behavior 2 illnessvalve reactions behavior improves clinical prescription signalseasonal regulate per severe et schedule antagonist weeks 4 major propranololbeta medical medication
clinictrialf__594,594,cardiac resynchronisation therapy in patients with heart failure: mechanistic insights from cardiac mri and electroanatomical mapping,system intervention precluding bearing patientsrate must pacemaker cardiac cardiac vascular effective atrial elective iitherapy child implant mechanistic electroanatomical aortic therapy surgery scheduled mapping peripheral pilot partner planned insights procedures grade significant resynchronisation tavi mri use disease contraception failure mri requiring fibrillation optimum medical crt surgical heart disease potential general anaesthesia nyha early valve uncontrolled child
clinictrialf__595,595,the crt-kir study (cardiac resynchronization therapy crt] in the early phase after heart surgery),effect study may hours benefitcardiac crtcoronary cardiac electrical surgical left block bundle diseaseheart function delayed activation atrial standard mitral right congenital cold artery aortic phase therapy variables early surgery contractility causing chronic fibrillation (= invasive lead treatment branch ejection abnormal lv term crt open ventricle reduced stimulation failure short bypass valve permanent study standard crt heart severe 72 mentioned kir procedures resynchronization patients graft fraction postoperative versus
clinictrialf__596,596,impact of left bundle branch area pacing vs. right ventricular pacing in atrioventricular block (leap-block),normal implantation block transcatheter blockvalve superior lbbap 40 impactpacemaker degree lv within ≥ functionleft due % high permanent including successful 50 burden failure aortic least pacing replacement ventricular without consent cava atrioventricular branch ventricular determine area subject implanted required percent induced heart new av criteria replacement pacing repair informed traditional achieve symptomatic hospitalization electrodes 1 %) vs 6 vp )> study vena severe valve septal cardiac cardiac dysfunction left bundle right months every first mechanical exclusion procedure require defect lvef 3 newly year rv stenosis leap whether tricuspid second
clinictrialf__597,597,biventricular pacing in patients with left ventricular dysfunction after cardiovascular surgery,graft patientsgive give aortic dysfunction cardiac implantation preferred transcatheter pacing coronary replacement ventricular routinely artery epicardial evaluationleft exclusion 2002 surgery lvef consent severe cardiovascular randomized pregnancy planned receive n 18 insync j ventricular consent temporary leads cabg written 2001 surgery cabg years stenosis biventricular compared bypass protocols med 3 multicenter often using biv engl clinical inabilityvalve managed criteria also inclusion patients research pacing undergo valve informed
clinictrialf__598,598,biventricular pacing in hypertrophic cardiomyopathy after aortic valve replacement,hypertrophic output aortic cardiac implantation low atrial pericarditisvalve transcatheter replacement ventricular aortic pacemaker exclusion fibrillation preoperative 18 years placement stenosis biventricular permanent cardiomyopathy severe pacingaortic inclusion criteria replacement pacing postoperative valve
clinictrialf__599,599,mascot study: management of atrial fibrillation (af) suppression in af-heart failure (hf) comorbidity therapy,effect study percutaneous angioplasty left standard atrial york 130 optimized hf delayheart cold coronary qrs artery therapy grafting ms exclusion mechanical surgery association years fibrillation af transluminal chronic end invasive lead 18 ejection ventricular spontaneous ≥ management stimulation comorbidity diastolic failure diameter 55 mm bypass regimen suppression interventricular heart new criteria afleft fraction medical mascot
clinictrialf__600,600,randomized study comparing both latest generation self-expanding valves and local anesthesia vs. conscious sedation in transcatheter aortic valve implantation,expanding sedationderived inc latest native . peptic active aortic pacing cardiac implantation antibiotic valves transcatheter transfemoral replacement symptomatic valve stenosis ventricular aortic exclusion sedation non according generation measuring randomized consent formvalve self 1 pro minneapolis transcatheter medtronic prefer undergoing pro annulus comparing vs studytranscatheter tavi infection + demonstrate written evolut treatment choice annulus cm² diameter stenosis ava 21 bicuspid requiring isolated study ≤ implantation severe anesthesia criteria conscious one local anesthesia valve informed ulcer
clinictrialf__601,601,circadian rhythms and cardiovascular risk,less circadian current hypertension bmi ablation arrhythmia cardiovascular myocardial cardiovascular fibrillation moderate high ahi treatment remote pharmacological )> riskprevious 15 severe rhythms osa cancer 40atrial syndrome
clinictrialf__602,602,focused ultrasound surgery in the treatment of pain resulting from metastatic bone tumors with the exablate 2100 conformal bone system,transducer pacemaker ultrasound child accessible structure treatment resulting within 2100 behind receiving disease metastatic ablation untreated including mrgfus following 19 8 four kidney site including compatible cva thermal may chemotherapy exablate vomiting tumor implanted beam unstable surgical new criteria pacemakers early experiencing devices intervention bearing system ebrt metallic pilot previously irradiated arrhythmia advanced invasive 13 ranges 6 9therapy external dose mri used mentioned disease focused local goals therapyexablate cardiac cardiac 4 produces pain fixed weight months two surgery exclusion control status bone radiation tumors last tavi regime 2000 lung treatmentmri conformal bony affected larger weeks patients developing device
clinictrialf__603,603,image supported lead placement in crt,intervention pacemaker fraction 35 cardiac association ii left bundle york block 130 function child class image % qrs documented ms lead allergic reaction pilot impaired supported crtlv branch ejection optimal ≥ treatment tavi placement studytherapy renal mri 150 ≤ surgical heart severe new clinical another insufficiency early medical
clinictrialf__604,604,remote cardiac monitoring of higher-risk emergency department syncope patients after discharge - a pilot study,permuted found department 5 implantation alarms transcatheter discharged ed syncope 18 among higher within due ≥ deaths obvious abuse inclusion allocated prolonged central aortic data remote reviewing false including replacement ventricular ) drug monitoring high emergency dischargecanadian blocks risk criteriavalve diagnostic home pacing events 24 minutes symptomatic event monitoring previously arrhythmia health 2 score 6 severe using station adverse seizure study higher cardiac cardiac patients pilot mental yield illicit months linkage every randomly serious sectionrisk capture 5 arrhythmias safety years year stenosis witnessed detecting board administrative status patients enrolled initial age
clinictrialf__605,605,optimize pro study,study intervention index vulnerable emea pacemaker provide cardiac multi 4 based include left anz york child individuals willingness outflow market replacement us aortic sites ) non consent association randomized pilot include studyprohibitive calcification pro ejection post ventricular centeroptimize tavi previous reduced functiontherapy subjects mri required procedure score whose ≤ surgical heart new tract katz fraction early follow valve informed prospective
clinictrialf__606,606,crt in narrow qrs heart failure: mechanistic insights from cardiac mri and electroanatomical mapping,intervention precluding bearing must pacemaker cardiac cardiac vascular effective crtrate atrial elective child mechanistic electroanatomical qrs aortic therapy surgery scheduled mapping peripheral pilot partner insights procedures grade significant lv tavi mri use disease contraception known failure mri requiring fibrillation optimum medical surgical heart thrombustherapy disease narrow potential iii general anaesthesia nyha early valve uncontrolled child
clinictrialf__607,607,amazing prague (prague-12),intervention pacemaker cardiac cardiac month atrial child coronary amazing exclusion surgery consent pilot fibrillation signingtherapy emergent bypass prague last consent 6 tavi 12signed mri surgical inclusion criteria early repair valve informed
clinictrialf__608,608,safety and efficacy of the swallow expansion device (sed) for improvement of swallowing in patients,pacemaker affect expansion profound normal child safety immobilitytherapy air went within device suture diminished may commissure subsequent improvement pressure able oral works mmhg without cough current test model sed dysphagia like surgical home well early looks intervention oropharyngeal patient unilateral dysphagia pulse pilot better vocal score attached feeding 6 sphincter dependent use swallowing mri safe defined extremely sphincter opening extreme abbreviated cardiac patients mental incompetence three long months upper thread fold 3 tavi sed therapy efficacyprofound tube different esophageal patients modelsswallow
clinictrialf__609,609,septal mapping and resynchronisation therapy- (smart) study,smartnegative pacemaker intrinsic block filling child pressuresseptal ecg consent lv within approximately otherwise successful rhythm hf provide experience site pacing test therapy investigation mapping consent published haemodynamic test elevated branch acute ventricular response landmark participation mid limit subject smaller surgical clinical worldwide 4 early million informed exercise intervention index showed give investigatortherapy 26 pregnancy people principle measurements affects pilot days suggesting improved correlated several sinus specific related compared mri 7 procedure study standard outcomes per required trials done study septal cardiac must capacity left bundle activation procedure showing resynchronisation tavi written studies decreased different true regions prior weeks minimum initial
clinictrialf__610,610,arrhythmias in myocarditis,usually progresses collected implantation transcatheter chronic leading ecg ischemia signed social 18 consent ≥ due disease ablation hospitalization already prolonged aortic percutaneous kidney blood replacement myocardial ventricular therapy ) peripheral current demographic implanted basic resting 12 pacing undergo informed affecting index young myocarditisvalve monitoring wrong decisions suspected advanced pro data process implantable cardioverter brain arrhythmiasicd standard severe clinically holter 100 inflammatory cardiac cardiac patients natriuretic serious include years stenosis adult problemmyocarditis therapeutic infarction resynchronization venous peptide age
clinictrialf__611,611,electrophysiological optimization of left ventricular lead placement in crt,month placement electrophysiological pacemaker glomerular despite block york child coronary targeting placementleft association optimal mstherapy lv ≥ mechanically imaging six resynchronization ct imgaging available )  either myocardial therapy ) consent (< branch ventricular segment surgical heart new combined early latest informed medical estimated intervention filtration strategy pacemaker epicardial veins according achieved 120 pilot recent guided mri bypass rate cardiac cardiac patients electrical left optimization bundle months every artery qrs thyrotoxicosis lead 3 tavi written crtmilliters placement targeting scintigraphy resynchronization graft minute activated
clinictrialf__612,612,safety and electrical performances of xfine leads,effect valvular whole µg 8 cardiac months performances electrical standard implant intraheart cold right method valve safety exclusion lead ) duration consent contraceptive according surgery chronic measuredxfine 12 2 invasive lead 5 post ventricular monitored subjects leads sodium newly infection phosphate involving adequate studies subject disease xfine dexamethasone stimulation failure implanted study heart tricuspid visits criteria replacement follow informed device safety310
clinictrialf__613,613,music therapy as an adjunct in cied lead extraction procedures,intervention performed must pacemaker cardiac months 4 ago child norwegian therapy extraction exclusion lead hearing pilot 12 2 planned criteria significant implanted read tavi see protocolcied mri diagnosis pacemakertherapy impairment study music 3 surgical psychiatric procedures inclusion criteria early adjunctacute
clinictrialf__614,614,reverse electrical remodeling of native conduction in cardiac resynchronization therapy,native cardiac aortic cardiac electrical implantation transcatheter replacement ventricular therapy exclusion pregnancy planned undergoing 18valve reverse age crt stenosis severe inclusion resynchronization criteria remodeling pacing conductionpatients
clinictrialf__615,615,decompressive cervical surgery and hypertension,effect decompressive analogue hypertensive 4 spine patients ≧ normotensive prior standard least cold trial antihypertensive two csm treatable spondylosis causeheart surgery exclusion need according consent 140mmhg chronic medications previously current longer invasive lead 18 hypertensionvisual population diseases systolic measured diseasesdecompressive ≥ spondylotic explain scale form years concurrent stimulation failure observed study bp theories common myelopathy clinical another inclusion criteria also general following csm approved informed cervical become
clinictrialf__616,616,rate registry - registry of atrial tachyarrhythmia atrial fibrillation (at af) episodes in the cardiac rhythm management (crm) device population,24 episodes cardiac months ablation atrial arrhythmia cardiovascular rhythm months myocardial documented patientatrial tachyarrhythmia fibrillation 18 population high rate patient device remote years management af3 device crm expectancy prior inclusion criteria crm syndrome cancer registry history life
clinictrialf__617,617,identify the genes polymorphisms related to non-familial bradyarrhythmia,effect identifyfamilial patients standard nonheart cold related exclusion surgery non chronic genes invasive lead diseases bradyarrhythmia open stimulation failure reversible organic severe heart inclusion criteria familial bradyarrhythmia polymorphisms
clinictrialf__618,618,sacral nerve stimulation in improving bladder function after acute traumatic spinal cord injury,effect improving bladder infections urethral functionchronic prior existing standard cold sacral would exclusion cic surgery chronic radiation back invasive lead cord injury acute fracture disorder nerve baseline perform neurological traumatic sphincter implant effect stimulation personally failure spinal posterior caretaker urinary tract prior physiology criteria pelvic progressive lessheart device
clinictrialf__619,619,the react-icd trial,defibrillator novel month old ™icd aortic cardiac months cardiac ™ data availablevalve implantation react3 atrial following least pacing transcatheter algorithm antitachycardia trial replacement burden months preventive atp ventricular therapy exclusion technology procedure programmed years previously blanking include collection specifically period 18 previously post reducing 3 last within 6 implantable ≥ diagnostic surgery extensive stenosis extends collection severe resynchronization criteria reactive six 9 pacing cardioverter af device chamber
clinictrialf__620,620,development and validation of performance metrics for cardiac device implant procedures,study cardiology reference cardiac aortic cardiac quality implantation guidelines transcatheter video implant expert replacement ). training routinely ventricular assessment experienced procedure procedurecardiac exclusion assure validation tool record current performed performance implants eligible consent implanters implant written validated stenosis informed recorded european patientvalve unable society performance severe metrics per developmentprovide procedures inclusion criteria patients already pacing valid done device
clinictrialf__621,621,transcatheter aortic valve implantation without predilation,. porcelain implantation ii function transcatheter 70 logistic signed (> grade ≥ induced arrest disease systemic 15 aortavalve cm2 predilationvertebral aortic refusing pacing replacement ventricular without ) consent current right narrowing (< transfusion ventricular response implantationtranscatheter renal thv implantation new caused criteria syndrome g pacing informed medical impaired valvular compromise patient hemodynamic blood surgical symptomatic aortic pacemaker according 1 controlled severely arterial fashion requires severe tract 20 valve functional inflammatory cardiac cardiac euroscore left outflow %) exclusion transcatheter burst ejection 180 stenosis insufficiency tricuspidal practice 0 bpm rapid fraction
clinictrialf__622,622,cardiac resynchronization therapy dyspnea and exercise tolerance in patients with congestive heart failure (chf),revascularization lung ergometry effect chfcoronary class congestive cardiac patients month chf standard dyspnea tolerance optimized cold decompensated months therapy entryheart exclusion cycle surgery chronic 1 (< pharmacologic invasive lead recent ischemic 3 within perform management primary disease concurrent stimulation failure study iv heart inclusion resynchronization criteria uncontrolled functional exercise
clinictrialf__623,623,usability of a novel cueing device for patients with parkinsons disease,updrs 22 novel intervention pacemaker ): cardiac parkinson qualified patients movements hypokinetic society child physician cognitive lesions ). skin unified pilot relevant gait 2 render walking moca diseasemovement ≥ tavi severely device gaittherapy cueing motor like fluctuations scale usability disorder mri surgical severe parkinsonian disease rating ability clinically parkinson early impaired skills item
clinictrialf__624,624,direct oral anticoagulant management for cardiac device implantation,direct cardiac cardiac 1or ablation 5 implantation atrial arrhythmia oral cardiovascular rhythm myocardial stroke therapy anticoagulant without fibrillation days fibrillationatrial high leads prevention doac remote receiving management implantationleast 2 prior inclusion resynchronization criteria syndrome cancer device
clinictrialf__625,625,british randomised controlled trial of atrioventricular (av) and interventricular (vv) optimisation (bravo),lung intervention av pacemaker treadmill cardiac dysfunction child trial british randomised pacemaker chronic would exclusion consent conditiontherapy pilot controlled atrioventriculargive systolic implanted due tavi written optimisation disease interventricular biventricular mri vv surgical heart inclusion criteria walking preclude early failure informed bravo
clinictrialf__626,626,deep brain stimulation for traumatic brain injury,effect provide neurologically disability months spectrum functioning standard scores outcome cold proven multiple cognitive severity interfere services would diagnosis exclusion surgery entire chronic current conditions medically 12 invasive rehabilitation lead injury insights teamtraumatic post last due neurological depressive co traumatic evidenceheart surgery stimulation scale stimulation24 disorder glasgow deep brain failure study injury safe severe clinical new stable inclusion criteria major impaired participation
clinictrialf__627,627,chronic electrical stimulation to reduce bladder hyperreflexia,effect complicated bladder intervention acutely contractions system continence effective months give electrical surgical capacity standard confirmed cold multiple studying problems chronic exclusion take diagnosis surgery consent control serious sclerosis chronic requirements englishheart restore invasive lead cord less injury gns stimulationsuprasacral post open reflex speak sclerosis stimulation failure reflexive neurogenic pressure spinal gns neural prostheses hyperreflexia study home using contractions encounteredreduce inclusion criteria sores following increased informed
clinictrialf__628,628,the role of preoperative melatonin in reducing the inhaled isoflurane requirements in open nephrectomy,presenting hour hypertension intraoperative ablation 30 cancer received inhaled pain arrhythmia cardiovascular ). myocardial aged revealed certain reducingheart exclusion borazan h years medications requirements fibrillation preoperative nephrectomy score undergoing psychoactive prostatectomy high syndrome significant anesthesia intraoperatively neurological open agentsinhaled remote uncontrolled melatonin arrhythmias pediatric anaesthetic 2 older et inclusion criteria isoflurane one patients general role requirements al postoperative failure disordersatrial melatonin radical
clinictrialf__629,629,left bundle branch block (lbbb) after intuitytm,may pacemaker conductive ablation intraventricular ™ july left block bundle deployment purposes arrhythmia cardiovascular replacement myocardial intuitytmqrs aortic 2012atrial ms lbbb exclusion 120 fibrillation preoperative branch complete high ≥ remote bioprosthesis stenosis disorder valve permanent severe defined intuity edwards criteria inclusion research syndrome cancer 2018 width
clinictrialf__630,630,his pacing feasibility and cardiac electrical activation,effect therapycardiac electrode hemodynamically septal enhanced system cardiac months patients electrical left standard activation guidelines kidney pacing function cold right traditional demand pacemaker using feasibilityright giving surgery ) activation position serious chronic ecg 12 (> transthoracic 40 invasive lead indication %) ejection ventricular consent disorder location document proximal written severely reduced stimulation %.heart failure hrs high permanent unstable reactions severe psychiatric echocardiography conduction resynchronization ct adverse eligible patients fraction 2018 pacing basal former scan expected
clinictrialf__631,631,bridge or continue coumadin for device surgery randomized controlled trial,heparin implantation rheumatic standard cold started lead continue nurse surgery disease failure full effect hours atrial mitral replacement either thrombocytopenia ) molecular novo vitamin invasive undergoing prosthetic stimulation risk induced heart criteria tilting start disc valvular scoreheart heparin 24 patient lmwh prior low trial aortic doses randomized unfractionated controlled endpoint inject primary dose bileaflet lmwh iv injections valve subcutaneous stroke elective kdevice weight bridgeprior exclusion surgery given chronic 5 criteria chads2 de flutter therapeutic prosthesis coumadin device
clinictrialf__632,632,registry of device implantation,1960sdevice underwent since aortic enables cardiac cardiac patients data implantation left block bundle sudden 2019 thyroid function kidney registryoperative transcatheter replacement 2011 us ventricular laboratory loop echovalve exclusion history recorder 2 branch operative consent evaluation implantable written liver hormone stenosis refractory taking developed till standard common implantation severe heart avoid clinical functional procedures inclusion investigations criteria pacing undergo failure informed device death
clinictrialf__633,633,ivabradine to prevent anthracycline-induced cardiotoxicity,effect less minute prevent 60 standard kidney cold drug chronic protocol exclusion surgery consent chronic anthracycline invasive lead hypersensibilityheart beats clearance creatinine rate previous disease stimulation failure inferior cardiotoxicity study induced heart per another inclusion criteria ivabradinewritten informed
clinictrialf__634,634,left bundle branch area pacing in avb patients,； hypertrophic % valvular indications recommended accordingvalve aortic cardiac scoreleft 4 patients implantation left bundle atrial scores pacing transcatheter right replacement synchrony myocardial ventricular pacemaker patientsinformed exclusion consent fibrillation signed 40 atrioventricular block branch avb 5 ventricular refused regular implant area follow disease persistent stenosis outpatients success permanent parameters amyloidosis implantation severe icd cardiomyopathy criteria patients rate pacing postoperative ratio life
clinictrialf__635,635,risk stratification using a combination of cardiac troponin t and brain natriuretic peptide in patients receiving crt-d,month hall standard stratification cold complications using chronic lead treatment consent within satisfy receiving failure exclude hf failure secondary effect hours provide atrial endpoints test prescribed walk troponin medications invasive conventional ventricular crt hospitalizations stimulation renal clinical one informed 24 patient active include 2risk epicardial 2 1 end medications global related brain study iv assessment cardiac 4 must natriuretic left index combinationleast assessment surgery status chronic fibrillation inotropic ejection 3 last leads year diastolic armheart prior stable classification patients weeks fraction minute peptide
clinictrialf__636,636,the effect of exercise training on gait and quality of life in parkinsons disease,effect intervention program balance pacemaker excessive cardiac laval child 45 training gait impairments quality exclusion university pilot could yahr minutes diseaselive problemstherapy tavi beyond scale limit mri surgical pain life inclusion criteria musculoskeletal parkinson early idiopathic exercise participation
clinictrialf__637,637,endothelial function and cardiac output in rv pacing,mode pacemaker aortic delay cardiac cardiac non normal natriuretic dual implantation endothelial function inhaled transcatheter pacing outputintact right replacement vp ). method ventricular using exclusion inert intervention equilibriums function gas invasive node lv inability functionrv validated sinus disease exercisevalve stenosis failure short angina unstable ensure heart severe using av stable inclusion criteria maximal type pacing peptide impaired chamber
clinictrialf__638,638,the deep phenotype of lamin a c cardiomyopathy,muscle ecg aortic cardiac indicated pacing lamin cardiac implantation metabolite ambulatory transcatheter blood replacement myocardial ventricular laboratory phenotype code would transplantation lead immediate c resonance gene analysis enzyme testing rna magnetic papworth urine trust targeted stenosis failure mri nhs cardiomyopathy hospital genevalve hour heart severe samples laminundergo clinically imaging preclude future resting 12 type undergo scan ).deep
clinictrialf__639,639,telemonitoring during phase 2-3 cardiac rehabilitation,intervention pacemaker telerehab cardiac disability cardiac chftherapy improve cad cardiopulmonary factors period3 child including trial coronary smoking artery test limiting ii exclusion phase ) nutrition control cardiovascular randomized pilot 2 healthy controlled attending psychosocial rehabilitation conventional prospective 3 icd tavi management telemonitoringcad risk mri continued bypass study surgical disease inclusion criteria patients graft maximal following early exercising cr exercise group participation
clinictrialf__640,640,micra transcatheter pacing system post-approval registry,estimated frequent system may intervention pacemaker system reportable practice events . confound results cardiac authorized pacing child occur postmicra exclusion scheduled duration geographical consent years post requirements provides pilot visits transcatheter withdrawal performance acute representative criteria enrolled tavi written implant registry *. per mri authorization approval care procedure standard priortherapy e institution surgical per micra criteria adverse 9 inclusion law required tps local follow early registrylegally total sub
clinictrialf__641,641,temporary epicardial pace wire with integrated sensor for continuous postoperative monitoring of myocardial function,system intervention 6 pacemaker provide activity appears cardiac enables integrated chest ).temporary based investigationtherapy pace cardiac function atrial child concerns ). myocardial epicardial sensorstudy exclusion without investigation consent monitoring motion years pilot wire electrodes 2 wall 18 continuous 5 abnormal procedures safety temporary tavi participation continuous cs1 written surgery related monitor mri requiring fibrillation study detector motion 3 called heart clinical surgical prior disease criteria also esophageal early called postoperative registered informed
clinictrialf__642,642,safety and efficacy of vanoxerine for the conversion of subjects with recent onset atrial fibrillation or flutter to normal sinus rhythm,torsades preceding drugs quinidine normal antiarrhythmic 30 ablation efficacy atrial arrhythmia cardiovascular including tachycardia class event drug myocardial safety aortic conversionpolymorphic calendar fibrillation days drug include dofetilide high recent ventricular 3 within subjects prevention de remote area flutter sinus pointes afl 1 thromboembolic excluded 7 onset requiring randomization ≤ prior iii cancer rhythm syndrome prioratrial regarding vanoxerine valve
clinictrialf__643,643,hv electrophysiology study in transcatheter aortic valve implantation patients,study pacemaker ecg provide aortic cardiac months must electrocardiographic patients implantation pilot block studypatients existent transcatheter replacement prevalve ventricular aortic exclusion procedure lbbb consent entire randomized post 12 atrioventricular measurements high consent degree regular continuous written tavi sinus stenosis electrophysiology hv informed permanent sick examinations unable implantation severe inclusion criteria syndrome patients surface pacing undergo valve proceduretranscatheter
clinictrialf__644,644,panacea feasibility study to assess the efficacy of burstdr spinal cord stimulation (scs),effect study active nrs 30 electrical conduct efficacy assessanother implantation standard background pain participants including cold female visceral would investigation painful exclusion scs feasibility lead surgery chronic signals require point invasive delivers cord episodes 18 way burst acute lead admissions stimulation impede secondary within painburstdr implantable scaleheart days needing years sometime panacea persistent stimulation significantly failure mri device spinal probably condition eleven constant pain clinical another criteria refractory dr pacemakers aged nerves abdominal
clinictrialf__645,645,physical therapy and occupational therapy after transcatheter aortic valve replacement,literature approach found implantation shd transcatheter would review surgery 0 procedures therapystatus major divisiontranscatheter day identified aortic access including requiredvalve replacement ventricular therapy without requirements appropriate checks number subject femoral catheter pubmed ford outcomes new heart replacement pacing access aim patient occupational events events improve henry transfemoral intra aortic additional nursing minor 2 structural bleeds ) procedure sladen severe library physical increased valve increasing cardiac patients stroke tavr treatments include transcatheter hospital post procedures 1 stenosis continued hospital gi dramatically via
clinictrialf__646,646,ecg for programming in crt,ecgs ecg system rv programming offset indicated aortic hall undergo cardiac implantation transcatheter different including implant defibrillator replacement ). ventricular without lead immediately history walk changes expectancy settings followvalve unsatisfactory 1 18 treatment crtlife systolic activate beats lv ≥ therapy device review years medical stenosis failure device chart indications care year study nominally ≤ crt appropriate heart standard new clinical resynchronized severe clinically patients minute pacing testprogramming medical
clinictrialf__647,647,sacral neuromodulation (snm) with interstimtm for bowel dysfunction following surgery for rectal cancers with sphincter preservation,old ). pointsbowel years lead 18 consent within ≥ remote meet clinic spinal following rectal deviceatrial bfi snm cardiovascular myocardial 14 12 point high bowel step implanted preservation criteria syndrome 4 informed interstimtmpatients ablation neuromodulation sacral dysfunction randomized days 1 suppressive stimulating stimulation temporary days 7 score electronic 2 sphincter later study must defect arrhythmia congenital months wire first surgery exclusion procedure fibrillation (+ - continuity lower 3 written blind providing crossover cancers weeks cancer change medication immune
clinictrialf__648,648,investigation of acute effects of local vibration and whole-body vibration applications,intervention pacemaker vibration cardiac independently vertigo patients child pregnancy months disorders patientstherapy exclusion walk pilot effects acute last vibration 6 neurological tavi spasticity applications positional mri body surgical inclusion criteria investigationbenign 50 status early local range whole age paroxysmal
clinictrialf__649,649,economic and clinical benefit of remote monitoring among defibrillator patients by indication subgroups (benefit-rm),system recruit less provide system ablation patients investigators implantation remote arrhythmia implant defibrillator event 556 cardiovascular myocardial randomly exclusion assigned subgroups cannot fibrillation 2 call 18 monitoring high consent among unscheduled due rm remote use continued required indication notification useatrial economicremote propose clinical inclusion accordinglyremote 0 adverse successful eligible criteria syndrome benefit follow cancer prospectively informed device
clinictrialf__650,650,reverse ramp pacing to terminate ventricular tachycardia ( rev-ramp),defibrillator untreatable provide interruption aortic cardiac cardiac implantation participants transcatheter defibrillator including tachycardia revsevere coronary replacement rhythm ventricular threatening painful exclusion rhythms without box serious problems ramp anticoagulation e likely less intracardiac undergoing ventricular nasty reverse resynchronisation consent inability testing change upgradevalve tachycardia stenosis device reduce thrombus heart severe new rhythms disease inclusion seems pacingterminate rhythm shocks change criteria pacing anti ramp informed revision life
clinictrialf__651,651,pressure wire guided cardiac resynchronisation therapy,intervention pacemaker thrombus cardiac cardiac vascular child replacement wire assessment aortic mechanical exclusion peripheral pilot ischaemic resynchronisation lv tavi guided therapyischaemic disease mri pressure fulfilling standard surgical heart severe nontherapy inclusion criteria including patients early failure valve
clinictrialf__652,652,attain starfix™ model 4195 left ventricular lead,attack effect involved attempt attain 30 ™ despite electrical left standard fast three blood cold signal exclusion surgery beat chronic beats monthsheart invasive lead unsuccessful within model ejection ventricular medications within implant days previous ventricle stimulation 4195 attempt failure heart past criteria travels fraction leadsevere failure starfix pumps
clinictrialf__653,653,management of fluid overload in tavr,effect prespecified ): measurement managementfluid consecutive months patients tavr overlaod randomization standard factors electrolyte kepler cold overload +- extracellular disorders aortic chronic exclusion surgery linz chronic absolute days 14 (= ) invasive lead 18 90 7 %) post 180 3 overload consent demographic ≥ dialysisheart written 360 years process stimulation 13 stenosis adult failure 7 informed measurementfluid water hospital fluid tavr bis 100 severe university relative prior inclusion criteria 1l × undergo interim age analysis
clinictrialf__654,654,prospective evaluation of exercise-induced cardiac conduction instability in predicting ventricular fibrillation events in hypertrophic cardiomyopathy,implantation whilst transcatheter inherited worked doppler prospective needing clinic attention clinic repeated following instability secondary conditions aortic sudden replacement myocardial ventricular specialist deathvalve test thought confirmed conventional ventricular currently unit telephone risk usingpredicting anterior induced unstable thickness icd criteria investigations pacing medical events low background clinics heartbeats wall abnormal 6 15mm score diseases fibrillation cardiomyopathy hypertrophy severe conduction disease dose natural extra hypertrophic vt cardiac cardiac three calculator months every exclusion causing incomplete motion radiation radiation maximum systolic exercisehaemodynamically 3 predicting evaluation thickness stenosis cos esc imaging cardiomyopathy
clinictrialf__655,655,benefit of dual-chamber pacing with closed loop stimulation (cls) in tilt-induced cardioinhibitory reflex syncope,valvular syncope cerebral transient attack cardiac aortic cardiac supraventricular implantation transcatheter diagnosed right replacement symptomatic ventricular loop therapy closed carotid ) dual 40 dysfunctions ischemic ventricular significant age orthostatic ≥ cls reflex benefiticd years stimulation sinus hypersensitivity tachycardia disease stenosis cardiomyopathy induced tilt 2 arrhythmogenic severe cardioinhibitory hypotension resynchronization clinically rapid >= pacing possibly withinvalve leading chamber paroxysmal
clinictrialf__656,656,pet-detected myocardial inflammation is a characteristic of cardiac sarcoid but not of arvc,granulomas diagnosed condition fulfil inherited histologically chest remote disease resolution high inflammation imaging potential areasdetected associated may frequently characteristic cardiovascular either myocardial ventricular although sarcoidosis rare high ventricular arvcknown findings breast arrhythmogenic clinical criteria also syndrome published force arvc ablation individuals manifestations occurs according caseating specificity criteriaatrial infiltrate feeding recent pathologically 10 sarcoid mri cardiomyopathy study lack ct task sarcoidosis septal cardiac patients left arrhythmia right identifies proven pathological myocardium involvement fibrillation characterised include mutation reports pet affected suggesting cancer women
clinictrialf__657,657,management of diabetes with metformin in patients with chronic heart failure,effect fraction mechanisms found hba1c beneficial patients 5 left standard hf including diabetic cold sensitization potentially ). figure statuschronic therapy affects exclusion surgery acids ucla metformin dm chronic current states 1 40 insulin dysfunctionheart united dm )( controlled %) ejection 7 systolic ventricular lead individuals medications cardiotoxic free ≥ metformin management stimulation invasive 13 failure inadequately renal study ≤ excluding functional heart comprehensive cardiomyopathy including also criteria center hf fatty fraction million inclusion diabetesleft anticipated impaired
clinictrialf__658,658,pet mri study in patients with cardiac sarcoidosis,study intervention indicate may fail sarcoidosis limited cerebral pacemaker cardiac cardiac indicated based demonstrated 18f function arrhythmia accuracy child contrast relatively clips sensitivity patientsstandard exclusion involvement autopsy pilot impaired suspected include contraindications 18 series apparent granulomatous case t2pet disorder emission ≥ tavi sensitive aneurysm years primary reports fdg mri renal agent high criteriontherapy diagnostic surgical positron yet multisystem imaging inclusion clinically ct criteria patients early tomography early fluid identify
clinictrialf__659,659,intrathoracic bloodvolume measurement by contrast enhanced ultrasound: validation of the technique and evaluation as a measurement of response to cardiac resynchronization therapy: a pilot study,study bloodvolume intervention 6 pacemaker measurement enhanced provide cardiac cardiac months 4 pulmonary ultrasound despite receptor pilot child class contrast artery therapy ii intrathoracic surgical validation blockers consent pilot 2 pressuretherapy evaluationcoronary systolic acute optimal 3 prosthesis 13 age ≥ therapy tavi written 18y surgery mri arterial bypass ≤ technique heart 3 iv defined functional hypertension 10 uncontrolled resynchronization iii biological response nyha early failure valve informed medical
clinictrialf__660,660,handheld ecg tracking of in-hospital atrial fibrillation,pacemaker cardiac ablation atrial internal arrhythmia cardiovascular trial myocardial documented throughout ecg fibrillation enrollment monitoring high fribourg trackingpreviously implantable device remote present department period hospital medicine handheld study inclusion criteria cardioverteratrial syndrome cancer
clinictrialf__661,661,endoscopic pyloromyotomy for refractory gastroparesis,muscle pacemaker normal implantation child indextherapy prokinetic empyting laxatives (> lead higher endoscopic disease colloid may peptic range albeit based least oral test without intrapyloric test gcsi validated success constipation surgical sulphur one early total intervention breath pyloromyotomyabnormal active surgical gastrointestinal emptying pilot gsci significantly 6 scores severity mri gastroparesis score symptom severe using per solid refractory rate injection gastric cardinal pyloric must cardiac play index pyloromyotomy drug spasms months upper varied treatments include involve subscale tavi determination options experiences thereforerefractory solid ulcer gastroparesis standardized
clinictrialf__662,662,model 20066 left ventricular (lv) lead study,study system aortic . based attempt patient 30 cardiac percutaneous angioplasty left implantation atrial transcatheter right coronary replacement valve ventricular mechanical exclusion lead consent transluminal specific model complete criteria lvprevious transvenous within lv implanted implant days previous form vasculaturevalve 20066 stenosis biventricular known cardiac standard crt heart severe inclusion criteria g meets venous required pacing informed
clinictrialf__663,663,scar location and acute haemodynamic response to multipoint pacing study in patients with ischemic cardiomyopathy,jude presence despite implantation function transcatheter msec contrast electroanatomical (> lead optimal ischemic consent lv ≥ % previous dimensional significantly clipsvalve bodies ° provide 35 aortic site pacing class replacement myocardial ventricular therapy haemodynamic n acute ventricular magnetic aneurysm scar images renal duration media cd3271 regarding pacing informed impaired medical information cranial give metallic 120 st location map mri compatible cardiomyopathy iv severe reconstructionmultipoint iii patients≤ nyha functional stemi study cardiac cardiac models ocular left months qrs quadripolar configurations correspondent resonance ejection elevation 3 foreign stenosis crt infarction imaging producing fraction response device
clinictrialf__664,664,sacral nerve stimulation for faecal incontinence - placebo or clinical effective,effect degrees selected patient months incontinence patients monthssacral 50 standard set suffering optimized including cold conservative )) either two group first programmer procedure surgery resections chronic test 20 faecal (< invasive tear period cord treatment 18 lead 3 last 160 stimulation incontinence irradiation nerve ≥ amplitude external placeboincontinence episode treatment neurological years stimulation diseasesheart step failure efficient option degrees spinal anal ≤ effective clinical sphincter (≥ successful one pelvic following rectal initial idiopathic postoperative injuries group
clinictrialf__665,665,high frequency jet ventilation in af ablation,movement frequency obstructive complications chronic variation exists directly due measures remote previous disease high real home university major oxford af demonstrating carries failed non data atrial cardiovascular ventilation myocardial therapy 12 time high jet ventricular significant airway trust catheter also syndrome surgeryhigh thereby ablation improve altogether related ventilation ablationpreviously hospitals randomized monthsatrial procedure requiring severe therefore design lung preceding cardiac pulmonary left arrhythmia oxygen first upper success risk fibrillation time ejection unless trial increasing stopping cancer foundation fraction asthma
clinictrialf__666,666,imaging cardiac electrical remodeling with electrocardiogram imaging (ecgi),pacemaker cardiac ablation electrical dual block atrial ecgiimplanted historyatrial cardiovascular arrhythmia suppressed myocardial exclusion electrocardiogram fibrillation medications complete high remote persistent sinus sick heart imaging imaging inclusion criteria syndrome cancer remodeling chamber
clinictrialf__667,667,the effects of selective site right ventricular pacing,electrophysiological effectspatients aortic cardiac ablation normal implantation pathway elective atrial site outcome procedural transcatheter right replacement ventricular pacemaker pregnantvalve +  exclusion contractility accessory echocardiogram fibrillation doppler feeding 18 function transthoracic feeding undergoing ventricular anterograde insitu measures studies rv breast stenosis echocardiographyselective permanent conducting measured tissue severe heart imaging criteria inclusion patients pacing age
clinictrialf__668,668,medtronic observational study in the real world of implantable electronic cardiac devices,study aortic cardiac patient probability pacing devices patients data observe observational implantation shall agrees market transcatheter replacement ventricular studyvalve exclusion without 20 2 medtronic eligible post involve patientsimplantable worldpatients implantable than18 inclusion form years stenosis cardiac high electronic real multicenter severe clinical defibrillators another centers resynchronization older release patients pacemakers criteria around 000 500 cardioverter requirements
clinictrialf__669,669,remote care for cied patients in korea,months outpatient 4 patients ablation remote korea20 cardiovascular arrhythmia months myocardial korea exclusion biotronic years fibrillation 2 questionnaire high 3atrial implanted 6 remote cied clinic 2 care implantation 3 visits criteria inclusion syndrome cancer
clinictrialf__670,670,effects of neuromuscular blocking agents on end expiratory lung volume during moderate-severe ards,ards lung effect leaks treated agents fistula fractures neuromuscular old standard cold ). patientsheart exclusion surgery volume effects18 chronic years moderate expiratory end invasive blocking lead air pleural belt berlin stimulation failure spinal eit unstable severe inclusion criteria positioning patients definition
clinictrialf__671,671,efficacy of ivabradine in patient with both persistent atrial fibrillation and heart failure with reduce ejection fraction,effect ivabradine old 8 standard atrial cold congenital rhythm efficacysevere ， surgery tolerance chronic years fibrillation recently carvedilol (< invasive lead 90 ejection due patient persistent dose stimulation failure reduce beta weekheart heart hypotension stable one maximal resting fraction day 50mg rate failure 90 medication
clinictrialf__672,672,a pilot study of interventricular septal puncture for cardiac resynchronization therapy to treat heart failure,placement put pacemaker normal guide child technique coronary via would using output provides route lv failure cavity inclusion route safely may failed far routetherapy pacing oral either therapy without used conventional allow ventricular maximizes indications surgical implantation heart criteria early pacing intervention speckle either duetreat dilated monitoring achieved pilot previously alternative invasive anticoagulation positioning sinus mri would study standard interventricular complication novel septal supporting cardiac cardiac left pilot puncture exclusion lead take guiding endocardial implanted tavi delivered crt resynchronization studylv
clinictrialf__673,673,exploration of arrhythmia burden in cardiac amyloidosis using implantable loop recorders,pacemaker affect investigators would loop invaluable degree repolarisation considerable remote high permanent common abnormalities inclusion small appear al burden transmural inserted may available provide diffuse data sudden cardiovascular including myocardial x increase ) techniques consent collection atrioventricular death approximate high ventricular ppm information blocks mm might diagnostic size criteria syndrome 4 regarding informed information indications ablation revealed existing monitor 45 potentially opinionatrial amyloid decompensation arrhythmia implantable primary ilr cardioverter 7 standard using disease adverse burdencardiac chamber provide cardiac cardiac left outcome arrhythmia exclusion whilst volume risk fibrillation observations earlier explorationwould written deposition amyloidosis cancer initial device recorders
clinictrialf__674,674,hemorrhage following small polyp resection in the colon in anticoagulated patients,months implantation transcatheter meeting noacs discontinuing rates chronic resection bleeding comparing colon6 prospective inclusion endoscopic approach known small major following anticoagulated accp hemostasis aortic replacement ventricular therapy ) diathesis 14 reporting enrolled bridging bridginghemorrhage resources considerable required antiplatelet clinical criteria consumes pacing performed patient based dual aspirin acs randomized polyp days period compared anticoagulation trialvalve related procedure study institute severe bleeding healthcare warfarin guidelines cardiac outpatient patients %) daily calls comparative exclusion mandatory clinics concomitant procedures therapy written suggest stenosis 40 phone gi another polypectomies patients via aged
clinictrialf__675,675,image fusion and calcification raising in trans aortic valve implantation,placement implantation tomography transcatheter fermoral admitted sapien consent ≥ patient device images nantes high inclusion may aortic fusion old replacement regurgitation stenosis ventricular intermediate without position novo fragile significant risk complications probably induced branch criteria also pacing improve surgical chu ® symptomatic image 3d aortic pacemaker affects rapidly 2 raisingtrans procedure evaluated study severe disease childbearing valve nowadays cardiac patients calcification left bundle exclusion womenvalve 3 impossible leads written de judiciary people contraception stenosis protected implantationtrans treat patients computed age
clinictrialf__676,676,cologne cardioversion study,(≈ itt may sided consentatrial bias cardioversion cardiac ablation alpha normal 5 electrical assuming single study4ms implantation corrected society internal cardioversion arrhythmia cardiovascular endpoints compare rhythm myocardial ra lead ) non chi power status relevant cause % comparing fibrillation 18 cv continuity high post efficacy german 230 age ≥ external 206 %  ( several years written remote sinus 1 rv vs smaller trialscologne recommends icd prior weeks cancer syndrome patients center 80 4 sensing analysis
clinictrialf__677,677,fluoroscopy reduction or elimination in cied implants,occlusion implantation transcatheter ). threatening accessible 18 device cied previous virtual urgent reported indication abnormalities abandoned life inclusion + - aortic replacement final ventricular implants requiring 15 reconstructed implants criteria one pacing - system needed patient vvi minutes center pacemaker eliminationknown st non needed complete implantable 10 anatomies electronic reduction severe using correct patientsvalve chamber fluoroscopy anatomy position cardiac 22 cardiac leads single implant right obtain two exclusion minutesfluoroscopy reports implanted ) studies stenosis experiences patients venous around
clinictrialf__678,678,correlation between 3d echocardiography and cardiopulmonary exercise testing in patients with single ventricle,correlationsignificant echocardiography old cpet aortic patient cardiac patients ultrasound data single implantation software transcatheter cpet coronary toxic replacement ventricular 3d visitcardiopulmonary artery exclusion 8 status years post echography performed within prospective testing record acquisition univentricular management check disease stenosis 2d ventricle care study supplementary heart using clinical echocardiography usual tomtec performing criteria inclusion severe eligible change required pacing eg cardiomyopathyvalve medical exercise
clinictrialf__679,679,changes in myocardial perfusion during chronic multi site biventricular versus right ventricular apex pacing in patients with normal left ventricular function undergoing his bundle ablation for drug-refractory atrial fibrillation,undergoing lvf ablation normal patients changessymptomatic left bundle atrial function site arrhythmia obstructive cardiovascular right drug coronary myocardial artery chronic multi quality surgery exclusion fibrillation function high apex ventricular poor nearly remote previous ventricle disease biventricular perfusion sound bypass permanent ablation imaging infarction criteria refractory inclusion expectancyatrial ultra syndrome cancer pacing versus life
clinictrialf__680,680,ablation of unresectable locally advanced pancreatic cancer with irreversible electroporation (ire) system,direct count white 5 ductal technique occlusionunresectable ecg portal tolerate remote disease adenocarcinoma metastatic ablation high consolidative cell anesthesia increases deviceatrial count resection may four tissue least symptomatic cardiovascular locoregional myocardial negative test cycles without absolute current stage high energy ablationlocally voltage cannot permeability adenocarcinoma often serum iii criteria neutrophil general syndrome pulses irreversible system ablation blood low either pregnancy image birth locally advanced performance guided electroporation short using ablates electroporation local synchronization unresectable less pancreatic electrical arrhythmia long exclusion control fibrillation vein like delivered ecog prior weeks cancer segment status ire become membrane
clinictrialf__681,681,attain model 4196 left ventricular (lv) lead,attack effect involved lv attempt attain 30 electrical despite left standard fast three blood cold signal ventricular exclusion surgery beat chronic beats monthsheart invasive lead unsuccessful within model ejection ventricular medications within implant days previous ventricle stimulation attempt failure heart 4196 past criteria travels fraction leadsevere failure pumps
clinictrialf__682,682,light emitting diodein the treatment of genitourinary syndrome of menopause,vaginal ablation arrhythmia degenerative cardiovascular replacement myocardial menopause instruments fibrillation criteriaatrial hormone diseases undergoing high treatment neurological sexual remote menopausechronic menopausal voluntarily light proposed infection emitting participate diodein intercourse inclusion cancer syndrome patients women genitourinary
clinictrialf__683,683,insync model 8040 (insync) and insync iii model 8042 (insync iii) registry,4194 study failed cardiac insync ablation leads attain 30 left arrhythmia cardiovascular right market 8040 myocardial therapy lead released fibrillation previously criteriaatrial lead medtronic model insync high deliver ventricular within 4193 remote days placement investigational registrycurrently approval 2187 condition inclusion resynchronization iii iii 2188insync pacemakers syndrome cancer 8042 registry
clinictrialf__684,684,bi-ventricular pacing in patients with atrial fibrillation and heart failure (biff-study),effect study patients month standard atrial function angina cold qrs chronic biff exclusion duration ms surgery chronic fibrillation criteriaheart pectoris invasive lead systolic bicabg ventricular within stimulation failure 150 2 unstable heart inclusion criteria iii nyha pacing failure
clinictrialf__685,685,beta-blockers to patients with chronic obstructive pulmonary disease,minute bronchodilator standard obstructive cold base statistically copd expiratory lead decrease assemblychronic within ≥ significantly disease failure 18th overt following syndrome analysis effect vital statistical provide pressure data negative without consent used cardiovascular invasive day value significant beats web stimulation asthma unexpected iii one )   80 informed medical system treated sponsor blood 50 blockers event rhythm according suspected effects forced working sinus care study standard severe per adverse bronchial page fev1 even pulmonary patients capacity consentheart plan surgery volume serious chronic betaspirometry showing systolic post unless written trial randomization sick world smart
clinictrialf__686,686,deep brain stimulation surgery for movement disorders,movement cochlear standard mattis cold nih chronically recordings lead needing disease failure dat imaging clinic secondary effect electrode including microelectrode ) immediate invasive significant disorder stimulation circuits macroelectrodes heart implants dementia criteria medical intervention shrapnel active recordingsdeep include uk obtained stimulating disorders efficacy stimulation fragments implant brain neural disease rating clinically refractory functional electrical precisely outcome activity surgery respiratory chronic include within operative bank macroelectrode motor underlying 1 scale measures localize disordersactive locations treat parkinson medically clinicheart
clinictrialf__687,687,ketamine in deep brain stimulation (dbs) surgery,effect task hour 60 patients satisfaction standard dbspatients iowa minutes cold cognitive ). anxiety fulfill routinely using microelectrode surgery tasks exclusion risk visual chronic test 18 requirements simple nucleus ) criteriaheart invasive questionnaire lead undergoing experience mg stimulation mm scaledeep 10 contextual stimulation images related failure seconds deep score overall brain 15 study per 25 performing subthalamic inclusion criteria patients kilogram memory increased aged done detailing ketamine
clinictrialf__688,688,conduction system pacing international registry (conspire registry),utilize system septal provide system psychiatric cardiac )  patient intrinsic devices capacity data systems left international bundle implantation transcatheter pacing collect including lcs multiple conspire rhythm replacement ventricular therapy severe exclusion ) association branch college comorbidity ventricular consent among proximal across area receiving american aortic stenosis approaches cardiac permanent criteriavalve strategiesconduction society physiologic outcomes clinical new registryaha conduction heart centers acc resynchronization acc patients meets inclusion approved pacing criteria prospectively registry
clinictrialf__689,689,feasibility study of remote support for implantable pulse generator (ipg) implantable cardioverter defibrillator (icd) implant,defibrillator study minute aortic )  cardiac defibrillation ipg implantation remote generator transcatheter implant crtvalve trial replacement ventricular exclusion without feasibility support pulse consent planned ventricular beats icd ipg implantable testing 110 icdsigned related stenosis severe clinical icd per planned another inclusion criteria basal rate pacing cardioverter threshold informed
clinictrialf__690,690,preventive approach to congenital heart block with hydroxychloroquine,approach block never 20 prospective within subjects large review remote addressing extensive disease hydroxychloroquineintense following may provide evidence demonstrated data intrauterine fetal cardiovascular myocardial prospect autopsy exclusion stage pregnancyatrial alarming state high facing centered determine combined includes lowered recurrence considered causal sufficient ≤ heart syndrome falsely replacement studiescongenital ablation blood efficacy pregnancy steady achieve preventive 19 retrospective prednisone 2 structural levels studies recent inhibition 10 days use lesions 7 discussion requires multicenter rate valve vitro specifically hydroxychloroquine arrhythmia doses two first documented fibrillation exposure mg studies suggest 1 taking chart whether another tricuspid cancer weeks around developmental
clinictrialf__691,691,r wave sensing after vt ablation,defibrillator drop (> optimal consent sign remote tachycardia ablation uncontrollable software 30 data atrial fast cardiovascular mitral myocardial sustained consent 12 undergoing high ventricular spss heart clinical wave proportional criteria syndrome regarding sensing undergo informed 22 model ablation cox preprocedural tachycardia multivariate structural monthsatrial %) term implantable change fibrillation prostheses using disease follow cardioverter valve drop done vt hazards dropr changes arrhythmia exclusion procedure fibrillation r last implanted therapy substrate ablationcardiac influenced sensing assessed resynchronization cancer patients version
clinictrialf__692,692,danish-crt - does electric targeted lv lead positioning improve outcome in patients with heart failure and prolonged qrs,effect prolonged crtsigned system improve patients block bundle standard cold coronary months artery exclusion lead surgery consent chronic previously invasive lead electric branch danish trialheart optimal establishing lvef 3 lv 35 implantable treatment positioning stimulation targeted failure implanted bypass medical ≤ crt heart clinical outcome another criteria graft qrs latest informed device
clinictrialf__693,693,arrhythmia burden risk of sudden cardiac death and stroke in patients with fabry disease,frequent cardiac 4 normal range predictive stroke dual surgical existing ablation modification fd fabry cardiovascular arrhythmia coronary algorithms myocardial ). mutation artery randomised power loop pathology causing according risk patientsknown ecg ilrsudden years fibrillation arrhythmia 2 specific recorder 40 inform controlled treatment prediction confirmed high abnormality revascularisation multicentre implantable device remote trial disease known risk compared unrecognised care oldatrial standard care whether disease cardiomyopathy infarction cancer label patients following syndrome burden assessing identify death associated
clinictrialf__694,694,does melatonin restore sleep architecture in autistic children,effect snoring old system spectrum universal congestion standard background cold childrendoor autistic spectrumheart chronic closed respiratory ) without nocturnal autism significant years surgery witch chronic restore health 12 invasive lead effort treatment consent neurological sleep written melatonin stimulation failure french study architecture disease healthcare nasal informed
clinictrialf__695,695,using electrical bioimpedance assessments to estimate perioperative total body water and postoperative fluid need,effect fat shifts provide patient perioperative calculate swelling electrical systems patients waysestimate standard water cold total traditional levels lesions skin assessment accurately surgery monitors currents assessments hernia chronic levels inguinal technology recoveryheart within morbidly organ invasive lead cholecystectomies consent obese postoperatively measures pregnant several unbalanced various stimulation monitor estimate different bioimpedance failure informed body requiring standard using initial small percentages following hospitalization needgeneral laparoscopic postoperative anesthesia repair fluid populations women become bodily
clinictrialf__696,696,safety of body composition analysis in heart failure patients with implantable cardioverter defibrillators (icds),frequencies 551lb aortic disability inbody four cardiac patients failure implantation wuch index icdsimplanted transcatheter replacement weight ventricular safety assessment composition exclusion without ) analysis effects scaleimplantable technology standvalve companies successfully biospace scales 6 maximums stenosis scale utilizing bioimpedance making mass body utilized unable heart 520 severe comprehensive icd defibrillators weight criteria adverse interpreting inclusion following hf physical pacing america cardioverter applied
clinictrialf__697,697,ablate post approval study - synergy ablation lesions for non-paroxysmal atrial fibrillation,. synergy ovale coronary ). safety grafting association consensus pump foramen cardiogenic remote form ablation european stand open af paroxysmal forms atrial cardiovascular lesions procedureatrial sustained myocardial without consent high statement beyond noneuropean heart syndrome undergo informed registry indication system ablation surgical rhythm commercial seven arrhythmia undergoingablate term open days use patent procedure approval bypass study e atricure study cardiac arm single shock society elective arrhythmia artery phase along procedure fibrillation concomitant post continued label cancer approved
clinictrialf__698,698,physical therapy as adjuvant treatment of vulvodynia: a randomized controled trial,muscle pacemaker criteriatherapy alpha child oxidase female using levonorgestrel chronic ) treatment diseases muscles treatment device previous reported sessions inclusion error monoamine inhibitor kinesiotherapy intrauterine degenerative therapy ii function variables perform equal assuming controled surgical self clinical thickness size calculation criteria pelvic antidepressant accept early estimated intervention type index penetration trial decompensated probability randomized pilot indexrandomized sample 1 questionnaire adjuvant controlled period vulvodynia ) sexual dependent delivery questionnaires floor mri single copper 2 using type physical independent vaginal characterized cardiac vulvodyniataking index answered exclusion tavi trial medication
clinictrialf__699,699,ferric carboximaltose on intra-myocardial iron load in patients with heart failure,iron months despite standard cold coronary lead pool within previous surgery disease failure ferric inclusion hf enteral effect may storage showing transferrin least myocardial invasive acute ventricular iron magnetic stimulation work heart iii criteria syndrome toxicity experimental total low t2 stores serve intracardiac carboximaltose detected moderate load related body using echocardiography nyha functional hepatic cardiac dysfunction patients valvar left intravenous occur months classmyocardial saturationheart exclusion surgery chronic transthoracic ejection 3 last worsening decreased absorption estimate resonance progressive fraction concentrations
clinictrialf__700,700,tptns: home vs hospital treatment for overactive bladder,effect intravesical electrode 6 9 5heart diagnosed unit vascular 4 overactive condition standard site cold skin greater affecting exclusion surgery commencing volume residual chronic peripheral participate void legs invasive lead treatment lower protocol treatment bladder botox urine tptnsprevious stimulation failure hospital study vs 3 home disease prior criteria women aged
clinictrialf__701,701,genetically determined response to atenolol in patients with persistent atrial fibrillation,treated dysfunction ablation determined patients association genetically york atrial arrhythmia cardiovascular class coronary months myocardial artery grafting atenololpercutaneous intervention fibrillation vaughan high node canadian within 6 currently induced remote persistent disease taking bypass iv heart severe new av failureatrial cancer iii patients syndrome response failure af
clinictrialf__702,702,the use of electrical bioimpedance to evaluate dry weight in patients with chronic renal failure in hemodialysis,217 improving effect software 24 weight patients seca electrical index standard kidney infectious cold program 2002evaluate protocolheart assessment chronic exclusion technology ) bioimpedance metalic surgery chronic current stage health biva seca invasive lead transplant 18 model treatment mis 5 implants portable hours statement bilbrey receive global conference use hemodialysis years stimulation dry scale floor units renal failure care hemodialysisundergoing stadiometer strenuous 813 fresenius outcomes kg per kdoqi disease prior criteria inclusion processes 4008 100 medical exercise
clinictrialf__703,703,considerations on the transfusion threshold in cardiac surgery,effect pacemaker cardiac patients standard cold surgery exclusion chronic 2015 invasive transfusion lead within hospital chu n brugmann placement stimulation failure defibrillatorheart inclusion criteria considerationsundergone threshold
clinictrialf__704,704,sudden cardiac death - screening of risk factors,aortic cardiac cardiac 12valve screeninginformed providing implantation sudden factors transcatheter replacement aforementioned ventricular exclusion consent 40 age years meet stenosis failure risk severe inclusion criteria pacing death
clinictrialf__705,705,impact of a ketogenic diet intervention during radiotherapy on body composition,tumor intervention predictions index rmetallic histologicallý aortic cardiac implantation parts transcatheter replacement impactmake ventricular disorders diet exclusion bia othe malignant metabolic karnofsky rare confirmed tumor consent ketogenic written insufficiencyvalve stenosis renal radiotherapy body 2 unreliable severe inclusion criteria 70 following >= composition pacing informed entities
clinictrialf__706,706,uk trial of percutaneous tibial nerve stimulation in patients with faecal incontinence,effect inflammatory conditions prevent provide precluding detailed incontinence percutaneous consentheart uk diaries standard cold trial prolapse sufficiently english would chronic patientsage exclusion leading surgery chronic years faecal invasive lead 18 diseases bowel incontinence nerve ≥ read external enough thickness stimulation placement failure full severe )* disease criteria tibial successful rectal required informed medical
clinictrialf__707,707,optimized heart failure therapy through continuous monitoring,ablation 30 pm monitoringoac cardiovascular arrhythmia oacatrial myocardial additional therapy documented exclusion documented fibrillation af 2 1 high neededoptimized consent description continuous remote informed year heart actual inclusion criteria cancer syndrome nyha failure af sec
clinictrialf__708,708,insync implantable cardioverter defibrillator registry: cardiac resynchronization therapy,aortic cardiac cardiac attain 30 implantation left atrial transcatheter defibrillator right replacement marquis studyvalve ventricular therapycurrently therapy lead released miracle lead medtronic model insync 4189 ventricular cardioverter within implantable includes days investigational stenosis 7277 7272 severe icd resynchronization pacing market registry
clinictrialf__709,709,paced and sensed electrical delay in crt therapy (pased crt),intervention investigation pacemaker provide cardiac delay )  active arm cardiac electrical transplant patients left criteriatherapy child pased qrs ventricular greater therapy exclusion lead association ecg pilot previously lead treatment pacedacc consent successfully lv tavi crt written implant receiving american mri duration crt surgical heart clinical 120ms another surface early sensed informed placed
clinictrialf__710,710,functional and metabolic imaging using magnetic resonance imaging and spectroscopy,clips intervention agents volunteersmetabolic central pacemaker specifically system evaluating . nervous cardiac normal researchers shavings ocular cardiac volunteer retinal child techniques contrast body giving part functional pilot resonance 18 spectroscopy provided implants functionalmr consent dimeglumine magnetic advances ) age technical stimulator tavi foreign breast mri gadopentetate metal implanted administration neural study informed surgical using new spectroscopic imaging imaging mrs g techniquestherapy early designed functional agent
clinictrialf__711,711,reachpr trial resynchronization therapy in heart failure patients with prolonged pr interval,effect frequent prolonged 35 pr block left bundle standard york %) cold coronary artery therapy surgery association chronic days beats 40 (< invasive lead branch recent lvef ventricular reachpr last degree within premature intervalheart trial stimulation failure renal bypass requiring heart dialysis third av new prior weeks resynchronization stable graft 4 interval failure patientschronic
clinictrialf__712,712,healthy lifestyles for children with complex heart problems,intervention lifestyles pacemaker provide activity cardiac lifestyle condition child verbally childrensignificantly exclusion problems pilot complex participate healthy questions consent requiring habits tavi followtherapy mri condition impacts going heart surgical answer inclusion criteria healthcare physical early informed provider participation
clinictrialf__713,713,use of oral anticoagulants and symptoms in patients with atrial fibrillation in örebro county,less patient ablation afatrial atrial register arrhythmia oral cardiovascular myocardial national exclusion diagnosis symptoms fibrillation 20 1 january anticoagulants identified high 31 remote use county patientsmedrave 2018 years december 2015 inclusion criteria cancer syndrome 4 age örebro
clinictrialf__714,714,transcutaneous electrical nerve stimulation (tens) in chronic pain responders and non-responders?,effect transcutaneous tens electrical dueheart standard pain cold sensory assessment chronic deficits exclusion surgery chronic responders health invasive lead treatment nonpain tens nerve neurological regular treatment previous stimulation questionnaires failure pain inclusion criteria relief besides medication
clinictrialf__715,715,pacing affects cardiovascular endpoints in patients with right bundle-branch block (the pace-rbbb trial),cardiac ablation patients rbbb dual block pacing inotropes cardiovascular arrhythmia trial right months location qrs myocardial pacemaker affects paceacute lead exclusion endpoints support cardiovascular ecg could complex fibrillation 12 time within branch high arrhythmias last icd within leads 6 ≥ hours remote limit rv exercise requiring 2 bundle biv criteria crisis syndrome cancer surface apical failure durationatrial chamber
clinictrialf__716,716,technical development of strain rate echocardiography,initiated system intervention central pacemaker since provide cardiac nervous development1 pulmonary ultrasound blood left function regional child pregnancy clips coronary ). every artery accessible cardiovascular motion doppler test recently pilot easily uncertain wall within administration branch data ventricular involve consent beats informationstrain tavi rate technical written 10 machine several aneurysm involving hardware mri tissue motion echocardiographic heart abnormalities sequences shunts echocardiography diseasetherapy surgical imaging strain status echo early protocols informed become placed
clinictrialf__717,717,mibrain - migraine and the brain: consequences causes and vascular interaction,intervention old pacemaker cardiac patient vascular 30 international accordingtherapy interaction child fluent consequences illness migraine migraine exclusion psychological serious years pilot causes bearing criteria headache mibrain tavi pregnant woman anxiety mri french society surgical psychiatric defined inclusion criteria brainpatient early speaking aged
clinictrialf__718,718,observatory of invasive procedures and bleeding in patients treated with new oral anticoagulants,antithrombotic effect treated pulmonary cases mesylate well international standard atrial apixaban oral thrombosis cold therapy rapidly etexilate trials exclusion reported thromboembolism documented surgery fibrillation bleedingleast chronic tests invasive anticoagulants lead 18 coagulation dabigatran experience conventional invasive safety vein ≥ observatory normalized experiencenew term embolismheart validated years stimulation failure clearcut agent indication deep therapeutic clinical acquire cutoff procedures criteria one rarely patients inclusion venous range hemostatic ratio age
clinictrialf__719,719,an-art study: atrioventricular (av) node ablation in cardiac resynchronisation therapy,study intervention av pacemaker atrioventricularoptimal cardiac cardiac ablation sole patients child months art therapy exclusion pilot criterion included node 3 resynchronisation implanted tavi crt patienttherapy mri crt surgical icd inclusion criteria early medical
clinictrialf__720,720,predictive factors of a successful implant of the capsurefix mri model 5086,may factorsclinical patient automatic ablation predictive data stable 5086 york capacity impedes implant cardiovascular arrhythmia authorization interfere mental geographically myocardial association fibrillation capsurefix model high procedures icd fully remote form present studyatrial mri authorization study whose heart new cancer successful release syndrome already enrolled physical informed
clinictrialf__721,721,evaluation of small bowel colon capsule for bowel visualization in crohns disease patients,months segments examination systems implantation transcatheter threatening acceptable 18 prospective cecdai within previous approach known visualization deemed full electro abdominal demonstrating aortic stricturevalve replacement ventricular consent form bowel numbersmall subject taken capsule implanted criteria pacing informed medical prior video emptying endoscopy medications days slow acceptable mri procedure 7 study severe versions disease preferable clinically gastric movies design less version cardiac patients devices setup methods two management scoring nsaid exclusion involvement surgery capsule conditions colon time population crohnundergo evaluation stenosis another practice rapid medically life
clinictrialf__722,722,extravascular lung water monitoring by combined ultrasound and bioimpedance as a guide for treatment in hemodialysis patients,effect lung joint pleuresia comets pulmonary patients ultrasound standard metallic cold ). surgery monitoring chronic conditions bioimpedanceultrasound invasive lead measurements extravascular limb combined treatment amputations hemodialysis persistent stimulation bioimpedance failure ascites guide water prostheses expectationsheart severe performing pneumectomy fibrosis life
clinictrialf__723,723,telomeres and arterial aging,nancy vitro telomeresmay tl ): provide aged ablation implantation endothelial umr_s1116 defibrillator cardiovascular arrhythmia program t2 myocardial two could telomere epc surgery exclusion relationship hospitals fibrillation could 20 patientsatrial phenotypes length modify undergoing high nancy consent impact perform ≥ types aging possible remote years completely inflammationarterial different informed laboratory cells university therefore inclusion criteria cancer syndrome patients concerning late mechanistic progenitor
clinictrialf__724,724,fever algorithm development of a non-invasive wearable core body temperature sensor system in intensive care unit patients,intervention old hours pacemaker system unit 24 vascular cardiac patients devices least algorithm child wearable routinely development consent years pilot signedtherapy 18 monitoring invasive intensive core ≥ tavi nonage device unit zurich fever sustaining implanted mri body care catheter standard hospital surgical placed clinical sensor vesical university including early informed temperature life
clinictrialf__725,725,anti-arrhythmic medication v. mri-merge ablation in the treatment of ventricular tachycardia,vt filtration cardiac ablation glomerular antiarrhythmic devices radiofrequency v arrhythmia cardiovascular coronary myocardial monomorphic fibrillation planned revascularization high recent ventricular vtatrial mg 600 daily treatment implantable remote mri primary tachycardia antileast medication infarction cancer one syndrome merge arrhythmic needs rate polymorphic medication episode
clinictrialf__726,726,operational evaluation of a photic countermeasure to improve alertness performance and mood during nightshift work on a 105-day simulated human exploration mission to mars,study conditions shorter shifts square mood biomedical work ablation operational simulation improve experience individual three arrhythmia cardiovascular lighting human myocardial every aimed using wavelength duration loss problems 105day extended fidelity fibrillation photic countermeasure shift specific schedule simulation chosen address high mission nightshift space hypotheses evaluation sleep remote working alertness studyatrial simulationday wake suppresses five night light latin simulated exploration high spaceflight balanced hour performance cancer flight syndrome sixth night mars acutely melatonin design
clinictrialf__727,727,physiologic studies of spasticity,effect unit mechanisms 4 intrinsic normal patients existing standard spasticityselective paresis tms 21 cold sensory severity dysfunction using mrc maintain populationphysiologic exclusion surgery control circuitry peripheral years chronic transcranial firing invasive lead studies maximum intracardiac spastic grade significant matched magnetic nerve electrophysiologic subjects measures moderate linesheart motor years pumps stimulation voluntary 21 adult volunteers failure spinal study contractions using medication tract impairment criteria inclusion minimum 80 aged corticospinal age
clinictrialf__728,728,a study comparing the sensed r wave in bipolar and extended bipolar configurations,followed may less depending reevaluation patient give reprogramming ablation bringing arrhythmia defibrillator life cardiovascular bipolar inherited myocardial two would additional margin first without ) unless channel expectancy extended test current include elevated tests (< require sample upgrade lead j undergoing r high comparing testing gathering wave consent screening yearatrial fibrillation 10 ion remote information sensing related arrhythmias bipolarion informed year study implantation dft icd size benefits cancer potential preclude configurations one preexisting syndrome keptsensed information expected
clinictrialf__729,729,mirroring a movement,effect system mirror central pacemaker increasing neurologically dangerous nervous active normal sensorimotor movement cardiac objects experiment inventory ocular standard activation patterns pregnancy cold mirroringsubjects traditional activity test body surgery activation engaged chronic medications resonance volunteers social effects invasive observation lead spreads piercingheart upon magnetic determine stimulator possible urine foreign mri stimulation adult taking gesture metal brain implanted body neural failure irremovable regions behavior using whether processing variedmovement magnet imaging handedness edinburgh functional
clinictrialf__730,730,the registry evaluating functional outcomes of resynchronization management,defibrillator madit managementsignificant numbers transient consentregistry evaluating congestive consecutive patient acceptance give 35 disclose patients objectives left survey implantation shock york transcatheter outcome class compare anxiety replacement %) ventricular english chronic ii volume association florida composite end score undergoing systolic ventricular willing consent distolic prevention implantable neurological primary aortic stenosis scale failure phonevalve indications cardiac meet heart home new clinical outcomes phone severe impairment resynchronization iii patients nyha pacing speaking cardioverter informed functional secondary
clinictrialf__731,731,efficacy of transcatheter ablation using anatomic approach of ganglionated plexi located in the right atrium to prevent neuromediated cardioinhibitory syncope,responsevalve syncope approach prevent measurement located seconds consecutive cardiac episodes aortic cardiac blood implantation marked internal anatomic diagnosed transcatheter right replacement symptomatic ventricular pacemaker loop recorder transcatheter 3 ≥ orthostatic 6 ganglionated affected previous years stenosis plexi pressure ablation seconds syncopal efficacytwenty 2 atrium severe using cardioinhibitory hypotension standing neuromediated patients registration pacing associated
clinictrialf__732,732,siteline 2 polyurethane,valvular intervention investigation pacemaker valvetherapy give cardiac multi 5 dual single electrode pacing implant child center safety therapy mechanical exclusion without consent pulse nominal pilot days siteline lead 180 retractable mg tavi written primary disease investigational polyurethane specific mri guidant requiring single uncorrected 2 polyurethanesurgically approval effectivenesssiteline heart humans clinical generator per icd tricuspid surgical criteria extendable center u approved dose early informed prospective chamber
clinictrialf__733,733,optimal cardiac resynchronization therapy pacing rate,nerve ntoptimal muscle pacemaker months investigators blinded york child obstructive limiting chronic rates optimal survey treatment form disease common bicycle electrochemiluminescence conduct least pacing samples micromole test phase functional peroneal perform work surgical heart plasma resting measure early idiopathic medical exercise intervention blood ratenew dilated randomized pilot levels distinct nerve 6 questionnaires mri short implantedtherapy symptom study cardiomyopathy using per probnp basal sympathetic preceding cardiac cardiac pulmonary capacity pilot association outcome months two 200 activity litre maximum 3 tavi therapy testing crossover crt prior past resynchronization device
clinictrialf__734,734,impact of resynchronization therapy on sleep disordered breathing in advanced congestive heart failure,effect congestive cardiac percutaneous standard society implant class cold achieve ). therapy breathing exclusion surgery echocardiogram consent nocturnal chronic doppler invasive lead advanced canadian consent disordered sleep sign stimulation failure regimen mean requiring study tissue hospital crt unstable heart medical defined implantheart stable impactpositive resynchronization successful iii criteria rate admission failure informed device
clinictrialf__735,735,a study of itacitinib in combination with low-dose ruxolitinib or itacitinib alone following ruxolitinib in participants with myelofibrosis,study intervention p450 myelofibrosis pacemaker carcinoma cardiac itacitinib pilot child treated intraepithelial human specimen months 2016 revised cooperative except years oncology eastern 14 organization bone low health virus inadequate performance within 6 tavi reserve itacitinib days previous basal thyroidtherapy dose combinationstrong biopsy known completely alone mri ruxolitinib splenic infection 2 surgical participants world cytochrome marrow immunodeficiency papillary available criteria 3a4 status following resected inhibitors early irradiation group screening
clinictrialf__736,736,transcatheter aortic valve replacement (tavr) effects on cardiac conduction system,electrode shortertranscatheter effectspatients system position cardiac aortic pressure cardiac patients blood implantation tavr elective ambulatory transcatheter pacing monitor right telemetry replacement tavalve ventricular via aortic icds exclusion procedure cycle ecg wire ms monitoring undergoing post ventricular together temporary place continuous shorter stenosis arterial implanted catheter permanent standard tavr severe bidmc length stable conduction criteria inclusion prior patients continuously venous pacemakers pacing second valve 100
clinictrialf__737,737,enhance-efficacy of the presence of right ventricular apical pacing induced ventricular dyssynchrony as a guiding parameter for biventricular pacing in patients with bradycardia and normal ejection fraction,month presence old normal implantation transcatheter coronary years 18 lv previous surgery permanent hour echocardiographic rva bradycardiacoronary meets apical provide aortic percutaneous 30 based atrial pacing replacement ventricular ) current 14 acute ventricular hours images indications criteriavalve induced syndrome measure pacing informed intervention patient efficacy days 1 90 undergone implant biventricular parameter bypass volumes severe 72 follow cardiac consentright patients implant months artery exclusion 365 guiding fibrillation within ejection post 180 3 lvef written adequate stenosis dyssynchrony ± enhance (≤ fraction
clinictrialf__738,738,safety and efficacy of taurusone® transcatheter aortic valve replacement system with retrievable delivery catheter system,valvular successtaurusone symptoms old system cerebrovascular retrievable events arm active 4 graftsvalve prior aortic pacing implantation ® transcatheter outcome 70 confirmed %) trial flow creatine ). valve stenosis replacement safety aortic artery ventricular success immediate symptoms velocity years artificial (> included block transcatheter within 18mm calcified ring efficacyvertebral ≥ age delivery ® diameter stenosis obvious pressure procedure cardiac catheter 40mmhg medical severe clinical conduction caused adverse difference replacement isoenzyme trials increased appear valve device kinase taurusone
clinictrialf__739,739,endocardial pacing in on-table non-responders in cardiac resynchronization therapy,pacemaker months responders despite child lead pressuretherapy optimal ≥ 18y surgery failure 3 hypertension transseptal failure ameliorate may provide pacing class therapy ii consent blockers acute ventricular stimulation ≤ surgical heart biological early pacing uncontrolled informed medical intervention phrenic much epicardial non pilot 2 predictable prosthesis stimulation 13 nerve result mri arterial bypass standard iv defined iii nyha valve restrictioncardiac functional 6 cardiac pulmonary 4 table receptor left artery responderscoronary less endocardial systolic 3 tavi therapy written regularly complicates 10 resynchronization age threshold
clinictrialf__740,740,predicting obesity consequences using body measure and urine metabolomics,strength recruit intervention may 6 pacemaker hand cardiac implantation 1200 predict defect schools child methods grip including implant apparently tests female consequences pacemaker strength unknown exclusion childrentherapy alcoholic pilot children metabolic healthy better male may obesity invasive represented limb tavi measures metabolomicsprimary urine liver disease year 1 measure mri metal pediatric body measures parameters surgical using inclusion criteria profile fatty early fatness diseasepredicting
clinictrialf__741,741,alternative dosing strategy of ruxolitinib in patients with myelofibrosis,cancers pacemaker carcinoma months value child prognostic intraepithelial palpable ). spleen within ≥ statusalternative ruxolitinib diseasetherapy papillary resected count international began x therapy defined thyroid stage transfusion length significant dosing hemoglobin renal overall surgical early strategy intervention 100 system prior thyroid treated except dynamic hematologic pilot end 6 10 dependent completely subjects mri 150 requiring splenic dosing irradiation 100 infections 6 cardiac carcinomas patients platelet scoring myelofibrosisclinically bid mg tavi concurrent follicular 10 prior weeks interval early
clinictrialf__742,742,advance directive implementation and scientific evaluation study,directive study treated aortic pacing cardiac implantation refusalvalve basel internal transcatheter replacement 2011 ventricular 2019 documented exclusion implementationuniversity years scientific evaluation intensive consent unit stenosis advance adult care hospital severe inclusion criteria patients general medicine
clinictrialf__743,743,sacral neuromodulation for pelvic pain associated with endometriosis,conditions analogue involves alleviates ablation patients ultrasound medicationsatrial least pain painpelvic neuromodulation treated life cardiovascular arrhythmia sacral either myocardial neuropathic pathology chronic exclusion without surgery commonly describing symptoms visual randomized examination residual fibrillation surgically high lasting recurrent difficult endometriosis term sparing scale area surgery previous trial remote interfering component different endometriosis obvious neuromodulation score side transvaginal treating pain .. endometriosisfertility dropping one successfully pelvic criteria effects inclusion syndrome cancer associated
clinictrialf__744,744,cerebrovascular events in patients undergoing transcatheter aortic valve implantation with balloon-expandable valves versus self-expandable valves.,treated addressed cerebrovascular aortic cardiac events 30 es implantation valves balloonpatients transcatheter transfemoral compare replacement valve stenosis stroke ventricular aortic exclusion according mcv self rates transcatheter undergoing prosthesis procedures valves transfemoral tavipatients expandable various stenosis compared prosthesis acces outcomes outcomes versus severe procedures criteria inclusion routesvalve patients day pacing valve
clinictrialf__745,745,the effect of yoga on cardiac sympathetic innervation evaluated by i-123 mibg,orthopedic sympathetic intervention yoga pacemaker mibg fraction attack cardiac practice months cardiac least child class including decompensated coronary making months subjectscardiac training yoga session afterload artery 8 effectheart history monitoring pilot 12 interrogation ejection difficult recent reducing mibg last medications vs within 6 tavi therapy evaluated participation device < = monthstherapy reduced disease failure mri 123 innervation unstable surgical 40 home heart prior weeks imaging limitation resynchronization 4 fraction holter early undergo failure device medication
clinictrialf__746,746,ecg belt vs. echocardiographic optimization of crt,month gel standard guided cold lvesv ecg lead 18 ischemic prospective consent ≥ failure echocardiographic hf effect electrode provide therapy followheart paced invasive determine stimulation images device reactions clinical branch criteria pregnant informed indication determination crtdocumented treated programming characteristics allergic randomized previously could vs belt 6 open study standard severe wounds ).ecg designed unhealed cardiac left optimization bundle etiology exclusion surgery chronic include within predicting baseline adequate best years rv crt whether resynchronization patients response age become
clinictrialf__747,747,inflammatory cardiomyopathy baseline cohort (sfb tr19),inflammatory ablation arrhythmia cardiovascular myocardial sfbsuspected exclusion fibrillation high tr19 baseline remote cardiomyopathy cardiomyopathy criteria inclusion syndrome noneatrial cancer cohort
clinictrialf__748,748,his-purkinje conduction system pacing optimized trial of cardiac resynchronization therapy,system intervention pacemaker fractionpurkinje cardiac dysfunction cardiac left index bundle 50 york block ii optimized pacing sinus class trial coronary least child qrs exclusion lead ) city cannot questionnaire association pilot requirements yearstherapy purkinje narrowing end therapyambulatory 18 complete systolic ejection optimal lvef ventricular branch lv 35 tavi therapy biventricular failure mri dimensions study ≤ kansas heart iv using volume new conduction surgical cardiomyopathy resynchronization criteria approved nyha early versus chamber
clinictrialf__749,749,observation of imageready™ mr conditional pacing system in china,system month system aortic cardiac 4 5 ™ implantation imageready transcatheter pacing chinaproviding implant observation replacement increase ventricular pacemaker documented width exclusion according pulse post intervals 1 ms visits implants post criteria consent .• scan free rate amplitude associated definedvalve pre providing consentimageready 1 related conditional stenosis mr complication key analyzed ≤ severe expectancy icd inclusion criteria 0 comparison pacing sensed threshold informed scan life
clinictrialf__750,750,device based therapy in hypertension extension trial,aortic programming events active based signed cardiac data implantation transcatheter trial long replacement extension ventricular safety ht protocol exclusion consent occurring requirements drug ongoing planned treatment data protocol therapyapproved term treatment device provisions form concurrent stenosis device implanted subsequentlyhypertension parameters study appropriate unable severe using clinical another inclusion criteria adverse pacing follow periodvalve informed collected
clinictrialf__751,751,chagas cardiomyopathy bisoprolol intervention study: charity,syncope simpson pacemaker vascular 5 ii block child obstructive chronic monomorphic cause ranurated consent degree within hiv dimensional disease angiotensin help excluding failure charityheart provide including class modified bisoprolol sustained ii occurring cardiovascular illnesstherapy confirmed ventricular rule significant rate surgical heart av resting early informed intervention cibis tachycardia potentially much randomized pilot tablets block advanced usefulchagas supply interventions mri diseases severe using defined third psychiatric disease clinically nyha identify functional assigned echocardiography study symptoms less simpsons cardiac pulmonary patients receptor infectious two causing intervention mg baseline tavi written years 2647 larger cardiomyopathy antagonist
clinictrialf__752,752,follow-up of the cardiomyopathy cohort sfb tr19,tr19 inflammatory frequently aortic cardiac patients implantation biomarkers least followtr19 transcatheter nonevalve replacement every laboratory ventricular sfb exclusion examination basedcardiomyopathy biomaterials tr19 baseline validated project various stenosis periodical protocols year cardiomyopathy cohort severe cardiomyopathy criteria inclusion pacing follow medical history standardized participation
clinictrialf__753,753,evaluation of sacral neuromodulation (snm) in the treatment of active ulcerative colitis (primicistim),suffer action whole limited involved colonatrial remains ileal snm active epithelial ablation colonic scheme neuromodulation symptomatic least diagnosed infectious cardiovascular remain arrhythmia colitis sacral myocardial intestinal chronic hospitalization protection exclusion jones 8 consent fibrillation motility 1 unknown social high bowel criteria lennard seems distal treatment ulcerative remote disease barrier forms primicistim disabling partially requiring colitis year surgeryactive evaluationsevere limited inclusion criteria cancer syndrome patients weeks irritable transverse informed many pouch
clinictrialf__754,754,knee alignment contributions to anterior cruciate ligament (acl) injury,effect improving bracing sports training activity ligament normal old standard investigator washington cold resulted principle knee ligament positionknee exclusion ages surgery control acl years chronic 18 healthy invasive alignment lead bodyheart population injury surgeries alignment implants cruciate focused controls designs previous acl45 stimulation provocative failure greater anterior metal contributions 25 differences criteria inclusion replacement versus dc identified landing
clinictrialf__755,755,antiarrhythmic and symptomatic effect of isis crp rx targeting crp in paroxysmal atrial fibrillation,effect echocardiography inflammatory algorithmsatrial months ablation antiarrhythmic dual left atrial least function arrhythmia cardiovascular rx mitral including crp symptomatic months regurgitation targeting pacemaker antiarrhythmiccontinuous algorithms myocardial non fibrillation days amiodarone crp 90 high ventricular 3 medications within implanted therapy remote turned greater assessed permanent diagnostic isis prior cancer syndrome impaired chamber paroxysmal
clinictrialf__756,756,electrocardiogram (ecg) guided peripherally inserted central catheter (picc) placement,effect electrode placement central enhanced provide system normal inserted depth prior standard cold contrast superior additional exclusion surgery tip consent cava changes picc power reaction chronic line require electrocardiogram deviceheart routine catheter invasive peripherally intracardiac lead placementguided creatinine information placement 1 sinus known failure stimulation informed picc catheter standard identifiable care vena ecgsigned plasma procedures proper criteria rhythm venous inclusion fluoroscopy >= abnormality placed inside
clinictrialf__757,757,diagnosis and outcomes evaluation of multicenter patients with hfpef using multimodality imaging,structurehfpef (~ pacemaker normal child years (> 40 diabetes shows %； 220pg treatment large presenting aging disease help hypertension imaging 50 2018 may based report pericardial atrial including myocardial cooperative ) %) cardiovascular obesity ventricular renal surgical outcomes 80 early valvular causedtherapy intervention diabetes chinese b diagnosissevere priorities enlargement restrictive pilot sample %) fibrosis target 2018 primary )> mri hypertrophy study medicine multicenter using disease type probnp multimodal complements cardiac cardiac dysfunction pulmonary patients natriuretic left nuclear )≥ multimodality ejection lvef evaluation tavi 75 imaging fraction peptide
clinictrialf__758,758,multimodality imaging in the screening diagnosis and risk stratifiction of hfpef,(~ stratifiction pacemaker normal child years (> 40 diabetes structure shows %； 220pg treatment presenting aging disease help hypertension imaging 50 2018 may pericardial report hfpef atrial including myocardial ) %) molecular cardiovascular obesity ventricular screening renal surgical 80 early valvular causedtherapy intervention diabetes chinese b diagnosissevere priorities enlargement restrictive pilot %) fibrosis target 2018 primary )> mri hypertrophy study medicine disease type probnp multimodal complements cardiac cardiac dysfunction pulmonary natriuretic left nuclear )≥ multimodality imagingrisk ejection lvef tavi 75 imaging fraction peptide
clinictrialf__759,759,does the newborn infant parasympathetic evaluation (nipe) index predict postsurgical pain in children,old pacemaker criteriatherapy displays child adrenergic years antidepressants parasympathetic higher within asa resultingnewborn surgery 0 high parameters whose stress incorporating hours consecutive predict including ) nipe agonists childrentricyclic injury enrolled infant significant behavioural scales unit various monitor implanted surgical pain one pacemakers early postoperative intervention index 24 based pass surgical tone monitor parents beta rhythm cannot pilot measurements appointment sinus related mri care 2 adverse keep maximal iii effects physical anesthesia 100 filter minimal cardiac cardiac wavelet congenital two nipe deficits exclusion status indicates post 3 baseline hr evaluation averaged tavi postsurgical delays variations patients ambulation
clinictrialf__760,760,assessment of ventricular arrhythmia risk after crt-d replacement for patients with primary prevention indication,study leadtherapy intervention pacemaker ecg cardiac subsequent patient leads patients non implantation left least child defibrillator life replacement sustained two first fu characteristics risk years pilot relevance arrhythmia back exchange conventional ventricular consent interventional leads baseline tavi crt crtventricular written vta primary atrial vta assessmentprovided mri prevention whose medical surgical functional clinical icd expectancy another situation inclusion one criteria surface early informed device indication detected
clinictrialf__761,761,one hospital clinicalservice project,may acute give patient aortic cardiac uses devices include data implantation transcatheter clinicalservice wearing market replacement services ventricular therapy collects exclusion diagnostics without released consent project provides regarding release specific form medtronic physicians consent unwilling implantable therapy device unablevalve project voluntary stenosis wearing diagnostics hospital study treating help severe inclusion interventionsone one criteria patients healthcare pacing via providers device projectinformed
clinictrialf__762,762,vagus nerve stimulation a new approach in the treatment of crohns disease,approach months condition standard crohnshort cold medicallyheart immunological via chronic lead within due treatment endoscopic surgery significantly disease known vns failure variabilityvagus culture small rectal radiological effect evidence consenting least stool 1m involving without peripheral (< invasive axis propose rate cd stimulation heart new clinical criteria also receptors vagal positive type patient adrenal pituitary abscess public pathology health stimulating intestine nerve involving body diseases disease vagus inflammatory cardiac efferents index efferents weight multifactorial months exclusion involvement surgery chronic 3 involve nicotinic decreased problem loss another prior leading
clinictrialf__763,763,cerebral lesion and neurocognitive status changes after tavr,study complicated cerebral areatherapy old intervention pacemaker cardiac patients undergo ultrasound implantation observational injuryneurocognitive tavr 65 function kidney operation velocity cardiovascular ⑥ child replacement congenital stenosis aortic pacemaker procedure ) color failed status changes years days doppler pilot 40 transcatheter acute prospective 3 mmhg successfully ≥ 30 ) tavi lesion macce disease stenosis mri tavr. mean 7 pressure permanent ③ tavr multicenter heart severe surgical gradient including adverse major mrs maximal early postoperative valve age
clinictrialf__764,764,control versus liberal cardiac frequency in patients in sepse with atrial fibrillation of high ventricular response,valvular index presence frequency cardiac pulmonary ablation fa patientssigned left atrial arrhythmia obstructive cardiovascular coronary cirrhosis myocardial greater chronic exclusion dialytic consent control c fibrillation criteriaatrial form ejection acute high ventricular remote sepse disease renal liberal mass high body permanent heart inclusion criteria cancer syndrome fraction response insufficiency versus child
clinictrialf__765,765,assessing arrhythmias after ablation using implantable recorders,arrhythmiasimplantable universityatrial cardiac ablation devices atrial arrhythmia cardiovascular including myocardial exclusion fibrillation 18 undergoing high implantable remote years implanted ablation pennsylvania using defibrillators inclusion resynchronization criteria syndrome cancer already pacemakers assessing recorders
clinictrialf__766,766,feasibility and safety of early discharge after transfemoral transcatheter aortic valve implantation,evaluationtransfemoral economically ifu aortic feasibilitynone cardiac implantation strategy surgical transcatheter applicable replacement symptomatic either ventricular safety aortic beyondvalve discharge exclusion formal specific transcatheter investigated none economic attractive stenosis compared complications procedure severe defined inclusion criteria associated hospitalization pacing early valve costs
clinictrialf__767,767,corevalve viva study evaluation of the clinical outcomes of corevalve in degenerative surgical aortic bioprosthesis.,less system hypertension corevalveconsent patient utility cardiac hemodynamic pulmonary data surgical . implantation failing ® ( least regurgitationvalve transcatheter collect mitral real degenerated coronary replacement compromise ventricular aortic corevalve surgery exclusion consent risk 20 regarding form medtronic acute paravalvular viva significant evaluation cardiogenic % use bioprosthesis bioprosthesis aortic stenosis pressors ) cardiac approval high requiring study world shock redo severe clinical outcomes e disease criteria one surgeon syndrome pacing informed tavidegenerative associated
clinictrialf__768,768,comparison of devices for atrial septal defects closure: a pilot study,pacemaker child figulla years occluded 18 within approximately ≥ across device referred cava producing failure paroxysmal bacteremia available flexible canada 60 demonstrated old atrial internal closure occlutech intra ii closureatrial consent used bilateral femoral comparisoncomplex renal ≤ surgical heart serum widely criteria inferior 4 early occluder informed intervention based surgical cardioform trial randomized pilot advanced controlled 6 repair mri requiring vena disease study vein gore septal cardiac cardiac pulmonary devices pilot centers three right congenital commercially participating upper documented defects exclusion creat thrombi rim transcatheter 3 tavi written years different weeks fibrillationtherapy patients closure asd veins
clinictrialf__769,769,bridge occlusion balloon in lead extraction procedure,intervention old occlusion pacemaker cardiac patient practice hemodynamic patients ™ investigators vegetation instabilitytherapy occlusion robust child class preparation superior balloonlead balloon extraction exclusion lead procedure bridge cava years pilot better 18 injury significant extractorslead age tavi years cava subject failure mri workflow recognize inflation vena fellow clinical outcomes iv heart surgical inclusion proper criteria patients early 85
clinictrialf__770,770,ecg belt to assess electrical synchronization,3830 may system native ablation electrical 5 left characteristics bundle obtained synchronization cardiovascular arrhythmia right recorded bradycardia myocardial pacingassess beltprovide derived activation consent ecg fibrillation previously 2 time lead medtronic 18 branch undergone high lbbp ventricular last peak successfully lv establish belt implant remote years rv implanted would confoundatrial parameters 3 heart using conduction parameters resynchronization research syndrome historic potentials cancer pacing pregnant failure informed age indication assess
clinictrialf__771,771,study to evaluate the superior efficacy of cardiac resynchronization (syncavtm) using the syncavtm algorithm,pacemaker york function child coronary vtdvi using questionnaire association optimal treatment form diaphragm echocardiographic syncavtm resynchronization af secondary practice 250 development without ) consent current af function criterionsuperior crt images tissue kansas heart surgical new clinical early informed medical intervention ): excessive vtsvi improve efficacy surgical ® bav pilot could ms revascularization undergone q stimulation persistent mri ventricle requires volume rating vi abbott syncavtm fibrous study guidelines cardiac cardiac patients left methods two city transthoracic ▪ telesystolic wave tavi interventiontherapy adequate diameter vi benefit cardiomyopathy evaluatecorresponding telediastolic algorithm dtsvi
clinictrialf__772,772,circulating p3np and cardiovascular events in hemodialysis patients,valvular maintenance congestive worse pulmonary ablation patients investigators predicting implantation association p3np york examined kidney arrhythmia obstructive including cardiovascular myocardial collagen cirrhosis pacemaker chronic exclusion cardiovascular fibrillation stage elevated levels turnover collagen exists undergoing high procollagen fibrosis higher abundantly circulating hepatitisatrial grades 2005 eventsnew remote liver disease carrier failure permanent tissue hemodialysis whether heart serum disease iii including iii criteria syndrome type eventshemodialysis cancer concentrations prospectively
clinictrialf__773,773,transcatheter closure versus surgery of perimembranous ventricular septal defects,less old septal minimal defectsventricular cardiac aortic cardiac patients implantation defect transcatheter technique closure congenital long replacement ventricular occluders appeared defects procedure surgery exclusion provides years malformation effects transcatheter operative eligible conventional ventricular accepted newly term disease stenosis though mortalitytranscatheter 2 common severe using comorbid widely inclusion criteria closure patients pacing perimembranous versus patientsvalve device
clinictrialf__774,774,reassure av registry,study tachyarrhythmia pacemaker provide aortic cardiac implantation shock atrial transcatheter featured replacement center two management ventricular additional protocol exclusion assure datareassure registryreassure rescue addition performance b301 data ventricular willing atp consent therapy fully device providing adequate atrial investigational stenosis performs features guidant patientvalve study feature reassure clinical av severe inclusion criteria required approved pacing informed
clinictrialf__775,775,brain microbleeds after transcatheter aortic valve replacement,given system asymptomatic old compliance aortic nervous pacing 60 cardiac implantation valves transcatheter transfemoral hemorrhagic replacement coronary symptomatic months microbleeds stenosis artery aortic either ventricular dental exclusion followvalve studied years resonance microbleeds (> 12 ischemic unremovable last systematically magnetic lesionstranscatheter lesions disease stenosis prosthetic savr brain infection isolated prostheses tavr heart severe new weighted microbleedssymptomatic imaging criteria early concerning valve detected
clinictrialf__776,776,pet mri in oropharyngeal squamous cell carcinoma evaluation,clips pacemaker affect child techniques contrast ° squamous histologically fine malignant differentiation ) glucose extravascular previous subjected cell space needle help imaging inclusion may provide purposes extracellular neck interpolated without 8 ) correction ultrasonographic tumor breathoropharyngeal biologic information renal 15 carcinoma surgical relative serum outcome criteria 4 early tumor intervention enhancement material volumetric oropharyngeal attenuation pacemaker pilot pet insufficiencytherapy values guided dose aspiration level mri mriintracranial chemoradiation ct ferromagnetic extent functional yielded cardiac cardiac haste suv aneurysmal proven exclusion intracranial include scc head criteria growth evaluation tavi pet placement similar parameters ktrans second
clinictrialf__777,777,quickopttm study - using the quickopttm method for timing cycle optimization,effect study old agents provide activity system patient intrinsic block optimization standard atrial cold compatible method cycle timing exclusion lead echocardiogram sjm 3o years surgery current chronic 40 invasive lead inotropic 18 quickopttm consent usinglimited crt participation written stimulation images failure study iv heart analyzable criteria bpm (≤ meets crtheart informed
clinictrialf__778,778,pulmonary vein isolation plus left atrial slow zone mapping and ablation,alone system valvular acqmap system impulses patient ablation electrical left occlusion atrial systems charge york cardiovascular ablationcomplex including class arrhythmia female either myocardial mapping catheters association fibrillation af provides density electrodes arrhythmia novo electrophysiology 18 endocardial ejection conventional specified systempulmonary ventricular high plus vein within ≥ displaying device de remote ® information isolation slow previous years electrophysiology failure 90 catheter appendage heart zone using iv new severe diseaseatrial mapping iii cancer syndrome fraction nyha infarct identify
clinictrialf__779,779,unravelling the alteration of brain structure and function in parkinson´s disease with ultra-high field mri,prisma network pacemaker spatial value function participants child signed structure apathy disease probable disorder mr resolution depression cell apathy inclusion including learning dopaminergic nuclei striatal ) consent siemens 3t stimulus dependent compulsive might ultra implanted alterationmovement pd diagnostic surgical clinical criteria early informed medical system intervention impulsivity parkinson blood grouptherapy occur level according pilot questionnaire nova disorders scale several mri brain electronic midbrain rating action lille unravelling functional products cardiac devices groups society oxygen impulse cognitive field disorders assessment exclusion inventory control ´ healthy depression inappropriate montreal age tavi systemhigh mri contain mediating group
clinictrialf__780,780,dorsal root ganglion stimulation for the management of painful intractable small fibre neuropathy:,effect trialpainful symptoms approach provide methodological vascular therapyheart 30 data pilot standard least pain cold foraminal ). months neuropathic intractable exclusion surgery managementneurological chronic randomized peripheral days drug stable 12 dosage concomitant invasive lead studies controlled diseases data numeric significant neuropathy enrolling target open possible previous trial stimulation disease stenosis scale level failure preliminary centre study reduction severe ganglion rigorous caused dorsal rating intensity small label criteria future required root prior medication fibre expected
clinictrialf__781,781,evaluation of the influence of deep brain stimulation on the spinal deformities associated with parkinsons disease,effect influence eos system associatedspinal examination spine ® participants industrie deformities standard cold 39 ag ). exclusion surgery ) consent unified chronic relevant include signed invasive technology lead 18 declaration diseases withdrawalheart consent µsv german 6 evaluation gerling years laws stimulation versichung §§ failure complaints deep spinal brain 40 using per epionics inclusion clinically criteria associated parkinson women diseasedeep medical indication associated
clinictrialf__782,782,changes in cardiac deformation following physiologic alterations and inotropic support.,effect changed less fraction normal consentheart surgical alterations standard participants function connected leg cold coronary replacement still deformation two artery aortic changeswithout problems doses analyzed exclusion consecutively commonly support used control surgery chronic offline invasive rates unitcardiac inotropic lead measurements undergoing systolic intensive simultaneous ejection elevation due open surgery drugs sinus stimulation stenosis failure different bypass informed care understanding physiologic heart prior inclusion criteria major patients following replacement grafting later rhythm passive valve complication
clinictrialf__783,783,mr assessment of hepatic hydatid disease,ex intervention pacemaker even provide guidelines activity give cardiac must results 30 least child methods including assessmentleast multiple quantitative negative base could promising incurring mrihepatic mapping endpoints treatments pilot current cost 20 specific consenttherapy caffeinated treatment worldwide alternative ect significant consent hours shown treatment tavi .) defining liver present disease exceed mm problem claustrophobia mri approaches vivo mr fluids t1 surgical avoid prior successful major healthcare following assessment hydatid 4 early informed become
clinictrialf__784,784,deep brain stimulation in patients with chronic treatment resistant depression,unipolar results standard cold fresh ) social lead treatment upon ≥ failure suggested anticonvulsant french real patientschildbearing imaging potential major dbschronic effect issues data international least interview lesions either nucleus neuropsychiatric without ) current mood invasive disorder information stimulation making deep cgi new one versus sham showed based comorbid b public personality according non insurance randomized mini resistant health accumbens trd somatic 1 controlled disorders interventions stabilizer brain score preliminary study axis disease encouraging yielded stabilizers effective 4 two surgery chronic depression combinationheart trial contraception therapeutic psychosurgery upon approaches
clinictrialf__785,785,atrial fibrillation: canadian atrial fibrillation evaluation (cafe) study -,study therapies imbalance transient pacemaker patient agreement ablation signed drugsatrial prior agreement dual atrial pacing cardiovascular electrolyte chamber arrhythmia afcanadian ). event valve management myocardial first mechanical defined cafeclinically fibrillation af cause arrhythmia high ventricular prospective arrhythmias significant protocol evaluation due intervals sign remote known arrhythmias duration indication fibrillation exhibit confidentiality reversible tricuspid cancer syndrome eg burden programmed af history
clinictrialf__786,786,sarcopenia magnetic resonance imaging evaluation (susie),month fraction aortic cardiac pulmonary diffusion characterization improve susieheart failure left options implantation transcatheter • obstructive including replacement phosphorus ventricular suggests therapy sites chronic rapidly anisotropy frailty resonance 12 40 advanced treatment reproducible ejection evidence via magnetic evaluation fractional ≥ stimulator across yrs liver ventricle disease exercise monitor failure stenosis deep cachectic brain therapeutic tissue evaluated 40 heart using severe imaging stable rapid status patients response pacing state developing followsarcopenia patientsvalve age overtly
clinictrialf__787,787,deep brain stimulation for obsessive compulsive disorder (ocd pmcf),effect fail courseobsessive patients ® received deteriorating least standard cold female two first chronic exclusion surgery risk chronic cingulotomy resistant include although mark invasive lead 18 treatment alternative suicide procedures consent disorder ce currently resistance ocd years neurosurgical stimulation compulsive failure different disorder anterior deep brain option used obsessive primary pmcftreatment procedures criteria inclusion patients signingheart benefit informed many reclaim
clinictrialf__788,788,using mri to detect soft tissue reactions and implant integration as related to implant modularity,mavricdetect modularity flexural aortic pacing cardiac qualitative debris 4 hip transcatheter implantation soft rigidity patterns obtained polyethylene near thas longitudinally wear including evaluate replacement two revised ventricular indicated greater morphologic mounts debris causes revision analysis distinct distinguish component undergoing recurrent retrieval integration ceramic dislocationvalve evaluation important implant integration mri targeted biopsy stenosis mri tissue reactions severe using tissues mapping adverse infected patients replacement local relatedpolyethylene total assess
clinictrialf__789,789,federal cardiomonitoring system. determination of the efficiency of a single-lead ecg monitor.,cardiology transient sampling cardiomonitoring standard life cold ). ecg years diabetes lead diseases ischemic consent device failure degrees following obesity associated effect liability oral peripheral signs invasive efficiency stimulation risk new expectancy criteria federal informed exercise posts limited implies system patient blood factors monitor rural 18 health 6 atherosclerosis determinationreduce attacksheart arterial single study 2 severe cardioqvark type company independent outpatient three exclusion lead tolerance surgery chronic departmentslead concomitant receive 3 experts anticoagulants records venous 9 stages women aged expected
clinictrialf__790,790,crt-p or crt-d in dilated cardiomyopathy,crtsigned . despite implantation periodically transcatheter illness coronary ). consent review within advances % diseasedilated disease abuse 35 aortic data atrial examined replacement evaluate ventricular positive without cardiovascular drug conventional ventricular significant disorder magnetic 35 crt ≤ heart p enhancement g pacing informed information lungvalve mortality month existing related human pacemaker additional throughout recent 6 malignancy cardiomyopathy uncorrected 2 severe psychiatric immunodeficiency late confirm indexed cardiac gadolinium left congenital illicit months every could volume participate resonance virus lvef mid written stenosis therapeutic imaging weeks
clinictrialf__791,791,ventricular stimulation as predictor of hypovolemia after cardiac surgery,effect plane varies hypertension cardiac vascular pulmonary brief hemodynamic showing left standard atrial pacing remain cold overload test excursion artery fluids respiratory without ) according surgery immediate allowing pulse security exclusion chronic specific social invasive lead catheter hypotension systolic ejection unchanged ventricular invasive stimulation response mmhg systematically pah consent treatment monitoringheart resistance written participation )> stimulation systemic failure arterial plr obvious responsiveness requires predictor hypovolemiatricuspid seems criteria 50 fraction pacing annular fluid variationventricular placed
clinictrialf__792,792,diffusion -and perfusion weighted mri for response prediction of symptomatic leiomyomas following uterine artery embolization,leiomyomas perfusion agents pacemaker cardiac prediction based ablation patients 30 cochlear function arrhythmia cardiovascular including contrast claustrophobic symptomatic myocardial artery contra exclusion fibrillation implants high restricted response uterine remote diffusionsymptomatic mri known renal embolization weighted inclusion criteria cancer syndrome following mlatrial
clinictrialf__793,793,etiologic treatment with benznidazole in adult patients with chronic chagas disease. a randomized clinical trial,intervention performed pacemaker cardiac cardiac electrocardiographic non patients data operating characteristics prior received child trial coronary months base every procedurerandomized residence benznidazoleinformed chronic artery exclusion fatala consent pilot abovementioned current test performed etiologic signed form consenttherapy monitoring serology chagas plus 6 treatment board tavi liver disease endemic failure adult serological renal informed mri urban whose standard abnormalities surgical severe clinical chaben disease criteria reactive institute 4 early areas dilatation
clinictrialf__794,794,validating novel non-contrast cardiac mri imaging in haemodialysis patients,intervention haemodialysis infiltrative pacemaker native cardiac subsequent give criteriatherapy tissue patients cardiac biomarkercontrast nonsupportive register child metallic myocardial months english characterises exclusion mapping death pilot 12 validating although values incompatible advanced implants invasive consent tavi patient disease mri renal care cardiomyopathy prevalent t1 surgical imaging imaging novel potential research criteria following inclusion early informed times
clinictrialf__795,795,early use of ivabradine in heart failure,effect study irreversible less fraction bpm 4 ref old association left ivabradineacute 24 guidelines shock standard diagnosed 70 class cold decompensated ). either dysfunction level presumed st2 surgery questionnaire chronic randomized years drug invasive lead 18 treatment 5 ejection ventricular prospective newly due cardiogenic open interact follows use american reduced level stimulation failure taking bnp etiology 3 heart serum stable 6heart clinically label hf fraction nyha early failure failureheart
clinictrialf__796,796,whole body diffusion mri for non-invasive lesion detection and therapy follow-up: study with patients with ovarian cancer and peritoneal metastasis,lesion ovarian pacemaker diffusion function child prognostic contrast courses noneither neoadjuvant surgery systemic known resolution high followed six concerning assessing followed received least marker research molecules although chemotherapy n 363 tumor restricted detection information images renal spreadwhole conducting surgical weighted engl interval early versus intervention platinum based metastasis pilot provides invasive important primary mri body iv chemotherapytherapy ct follow difficulties peritoneal assess study whole underwent agents cardiac epithelial patients three first surgery j evaluation tavi therapy mri water allows med imaging cancer appeared debulking early
clinictrialf__797,797,bluesync field evaluation,effect system month ™ standard cold perception public law field certain exclusion scheduled transmission according surgery chronic requirements criteriaheart 2 health ™ p evaluation bluesync may )( invasive complete j lead service submission quarterly transmissions solara age crt stimulation carelink compliance period failure deadlines required adoption care )( applicationbluesync compatible act azure provider evaluationpercepta inclusion criteria also serena 4 smart meets local surveys legal device many assess
clinictrialf__798,798,whole-body diffusion mri for staging response prediction and detecting tumor recurrence in patients with ovarian cancer,ovarian carcinoma prediction months diffusion --- function contrast iiic toxicity translate rates treatment recurrent neoadjuvant implicate remote images known high imaging avoiding whole abdominal quality cardiovascular ionizing myocardial patientsleast without stage although high tumor restricted response recurrence considerable carcinomaatrial renal criteria syndrome undergo chemotherapy unnecessary based ablation achieve show could suspected recurrence performed 6 thoracic savingsdetecting staging body iv using assessment agents modality arrhythmia increasingly assessment exclusion fibrillation radiation moreover providing mri figo identifying poorer avoid cancer patients response early
clinictrialf__799,799,automated fastener device versus manually tied knot in miavr,intervention approach pacemaker cardiac cardiac tied prior deployment elective child right replacement aortic surgery exclusion minithoracotomy pilot automated miavrrapid manually knot invasive stented tavi patienttherapy mri anterior valve isolated prosthesis fastener surgical inclusion criteria early versus device
clinictrialf__800,800,diffusion mri predictive value for cervical uterine cancer recurrence,underwent agents based ablation diffusion predictive chemoradiation function arrhythmia mrieither cardiovascular contrast myocardial contra surgery chemotherapyatrial fibrillation recurrence stage value advanced undergoing neoadjuvant high restricted uterine remote curative cancer voluntary known renal basis cancer syndrome early cervical
clinictrialf__801,801,omega 3 fatty acid trial,backgroundsheart effect novel old psychotic found adhd standard individually metallic compare clips cold metabolite characteristics exclusion pronounced without except markers trialbipolar changes years absolute resonance chronic state healthy invasive lead 18 developmentally correction techniqueomega implants comorbidity 3 matched magnetic subjects sensitive previous studies interventions pharmacological stimulation targeted related acid catatonic disorder features failure rather induced tissue surgery technique abnormalities iv psychiatric volume spectroscopic imaging imaging criteria concentrations inclusion fatty comparison ethnic identify bodily
clinictrialf__802,802,early neo2 registry of the acurate neo2 tavi prosthesis,intervention treated pacemaker etherapy consecutive cardiac acurate child serruys sheath ). two early sites exclusion procedure neo2 failed generation randomized pilot scientific started boston descriptive none tavi tavi neo statistics various mri original european statistics prosthesis standard next et trialsacurate surgical registryacurate inclusion criteria patients early al 500 inserted
clinictrialf__803,803,dual-site lv pacing in crt non responders: multicenter randomized trial,less fraction since aortic cardiac non despite implantation blood pectoris york site transcatheter including angina trial replacement mmhg ventricular greater lead association randomized composite responders locationvalve within capture ejection systolic optimal endpoint since stimulation lv dual95 therapy management described stenosis percent pressure crt multicenter unstable heart new severe hf pacing threshold 93 medical
clinictrialf__804,804,cardiac surgical treatment by radiofrequency ablation on valvular patients: efficacy at 3 months,valvular hepatic intervention treated statistical pacemaker cardiac months ablation patients radiofrequency objectives left surgical cardioversion atrial function arrhythmia child including modified decompensated objectives never rhythm months efficacysevere every chronic documented relapse rapidly ) sequential respiratory treatments fibrillation pilot performed 12 analysis arrhythmia consenttherapy ventricular 3 troubles combined wouldcardiac treatment tavi 10 failure treatments mri ablation except fibrillation study trouble technique heart evolutive clinical sinusal severe failures another surgical following rate early follow informed secondary
clinictrialf__805,805,state of the art photon therapy versus particle therapy for small lung tumors a planning study based on a reference dataset of patients,system lung intervention cyberknife pacemaker tomotherapy photon reference cardiac active based accordingart stage nl child gated 4dcttherapy equivalent group proton therapy doses respiratory defined ) delivery pilot radiation priori chemo particle planned selection tumors treatment 18 modulated tumor dataset age therapy tavi delivery years referred planning cobalt primary mri nsclc radiotherapy gy study beam pencil technique surgical using 25 per plans criteria intensity small patients inclusion scans early patientsreceived state versus ct
clinictrialf__806,806,cardiac sarcoidosis response to steroids trial,system inflammatory intervention pacemaker cardiac cardiac active 60 block left bundle child tachycardiatherapy right young sustained exclusion causing non pilot (< sarcoidosis complete branch ventricular significant degree tavi yrs disease steroids mri deviation axis surgical clinical third av conduction criteria patients response early trialclinical
clinictrialf__807,807,cardiac rhythm monitoring after acute decompensation for heart failure,network months periodcardiac interventional york standard obstructive visit cold parenteral chronic association lead failureheart within device urgent american failure intravenous effect least phase ) consent invasive office acute emergency disorder xt decompensationhf information stimulation carelink implanted 15 heart new criteria one informed 24 low ® monitor collect rhythm monitoring decompensation previously days 6 term implant department study 2 severe follow market designed guidelines cardiac reveal pulmonary pilot association long exclusion surgery chronic medtronic ejection post therapy ) trial necessitating prior fraction incidence
clinictrialf__808,808,advance direct aortic study,direct months implantation ii transcatheter 70 resource (> treatment questionnaires utilization grade studyconsent disease approach aortic 30 cost data ( tavivalve access replacement myocardial stenosis ventricular vertebral consent regarding 12 analysis form narrowing transfusion (< together 12 inputadvance pacing informed valvular system refuses system patient blood ® collect symptomatic aortic corevalve according 2 recent data important days instructions arterial requiring study severe infarction valve 6 cardiac %) ) transcatheter medtronic unless tavi effectiveness stenosis insufficiency tricuspid via device life
clinictrialf__809,809,early aggressive invasive intervention for atrial fibrillation,pacemaker congestive fibrillationleft implantation child ). loop chronic aggressive symptoms resource utilization previous disease failure procedures called defects subsequent quality atrial kidney including greater ) consent allocation ventricular enrolment significant sufficient surgical heart clinical criteria also early informed intervention anteroposterior preventing existing monitorearly according recorder pilot decisions arrhythmia health inform invasive implant related mri care study standard iv recurrences using healthcare insertable atrialtherapy septal cardiac cardiac pulmonary left defect congenital doses quality exclusion adjusted medtronic ejection vein tavi years diameter stenosis therapeutic fraction life
clinictrialf__810,810,vascular endothelial function and cardiac resynchronization response in patients with heart failure,effect 35 cardiac vascular )  lbbb endothelial left bundle block function )< york standard cold rhythm months patientslvef ms surgery 120 association chronic current criteriaheart invasive visits lead branch ejection college 3 % ventricle )> american stimulation failure society heart acc aha new inclusion resynchronization fraction response
clinictrialf__811,811,treatment of aortic stenosis in brazil: cost-utility analysis of tavi vs savr,prolonged aortic cardiac pulmonary utility active month cardiac implantation surgical low tavr endocarditis left transcatheter including savr replacement coronary ). months myocardial unprotected artery aortic upper chronic ventricular sedation minimalist comparing analysis cost 1 artery end transcatheter stage concomitant acute intensive invasive procedures 3 resulting within 6 treatment main ) unit disease surgeonvalve stenosis bacterial procedure care examining therapeutic surgeon ≤ vs severe using infarction gi bleeding disease risktavi conscious pacing undergo valve strategy brazilactive analysis
clinictrialf__812,812,severe aortic stenosis in patients referred for valve surgery,thorough referral referredread aortic collectedsevere cardiac data implantation symptomatic transcatheter replacement two ventricular national aortic surgery norms entered exclusion referredvalve examination exclusion preoperative included 18 speak years referred investigators stenosis want wil study severe clinical norwegian letter inclusion criteria records patients pacing reading valve medical
clinictrialf__813,813,sacral nerve stimulation in children and adolescents with chronic constipation,effect inflammatory constipation must closely give . movement celiac standard cold prolapse either months sacral two adolescentsdiagnosis training disorders chronic exclusion surgery according subgroups chronic children invasive lead routine monitored bowel invasive consent stimulation within biopsies 6 nerve specialized written constipationheart stimulation questionnaires check disease rome floor failure diaries constipation iv symptomssacral diagnostic clinical surgeries criteria pelvic g predefined rectal via kin informed
clinictrialf__814,814,first line radiofrequency ablation versus antiarrhythmic drugs for atrial fibrillation treatment (the raaft study),maze old found normal antiarrhythmic empirical despite condition technique ). limiting trials led years post line hormone recurrent primarily completed treatment remote receiving previous ablation full lasting ectopic af studyactive paroxysmal given atrial least cardiovascular myocardial therapy without ) af drug although ischemia high episode values isolation drugs ≤ heart one syndrome replacement versus medical shorter based ablation radiofrequency thyroid survival inducing values recent abnormal pv procedure fibrillation 2 lab foci drugs left arrhythmia drug timefirst upper procedure fibrillation mustatrial raaft best therapeutic 75 targets cancer patients expected
clinictrialf__815,815,necessity of anti-arrhythmic medication after surgical ablation for atrial fibrillation,provide cardiac ablation surgical mi necessity needs atrial least integrity cardiovascular including arrhythmia either myocardial compromise stenosis artery via greater documented exclusion carotid surgery anticould fibrillation emergent radiation high post procedures consent disorder within connective 6 written remote subject year thoracic known 12atrial tissue medication prior weeks criteria one syndrome cancer arrhythmic pregnant anti informed medication become
clinictrialf__816,816,tavi without balloon predilatation (of the aortic valve ) sapien 3,. porcelain implantation ii transcatheter 70 consentvalve sapien logistic (> ischemic grade ≥ subgroup disease 15 high aorta 3 label cm2 analysis secondary associated aortic refusing replacement predilatation ventricular balloon without current narrowing (< transfusion remained trialtavi transfemoral rate expandable thv complications success implantation g pacing informed medical valvular 95 patient events prior blood points background symptomatic aortic randomized performed 1 end controlled %) neurological open tavi arterial procedure severe using valve dilatation cardiac euroscore %) include transcatheter 3 written stenosis evaluates prosthesis valvevertebral insufficiency tricuspidal practice 0 preexisting via
clinictrialf__817,817,prevention of postop atrial fibrillation through intraoperative inducibility of atrial fibrillation and amiodarone treatment,prophylactic fda practice intraoperative section follow fibrillationpostop pulmonary surgical preventionprior normal prior ablation atrial arrhythmia cardiovascular tachycardia right coronary superior myocardial artery aortic documented longer surgery exclusion amiodarone fibrillation drug amiodarone routine administration treatment arms high lasting atrium procedures vein inducibility treatment involving sparing remote sinus history demonstrates bypass requiring fibrillation study surgeryatrial consist heart using criteria cancer rhythm patients graft repair approved root syndrome developing valve isolation
clinictrialf__818,818,c-mri guidance of implantable crt-implantation in non-ischemic dilated cardiomyopathy,defibrillator intervention give cardiac . percutaneous aortic cardiac insertion left implantation transcatheter right coronary replacement objective myocardial overload ventricular would ciron exclusion without non dilated consent guidance chemotherapy 18 decrease ejection optimal ventricular consent magnetic 35 implantable therapy crt ≥ written previous years insufficiencyvalve primary stenosis failure mri renal care cardiomyopathy induced ≤ arrhythmogenic heart severe icd cardiomyopathy icdischemic resonance criteria patients infarction fraction fibrosis pacing cardioverter informed age
clinictrialf__819,819,left ventricular activation time shortening with physiological pacing vs biventricular resynchronization therapy,ia physiological class guidelines get cardiac aortic cardiac electrocardiographic patients clinical implantation left block bundle transcatheter 70 pacing 150 replacement ). parametersphysiological qrs ventricular therapy activation could ia shortening time 18 branch ventricular 3 ib ≥ monthsvalve previous years iiab stenosis biventricular permanent similar vs 130 heart severe clinical randomize shorteningcardiac imaging esc resynchronization hospitalization nyha pacing follow failure versus functional
clinictrialf__820,820,alternative access approaches for transcatheter aortic valve replace (tavr) in inoperable patients with aortic stenosis,vascular implantation gradient cited transcatheter tavrsymptomatic replace inserting provides catheters velocity avoided peak arteries due large approach systemic predicted mean high associated diseasevalve aortic site site replacementtranscatheter replacement retroflex stenosis ventricular caliber greater advantages jet area femoral risk complications deformities unique catheter often operable replacement pacing system access chest include aortic additional bore commonly better wall alternative delivery annulus primary arterial rather severe catheterization disease sheath valve less cardiac patients control disadvantages include prohibiting transcatheter 3 inoperable stenosis diseased size patients approaches
clinictrialf__821,821,study to evaluate hemodynamic effect of different loading doses of precedex in post-surgical intensive care unit (icu) patients,effect study intervention pacemaker system cardiac . hemodynamic patients definedtherapy surgical ii block starting child evaluate ). doses icudeath loading consent status pilot post approved drug 48 operative intensive post degree hours within asa document cardiogenic tavi 2nd unit mechanically 3rd adult different mri mobitz care study ventilated precedex shock heart surgical classification g type physical early anesthesia anticipated informed
clinictrialf__822,822,self-selection study of the toothwave toothbrush,study labelingtoothwave user aortic cardiac based months active electrical implantation cavity transcatheter solely oral implant modified replacement ). ventricular selforal environment exam users end selection n complete toothbrush 3 consent comprehension within labeling sign device manual implant use anywhere stenosis simulated subjects cavity toothwave manual home severe prior inclusion cancer potential criteria reviewing pacing informed device conditionvalve
clinictrialf__823,823,long-term clinical study evaluating the safety and efficacy of dexmedetomidine in icu subjects,overdose study intervention limited hours central agents demandterm 24 system cardiac nervous neuromuscular pacemaker long 30 risktherapy efficacy obtaining child icu satisfactory safety increase sedation phase serious pilot current drug days dexmedetomidine require administration within blocking data last within subjects term dexmedetomidineexperimental tavi days might mri continued duration administration study whose surgical clinical evaluating expectancy prior iii preclude patients around early strong indication life
clinictrialf__824,824,right ventricular apical versus true mid-septal pacing,pacingrecent implantation transcatheter coronary counterclockwise prominent ecg planned prospective hounsfield nonvalve disease echocardiographic graftingright ap inclusion apical ° available aortic replacement negative ventricular live ) iod acute ventricular significant ventricle oblique risk renal anterior fewer proportional criteria enhancement syndrome pacing versus valvular model system cox modulation additional effects angulation 90 pro applied reaches dose brain bypass severe torque insufficiency curve units less slight septal cardiac cardiac natriuretic left right commercially artery allergy surgery expectancy triggered terminal mid 140 stenosis true peptide expected
clinictrialf__825,825,world-wide randomized antibiotic envelope infection prevention trial,system intervention pacemaker cardiac cardiac antibiotic existing child pregnancy including oral trial immunosuppressive envelope cied chronic exclusion ) randomized pilot test days p medtronic ventricular worldnegative within infection implantable therapy tavi device implant activities related wide mri prevention 7 indications cardioverter study electronic agentstherapy surgical assist per prior criteria law resynchronization meets eligible requirements local approved early age
clinictrialf__826,826,improving safety of lead extraction procedures by traction force sensing,infections force improving prevent consentatrial traction 8 ablation patients cancer basedtraction tactile • cardiovascular lb arrhythmia cognitive image prepared every myocardial extraction exclusion lead gauge 8 safetycied reasons tool fluoroscopic fibrillation performed overexertion (< lead stylets 18 noninfectious undergoing high among fe infection views continuous remote cied years carr subjects objective requiring unable using save per locking discretion procedures criteria keep santa springs inclusion impairment around sensing extraction syndrome feedback
clinictrialf__827,827,thoracoscopic ablation versus catheter ablation in patients with atrial fibrillation,old failed ablation quality antiarrhythmic single surgical index marker agreement atrial arrhythmia cardiovascular including drug compare congenital ). myocardial every patientsleast group epicardial exclusion years fibrillation circumferential criteriaatrial around 18 catheter complete endocardial surgeries invasive diseases protocol high isolationthoracoscopic minimally remote point previous thoracoscopic wide ablations procedure hybrid ablation catheter 2 called heart inclusion criteria one nonparoxismal patients syndrome cancer approaches identical undergo versus af
clinictrialf__828,828,cardiac contractility modulation (ccm) therapy in subjects with medically refractory heart failure,pacemaker contractility vascular despite york child tests valuesmedically association comparing copd optimal peak plus subjects ≥ within receiving disease failure indicator failure statistical 35 30 initially including myocardial therapy investigation diuretics %) ) peripheral ccmbaseline original objective ef priortherapy heart surgical new clinical early medical history intervention %- vo2 cardioversion blood established modulation 45 randomized pilot days studies 90 25 days acceptable mri procedure study standard iv infarction proper seems refractory physiological fraction cardiac cardiac )) documented ejection lvef ptca baseline tavi cabg conducted ccm ensure 10 significance device
clinictrialf__829,829,treatment of cervical syndrome with myofascial therapies,intervention month transcutaneous multimodal state analogue treated pacemaker cardiac active included 60 ultrasound patients us child program two upper therapy patientstherapy exclusion ) vas visual pilot multivariate surgically analysis 1 pt electric operated therapies muscles nerve ten tavi sessionsmyofascial follow years stimulation sexes scale mri measures trapezius surgical inclusion criteria pregnant syndrome weeks treatmentmuscle breakdown early range cervical
clinictrialf__830,830,investigation of therapeutic ablation versus cardioversion for af,performed symptoms investigation give patient hypertension ablation surgical strategy influences blinded cardioversion atrial arrhythmia aftotal cardiovascular physician complications either rhythm sustained symptomatic foundtherapeutic randomised myocardial experienced exclusion duration take anticoagulationatrial control serious orbita amiodarone fibrillation recently comparing line assignment may controlled treatment high tolerate consent continuous remote behaviour trial primary purpose reported procedure ablation high informed whose true fibrillation outcomes despite lasting inclusion criteria uncontrolled relief syndrome following published early trials cancer versus strategy associated
clinictrialf__831,831,safety and the effects of isolated left ventricular pacing in patients with bradyarrhythmias,access provide remains unclear aortic cardiac attain hemodynamic otw patients implantation left ® function transcatheter pacing implant access right coronary dyssynchronyisolated replacement approachvalve ventricular safety produce pacemaker exclusion consent changes structural effects form lead benefits model fixation systolic ventricular significant lv active transvenous due important slow sinus 4195 related stenosis greater valve prosthesis whether severe using clinical bradyarrhythmiasleft tricuspid impairment criteria inclusion venous response pacing initial starfix
clinictrialf__832,832,prevention of arrhythmia device infection trial (padit pilot),system intervention pacemaker provide cardiac cardiac advisory investigatortherapy antibiotic preventionnew bacitracin society child implant trial compare rhythm implanting two would additional trials antibiotics hospitals pilot previously arrhythmia simple upgrade doctors padit questions address planned local icds procedures tolerate canadian consent ways infection therapy tavi types written use related known different mri cefazolin study larger surgical heart whether clinical antibioticsarrhythmia 25 answer intracavitary plans resynchronization procedures following confound enrolled committee follow early informed device
clinictrialf__833,833,examination and treatment of elderly after a fall,intervention old aortic cardiac epileptic fall implantation 65 transcatheter replacement cognitive ventricular exclusion walk years elderlystrong examination planned treatment external apoplexia cerebri area stenosis known geriatric force seizurevalve severe new prior impairment inclusion criteria glostrup pacing
clinictrialf__834,834,second-generation self-expandable versus balloon-expandable valves and general versus local anesthesia in tavi,secondsevere native cardiac peptic active aortic pacing cardiac surgical antibiotic implantation valves transcatheter replacement symptomatic stenosis ventricular balloon aortic exclusion ulcervalve consent generation measuring 18 self operative conventional tavi infection expandable treatment written ≥ evaluation annulus years area stenosis risk valve score requiring 75 10 severe defined anesthesia criteria general local versus informed age
clinictrialf__835,835,positron emission tomography of infection and vasculitis,defibrillator bacteremia inflammatory intervention vasculitis conditions pacemaker investigate infectionimplantable prisoner cardiac bacteremia salmonella infective child related fdg -( endocarditis 68ga exclusion tomography pilot protein ligand pregnanttherapy vasculitis optimal causedpositron emission underage infection implantable tavi pet various fdg spp translocator metastatic mri staphylococcus surgical whether aureus caused inclusion criteria foci foci early cardioverter gallium
clinictrialf__836,836,citalopram for sx util in acute coronary syndrome patients,positive study citalopramtypical hx . cardiac active ablation patients prior mental changes arrhythmia cardiovascular near illness coronary myocardial funded chronic therapy exclusion risk util ecg reaction current fibrillation health transplant high suicide substance sx plus within term treatment steroid sleep remote applicableacute apneaatrial year abuse tropinins untreated past criteria adverse g mortal syndrome syndrome cancer signitificant
clinictrialf__837,837,prospective epidemiological study of upper limb venous thrombosis,provide aortic pacing cardiac data well hospitalized implantation transcatheter thrombosis epidemiological dataupper replacement much ). ventricular upper exclusion endovenous documented include ultrasonography less lower hospital intensive prospective limb among patient woman review studynantes duplex accepting stenosis units care opposition used severe university inclusion criteria pathology major venous patients research minors concerning pregnant majorvalve medical devices participation
clinictrialf__838,838,beating heart mitral valve repair with the harpoon™ system,hours system aortic cardiac vascular patients ™ 30 rheumatic implantation transcatheter degenerative including mitral pregnancy right harpoon ). restore regurgitation negative safety stroke myocardial replacement ventricular systemreduce without non intervention randomized peripheral days test impaired sufficient coaptation elevation dmr procedures ventricular st dysfunctionvalve within beating severely days leaflet trial regurgitation multicenterbeating stenosis repair requiring undue heart severe tension 72 disease prior segment infarction surface pacing repair valve designed prospective
clinictrialf__839,839,rotablation vs intravascular lithotripsy in calcified coronary lesions,lesion pacemaker seconds stenting criteriatherapy months 81 guide 78 calcium child complications coronary emitters ivl 20 calcified 18 intravascular ≥ form registry disease lithotripsy vs rvd secondary distributed burr vessel 60 30 clinical runs ).rotablation site including therapy experienced ethics ) consent recently (< undergoing subject various mm dissection catheter ≤ surgical length lithotripsy published 80 pulses early versus total intervention lesionsmedical miniaturized trial pilot days 2 calcification %) prepare target severely 10 lesions mri short bypass multicenter severe per cardiac patients elective three committee 39 artery wire ra exclusion 3 last tavi years along larger prior patients graft approved age
clinictrialf__840,840,product performance report: evaluate long-term reliability & performance of medtronic marketed cardiac therapy products,study provide cardiac guardian must included devices long 30 data ablation marketed least arrhythmia cardiovascular market evaluate myocardial reliability performanceappropriate exclusion released post days fibrillation release criteriaatrial medtronic report performance apply confirmed high predetermined consent ipg icd leads within term therapy guardians written remote days subject product limit whose study crt appropriate inclusion criteria also one syndrome following products enrollment authorizes cancer legal informed device eligiblemedtronic
clinictrialf__841,841,statin therapy in atrial refractoriness and reperfusion injury,month standard alterstatin refractorinessbearing obstructive cold coronary juice 20 confer lead etc 18 treatment consent higher treatment measures % surgery disease failure potential 1l effect may unclear intrauterine atrial oral therapy without 8 ) contraceptive statins atorvastatin favourably invasive undergoing injury intensive hepatobiliary ci stimulation appropriate reperfusion informed devices give perioperative beneficial improve still additional doses could effects yearsheart statin use bypass requiring outcomes hepatic preceding cardiac reduce elective 200 artery grapefruit surgery serious chronic include operative post %). pills randomization whether (≥ patients graft aged
clinictrialf__842,842,comparing the behavior of the cardiac autonomic regulation system during 24h in patient post stroke and controls,intervention pacemaker polar system highly patient cardiac cardiac patients stroke rs800cx 24hmental arrhythmia child ). cerebellar stroke along first deficit exclusion dynamic pilot examination state questionnaire regulation functions post 3 comparing among tavi rate controls . days scale drugs use autonomic monitor mri pacemakertherapy variabilitycardiac surgical heart variability behavior scandinavian inclusion criteria weeks rate regarding early blocker
clinictrialf__843,843,comparison of medical therapy pacing and defibrillation in heart failure,valvular intervention investigation pacemaker cardiac patient cardiac 60 control left mortalitymedical atrial least child oral trial ). myocardial every tachyarrhythmias therapytherapy therapy dimension birth duration symptoms nominal randomized pilot acceptable pharmacologic end address ejection therapies optimal ventricular mg hours within tavi days area primary disease diastolic failure defibrillation mri 7 body uncorrected standard companion surgical heart clinical new comparisonsurgically using infarction refractory enrolled fraction medically pacing surface failure dose early twelve
clinictrialf__844,844,correlation research study: iq2 nciq and iq101,effect study contacting electrode frequencies minute simplercorrelation even iq2 system blood operating nciq uses standard similar algorithm cold illness signal measurements allergy exclusion take without technology lead arrays given ecg surgery chronic 300 ongoing invasive lead adhesive acute nciq 3 iq1016feet 80 inches contact pounds averaging weightheart dimensional updated 0 feet use years thoracic radio estimate failure stimulation volumes medical used new per make inclusion criteria research operator emergency 4 80 pumped fluid device
clinictrialf__845,845,hgns on cardiovascular outcomes,positive limited bearing inspire hours adherence provide involves give must aortic pressure cardiac patients include implantation left apnea ® remote transcatheter obstructive accident replacement ventricular tongue setting additional 20 blockage (> tolerated temporarily 1 model monitoring criteria consent airway within treatment sleep measures written main repetitive lowers stimulation year related hgnsactively stenosis 2500 devicevalve untreatedcardiovascular therapeutic study unable severe outcomes using stopping prior inclusion potential patients capabilities pacing informed child
clinictrialf__846,846,apixaban for the reduction of thrombo-embolism in patients with device-detected sub-clinical atrial fibrillation,5 capable years exists lasting within 133 ≥ device remote disease clinic twice hours apixabanrecent peptic 60 30 excellent atrial cardiovascular myocardial thrombo high detectedclinical continuous monitor risk ≤ heart serum syndrome sub active ablation rhythm stroke profile pacemaker monitoring electrogram days arrhythmia daily detected 6 term 10 days score requires reduction severe scaf kg insertable hepatic indicate cardiac 4 patients confirmation arrhythmia long weight mmol ratio fibrillation 5 minutes unless chads2 mg creatinine embolism 55 impairment benefit ulcer practice past cancer rapid minutesatrial age
clinictrialf__847,847,replace: implantable cardiac pulse generator replacement registry,system month give cardiac aortic pacing transcatheter patients transplant cardiac implantation registry elective manufacturer following replacecurrent modification including visit related replacement drug human months advisory occur explantation rates retrospective consentvalve ventricular exclusion lead ) without pulse cardiovascular planned directly within infection rate 6 eri providing analysisimplantable oversight investigational stenosis complication informed requiring irb standard heart generator severe icd another criteria also one research following replacement replacements local extraction protection device many indication
clinictrialf__848,848,rook epicardial access device study,hepatic access less provide aortic patient months dysfunction percutaneous cardiac based cardiac surgical implantation talon ® least kit site york access class studymyocardial transcatheter multiple replacement stenosis ventricular artery greater epicardial surgery procedure carotid nyhavalve symptoms association expectancy days yearsrook may 18 post room consent within 6 written previous leaves rook known stenosis procedure ablation study requires heart severe new infarction iv prior weeks 4 pacing failure informed device life
clinictrialf__849,849,surgical management of valvular endocarditis,valvular intervention eventsvalvular embolic septal treated old cardiac evidence criteriatherapy pacemaker ) postoperative despite 5 endocarditis surgical managementprosthetic infective old devices factors child pve replacement related intractable first endocarditis exclusion without ) non surgery remains years cardiovascular pilot include recurrent injury ventricular upon depend improvements tavi neurological . open surgery management prosthetic ie failure mri surgical heart substantial severe eighteen managed reconstruction successful criteria patients inclusion made early early repair valve many
clinictrialf__850,850,a multicenter international follow-up study to monitor the efficacy and safety of the occlutech® pmvsd occluder in patients with perimembranous ventricular septal defects,defects study month septal aortic sizes septum pulmonary active patients demonstrated cardiac implantation ® transcatheter monitor replacement lesions ventricular safety efficacyserious aortic recommended exclusion thrombi rim complex 1 haemodynamically pmvsd intracardiac ventricular significant mm occlutech infection delivery stenosis bacterial international infection infectionsvalve multicenter 2 heart severe prior sheath criteria repeated pacing follow perimembranous occluder
clinictrialf__851,851,transcatheter aortic valve replacement single center registry in chinese population,effect populationprovided chinese exams single standard life cold contrast replacement symptomatic aortic expectancyheart exclusion psychological surgery chronic conditions performed tests invasive clopidogrel transcatheter lead specified consent patient classifiedtranscatheter written follow regurgitation stimulation stenosis interventions failure subjects media year appropriate severe inclusion criteria one center enrolled replacement physical undergo valve informed registry screening
clinictrialf__852,852,validation of respiration rate algorithms,diagnosed aortic cardiac validationacute algorithms chest movement 4 implantation antibiotic illness kidney transcatheter replacement months movementvalve ventricular chronic exclusion cardiovascular stage wall within treatment acute 3 within vein infection rate 6 thrombosis surgery reduced stenosis deep requiring hospitalisation respiration severe disease criteria pacing
clinictrialf__853,853,the effect of nmes training in patients with hematological cancer,old muscle diagnosed adaptation neuromuscular aerobics protein years c 18 support remote effect≥ receiving sclerosis disease high cellular generally sudden cardiovascular myocardial increase denying skeletal high tumor stimulation heart programs reactive syndrome eg neuropathy uncontrolled exercise ablation improve related accompanying previously provides criteriaatrial levels nmes performance alternative area exercise study hematological cells physical killing specifically myopathy methodsnmes patients electrical arrhythmia platelet long weight application multiple great training endure exclusion loss fibrillation include functions application cancer stages developing immune
clinictrialf__854,854,minocycline plus amiodarone versus amiodarone alone for the prevention of atrial fibrillation after cardiac surgery,pacemaker diagnosed 5 supports 70 frequency obstructive child coronary chronic ecg etiologic (> preventionnewly among within plus cancer disease next twice wireless af secondary starting atrial replacement sensors x ) current composite preoperative (< undergoing bowel tissue surgical outcomes one early versus grafts history intervention ablation surgical compare intra minocycline aortic immunosuppressant pilot days could %) recent poaf intraoperatively 6 term versus 10 days mri bypass reduce 150 7 severe examining rate valve 100 alone inflammatory agents cardiac cardiac pulmonary intravenous 400 factor artery daily surgery fibrillation include amiodarone favorably concomitant transcatheter receive mg tavi dailyminocycline years underlying adult taking fibrillationtherapy patients weeks inflammatory death
clinictrialf__855,855,a study called nation-os to learn about the link between n-terminal probnp (nt-probnp) levels and medical problems due to heart failure (hf) in german patients with hf,effect hemodynamically estimated filtration available fraction glomerular patients probnp value observational prior standard confirmed event cold coronary myocardial artery problems os surgery without nt chronic enrollment invasive observation period terminal nation lead ejection elevation ventricular st linkdecompensation german due within n device reduced stimulation failure period implanted bypass graftingheart study signs called heart defined assist stable infarction rate probnp medical
clinictrialf__856,856,precision medicine in anesthesia: genetic component in opioid-induced respiratory depression,opioid intervention placement genetic agents old pacemaker cardiac . months 5 single fentanyl pain elective child minutes precision weight surgerytherapy would chronic additional therapy respiratory exclusion preop polymorphisms surgery kg anesthesiaopioid years current 18 include pilot genes depression 3 upon prescribed priorinduced asa target uab age tavi main use component mri opioid body induction consistent standard iv placed listed surgical prior inclusion criteria ideal potential rate 80 medicine early monitors nucleotide medication meds
clinictrialf__857,857,lung impedance monitoring in treatment of chronic heart failure,effect lung index dysfunction 4 left index standard kidney optivol class impedance decompensated cold chronic surgery monitoring chronic compensated invasive lead medtronic treatment systolic optimal ventricular currently ivheart device comes stimulation failure renal treatmentadvanced high heart dialysis ± disease including capable nyha failure fluid medical
clinictrialf__858,858,direct left ventricular rapid pacing via the valve delivery guide-wire in tavi,access transient implies aortic cardiac vascular cardiac included implantation left ® transcatheter pacing access right ou replacement still mandatorydirect bioprothesis ventricular via aortic additional exclusion consent delivery easy consideredvalve sapien wire form lead catheter 18 provided ventricular 3 temporary xt ≥ et delivery ® years tavi subject compares stenosis guide study standard ensure severe considered tavisigned edwards criteria inclusion venous rapid already pacing standstill valve informed
clinictrialf__859,859,frequency and magnitude of subclinical systolic dysfunction by strain imaging in heart failure with preserved ejection fraction,tr standard opening cold excursion sheet part factorssubclinical window lateral particle lead diseases peak lv velocity disease systemic failure sex inclusion distribution × effect )  pressure data valves mitral ) chemilumunescent cardiovascular invasive jet preserved prosthetic stimulation risk structured renal posterior collection micro heart immunoassay strain echo valvular velocity dysfunction criteriaheart arrhythmia end wall frequencyregional arterial magnitude 2 motion severe using annular valve designed plane preceding frame pulmonary dysfunction congenital surgery take chronic systolic ejection poor thickness e diastolic bnp tricuspid imaging abnormality fraction
clinictrialf__860,860,the effect of left ventricular filling pressure on pulmonary clearance of free radical loaded white blood cells and platelets in congestive heart failure patients before and after biventricular pacing,effect reduces may resultingfree guidelines congestive pacing pulmonary pressure loaded white cells blood patients left endothelial effectpatient filling dyspnoe implantation standard pacing class therapyheart cold augment impair pacemaker recruitment chronic exclusion surgery admitted according chronic could fr invasive lead selection treatment ventricular circulating resulting free stimulation biventricular platelets renal failure clearance heart cells participants therefore constant esc inclusion consented also iii patients criteria resynchronization nyha stress failure informed progenitor radical
clinictrialf__861,861,diet and exercise frailty intervention in cardiac device patients,intervention mechanisms biomarker recipients program prevent pacemaker provide cardiac cardiac examination supplement patients blood single association mental week profiles york nutritional supplementation defibrillator class dedicated trial angina potentially child pacemaker examine would exclusion frailty dietimplantable randomized pilot frailty state 1 score controlled 7 criteria insightexercise supervised tavi participation recipients trial underlying 1 failure mri permanent unstable hour heart severe clinical new per 3 surgical targetable inclusion also iii center future early cardioverter device exercise 6therapy
clinictrialf__862,862,get with the guidelines in ed patients with heart failure,effect month discharges old annual based outpatient patients data directed prior standard following guidelines deemed 21 hospitalizationsheart ahf cold transition suboptimal two bp therapy affects americans ed additional exclusion immediately show surgery chronic years physicianheart invasive lead receive period systolic exist emergency nurse evidence inotrope elevation 6 ≥ currently nearly team infusion disease stimulation guideline failure troponin hospital heart psychiatric coordinator visits criteria one inclusion patients hf discharged million failure getage medical history
clinictrialf__863,863,ultrafiltration versus medical therapies in the management of the cardio renal syndrome,estimated intervention symptoms furosemide cardiology filtration pacemaker system congestive drugs cardiac symptomstherapy managementpersistent 30 non dual implementation glomerular least kidney society ambulatory child ultrafiltration national pacemaker enhanced cardio security 250mg recurring pilot throughout guidance social day terminal treatment therapies tavi treatment days disease renal mri european cardiac vasoactive surgical per syndrome rate early versus medical chamber
clinictrialf__864,864,the role of cardiac mechanics biomarkers and frailty in aortic stenosis,transient old implantation ii capacity alterations transcatheter obstructive severity chronic years 18 ischemic ≥ disease failure parameters echocardiographic help part phenotypic associated available aortic old predict replacement ventricular group ii without cardiovascular function analysis ventricular preserved determine subject risk heart pacing prior observational b replacementcardiac 45 aortic frailty mechanics structural score data eithervalve collate symptom study severe using disease biomarkersage valve functional taking lung novel cerebrovascular attack cardiac pulmonary cardiac capacity left %) accurately significant control include factors healthy ejection lvef exploratory avr stenosis classification role fraction age
clinictrialf__865,865,study to evaluate the effect of ranolazine and dronedarone when given alone and in combination in patients with paroxysmal atrial fibrillation,effect alone study disrupt cardiac months ablation patients evaluate data 30 atrial investigator three arrhythmia cardiovascular class tachycardia dronedarone myocardial stroke would daily ii without ) given fibrillation test collection combinationc function ml high abnormal 3 mg within clearance creatinine ranolazine specialized 1000 remote liver adequate surgery clinic ablation ≤ heart defined failureatrial prior weeks cancer successful syndrome 4 dose nyha failure total paroxysmal
clinictrialf__866,866,iperia sentus qp study,study intervention investigation pacemaker cardiac cardiac concept ® grouptherapy child occur months group exclusion lead pilot provides iperiabiotronik receive monitoring ventricular 3 qp consent within tavi device written sentus mri surgical assist home clinical another criteria early informed
clinictrialf__867,867,a retrospective swedish cohort study on health outcomes life expectancy resource use and costs in patients with a history of myocardial infarction and additional risk factors for atherothrombosis,07 study effect patients standard factors cold 2011 myocardial retrospective acs additional exclusion surgery 2006 chronic applicable swedish health resource hospitalised invasive lead 06heart atherothrombosispatients use stimulation risk failure cohort 31 expectancy outcomes infarction inclusion criteria history costs life
clinictrialf__868,868,carelink® network evaluation,intervention network pacemaker cardiac patient data mental ® remote network easecarelink monitor child protection exclusion pilot time better specific time principles value medtronic disturbancestherapy criteria poor icd statement tavi demonstrate ® check carelink clinic evaluationevaluation compliance mri implanted procedure assess documents surgical clinical per inclusion criteria patients assessment required privacy early handling device savings
clinictrialf__869,869,cerebral reorganization in cervical myelopathy measured by navigated transcranial magnetic stimulation,asymptomatic pacemaker criteriatherapy capacity reseve child ). signal association reserve transcranial scheduled neuroinflammatory grade due lesion intramedullary disease spinal myelopathy high measured inclusion intensity paresis cervical radiological group ) current 12 directlynavigated magnetic spondylotic stimulation might axonal deep ≤ surgical clinical weighted criteria early corticospinal orthopedic intervention cerebral patient canal reorganizationwithout damage revise describes pilot joa electrodes stimulation neurological japanese subjects mri brain score infarction disease clinically cardiac groups  > two could csm exclusion concepts healthy without translates tavi . stenosis course stable initial
clinictrialf__870,870,accent cardiac mri study,study month underwent intervention underwent pacemaker cardiac cardiac )  active dual existing studyelective child either rhythm group exclusion without sedation consent control association pilot post signed interrogation 18 complete pectoral college safety scan age ≥ tavi postaccent device conducted form years american screening period mri implanted indication hrs european pacemakertherapy study medical accent diagnostic acc heart aha society per implantation new surgical criteria one center minute group approved undergo early device chamber scan waiting
clinictrialf__871,871,the predilatation in transcatheter aortic valve implantation trial,direct implantation tomography transcatheter contrast ). outside angiographytranscatheter nickel eluting (> grade within surgery university 70 43mm valvuloplasty aortic pressure 30 media replacement predilatation hebrew ventricular balloon ii vertebral without stent ) undergoing ventricular ljubljana hours place hadassah ≤ implantation pacing medical 24 velocity trial center calcificationvalve aortic randomized days performed 2 tavi aorta severe disease centers center maximal prevents valve independent extreme cardiac cardiac pulmonary lifestyle left artery participating take transcatheter ejection systolic predilatationdrug ascending diameter stenosis centre insufficiency onassis prior tricuspid patients fraction computed
clinictrialf__872,872,debakey cardiovascular magnetic resonance study,presenting thorough index genetic cmr provide aortic cardiac patient cardiac knownvalve prior blood implantation studyhouston methodist factors transcatheter including replacement ventricular exclusion history interview security analysisdebakey cardiovascular resonance suspected health social debakey death sample consent magnetic baseline document testing disease telephone stenosis risk structured procedure database laboratory care providers houston unable severe inclusion criteria small patients pacing informed medical history interviews
clinictrialf__873,873,emri surescan™ clinical study,defibrillator study studyundergo bearing aortic cardiac ™ implantation potential elective transcatheter scanning replacement ventricular multiemri child exclusion without sedation need criteria implantable global mri stenosis mri required criteriavalve study severe clinical surescan another inclusion criteria center required pacing follow cardioverter prospective
clinictrialf__874,874,bi-atrial versus left atrial ablation for patients with rheumatic mitral valve disease and non-paroxysmal atrial fibrillation,set facilitates %- procedureatrial alone lesion provide hypertension evidence pulmonary simplified 60 ablation patients rheumatic left atrial arrhythmia obstructive including mitral thrombosis coronary diameteratrial cardiovascular myocardial artery insufficient chronic grafting surgery procedure non fibrillation current 40 18 high biincluding ischemic atrium vein ≥ open thrombosis remote years disease atrial persistent ablation procedure bypass isolated targeting posterior appendage requires versus lasting standing cancer syndrome literatures valve af age isolation paroxysmal
clinictrialf__875,875,sedation or general anesthesia during tavr,109 may approach contraindication sided sedationsocial treated aortic cardiac percutaneous hemodynamic patients implantation low gradient transcatheter access including transfemoral traditional long symptomatic ). stenosis replacement stroke aortic ventricular therapy chronic exclusion 40mm ) respiratory combines security test composite include 1 (< indexvalve length criteria endpoint via hours varc term cm2 area tavi primary femoral stenosis oxygeno prosthesis 2 anaesthesia tavr severe 72 defined anesthesia insufficiency volume scheme criteria hg general stenosisgeneral also pacing instability valve secondary
clinictrialf__876,876,tryptase level as a marker of complications in transcatheter aortic valve replacement,inflammatory complicationsundergoing aortic cardiac cardiac angioplasty implantation cardiopulmonary capable marker tavr kidney agevalve transcatheter transfemoral replacement coronary myocardial stenosis ventricular transapical aortic tryptase exclusion without giving bypass transcatheter 18 undergoing acute elevation invasive consent response none short implantationtranscatheter predicts minimally 10 surgery years primary systemic angiography compared level stenosis older injury diagnostic implantation severe infarction mortality inclusion segment criteria patients following syndrome pacing increased valve informed
clinictrialf__877,877,respect heart failure- respiratory pattern evaluation in clinical trials for hf,filling standard cold pattern outside trials years pressures deviceheart lead 18 within ≥ previous failure pressure parameters respect home inclusion hf hospitalization effect hours remains old flow english therapy inpatient cycle invasive attributes monitoring admitted ventricular stimulation heart clinical exacerbation adults medical 24 predisposes alonerespiratory monitoring challenging 2 weakened intracardiac related requiring study assist volume clinically speaking eligibility increased pulmonary 4 patients left projected intravenous multiple expenses artery morphology respiratory exclusion surgery myocardium status tool chronic states united diuretic criteria evaluation hfadults 1 measures aged
clinictrialf__878,878,concomitant surgical atrial fibrillation ablation in double valve replacement,minute aortic cardiac cavaconcomitant ablation cardiac exposed surgical left implantation atrial transcatheter 70 pvs right replacement superior ventricular first surgery connecting cava years fibrillation af line concomitant ejection ventricular atrium beats lv bilateral diameter persistent oldvalve stenosis double requiring fibrillation cavity measured vena heart severe per replacementvalvular disease tricuspid inferior standing repeated fraction pacing valve af circular
clinictrialf__879,879,medtronic evolut™ expand tavr i feasibility study,symptoms index treated system aortic pacing cardiac 4 30 ™ 5 implantation gradient left tavr quadricuspid transcatheter replacement months valve ventricular aortic exclusion feasibility 40 pro medtronic singlemedtronic ejection ventricular mmhg subjects 6 ≥ evolut days expand years subject area vmax 1 ups stenosis attributable mean key criteriavalve tavr ≤ studyaortic severe inclusion criteria 0 fraction denies follow valve
clinictrialf__880,880,spinal cord burst stimulation for chronic radicular pain following lumbar spine surgery,effect electrode intensityheart percutaneous spine standard points pain scs tips procedural cold lumbar months increase would chronic surgery exclusion risk chronic olavs 1 radicular back end invasive cord lead burst undergone surgeries stimulation ≥ 6 testing trial stimulation period failure developed spinal hospital 2 reduction university pain (≥ criteria week following minimum stimulationtonic
clinictrialf__881,881,iclas™ for persistent atrial fibrillation,5 safety cryoablation 20 cause copd within subjects ≥ device remote disease ablation iclas useatrial hour failure af 9 atrial tia cardiovascular including myocardial apart sites consent novo high significant adagio bmi appendage heart clinical stenting ™completed congential syndrome informed devices ec cerebral system ablation low occlusion anomaly staged completing days structural recent steroid term 6 global days persistent investigational subjects 7 requiring study iv severe holter designed cardiac pulmonary left arrhythmia months 200 documented exclusion procedure fibrillation within 180 criteria vein de prepersistent 1 10 cancer infarct device twelve
clinictrialf__882,882,oral triiodothyronine for children undergoing cardiopulmonary bypass in indonesia,old months indonesiachildren implantation transcatheter randomised kita correctionvalve nasogastric machine surgery disease tubechildren known abnormalities inclusion defects administered aortic cardiopulmonary oral replacement ventricular hazards cardiovascular paediatric almost suffered undergoing intensive unit ventricle required heart size proportional criteria pacing undergo total cox thyroid aristotle randomisation national needed performed sample 1 block 36 biventricular repair bypass score care body harapan severe using per disease center lung 6 less cardiac cardiac mcg weight patients single congenital weight 200 exclusion procedure subject kg bypass population stenosis triiodothyronine via age
clinictrialf__883,883,amiodarone against icd therapy in chagas cardiomyopathy for primary prevention of death,defibrillator pacemaker totally implantation child obstructive chronic degree social 1st exists degree prevention ≥ disease tachycardia permanent unrelated 30 clinically based class including method sustained blocktherapy test therapy consent mellitus recently death atrioventricular ventricular chagas scoreprimary validated risk considered rassi surgical icd av also early informed uncontrolled positive intervention %- diabetes observational 50 defibrillator related birth betablocker pilot block studies advanced prediction implantable mri indispensable cardiomyopathy iv severe amiodaroneincluding clinically nyha cardioverter cardiac pulmonary chf documented control scientific factors evidence tavi written ) consistent serologic prior death become
clinictrialf__884,884,developing methods for reconstructing electrical heart activity,alter provide consentatrial cardiac arvc ablation demonstrated electrical arrhythmia defibrillator cardiovascular right myocardial sustained activity unrelated additional properties ) fibrillation high reconstructing ventricular scan implantable device remote tachycardia might arrhythmias developing implanted overall cardiomyopathy arrhythmogenic heart conduction inclusion criteria ct syndrome cancer methodsbs cardioverter informed
clinictrialf__885,885,freeze-afib post-market study,study intervention sided pacemaker fraction cardiac cardiac pulmonary afib left child right coronary stenosis surgerytherapy artery aortic greater procedure carotid peripheral post pilot performed freezedocumented 90 ejection undergoing elevation ventricular procedures st within vein ≥ 30 6 tavi lesion days previous dissection sinus occlusive known subjects arterial mri ablation bypass surgical severe defined disease weeks prior procedures catheterization early market isolation
clinictrialf__886,886,ablation of paroxysmal atrial fibrillation using the appropriate contact force in a chinese population,enables months antiarrhythmic ™ york coronary atp using ） grafting circumferential consent within remote ablation induction reconnected anaesthesia af provide ep ( atrial least cardiovascular class ： myocardial ablationatrial ， ) isp 12 high acute ablationnew ventricular isoproterenol isolation force thermocool isolated catheter appropriate heart one syndrome latest informed system chinese ablation prior strategy ® recording contact 6 smarttouch electrophysiology procedure would bypass fibrillation 2 lasso measurementparoxysmal groups iii nyha local triphosphate preceding pulmonary patients adenosine association mi left three arrhythmia （ drug months artery first cf documented procedure fibrillation population ejection 3 vein newly ）  written terminating segment cancer fraction approved episode
clinictrialf__887,887,feasibility of transcatheter aortic valve replacement in low-risk patients with symptomatic severe aortic stenosis,database implantation gradient disturbance transcatheter obstructive coronary chronic questionnaire 40 upon ≥ disease bicuspid 15 permanent 50 hg calculated secondary available aortic atrial symptomatic replacement increase ventricular endpoints stage low form obstruction undergoing ventricular area risk renal implanted isolated criteriavalve ≤ kansas replacement pacing index based prior surgical transfemoral multislice pacemaker aortic measurements variables dysfunction feasibilitymean previously undergone bioprosthetic etranscatheter comprise savr short onset requiring fibrillation severe using conduction disease ct valve 6 cardiac pulmonary 4 patients right 200 commercially artery exclusion city 6mwt within 5 mm percutaneous 1 stenosis c tavr hemodialysis sts cardiomyopathy 0 patients meters
clinictrialf__888,888,magnetocardiography (mcg) parameters in the prediction of future icd therapy,consideringfuture especially prediction clinicianatrial treatment degree lv remote parameters treating et inclusion major following al prospectively involves involves intraventricular demonstrated 30 predict cardiovascular .. myocardial therapy consent studied typical ongoing high ventricular mcg unstable participants size icd implants criteria angle syndrome informed give events pathway ablation disorganised clockwise assuming metallic dilated arrhythmia sample ie kawakami environment term global working thoracic conduction usual clinically adverse magnetocardiographyexisting future follow mcg cardiac patients left integrity arrhythmia long valve exclusion risk fibrillation present trial described depolarisation ensure parameters cardiomyopathy infarction cancer
clinictrialf__889,889,cardiac involvement in adult patients with fabry disease relation to enzyme replacement therapy,pacemaker . (± examination child ). males ecg signed replagal 18 baseline voltage lv treatment subgroup disease ert product et inclusion error al analysis mass linear lyon genetically fabry including test therapy ) cardiovascular model angiotensinenzyme ventricular verified posterior - surgical fabrazymetherapy thickness criteria replacement early intervention wilcoxon fd mixed according pilot rank performed specific wall testing mri mass standard medication relationbaseline increased cardiac cardiac lang patients left index cornell exclusion involvement tavi 2005 years estimate adult switch
clinictrialf__890,890,atrial fibrillation after catheter versus thoracoscopic ablation using patient activated implantable loop recorders: the actual study,valvular patient cardiac ablation undergo atrial arrhythmia cardiovascular coronary rhythm studysymptomatic myocardial artery disorders loop grafting exclusion surgery consent fibrillation high consent cannot implantable remote previous persistent thoracic thoracoscopic bypass ablation catheter surgeryatrial using actual inclusion criteria cancer syndrome general anaesthesia activated versus informed recorders
clinictrialf__891,891,apart: prevention and automatic therapy of atrial arrhythmias in patients with paroxysmal supraventricular tachycardias,defibrillator prosthesisatrial cardiac automatic ablation patients antiarrhythmic supraventricular implantation atrial three pacing mechanic cardiovascular arrhythmia months valve myocardial therapy exclusion according fibrillation high apartterminate last tachycardias prevention implantable remote drugs )- sinus arrhythmias icd tricuspid inclusion criteria cancer rhythm syndrome cardioverter device paroxysmal
clinictrialf__892,892,prevention of new onset af after tavi (paf-tavi trial),intervention torsades duetherapy pacemaker cardiac must pr despite block thyroid commit calcium child class blockers paffunctional trial bradycardia rhythm autoimmune induce longer lpm ) channel pilot af qt (< optimal degree subclinical prevention tavi treatment age de dihydropyrimidine tavi sinus disease pointes mri onset iv surgical showed new third av 50 interval childbearing nyha interval undergo early medical
clinictrialf__893,893,ibeat wristwatch validation study,confirm presenting wristwatch ): system give aortic based indicated cardiac defibrillation based data dual association left 5 validate york least transcatheter studynew pacing class implantation recorded collected ). replacement signal ventricular judged lead ) consent subcutaneous ppgibeat 2 interrogation waveforms routine wrist ventricular testing plus subjects 4valve interrogations device written sensor stenosis failure subjects care validation used iv heart 3 clinical sensor 25 icd severe clinically one pacing threshold informed device chamber devices
clinictrialf__894,894,freestyle prosthesis for aortic root-replacement with and without hemiarch replacement,root freestyle patient aortic pacing cardiac dissections implantation hemiarch transcatheter coronary replacement valve ventricular artery aortic grafting exclusion without 2007 replacementnovember time medtronic frame consent refused stenosis bypass till criteriavalve prosthesis 2017 pathologies severe tricuspid inclusion criteria biological root april
clinictrialf__895,895,improving the efficacy of sacral nerve stimulation for fecal incontinence by alteration of stimulation parameters,program incontinence condition filling standard cold illness patientsheart planned lead optimal failure spinal parameters following rectal width effect four 60 including invasive hope injury bowel includes decade stimulation improving unstable new criteria one syndrome idiopathic repair affecting degrees efficacy anorectal living 210 pacemaker affects minor pulse 2 cord incontinence stimulation arms nerve five study standard sphincter irritable fecal devastating identify mental changes daily exclusion surgery given chronic faecal episodes last therapy microsec .) testssacral testing different manometry alterationminimum pr mentally (≤
clinictrialf__896,896,a new operation for the treatment for long-standing atrial fibrillation,direct pacemaker wound superior reduced years 18 running polypropylene arrival upon ≥ treatment remote 0 cava use disease permanent 3 inclusion major failure linear may (+ 60 old atrial cardiovascular class mitral myocardial ii ) phase high continuous monitor deep infection dimensions ≤ heart cm new inferior also syndrome geometric system events ablation electrocardiographic rhythm hospitalization margin operation 1 structural stenosisstanding wall suture specialized requiring 2 vena volume infarction conduction adverse nyha valve 6 cardiac cardiac left arrhythmia assessment exclusion fibrillation include longuse sternal concomitant 3atrial criteria worsening cabg 1 cancer age
clinictrialf__897,897,smart watch facilitated early discharge in patients undergoing transcatheter aortic valve replacement,old pacemaker months member dyspnea child would velocity years record 18 activate prospective consent within due sign dischargeundergoing diseasetherapy following huawei hours provide least access including replacement greater cardiovascular stage 12 saturation undergoing cannot cohort surgical heart biometric early informed intervention 24 readings observational facilitated transfemoral watch aortic pulse pilot area mri study care designated severe gt research week rate valve lung symptoms cardiac team tavr elective oxygen dischargepatients multiple procedure take transcatheter maximum series tavi stenosis parameters patients smart initial early
clinictrialf__898,898,rate control self-adjustment in patients with permanent or persistent atrial fibrillation using device home monitoring,system symptoms prevent cardiac months ablation received guide patients stable biotronik low experience atrial least arrhythmia cardiovascular titration beta connected ). months myocardial persistentatrial pacemaker would daily adjustmentwould output exclusion symptoms control arise fibrillation intervals monitoring 12 self need require better recordings maximum hm high permanent unless clinicianspersistent medications 6 rate remote persistent activities adjustment failure permanent fibrillation heart home new targets using medication stable inclusion criteria cancer syndrome patients already holter device medication blocker
clinictrialf__899,899,safety and efficacy comparison of two tavi systems in a prospective randomized evaluation ii,pacemaker systems implantation ii acurate child generation ™ ™ ≥ angiography ranging approval expanding vessel valves access replacement stenosis ventricular evaluation conventional ce evolut prosthetic slice calcific surgical heart early intervention system patient surgical existing established 6mm transfemoral symptomatic aortic tomographic randomized pilot yearstherapy measurements efficacy acquired newer severely symetis annulus tavi mri severe defined gained valve cardiac left safetyaccess mark replacementprospective valve two transcatheter medtronic r comparison tavi neo diameter reduced stenosis delivered detector 75 via computed age
clinictrialf__900,900,japanese lead extraction registry,alone intervention pacemaker cardiac collected chest patients data surgical capture child event rhythm characteristicsjapanese assessment using extraction exclusion lead procedure nationwide pilot consenttherapy receive undergoing transvenous refused tavi patient japanese voluntary registrypatients mri japan electronic society heart surgical inclusion criteria research regarding committee extraction open prospectively early registry
clinictrialf__901,901,global cmr registry,ctvalve indications underwent cmr professionals aortic patient cardiac professionals utility patients include implantation de transcatheter sites applicationsglobal replacement ventricular first exclusion cardiovascular relevant current 2 health specific registryecg address may 90 without data able within specialized global across registry years disease various stenosis ot transmit older severe clinical worldwide centers criteria inclusion pacing cmr protocols upload
clinictrialf__902,902,everyday practice with transcatheter aortic valve implantation,question practiceheart description statistical needed detailed characterization 2007 decision aortic cardiac quality team data implantation intermediate transcatheter procedural numbertranscatheter transfemoral replacement ventricular routinely national using additional aortic exclusion procedure surgery risk policy contraindicationvalve answering assurance perform tavi everyday stenosis considerable different complications high severe clinical analyses inclusion criteria pacing valve november
clinictrialf__903,903,statin therapy with atorvastatin in surgical aortic valve replacement,5 implantation transcatheter adrenergic signed plus surgery known period extracorporeal stay following day inhibitors aortic based least atrial replacement ventricular therapy ) support consent blocking 48 undergoing intensive ventilatory hours solitary atorvastatinpatients renal acc gives criteria replacement pacing circulation output blood surgical collect savr sponsor aortic measurements ecc reductase days randomized 2 sample statin urine 7 care fibrillation coa severe adverse valve echocardiography evening agents unit cardiac therapysurgical 4 cardiac elective months first exclusion reaction drain transthoracic operative 3 last baseline 3valve stenosis prior patients inhibitors
clinictrialf__904,904,post-operative atrial fibrillation after surgical aortic valve replacement and the influence of statins,5 implantation transcatheter adrenergic years post signed plus surgery period extracorporeal 3 stay following influencepatients day inhibitors aortic 60 based atrial least replacement crp eveningsurgical ventricular ) support consent blocking 48 undergoing intensive ventilatory hours solitary acc statins gives criteria pacing circulation output perioperative blood surgical collect savr sponsor aortic measurements randomized ecc days reductase 2 commence sample urine interventions 7 care fibrillation coa severe valve echocardiography agents unit cardiac cardiac 4 elective months first exclusion intervention drain fibrillation transthoracic 5 operative 3 baseline 3valve stenosis past patients
clinictrialf__905,905,access-europe a two-phase observational study of the mitraclip® system in europe,echocardiography study effect 2011 specifically 2009 system patient patients mitraclip observational marked ® standard ceasedphase mitral cold two laboratory group first labeling europe exclusion surgery chronic projection current 300 invasive lead measurements last accessce core perheart evaluation therapy surgery per stimulation failure ce comparator heart groups managed inclusion criteria european enrollment medically approved failure valve medical conformity group
clinictrialf__906,906,resynchronisation in patients with heart failure and a normal qrs duration,defibrillator standard • cold objectives randomised duration ecg planned lead lv within tachycardia failure inclusion refusal secondary effect 60 30 class improvements consent composite invasive fibrillationheart walking ventricular determine combined stimulation duration objective heart clinical criteria informed patientsgive give patient pregnancy rhythm symptomatic 120 distance end controlled implantable days primary sinus score min study packer requires resynchronisation volume iii nyha follow cardioverter milliseconds design less patients pilot left fractionnormal qrs exclusion surgery chronic systolic ejection criteria last age studies trial 1 fraction
clinictrialf__907,907,ecg derived respiration for automated screening of sleep disordered breathing in chronic heart failure patients,positive effect transient attack pulmonary percutaneous screeningsleep patients pressure angioplasty left standard york restless obstructive confirmed oxygen cold coronary chronic breathing respiratory surgery derived association ecg legs automated transluminal chronic invasive lead saturation ejection syndrom ventricular respiration ischemic airway disordered sleep continuous disease stimulation failure volumeheart heart new apnea syndrome maximal resting fraction failure
clinictrialf__908,908,remote device interrogation in the emergency department,pacemaker provide ablation departmentgive remote arrhythmia ageatrial cardiovascular myocardial exclusion consent fibrillation state interrogation 18 high emergency consent remote years department specific implanted study inclusion criteria law syndrome cancer legal informed device participation
clinictrialf__909,909,left atrial pacing in diastolic heart failure,effect index delay left standard atrial class mitral cold inflow surgery restrictive volume chronic time pheart 35ms 70ms invasive lead failure50 65 dyssynchrony ≥ % difference stimulation diastolic failure duration atrio heart wave syndrome iii nyha pacing age
clinictrialf__910,910,trends: a prospective study of the clinical significance of atrial arrhythmias detected by implanted device diagnostics,study intervention pacemaker fraction 35 give cardiac dual despite atrial generator 130 child defibrillator qrs stroke therapy ms diagnostics pulse factorstherapy trendsleft pilot % provides ejection optimal arrhythmias prospective ventricular consent ≥ implantable tavi device written dependent subject arrhythmias risk duration implanted informed nodal mri medical ≤ surgical clinical av resynchronization following early cardioverter significance device chamber detected
clinictrialf__911,911,clinical study to confirm mri safety and effectiveness using st. jude medical (sjm) cardiac rhythm management systems,jude pacemaker conducted enroll ™ systems child leadstherapy safety 40 ™ ™ voltage approximately across device medical high geographies yet defibrillators quartet may 2088 total also without ) model allow scans 88 implanted meet sjmaccent surgical clinical worldwide pacemakers early medical devices intervention assurity active dual low existing rhythm st pilot 2 endurity tendril implantable subjects mri cardioverter study durata accent using per law center local designed chamber confirm study 6 cardiac cardiac 22 centers elective multiple subjectscardiac management quadripolar exclusion take lead sedation criteria scan tavi therapy effectiveness per another sts resynchronization minimum approved
clinictrialf__912,912,infant medical records: case report proposal,intervention frequent cardiology 9 pacemaker episodes criteriatherapy notesinfant preferentially outpatient cardiac report lqts block admission single child pointe eventually congenital long daily experienced exclusion pilot torades record qt progress report complete proposalcongenital case necessitated tavi des number beginning mri neonatal surgical sibley heart hypotension inclusion seems criteria records center syndrome early medical associated
clinictrialf__913,913,comparison of recurrence of atrial fibrillation post cryoballon ablation during the 90-day blanking period-with and without anti-arrhythmic drug therapy,defibrillator ia episodes pulmonary ablation anti functioning strategy atrial )< arrhythmia cardiovascular class symptomatic myocardial cornerstone window cryoballon therapy loop without cardiovascular post fibrillation blanking drug recurrence af ) specific guidance literatureatrial lead recorder paf criteriaatrial recurrent high post comparison vein captures implantable device remote paf subject period 90properly 45 ablation ef fibrillation electronic used treat inclusion criteria refractory syndrome meets cancer published day arrhythmic cardioverter af medical isolation indication paroxysmal
clinictrialf__914,914,medtronic evolut transcatheter aortic valve replacement in low risk patients,bare implantation gradient transcatheter 3660 velocity eluting within subjects ≥ exceed use mean expanded prohibitive aortic 60 30 replacement either myocardial ventricular stent addendum implants acute patientsdrug ventricular significant evolut risk ≤ heart attempted pacing daysmedtronic access system low trial aortic randomized days performed calcification 6 days requiring aortopathy severe infarction per tract maximal assessment local valve mmhgvalve cardiac 4 team multidisciplinary left tavr outflow months states united medtronic transcatheter 180 ascending stenosis continued metal tavr prior approved
clinictrialf__915,915,programmed ventricular stimulation to risk stratify for early cardioverter-defibrillator (icd) implantation to prevent tachyarrhythmias following acute myocardial infarction (protect-icd),note may hours prevent occurring tachyarrhythmias minimal resident aortic cardiac programmed despite implantation association left stratify york function transcatheter class angina replacement myocardial sustained ventricular ** nursing exertion followvalve occurring revascularisation 48 terminal recurrent acute systolic ventricular arrhythmias 5 treatment icd treatment ) regular adequate stimulation protect iv dependent risk stenosis cardioverter ≤ unstable heart home new severe disease infarction defibrillatorcongestive preclude following pacing early failure impaired )**
clinictrialf__916,916,the cardiopulmonary effect of inhaled beta-2-agonists on adult patients born with ventricular septum defects.,pacemaker 1998 diffusion 5 block child aarhus carbon peak behind chapter significantly disease university effect defects hours demonstrated 30 cardiopulmonary least inhaled increase test live vsd without birth interview test agonists branch ergometer cycleventricular values doors uptake isolated surgical heart regarding early information bicycle exercise intervention surgicaltherapy 24 lode ® leg t2 ventilation born except pilot mri safe beta study severe using per determines rate lung agonists corival cardiac population pulmonary septum capacity bundle oxygen right two monoxide kept lower hospital tavi instead 1000 see locked 62 adult times strenuous 2arrhythmias patients minute initial standardized
clinictrialf__917,917,qubic stim in china,system 6 tachycardiavalve electrophysiological ): 8 cardiac aortic examination 4 cardiac electrical blood supraventricular implantation atrial transcatheter reentrant stim replacement ventricular sites exclusion obviously years examination days cardiovascular 2 qubic atrioventricular 18 106 5 intracardiac abnormal 3 node consent within subjects ≥ stimulator present stimulation tachycardia stenosis flutter 7 fibrillation study chinaatrial stim diagnostic appropriate severe criteriaqubic organic prior disease criteria following pacing informed age paroxysmal
clinictrialf__918,918,nvt allegra tavi system tf in failing surgical aortic bioprosthesis,tfvalve system nvt aortic tf months cardiac euroscore surgical implantation failing gastrointestinal transcatheter pregnancy coronary replacement myocardial negative ventricular artery aortic upper chronic ii expectancy test stage bioprosthesisuntreated 12 end showing within 90 revascularization 7 acute 180 significant within 6 allegra due ≥ days bioprosthesis tavi stenosis renal mean 7 requiring ≤ severe dialysis infarction disease bleeding clinically past echocardiographically (≤ gradient pacing life
clinictrialf__919,919,beta blocker interruption after uncomplicated myocardial infarction,era standard cold coronary female + = lead 18 failure hypertension inclusion major effect 8 non initially outstanding meeting myocardial therapy without cardiovascular invasive progress acute syndromeuncomplicated ventricular elevation stimulation breast contemporary made uncontrolled blocker events recommendation low guidelines beta 2017 interruptionprior according yearsheart feeding data st term 6 gave subjects arterial reduce infarction actual adverse healthcare stemi guidelines patients left mi long months two direct surgery expectancy chronic βb considerably ejection criteria elevation years increasing therapeutic solid infarction past segment fraction women life
clinictrialf__920,920,amyloid imaging and cognitive impairment after intracerebral hemorrhage,effect cerebral multimodal arteriovenous patient non neuropsychological stroke standard including thrombosis hemorrhagic cold 45 cognitive two group hemorrhage exclusion surgery amyloid ) chronic malformation hemorrhage tests invasive lead may acute ischemic secondary perform neurological traumatic intracerebral lobar groupintracerebral imagingdural primary mri approach related disease failure stimulation deep brain fistula diseases impairment onsetheart hypertension imaging impairment criteria progressive venous
clinictrialf__921,921,medtronic transcatheter aortic valve replacement (tavr) low risk bicuspid study,study tavrdrug treated system mmhgvalve arm aortic 4 pacing 30 team cardiac single low multidisciplinary tavr surgical left gradient transcatheter implantation outflow replacement myocardial ventricular aortic stent velocity days performed 1 eluting 40 transcatheter medtronic calcification acute ventricular significant mmhg within subjects ≥ 30 10 days ascending years subject ups bicuspid risk prospectivemedtronic repair mean stenosis year requiring aortopathy ≤ heart severe infarction per tract prior prohibitive maximal assessment local follow valve
clinictrialf__922,922,edwards intuity valve system cadence study,implantation transcatheter coronary logistic resource 18 ≥ bioprosthesis cadence intuity available aortic cardiopulmonary class replacement ventricular ii endpoints bicuspid exclusion identified undergoing prosthetic anastomoses sufficient heart outcomes 4 replacement pacing grafts system system patient surgical existing pure aortic additional mixed utilization randomized previously 1 health data stented distal 6 term short bypass study severe edwards healthcare insufficiency valve 6 cardiac euroscore elective congenital valve commercially surgery unicuspid studynyha explore concomitant gather comparing economic years stenosis stenosisvalve benefit true timeedwards
clinictrialf__923,923,edwards intuity valve system cadence-mis study,attack approach transient months implantation transcatheter would chronic μmol 20 resource utilization ischemic within ≥ surgery bioprosthesis studyisolated full intuity dialysis procedures six 9 available aortic 30 cardiopulmonary class ventilation replacement clamp ventricular ii without endpoints support stage identified undergoing acute minimally renal isolated sufficient ≤ outcomes serum replacement pacing system system patient surgical instability aortic additional previously 90 mis invasive data term days result short bypass requiring standard severe cadence disease edwards healthcare nyha valve cardiac mi elective 200 commercially mechanical respiratory scheduled explore time concomitant 5valve inotropic gather creatinine stenosis benefit sternotomy 17 prior timeedwards
clinictrialf__924,924,medtronic corevalve evolut r u.s. clinical study (evolut 34r addendum),5 implantation gradient transcatheter coronary safety outside chronic years eluting artery within subjects disease mammary following u day aortic 60 30 internal site replacement myocardial stenosis ventricular sites involving stent carotid drug stage addendum acute ventricular significant evolut renal implanted 15 ≤ appropriate clinical armmedtronic pacing studyuntreated system low aortic corevalve mixed controlled days performed end historical revascularization data 10 days patent requiring study severe infarction disease clinically prevents valve independent cardiac lifestyle single left artery states control united medtronic ejection r stenosis stenosisvalve dialysis prior weeks fraction 34r
clinictrialf__925,925,remote ecg monitoring of tavi patients,pacemaker criteriatherapy implantation block child would busy ecg shows grade consent degree plus pre surgery 3rd represent patientslead high common inclusion many awaiting provide cost remote setting lahb including replacement monitoring service tertiary mobile minimally meet surgical called heart new clinical av criteria also replacement early informed valvular intervention pathway surgical pathway rbbb aortic monitoring pilot arrhythmia invasive service tavi mri care diagnostics diseaseremote valve novel cardiac cardiac first exclusion procedure transcatheter within tavi 2nd hospital patients savings
clinictrialf__926,926,impact of clinical care pathway on prognosis and therapeutic medical care of infective endocarditis,impactduke study intervention pacemaker cardiac patients prior endocarditis pathway infective child endocarditis exclusion according led pilot criteria inclusion tavi episode mri care therapeutic medical care surgical clinical new adulttherapy inclusion criteria early prognosis episode
clinictrialf__927,927,medtronic corevalve evolut r u.s. clinical study,5 implantation ii gradient transcatheter coronary safety outside chronic years eluting within subjects approximately disease untreated following u day aortic 30 250 site class replacement myocardial stenosis ventricular sites involving stent carotid stage durationmedtronic acute ventricular significant evolut renal implanted ≤ appropriate clinical pacing estimated system low aortic corevalve mixed days performed end historical revascularization data 10 days 150 requiring study severe infarction 25 disease clinically prevents nyha valve functional independent 6 cardiac lifestyle left artery take control medtronic studydrug ejection r stenosis stenosisvalve dialysis prior weeks fraction
clinictrialf__928,928,electrophysiologically guided pacing site selection study,transient old episodes delay patient attack normal dysfunction aortic data implantation left pacing atrial site pacing transcatheter right replacement symptomatic months either every anamnestic pacemaker ventricular ra exclusion scheduled consent years signed period selection monitoring model 18 lasting reducing ischemic node last 3 6 undergoes guided years ).electrophysiologically sinus t70 stenosis diameter light informed cardiac studysevere criteriavalve 2 severe expectancy conduction disease inclusion criteria rhythm regarding later version af life
clinictrialf__929,929,this study observes the usage of non-vitamin k antagonist oral anticoagulants (noacs) in elderly patients with a heart rhythm disorder in spain,valvular months ablation patients nvaf least atrial arrhythmia oral cardiovascular noacsprovide rhythm ). noac myocardial elderly characteristics non consent according fibrillation antagonist vitamin anticoagulants treatment high 3 disorder ≥ treatment k written approvedatrial remote years product indication observes spain study 75 heart prior cancer usage patients syndrome informed
clinictrialf__930,930,mitigating the health effects of desert dust storms using exposure-reduction approaches,effect exhaled activity give episodes storm windows months 5 dual week standard us cracks site least sealing eventually cold ). mitigatingleast two storms exclusion 105 ) reduction surgery chronic desert children days intense health effects invasive lead exposure monitoring household asthmatic 6 fractional oxide unscheduled visit possible use stimulation failure nitric oneheart year permanent study tools dust avoid using per icd outdoorsdesert prior criteria one inclusion patients spirometry around upcoming physical approaches af medical
clinictrialf__931,931,beta blocker de-prescription following coronary artery bypass graft surgery (beefburger trial).,hospitalprescription effect syncope index treated graft groups prior supraventricular 6months de standard atrial including angina beta coronary 45 cold strokeheart two artery continuation therapy surgery without 8 questionnaire ).age chronic years fibrillation function invasive lead 18 treatment %) systolic ejection operative ventricular lv within ≥ cabg cabg uncomplicated trial reduced seattle stimulation failure 45 valve bypass ef beefburger isolated care heart clinical university usual royal weeks (≥ assessed following fraction repair versus blocker
clinictrialf__932,932,tricuspid regurgitation study,higher provide give septum months enroll leads pulmonary hypertension aortic implantation left existing placing transcatheter pacing right coronary congenital either regurgitation 200 myocardial replacement pacemaker ventricular mayo exclusion pacemakertricuspid consent sexvalve moderate 12 tr apex post ventricular consent within subjects baseline implant days sinus disease stenosis known studyacute 7 cardiac similar heart whether severe icd infarction tricuspid inclusion criteria clinic 50 eligible assessment following pacing via failure informed
clinictrialf__933,933,surgical implantation of transcatheter valve in native mitral annular calcification (sitral) study,months implantation sitralend york transcatheter complications coronary ). grafting association resulting within failure reported vasoactive pci dialysis associated aortic )  kidney including mitral replacement myocardial ventricular medications stage injury acute ventricular dysfunctionvalve includes subject unplanned renal success heart new pacing native events surgical instability structural 1 calcification invasive ) related tract bypass procedure requiring severe disease bleeding adverse annular study cardiac cardiac dysfunction calcification left outflow right valve artery motionnative success respiratory serious motion concomitant transcatheter 3 cabg reintervention leaflet year reduced stenosis therapeutic dialysis prior infarction graft device
clinictrialf__934,934,finnish registry of transcatheter and surgical aortic valve replacement for aortic valve stenosis: finnvalve registry,eur implantation transcatheter coronary would grafting generation coornary bioprosthesissurgical among plus registry bioprosthesis university pci procedures major failure aortic percutaneous atrial replacement finnish ventricular endocarditis transcathetersurgical without sutureless undergoing acute allow conventional appendagevalve regurgitation isolated heart associated pacing versus registry intervention complementing prior surgical surg aortic revascularization recent stented ) choice tavi primary savr bypass prostheses prostheses severe third nationwide valve cardiac cardiac 4 left finnvalve artery 2012 surgery procedure concomitant cardiothorac j stenosis different hospital turku 10 17 patients second
clinictrialf__935,935,tyrx™ envelope for prevention of infection following replacement with a crt or icd,intervention asymptomatic pacemaker 24 cardiac cardiac months arm transplant ™ surgical tyrx uti child implant replacement months retrospective mechanical without lead control pilot revision 12 incision death planned historical undergoing revisiontyrx envelope icd matched prevention infection implantable within 6 device implant cied bacteriuria armtherapy tavi beginning subjects mri bacterial required contamination electronic ≤ surgical heart generator prior following published replacement early extraction crtheart complication group
clinictrialf__936,936,magnetic stimulation to treat vt storm,effect vt 24 episodes ocular cochlear standard implant cold exclusion surgery chronic stimulationimplanted invasive storm lead ventricular 3 hours magnetic ≥ implanted stimulator device pumps stimulation failure vtheart implanted brain metal assist medication treat inclusion criteria
clinictrialf__937,937,evolut pro china clinical study,intervention pacemaker system 8 arm agreement chinese cardiac team ™ 6months single old 65 70 china child obtain implanting valve national aortic prom ii corevalve exclusion documented ) max studynyha years % pilot 2 calcified administration medtronic pro data endpoint support subjects trialevolut ≥ sievers tavi evolut area primary bicuspid mri product velocitytherapy score 15 ≤ 3 heart estimating clinical surgical centers criteria classification 0 registration type early market valve medical
clinictrialf__938,938,swisstavi registry,performed refuses registrydegenerated native patient probability aims decided devices patients aortic implantation observational transcatheter outcome coronary replacement ventricular group aortic swiss exclusion consecutively cardiovascular requirements include treatment population acute consent ce tavi dataswisstavi bioprosthesis working present registry regurgitation stenosis risk cardiac requiring high severe clinical centers criteria inclusion participatevalve patients syndrome approved pacing valve informed registry
clinictrialf__939,939,vitaflowtm ii transcatheter aortic valve system study,vitaflow system 9 system 8 arm aortic 4 results month 5 ™ single gradient 30 implantation transcatheter including vitaflowtm trial mitral class replacement regurgitation myocardial valve stenosis aortic ventricular chronic ii investigation carotid entire days stage (> 1 yearsvitaflowtm transcatheter controlled historical 7 recent acute 3 acquired within ≥ 4valve across delivery studyassessment introducer stenosis compared renal mean pressure calcific cardiac requiring ≤ implantation severe clinical recommends dialysis infarction +) tricuspid disease prior nyha pacing valve
clinictrialf__940,940,cardiogenic shock intravascular cooling trial,pacemaker ™ child coronary c years 18 intravascular plus ≥ management infusion pressure french 3 4therapy ° 35 pressure 60 access either exchange trialmaintain without thermal therapycardiogenic measured beats preserved femoral catheter ≤ surgical 89 criteria capillary early medical system intervention blood ® achieve maintain ivtm pilot 2 catheter tip target mri care occurs standard care per wedge temperature alone heat fraction unit cardiac pulmonary shock chicago exclusion 7 systolic ejection 3 tavi th temperature years quattro 90mmhg along automatically venous cooling minute approved via age
clinictrialf__941,941,antibiotic prophylaxis based on infective risk in cardiac implantable electronic device,hours pacemaker prophylaxis aortic cardiac patient cardiac others based implantation antibiotic infective intravenous clavulanic received transcatheter including replacement every ventricular antibiotics first therapy exclusion ) 8 ongoing 12 1 upgrade pregnancy administrationcardiac 18 riskexpress mg 600 hours consent eight 450 implantable device years stenosis acid risk continued high electronic followed inabilityvalve severe icd inclusion resynchronization one g criteria pacing informed age group
clinictrialf__942,942,optical tissue identification for myocardial architecture,ecgs defects study vsdheart effect genetic old septal pulmonary dysfunction results pr surgical block standard analyze defect function cold congenital myocardial stenosis exclusion surgery chronic randomized years atrioventricular invasive lead 18 controlled complete abnormal ventricular node interventional confocal baseline pre architectureunderlying muscular sinus stimulation usedoptical renal failure fiberoptic study similar standard tissue common heart abnormalities canal av microscopy conduction procedures criteria progressive patients following syndrome apical interval postoperative identification identify associated
clinictrialf__943,943,impact of predilatation between self-expanding valves,implantation transcatheter acurate contrast ). outside nickel eluting (> rates grade within ≥ et 70 silesian may aortic vessel 30 valves replacement predilatation stenosis ventricular perspective whereas ii vertebral stent ) time 7valve boston conventional toutouzas mm media success ≤ pacing system intervention impactdrug access poland surgical 6mm transfemoral center symptomatic aortic athens days performed self tavi greece aorta severe defined disease center prevents valve independent cardiac lifestyle euroscore neotm al valve artery participating scientific 43 hospital 3 ascending neo diameter stenosis neo naval insufficiency prior tricuspid change valveexpanding device
clinictrialf__944,944,prospective european multicenter study on aortic valve replacement: (e-avr registry),cad implantation transcatheter epatients savs consecutively ) consent treatment referred arrest european cut help circulatory lab central statistical aortic percutaneous mitral replacement issues ventricular without current physicians undergoing labprospective prosthetic regurgitation might laboratory isolated criteria associated regarding cad postoperative pacing informed registry statistic patient surgical observational pure similarly aortic damage dysfunction surgeryvalve core neurological external open requiring multicenter severe root valve study independent aetiology precluding controversial cardiac dysfunction cardiac tavr surgery procedure exclusion concomitant avr adequate stenosis different endocarditic ± tricuspid alternatives
clinictrialf__945,945,prolonged continuous ecg monitoring prior to transcatheter aortic valve implantation,precluding prolonged pacemaker aortic cardiac months prior week implantation ® least transcatheter implemented including replacement stenosis ventricular aortic using accepted procedure yearly monitoring ecg post logistic 1 specific transcatheter within monitoring implantationsevere prospective cardiostat 3 continuous urgent registry tavi year stenosis measures permanent therapeutic heart severe reasons thereafterprolonged prior inclusion criteria patients upon week teamvalve pacing follow valve device
clinictrialf__946,946,electromagnetic interference and automobile remote keyless entry in cardiovascular implantable electronic device (cied) patients,manufacture storage 6 sensitivity seconds give automatic months ablation patients 30 old default remote setting least arrhythmia cardiovascular event keyless myocardial capability consent cardiovascular years fibrillation 2 18 high 4atrial capability 3 episode implantable regular device remote triggering cardioverter entry ciedoperate electronic 3 self electromagnetic cancer syndrome interference automobile informed threshold recorders
clinictrialf__947,947,atricure cryoice lesions for persistent and long-standing persistent atrial fibrillation treatment,persistent eliminates longclass york obstructive coronary association ablate 4atrial within ≥ treatment 30 remote known ablation european ehra effectively )  60 tissue atrial cardiovascular lesions myocardial peripheral high ventricular significant occlusive tissue heart new cryoice syndrome system ablation surgerystanding treated rhythm performed arrhythmia disorders 25 connective open days persistent arterial hrs bypass fibrillation iv severe defined standing disease clinically catheterization atricure hypertrophic fraction cardiac patients left arrhythmia artery surgery fibrillation 26 concomitant ejection proportion procedures society cardiomyopathy cancer graft device
clinictrialf__948,948,the dutch asymptomatic mitral regurgitation trial,asymptomatic prevent diseasevalve trialpulmonary aortic pacing dysfunction cardiac also left dimension waiting surgical function kidney transcatheter implantation mitral replacement 45 valve inherently regurgitation ventricular randomised mv exclusion comparing (> end end risks systolic ejection ventricular comparing mmhg lv higher preserved cardiothoracic ventriculardutch trial regurgitation mm stenosis repair diameter valve surgeon ≤ organic severe watchful describe show hypertension criteria 50 future fraction trials early versus expected
clinictrialf__949,949,safety and performance of the accucinch® system,intervention less pacemaker system cardiac withintherapy pulmonary pressure 30 rankin directed preventing ® child constraints access modified fixed coronary mitral defibrillator safety artery pathology therapy carotid causing pilot structural revascularization systolic optimal significant within accucinch performanceuntreated ≥ implantable tavi scale days surgery area guideline failure mri requiring appropriate surgical heart organic disease clinically 4 early cardioverter valve disability medical
clinictrialf__950,950,multi center registry of transcatheter aortic valve replacement in northeast china,echocardiography central discharge system aortic cardiac registration 60 4 percutaneous value implantation registry tavr transcatheter confirmed multiple replacement preliminarily ventricular aortic multi requirements 40 transcatheter 5 ejection consent peak mm ≥ fully area china-- stenosis informed 1valve researchers ≤ 3 severe northeast inclusion criteria centers hg center replacement pacing valve informed medical history criteriatranscatheter
clinictrialf__951,951,comparison of eligible tavi-valves - cohort b,intervention tte routinely pacemaker give cardiac team implantation conference valves least implantationseligible dedicated hct child national aortic pacemaker test via participating ) walk pilot comparisongiven signed performed transthoracic inform b cases consent valves implanted tavi technical written registry transesophageal tavi centertherapy stenosis mri implanted cohort 15 2 surgical heart severe clinical new echocardiography considered minute early follow informed device
clinictrialf__952,952,perceval sutureless implant versus standard-aortic valve replacement,study available areavalve perceval native aortic 4 60 30 pacing cardiac implantation left international standard york transcatheter including mitral replacement coronary symptomatic valve commercially ventricular aortic sites surgery without according replacementcritical association sutureless randomized days ) planned worldwide ejection sutured ventricular within implant area annulus investigational stenosis enlargement bypass standard multicenter heart severe versus defined size new prior biological graft replacementperceval fraction initial repair valve
clinictrialf__953,953,atrial fibrillation follow-up investigation of rhythm management (affirm),system depending investigation arm nervous arm bleed ablation atrial factors affirmrisk cardiovascular arrhythmia therapyatrial achieve rhythm myocardial affirm national ii elderly control used randomized amiodarone noncentral drug fibrillation atrioventricular rates high therapies node february among 1994 conduction rate target remote choice slow management various strokeatrial step innovative fibrillation heart heart cancer major exclusions following rate initial approved follow women syndrome men
clinictrialf__954,954,antibiotics vs antibiotics and surgical therapy for infective endocarditis,(≈ sided pacemaker class yearsantibiotics impossible child ). 20 vegetation consent among within ≥ sign clear possible surgery disease extracorporeal high deemed vs 85 hours twenty international least class therapy antibiotics current (< 48 ventricular perform surgical heart criteria one early informed intervention mortality surgical circulation cirrhosis pilot %) die open team ie => mri severe defined centers endocarditisleft local valve fraction cardiac pulmonary endocarditis centers infective great surgery exclusion variation ejection case 3 last tavi liver years pugh year 1 10mm patients btherapy age
clinictrialf__955,955,pilot-tart cherry mitral transcriptome and poaf incidence,intervention mvr juices pacemaker diagnosed cardiac cardiac prior cvc elective child mitral transcriptome autoimmune cherry orange 11 surgery years pilot 2 pilotacidic 5 undergoing without poaf ≥ tavi previous cabg surgery like proceduretherapy repair mri ablation juice surgical disease tricuspid clinic also patients tart 80 incidence early repair valve age
clinictrialf__956,956,rheia (randomized research in women all comers with aortic stenosis),attack rheia transient . recovery implantation gradient 1200 calcium • transcatheter coronary female sclerosis velocity (> ischemic within ≥ 4valve main registry pressure major male %randomized aortic worse demonstrated 30 individual replacement % regurgitation unprotected myocardial ventricular research tvt undergoing acute jet risk 57 ≤ acc heart despite comersg replacement pacing versus strategy ): patient active month surgical low survival assistance aortic match 2 1 90 improved prosthesis term open days tavi related arterial score severe infarction bleeding differences +) profile 54 valve au cardiac pulmonary patients endocarditis left long artery mechanical surgery 7 systolic 180 3 avr (- stenosis bacterial patients women
clinictrialf__957,957,forward pro study interventional post-market study with the evolut™ pro system,estimated intervention depending pacemaker system native mortality cardiac 4 deviceforward ™ failure surgical studycombined child replacement symptomatic valve aortic sites europe mechanical without consent pilot post 40 pro may pro representative bioprosthetic obtained 600 interventional legal implanted approximately ≥ tavi written evolut regulatory stenosis risk subjects mri score study added hospital necessitating priortherapy regions assistance heart surgical sts status preexisting early market valve informed
clinictrialf__958,958,medtronic terminate af study,intervention novel maze pacemaker hand fraction cardiac cardiac devices 30 surgical mi left atrial child oral coronary months artery labeling documented expansion surgery procedure pilot fibrillation days include 2 12 concomitant anticoagulants terminate undergoing ejection ventricular within tavi 30 open studyleft cryoflex trial persistent renal product diameter ablation indication bypass requiring mri ≤ held treatmentmedtronic irf redo dialysis heart surgical standing prior relatedtherapy grafting cardioblate early pregnant failure af device paroxysmal
clinictrialf__959,959,norepinephrine infusion during cardiopulmonary bypass,study may perfusion less aortic cardiac cardiac pressure patients cardiopulmonary left index low implantation transcatheter trial long replacement cpb %) ventricular surgery randomized bypasselective time 40 preoperative period controlled resultsnorepinephrine ejection ventricular since endotracheally provided consent higher interventional emergency ventilatorvalve patient written % machine adequate surgery infusion result maintaining stenosis perfusion mean bypass proposed body mass arterial tissue ef severe clinical using intubated another general fraction pacing anesthesia informed male
clinictrialf__960,960,corevalve™ evolut r™ forward study,system geographies may provide native patient practice agreement 60 team ™ mortality surgical 8 centers implantation market studycombined medico contextvalve transcatheter replacement symptomatic forward valve ventricular aortic documented europe mechanical studycorevalve without consent include routine performance bioprosthetic r post consent subjects combined approximately large age ≥ evolut 1000 years economic aortic stenosis implanted cardiac hospital necessitating used heart assistance outcomes severe worldwide preexisting 80 pacing failure valve informed device cohort
clinictrialf__961,961,a two -stage first in human (fih) feasibility   pivotal study of the vienna aortic valve se system,. 5 implantation transcatheter visit coronary two radionuclide phases fih vienna completed ck within ≥ across meet 3 twice human aortic pressure 30 degenerative replacement stenosis ventricular investigation carotid phase ) stage visits first significant pivotal se fih calcific clinical spread visits g 4 pacing extending comprises total v7 > system native active feasibilityuntreated aortic days performed abnormalitiesvalve 90 revascularization thick 6 days 7 requiring study ventriculography severe surveillance conduction disease clinically follow eligibility market valve study normal cardiac must endocarditis months two artery systolic elevation 3 mm protruding stenosis bacterial pa prior patients criteriavienna
clinictrialf__962,962,safety & efficacy study of the medtronic corevalve® system-treatment of symptomatic severe aortic stenosis with significant comorbidities in extreme risk subjects who need aortic valve replacement,enrolledsymptomatic implantation regurgitationvalve transcatheter coronary would within subjects due treatment excluded untreated associated prevent aortic 30 degenerative replacement myocardial ventricular therapy need stage acute significant pivotal area risk predicted renal ≤ 4 replacement pacing irreversible index system surgical ® symptomatic aortic corevalve days performed revascularization efficacy days subjects morbidity procedure requiring severe infarction mortality disease clinically +) valve study extreme cardiac population safetyperipheral artery risk medtronic operative interventional adequate trial senile stenosis perfusion necessitating prior tricuspid 0 comorbidities
clinictrialf__963,963,accelerometer sensing for micra av study,study intervention bearing old pacemaker system cardiac specialist must accel child drugtherapy applicable regulations synchrony ). potentially sensingpregnancy seven chronic micratm released duration implantedmicra consent years necessary 20 test days pilot sample time 18 medtronic model undergo mc1avr1 procedures within approximately target ≥ infection tavi implant cied subjects accelerometer required mri study confounding surgical institution clinical av size per prior micra centers research potential center 12 law early local market total expected
clinictrialf__964,964,safety and efficacy aspects of a standardized stepwise anatomical approach for avnrt ablation,approach sided ii ). ° rates years rao signed remote previous compact disease ablation deliveries et 3 ideal varying al extensions avnrt distributed may slightly 30 cardiovascular myocardial ) consent undergoing acute high node energy aspects success posterior catheter involve tissue av rarely syndrome 80 informed pathway ablation pathway electrogram anatomical tachycardia symptomatic aortic tip 2 rightatrial unsuccessful efficacy sp slow nodal circuit . valve sends towardsstandardized 4 rf arrhythmia two input fibrillation stepwise safety7 like attempt psvt cancer patients lee
clinictrialf__965,965,early valve replacement guided by biomarkers of lv decompensation in asymptomatic patients with severe as,asymptomatic prevent 8 aortic cardiac 4 patients implantation left consider transcatheter guided replacement ventricular aortic would exclusion surgery velocity decompensation 16 require transcatheter undergoing ejection jet enrolment ventricular lv ≥ indexed severe previous area stenosis 15 3 implantation severe biomarkersaortic criteria fractionvalve replacement pacing early valve
clinictrialf__966,966,evaluation of decreased usage of betablockers after myocardial infarction in the swedeheart registry (reduce-swedeheart),ffr followed population ablation normal driven left quick reduce outcome oral obstructive obtained cardiovascular coronary arrhythmia ). myocardial either artery 944 endpoints consent according documented swedish fibrillation 18 systolic ejection allow ventricular inclusion endpoint chosen betablockersstenosis %). undergone preserved evaluation treatment ≥ measures age % written decreased years remote primary related angiography prevention ifr ef beta ≤ new high disease infarction swedeheart 0 usage 50 angiographyatrial fraction regarding regardingmyocardial syndrome cancer informed registry information swedeheart secondary
clinictrialf__967,967,stress echo 2030: the novel abcde-(fglpr) protocol to define the future of imaging,protecting highly converging objectives coronary post doctors regulations 2030novel remote real yet inclusion stress tetralogy selected towards definesuspected cardiovascular myocardial privacy knownatrial academic ) simple high facing se vulnerabilities fglpr clinical new criteria syndrome echo 4 repaired recruit valvular ablation -( strictly protocol outside project abcde relevant fallot specialized primary cardiomyopathy 2 cardiomiopathy disease centers possibly hypertrophic future patients centers arrhythmia artery exclusion problems status fibrillation 3 2030 outlining studies different innovative therapeutic targets imaging cancer hypertrofic
clinictrialf__968,968,long-term results of ddd pacing in obstructive hypertrophic cardiomyopathy,effect hypertrophic obstruction minute results hemodynamic switchedobstructive patients gradient standard following received changes 70 pacing pregnancy cold outflow long ). two negative test surgery continues relieves symptoms years chronic 20 ago ddd invasive modalities longleast lead significant beats lv determine term years stimulation failure tract pressure cardiomyopathy hcm obstructionheart whether improves per lvot patients 4 pacemakers pacing selected gradients
clinictrialf__969,969,echocardiographic predictors of atrial fibrillation,vascular diffusion ambulatory ecg electrocardiogram 18 arteries electromechanical ≥ remote images angiography mr whose echocardiographic attributed small 50 predictors day frequent atrial cardiovascular including fibrillationintracranial either method myocardial ) monitoring high ventricular together targeted images largest percent deep catheter weighted length strain syndrome undergo total vessels periodsechocardiographic cerebral delay ablation monitor measurements penetrating implantable mri luminal using volume conduction fractionatrial septal cardiac must infarcts left index arrhythmia multiple dimension causing intracranial  < fibrillation time ejection simultaneous t2 years 1 stenosis detection atherosclerosis thromboembolism imaging cancer patients via age
clinictrialf__970,970,the value of add-on arrhythmia surgery in patients with atrial fibrillation undergoing cardiac surgery,valvular may generally shorter agents remains patient population cardiac recovery patients ablation relapses wishes admission atrial dutchatrial oral always cardiovascular arrhythmia coronary myocardial valvularatrial persist affects documented chronic surgery anticoagulant dutch fibrillation arrhythmia even specific value almost undergoing results high consent due read written speak percentages add surgery remote enhance sinus might reported informed paroxysmal success fibrillation hospital sick heart untreated addgiven therefore cancer morbidity patients syndrome indeed varying undergo failure af worsen meaningful intended
clinictrialf__971,971,zips study - zip incision approximation vs. suture,effect study provide superior cardiac 4 devices wound surgical latex standard changes closure cold either zip skin method prone exclusion surgery approximation chronic cardiovascular incision 1 yearsheart invasive lead speed 18 complete healing invasive protocol disorder vs implantable zips ) device implant adhesives sutureatrophic year stimulation suture known disorder failure deemed requiring electronic study 3 generator bleeding clinically closurezip criteria closure patients called device affecting
clinictrialf__972,972,comparison of cyanoacrylate tissue adhesive and suture for closure of cardiac device pockets,pacemaker aortic cardiac cardiac implantation transcatheter closure replacement ventricular exclusion scheduled implantationvalve phoenix hospital one suture cyanoacrylate comparison closuremayo clinic stenosis pockets tissue materials deltopectoral severe adhesive region inclusion criteria pacing device
clinictrialf__973,973,valvosoft first-in-human study in severe symptomatic aortic stenosis,month delivering cerebrovascular aortic pacing events cardiac month ultrasound based beam implantation suffering transcatheter mitral related congenital human symptomatic replacement stenosis ventricular aortic valvevalve detect mechanical technology procedure according consent status complex calcified 18 first mobility within leafletssevere ≥ therapy written involving years leaflet disease disruptive stenosis valvosoft implanted procedure overall studysevere restoring heart severe clinical new treat prior tricuspid one patients focused valve informed age
clinictrialf__974,974,strategy of early detection and active management of supraventricular arrhythmia with telecardiology (setam),antithrombotic study pacemaker cardiac active anti ablation groups dual supraventricular arrhythmia telecardiology class practicesupraventricular platelet notifications cardiovascular ). vasc sustained two geographically pacemaker myocardial exclusion technology commonly generation relevant fibrillation provides 2 encountered treatment monitoring setampatients provided high consent detection ≥ remote management therapyatrial specific informed score evia new clinical often sinusal stable another criteria iii inclusion rhythm syndrome cancer early strategy medical chamber associated
clinictrialf__975,975,a study of triple-site ventricular pacing in patients who have not responded to conventional dual ventricular site cardiac resynchronization therapy,study co agents patientsrecent aortic cardiac months outpatient cardiac dual mi scheme implantation randomization site transcatheter including class illness replacement months ventricular therapy according previously 1 (< visits inotropic may previously responded conventional ventricular protocol 6 attend morbid stenosis devicevalve indications 2 crt iv severe resynchronization repeated pacing follow triple
clinictrialf__976,976,transcatheter or surgical aortic valve replacement in all-comers with severe aortic valve stenosis,native aortic pacing cardiac surgical endocarditis implantation transcatheter mitral replacement coronary months valve ventricular artery aortic surgery ) ml concomitant institutional acute 3 significant review within 6 board monthsvalve annulus area disease anemia stenosis aorta bacterial requiring appropriate severe size disease initial comersactive valve
clinictrialf__977,977,assessment of arrhythmias in patients undergoing transcatheter aortic valve implantation using a small insertable cardiac monitoring device,arrhythmiassevere selected system aortic cardiac reveal patient pacing bioprosthesispatients irrespective cardiac implantation insertion icvalve atrial least transcatheter drug replacement symptomatic ). stenosis ventricular aortic using therapy exclusion participating fibrillation ) transcatheter medtronic monitoring undergoing tavi implantable currently institution device tavi stenosis onset prosthesis study implantation severe new evaluating another weeks criteria small linqtm resynchronization 4 assessment inclusion missing insertable valve
clinictrialf__978,978,rheos® pivotal trial,valvular diseasevalve aortic cardiac pulmonary cardiac blood implantation ® kidney ambulatory transcatheter pregnancy cvrx obstructive illness replacement negative ventricular test greater chronic psychological rheos consent structural systolic significant airway pivotal form disease stenosis diastolic pressure cuff hour severe serum trialoffice clinically reactive approved pacing informed
clinictrialf__979,979,the align-ar pivotal trial: jenavalve pericardial tavr aortic regurgitation study,study system aortic )  pacing cardiac pericardial surgical ii implantation tavr regurgitationvalve transcatheter class mitral trial replacement symptomatic regurgitation valve instability studyjenavalve aortic jenavalve using morphology ventricular ethics support performed ) transcatheter inotropic provided invasive ventricular consent pivotal minimally open written use previous device regurgitation prosthetic bicuspid stenosis procedure informed requiring irb tavr help severe alignhemodynamic assist ar treat replacement nyha committee valve designed functional inside
clinictrialf__980,980,the confidence registry,study intervention index 6 pacemaker 8 cardiac active sponsor 4 ™ prior implantation ii endocarditis atrial symptomatic child configuration class implant including aortic exclusion procedure procedureconfidence unicuspid consent pilot portico 2 calcified transcatheter provided 5 data unless registryrespective consent subjects ≥ approximately tavi written 1000 signing annulus registry subject leaflet stenosis confidence mri thrombus approval surgical heart severe clinical improbable criteria center nyha early undergo valve informed 3therapy
clinictrialf__981,981,resuscitative tee collaborative registry,aroundresuscitative initiatives units effect vulnerable tee teams sharing aims patients resuscitative data facilitates setting capture tee standard collaborative cold critically involving exclusion surgery shared chronic partheart standardize collection institutional invasive lead receive 18 ill intensive emergency catalyze registry department years stimulation adult different failure teams care clinical enabling registryroutine make inclusion criteria research following populations open focused strategic
clinictrialf__982,982,response to diaphragmatic pacing in subjects with pompe disease,intervention 6 ventilator phrenic neurx pacemaker activity cardiac pulmonary 4 inspiratory pressure blood implantation pacer diaphragmatic least daystherapy 21 child ventilation exercises pattern breathing tests gaa dependence therapy mechanical respiratory breathing consistingpompe pilot settings tests function 2 levels expiratory forced questionnaire 7 gas conditioning enzyme without invasive spontaneous complete testing stimulation daily magnetic nerve evaluation subjects external support tavi dps disease mri assay arterial surgical severe stimulator insufficiency maximal resting replacement early pacing strengthening responsetraditional diaphragm
clinictrialf__983,983,telestroke for comprehensive transient ischemic attack care in acute stroke ready hospitals,attack transient old diagnosis association years 18 ischemic treatment remote urgent american improves expertisecomprehensive fairview inclusion may telestroke follow individual cardiovascular myocardial inpatient specialist emergent high deliver acute service emergency accepted determine heart neurology clinical available criteria syndrome medical hospitals sub ablation ready guideline rural stroke additional recommendations 18 telestroketreating evaluated consultation primary diagnosisatrial care care per attack effective outcome person arrhythmia exclusion rounding fibrillation include receive areas room evaluation analyses ridges guideline measures hospital whether advice cancer age
clinictrialf__984,984,para-heart pilot implementation,assurance community integrated implantation stratification transcatheter coronary parawake diagnosis ed forest within significantly extensive wake known ).heart inclusion baptist shifts aortic quality implementation ( replacement ventricular without ) paramedicine evaluations time length emergency mobile traumatic towards risk ) objective unstable criteria pacing undergo ems gains system vitals chest efficiency discomfort acs angiography health testing transportation consistent important short reduce care severe healthcare medicine prevalve symptoms less cardiac cardiac multidisciplinary pilot us pain occur leaders exclusion expectancy terminal typically stenosis shorten integrating hospital tools signs projects records missing life
clinictrialf__985,985,subclinical postoperative atrial fibrillation,maze pacemaker 5 address poaf ). vasc duration periodic ecg ≥ remote systemic obvious high 3 4subclinical inclusion af discharge 30 quality atrial cardiovascular including myocardial without consent current form office high considerable infection therombo visits precipitating criteria syndrome postoperative informed active ablation dual activation according 120 days precipitated provides 2 criteriaatrial 90 elapsed anticoagulation detected term mainly morbidity requiring chamber since guidelines factor arrhythmia long sec two every first documented exclusion procedure fibrillationsigned fibrillation post newly c hospital cancer minute recording episode
clinictrialf__986,986,heal-hf: a cardiac resynchronization therapy (crt) outcomes study,study arrhythmiasvalve aortic crtqrs pacing cardiac month implantation left least atrial transcatheter hf including msec class replacement hemodynamics ventricular group qol therapy chronic exclusion symptoms walk 120 fibrillation 1 lead measurements acute obtained lv magnetic best stenosis failure duration ventricle assessed standard angina unstable heal heart outcomes iv severe inclusion resynchronization criteria iii hf echo minute >= nyha uncontrolled responsecardiac placed
clinictrialf__987,987,an exploratory study on the effects of repeat doses of albiglutide compared to exenatide on gastric myoelectrical activity and gastric emptying in type 2 diabetes mellitus subjects,. months affect investigator ). albiglutide chronic medicinal glucose exenatide pump within subjects otherwise remote dl significantly reported effects4 gonadotrophin )  oral cardiovascular myocardial negative proton ) contraceptive 12 function (< high pill protocol combined co 110 g chlorpropamide serum g syndrome eg diabetes chorionic ablation human doses except inhibitorsatrial medications change investigational mellitus compared subjects excluded 2 per disease type gastric myoelectrical study emptying must products arrhythmia repeat activity assessment upper fibrillation include 3 exploratory sodium liver gi prior stable cancer
clinictrialf__988,988,randomized controlled trial of a multiple intervention program to decrease heart failure rehospitalization,effect education estimated program fraction patient cardiac standard intravenous cold trial multiple cognitive making platform center assistance causeheart hospitalization therapy output surgery without leading allowing intervention randomized chronic 40 invasive rehabilitation lead controlled ejection %. diuretic reducing ventricular transferred significant acute interventional consultations perfect treatment rehospitalization directly programleft stimulation readmissions failure computer requiring documents therapeutic cell ≤ optimize reversible heart appointmentsdecrease expectancy phone impairment patients decompensation hospitalized early failure medical life
clinictrialf__989,989,safety and efficacy continued access study of the medtronic corevalve® system in the treatment of symptomatic severe aortic stenosis in very high risk subjects and high risk subjects who need aortic valve replacement,bare study access index prevent extreme system aortic cardiac 30 23mm implantation ® us transcatheter including trial replacement coronary symptomatic myocardial ventricular artery aortic would chronic corevalve need peripheral days performed stage end medtronic safetyuntreated revascularization acute efficacy upon significant interventional within subjects pivotal treatment trialvalve days area tavi completion adequate stenosis risk renal continued perfusion procedure high requiring ≤ severe dialysis infarction disease prior clinically 0 metal enrollment pacing valve mcs
clinictrialf__990,990,safety and efficacy study of the medtronic corevalve® system in the treatment of symptomatic severe aortic stenosis in high risk and very high risk subjects who need aortic valve replacement,bare study index prevent system aortic cardiac months 30 surgical implantation ® transcatheter degenerative including replacement coronary symptomatic myocardial ventricular artery aortic would chronic corevalve need risk stents peripheral days drug performed stage eluting end medtronic safetyuntreated revascularization acute efficacy significant interventional within subjects 6 treatment days adequate area senile stenosis risk renal perfusion metal procedure stentsvalve high requiring ≤ severe dialysis infarction disease prior clinically 0 pacing offered valve placed
clinictrialf__991,991,safety and efficacy study of the medtronic corevalve® system in the treatment of severe symptomatic aortic stenosis in intermediate risk subjects who need aortic valve replacement (surtavi).,study index system aortic cardiac pulmonary safetyperipheral 30 surgical left implantation ® transcatheter obstructive surtavi replacement coronary symptomatic ). myocardial unprotected stenosis aortic would intermediate chronic corevalve ventricular carotid need necessitate days performed stage end artery medtronic acute efficacy interventional within subjects 4valve treatment refused severe days main disease stenosis risk renal procedure score requiring ≤ severe dialysis infarction clinical katz prior disease classification six weeks root pacing valve
clinictrialf__992,992,chloroquine for patients with symptomatic persistent atrial fibrillation: a prospective pilot study,study 24 cardioversion months indicated ablation patients 30 termination pilot atrial arrhythmia defibrillator including mitral cardiovascular symptomatic chloroquinecardiac regurgitation two methods myocardial exclusion consent fibrillation af drug days acceptable structural signed pi administration 7 high continue prospective within remote pharmacological terminating persistent subjectssymptomatic guidelinesatrial practicing agent readouts 15 ablation informed study 2 abuse heart per discretion prior disease criteria potential syndrome weeks cancer role local af
clinictrialf__993,993,managed ventricular pacing (mvp) trial,defibrillator mvp congestive implantation ii york transcatheter chronic chamber trialidcm within coverage use failure af supports may aortic ( atrial pacing class replacement myocardial ventricular ii ) pacingmanaged ventricular send ) heart new managed criteria one pacing anticipated prior national wire signals recent prevent 6 implantable corresponding fibrillation severe infarction action centers research nyha cardioverter fraction cardiac transplant electrical mi association left right settings months two services failurevalve exclusion medicaid states ) united lower without ejection lvef pumping labeling determination decreased stenosis approved device
clinictrialf__994,994,prophylaxis to reduce postoperative atrial fibrillation in cardiac surgery,prophylactic alone hepatic factorial statistical cardiac ablation regression data low observational thyroid atrial arrhythmia chisquare including cardiovascular multiple myocardial x profile stratification surgery exclusion formal ascorbic suggests fibrillation logistic tests medications fibrillationatrial high since exploratory emergency determine open remote effect flutter use disease acid failure side comparisons 2 prophylaxisurgent study whether heart using analyses untreated inclusion criteria cancer syndrome testreduce acid postoperative repair valve tested design
clinictrialf__995,995,cardiovascular registry of atrial fibrillation,antithrombotic followed discontinuation fibrillationleast ablation collected possibility atrial electrographic arrhythmia cardiovascular 24h patientscardiovascular months myocardial laboratory therapy exclusion without fibrillation days signed 1 rates fibrillationatrial high data apart last consent 6 baseline visit ) remote flutter flutter year 15 2 clinical outcomes inclusion criteria cancer records patients rhythm syndrome informed registry
clinictrialf__996,996,analysis in the emergency between transvenous cardiac pacing guided by fluoroscopy versus echocardiogram,fluoroscopy index aortic cardiac pulmonary cardiac signed patients congestion implantation left transcatheter pacing oral guided coronary replacement symptomatic pagewriter months ventricular greater bradicardia consent recruitment planned 18 recruited ejection acute anticoagulation stimulation ecchocardiogram lower subjects approximately echocardiogram analysissystolic syndromes device electrocardiogramtransvenous tc30 ventricle stenosis period arterial pressure mass 150 body criteriavalve severe using inclusion emergency submitted healthcare fraction pacing envisor versus informed philips
clinictrialf__997,997,subcostal temporary extracardiac pacing study,activity . implantation excavatum transcatheter obstructive chronic ecg cause recordings lead ≥ high may diseasevalve 35 valvuloplasty aortic bmi brief pericardial pacing replacement atacor ventricular balloon therapy released ) without fluoroscopic deliver transvenous rate images monitor latent placed new adhesions pacing eventssubcostal system chest prior transfemoral aortic throughout pectus invasive temporary investigational effusions study severe using kg insertion adverse holter extracardiac nyha valve functional cardiac cardiac pulmonary tavr documented lead procedure periods radiation require transcatheter stealthtrac concurrent iv stenosis studyg prior classification
clinictrialf__998,998,thrombolytic therapy versus surgery for obstructive prosthetic valve thrombosis,effect dicle atatürk kars diyarbakır randomization standard obstructive thrombosis nonheart cold relatively two training i̇zmir group faculty surgery exclusion erzurum chronic kafkas thrombosisobstructive regimenthrombolytic invasive lead ersek kosuyolu therapy thrombosis prosthetic stimulation failure different kartal siyami heart university versus inclusion criteria faster tt valve
clinictrialf__999,999,neurotoxicity and cardiotoxicity in total joint arthroplasty,effect study joint vagal since system neuro standard inserted cold pill tests evaluate eye management abilities mayo surgery consent chronic years resonance invasive surgeryheart teststotal 90 lead reflux last coordinator camera magnetic visit stimulator 10 involving days arthroplasty stimulation various described clinic failure deep brain study injury skills thinking past imaging research metal esophageal activities physical document neurotoxicity second cardiotoxicityleast informed revision
clinictrialf__1000,1000,early feasibility study of the neovasc tiara™ mitral valve system,system study system aortic arm neovasc cardiac chest cardiac ™ single surgical implantation transcatheter unsuitable anatomical mitral class replacement symptomatic regurgitation valve ventricular via eligibility surgery exclusion feasibility states risk structure transcatheter united open team delivery regurgitation riskvalve stenosis studyiv requiring high heart severe clinical tiara inclusion criteria iii criterianeovasc prohibitive nyha pacing early failure valve
